{"meta":{"query_hash":"2d921af8bae2","filters":{"venue":"JAMA Oncology"},"cohort_total":219,"direct_labels_cover":4,"predictions_cover":219,"exported":219,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/2d921af8bae2","api":"https://metacan.xera.ac/api/v1/cohort?venue=JAMA+Oncology"},"results":[{"id":"W1480334271","doi":"10.1001/jamaoncol.2015.2239","title":"Effects of a High vs Moderate Volume of Aerobic Exercise on Adiposity Outcomes in Postmenopausal Women","year":2015,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services; University of Alberta; Alberta Cancer Foundation; University of Calgary","funders":"University of Alberta; Alberta Health Services; Eli Lilly and Company","keywords":"Medicine; Body mass index; Aerobic exercise; Waist; Interquartile range; Internal medicine; Breast cancer; Waist–hip ratio; Body fat percentage; Cancer","score_opus":0.013680576565805758,"score_gpt":0.2893089354087831,"score_spread":0.2756283588429774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1480334271","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975063,0.00016537365,0.000008415031,0.00096292817,0.0002996564,0.0004954338,0.000011143348,0.00001670773,0.0005340426],"genre_scores_gemma":[0.99859965,0.000043466356,0.00016438085,0.00054031704,0.000042145086,0.00005951638,0.0000072356734,0.000015054614,0.00052823575],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99898255,0.000084512074,0.00031579036,0.00019019014,0.00017413993,0.00025282684],"domain_scores_gemma":[0.9992239,0.00015135513,0.00015504574,0.00020463047,0.000098424025,0.0001666502],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024004675,0.00013079768,0.0008879697,0.00017169378,0.000009955688,0.0000028120874,0.000080399426,0.00019689191,0.000039822873],"category_scores_gemma":[0.0001320213,0.00010487916,0.000047560115,0.00013868806,0.00008488116,0.000046537578,0.000048958198,0.00020926015,0.000017849881],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.060141746,0.009181475,0.7851157,0.0013139194,0.0005814869,0.0010471395,0.017882556,0.0005639449,0.035067204,0.000881434,0.009620712,0.07860264],"study_design_scores_gemma":[0.013463817,0.0154586,0.95337176,0.00017439095,0.00013325848,0.000012532938,0.00015583949,0.00016328199,0.014920299,0.00042238715,0.0015824777,0.00014136237],"about_ca_topic_score_codex":0.0025289357,"about_ca_topic_score_gemma":0.00016925075,"teacher_disagreement_score":0.16825601,"about_ca_system_score_codex":0.0005680397,"about_ca_system_score_gemma":0.00030683365,"threshold_uncertainty_score":0.42768478},"labels":[],"label_agreement":null},{"id":"W1961570053","doi":"10.1001/jamaoncol.2015.1333","title":"Genomic Profiling","year":2015,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Leukemia and Lymphoma Society; Damon Runyon Cancer Research Foundation; National Cancer Institute; National Science Foundation; Prostate Cancer Foundation; Weill Cornell Medical College; U.S. Department of Defense","keywords":"Humanities; Philosophy; Physics","score_opus":0.020649862484884686,"score_gpt":0.28348847576283914,"score_spread":0.26283861327795444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1961570053","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.032995373,0.008252794,0.00033336086,0.8667103,0.0058280407,0.0010358591,0.0008121298,0.00005969057,0.083972424],"genre_scores_gemma":[0.0015238433,0.0009000147,0.0025611573,0.95367986,0.030158548,0.00012119105,0.0045441175,0.00013216452,0.0063791093],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983632,0.00010611387,0.00031761613,0.0005963084,0.00014472313,0.00047204437],"domain_scores_gemma":[0.99880314,0.00006065166,0.00022548712,0.00060545345,0.00020723275,0.00009806037],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00026458869,0.00029864215,0.0003963054,0.00007607253,0.000049525428,0.00004901999,0.00043789312,0.0022289802,0.000046096335],"category_scores_gemma":[0.00026608218,0.00031252683,0.00015867024,0.00004934828,0.000112276575,0.0000014372288,0.0003579726,0.00096705207,0.00018101558],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005318608,0.000022341661,0.00014170575,0.00003355271,0.00008083582,0.00022129025,0.000015546106,0.000024259547,0.013694995,0.000023388939,0.9805446,0.0051442636],"study_design_scores_gemma":[0.0007236595,0.00067970925,0.00003752895,0.000008178799,0.00006008635,0.000114783405,0.000014544813,0.000013575633,0.0030654566,0.00030221144,0.9946165,0.00036375885],"about_ca_topic_score_codex":0.00004892735,"about_ca_topic_score_gemma":0.000051062932,"teacher_disagreement_score":0.08696953,"about_ca_system_score_codex":0.00026619516,"about_ca_system_score_gemma":0.0015302089,"threshold_uncertainty_score":0.9999327},"labels":[],"label_agreement":null},{"id":"W2020095621","doi":"10.1001/jamaoncol.2015.0387","title":"5α-Reductase Inhibitors and the Risk of Cancer-Related Mortality in Men With Prostate Cancer","year":2015,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont; McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Prostate cancer; Cancer; Hazard ratio; Internal medicine; Proportional hazards model; Cohort; Cohort study; Propensity score matching; Oncology; Retrospective cohort study; Confidence interval","score_opus":0.01920276632136555,"score_gpt":0.32753211426995127,"score_spread":0.30832934794858574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020095621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9764465,0.0078817615,1.7965662e-7,0.012076064,0.0001364477,0.0010931909,0.00008990075,0.000017367622,0.002258565],"genre_scores_gemma":[0.9908033,0.007869839,0.000068551635,0.00030444533,0.00007102501,0.0007269455,0.000013452422,0.000013665998,0.00012879992],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99890506,0.00018484492,0.00030862188,0.00023443064,0.00016185372,0.00020518781],"domain_scores_gemma":[0.9991616,0.00012054682,0.00024690066,0.00019301676,0.00014072607,0.00013721384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005240709,0.00013322315,0.0004745549,0.000055537384,0.000028198272,0.000006629686,0.000044757202,0.00010007718,0.000026505346],"category_scores_gemma":[0.000067692876,0.000070336566,0.000035012632,0.00021226717,0.00035875457,0.000057363017,0.00003951177,0.00022636098,0.0000013965549],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030706949,0.00039249807,0.965922,0.000050750525,0.00052067055,0.00011202026,0.0062574022,0.00012788113,0.000048174927,0.00013542725,0.0032948686,0.020067636],"study_design_scores_gemma":[0.041977435,0.0019541804,0.93679076,0.0002519072,0.0010691462,0.000031691237,0.0016431111,0.00044151035,0.0038883646,0.0007060804,0.011100333,0.00014545096],"about_ca_topic_score_codex":0.02968482,"about_ca_topic_score_gemma":0.007697135,"teacher_disagreement_score":0.038906742,"about_ca_system_score_codex":0.00056189747,"about_ca_system_score_gemma":0.00089878216,"threshold_uncertainty_score":0.9767766},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"agree"},{"id":"W2043881730","doi":"10.1001/jamaoncol.2015.0197","title":"Germline<i>TP53</i>Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry","year":2015,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"National Cancer Institute","keywords":"Medicine; Microsatellite instability; MUTYH; Colorectal cancer; Germline mutation; Family history; Germline; Lynch syndrome; Cancer; Population; Genetic testing; Oncology; Internal medicine; Cancer registry; Genetics; DNA mismatch repair; Mutation; Biology; Microsatellite; Gene; Allele","score_opus":0.019329175602541052,"score_gpt":0.30515829414331114,"score_spread":0.2858291185407701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043881730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878624,0.000569429,0.000012506338,0.004918231,0.00046180576,0.0011280279,0.00014423608,0.000033344262,0.0048700157],"genre_scores_gemma":[0.9957109,0.000066470995,0.00015243344,0.0029208001,0.00014332154,0.00074956904,0.00009837591,0.00003451654,0.00012360429],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982293,0.00025563798,0.00036277412,0.0003530556,0.0003886652,0.00041056584],"domain_scores_gemma":[0.9989622,0.00015128498,0.00018652834,0.0002900873,0.0002666503,0.00014321145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036277145,0.00019182748,0.00040720045,0.00018704179,0.00004352135,0.000018336637,0.00018444043,0.0003425188,0.00003687801],"category_scores_gemma":[0.00021726494,0.00014166757,0.000049145954,0.00070077594,0.00020877297,0.00008499925,0.000045498597,0.00075718726,0.000020248783],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043769027,0.0008555263,0.96210295,0.000029928226,0.00008707735,0.0005685268,0.005321081,0.0010868286,0.0007549915,0.000054680855,0.016414095,0.00834743],"study_design_scores_gemma":[0.013089749,0.0020776184,0.9697005,0.0001539962,0.00011303256,0.000041383464,0.00073586125,0.00013547533,0.0001603717,0.000073665724,0.013535847,0.00018251123],"about_ca_topic_score_codex":0.0060665137,"about_ca_topic_score_gemma":0.021747218,"teacher_disagreement_score":0.015680704,"about_ca_system_score_codex":0.0016070268,"about_ca_system_score_gemma":0.0022310156,"threshold_uncertainty_score":0.99610335},"labels":[],"label_agreement":null},{"id":"W2105956673","doi":"10.1001/jamaoncol.2014.168","title":"Hereditary Diffuse Gastric Cancer Syndrome","year":2015,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":687,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Dr. H. Bliss Murphy Cancer Centre; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Vancouver General Hospital; Occupational Cancer Research Centre; McGill University Health Centre; University of British Columbia; BC Cancer Agency","funders":"National Institute for Health and Care Research; Cancer Research UK","keywords":"Germline mutation; Medicine; Breast cancer; Cancer; Penetrance; CHEK2; Proband; Genetics; Oncology; Mutation; CDH1; Genetic testing; Internal medicine; Biology; Gene","score_opus":0.025806393917823713,"score_gpt":0.2901571075128544,"score_spread":0.2643507135950307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105956673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98504275,0.0030197094,0.00021684713,0.0016533289,0.0014359306,0.00013516434,0.000017363329,0.00003081385,0.008448091],"genre_scores_gemma":[0.9892688,0.0003114924,0.0010045025,0.0020071839,0.0009803525,0.00012976736,0.000113622256,0.0000300594,0.006154225],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989148,0.00007890676,0.00020204048,0.00032681992,0.00015214666,0.00032531287],"domain_scores_gemma":[0.99936056,0.00001530543,0.00008470319,0.00022004751,0.00013541692,0.00018395518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023582217,0.00015529708,0.00019552889,0.000051903113,0.00004601233,0.000017651048,0.00025577063,0.0003043271,0.00019364306],"category_scores_gemma":[0.00008122986,0.00014299616,0.000062102554,0.00012846914,0.00009111117,0.000005982108,0.00015183083,0.00014155051,0.00008647221],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005023176,0.0003393421,0.023297498,0.00002411723,0.0002585885,0.0004026412,0.0002693893,0.0002454922,0.08362861,0.00005687392,0.86177367,0.029201452],"study_design_scores_gemma":[0.0026246682,0.0010177001,0.008733695,0.000017116356,0.00004099631,0.00057223253,0.0001835445,0.000037018555,0.017162183,0.00022644542,0.9690326,0.00035183752],"about_ca_topic_score_codex":0.000084790365,"about_ca_topic_score_gemma":0.00007428618,"teacher_disagreement_score":0.107258886,"about_ca_system_score_codex":0.00012877047,"about_ca_system_score_gemma":0.00061456085,"threshold_uncertainty_score":0.5831214},"labels":[],"label_agreement":null},{"id":"W2148287035","doi":"10.1001/jamaoncol.2015.0735","title":"The Global Burden of Cancer 2013","year":2015,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":2758,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of British Columbia; University of Toronto; Health Canada; University of Ottawa","funders":"University of Colorado School of Medicine, Anschutz Medical Campus; National Institute of Environmental Health Sciences; Barts and The London School of Medicine and Dentistry; Wageningen University and Research; Institute of Infection and Immunity; Allergan; Mekelle University; Addis Ababa University; Università di Bologna; National Center of Neurology and Psychiatry; Universitetet i Bergen; Sahlgrenska Akademin; University of Hong Kong; Northwestern University; Universiti Tunku Abdul Rahman; Göteborgs Universitet; Kyung Hee University; National Research University Higher School of Economics; University of Queensland; Public Health Foundation of India; National Heart, Lung, and Blood Institute; Tehran University of Medical Sciences and Health Services; Australian National University; Genentech; University of Oxford; James Cook University; Wellcome Trust; University College London; Istituto di Ricerche Farmacologiche Mario Negri - IRCCS; National Institute for Health and Care Research; University of the Philippines; Institute for Health Metrics and Evaluation; Northumbria University; Faculty of Medicine and Health, University of Sydney; Philipps-Universität Marburg; Health Canada; Harvard University; Jackson State University; Karolinska Institutet; Bill and Melinda Gates Foundation; Rijksuniversiteit Groningen; Faculty of Medicine, University of British Columbia; National Institutes of Health; Regeneron Pharmaceuticals; Arak University of Medical Sciences; U.S. Department of Veterans Affairs","keywords":"Medicine; Cancer; MEDLINE; Internal medicine","score_opus":0.10981261299171613,"score_gpt":0.4293837995996755,"score_spread":0.31957118660795936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148287035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7735809,0.010969654,0.000053770087,0.08266068,0.000953929,0.00025227483,0.000015735923,0.000032972664,0.1314801],"genre_scores_gemma":[0.9954349,0.00043375688,0.00047210316,0.0019320692,0.00069968734,0.000024556899,0.0000024524957,0.000004506391,0.0009959908],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992512,0.000046488753,0.00018019878,0.00010628171,0.00021899596,0.00019687368],"domain_scores_gemma":[0.99925387,0.000065138345,0.00009217481,0.00017707839,0.00027325164,0.00013851633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033004838,0.00006122516,0.00019806687,0.00001142601,0.00003609755,0.0000073481815,0.00013039095,0.000111967944,0.000070757465],"category_scores_gemma":[0.00022300378,0.0000382262,0.00004906554,0.0001366208,0.0001367836,0.00004439065,0.000057733414,0.00011534569,0.00004962503],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015137207,0.000045385295,0.131755,0.000018598737,0.00012982443,0.00011724691,0.00068390876,0.00022991256,0.00025816992,0.005079848,0.5045632,0.35560519],"study_design_scores_gemma":[0.0015151432,0.0007499918,0.02375257,0.000036471625,0.00006425189,0.000084784435,0.0013884438,0.0002819436,0.00014230446,0.0012934526,0.97064185,0.000048814036],"about_ca_topic_score_codex":0.011744754,"about_ca_topic_score_gemma":0.0026359435,"teacher_disagreement_score":0.46607864,"about_ca_system_score_codex":0.0004452698,"about_ca_system_score_gemma":0.00074034306,"threshold_uncertainty_score":0.99483615},"labels":[],"label_agreement":null},{"id":"W2168590528","doi":"10.1001/jamaoncol.2015.103","title":"Active Surveillance in Prostate Cancer","year":2015,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cancer; Prostate cancer; Prostate; MEDLINE; Oncology; Gynecology; Internal medicine","score_opus":0.033394488229505845,"score_gpt":0.34510457709868136,"score_spread":0.3117100888691755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168590528","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018393261,0.004500415,2.3456727e-7,0.9588453,0.0011659982,0.0013938869,0.0005658274,0.000050683582,0.015084349],"genre_scores_gemma":[0.010688765,0.0071603144,0.000111521695,0.96532035,0.0048453575,0.002666139,0.0013929943,0.00010260636,0.0077119465],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979603,0.00019395012,0.00036964956,0.00059544365,0.00029980723,0.000580833],"domain_scores_gemma":[0.9987335,0.00023539556,0.00025992896,0.0003685995,0.00028127158,0.0001212965],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022829467,0.00033996548,0.0010721297,0.0002015247,0.000021918224,0.000016876167,0.00011641566,0.0008888603,0.00028813788],"category_scores_gemma":[0.00010178567,0.00027517608,0.00011200652,0.00021738523,0.00011908535,0.0000643446,0.00007334799,0.0018385759,0.00011330899],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049882376,0.00017583916,0.029801171,0.00016822883,0.00018631405,0.008413534,0.00042340675,0.000003163281,0.000006249537,0.0000025584823,0.8843563,0.07596438],"study_design_scores_gemma":[0.0049962234,0.0011679264,0.032287285,0.00026887702,0.00008298414,0.000103419756,0.000042576867,0.0000062537483,0.00009264437,0.0001388878,0.9605783,0.00023460318],"about_ca_topic_score_codex":0.0016872743,"about_ca_topic_score_gemma":0.0015616632,"teacher_disagreement_score":0.07622199,"about_ca_system_score_codex":0.004249178,"about_ca_system_score_gemma":0.0022998708,"threshold_uncertainty_score":0.99997},"labels":[],"label_agreement":null},{"id":"W2175480754","doi":"10.1001/jamaoncol.2015.4685","title":"PD-L1 Testing in Cancer","year":2015,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":156,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cancer; Oncology; Internal medicine","score_opus":0.12754339395627157,"score_gpt":0.3985948787585825,"score_spread":0.27105148480231095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2175480754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92222416,0.0016896148,0.0000075462012,0.01292841,0.0005428139,0.00017971903,0.0000024280469,0.000037398444,0.06238792],"genre_scores_gemma":[0.9891535,0.000090404545,0.0012554765,0.0073463446,0.00046488913,0.000056828605,0.000004083371,0.000012747876,0.0016157102],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993701,0.000044637927,0.00017793805,0.00013190928,0.00009008239,0.00018531086],"domain_scores_gemma":[0.9995781,0.000101011865,0.00005353067,0.000110217814,0.000077551726,0.00007956524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035562392,0.00006502014,0.00019475016,0.00007624747,0.00001361356,0.0000053999406,0.00005041582,0.00013212644,0.00016823581],"category_scores_gemma":[0.00025442833,0.00005410543,0.000029584946,0.0002527772,0.00005905236,0.000040755993,0.000020868218,0.00016733554,0.000030041949],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003890615,0.00024278185,0.21174966,0.00002934516,0.000048343525,0.0002929324,0.001048976,0.000011894261,0.016858963,0.00003896666,0.040998224,0.7247893],"study_design_scores_gemma":[0.008962834,0.0012892316,0.33545008,0.00009689325,0.000023305278,0.00016992474,0.00043626656,0.0002628586,0.0010124,0.00013398637,0.6520588,0.000103426864],"about_ca_topic_score_codex":0.002656299,"about_ca_topic_score_gemma":0.0010826987,"teacher_disagreement_score":0.72468585,"about_ca_system_score_codex":0.00061178673,"about_ca_system_score_gemma":0.0007012192,"threshold_uncertainty_score":0.40155473},"labels":[],"label_agreement":null},{"id":"W2190282709","doi":"10.1001/jamaoncol.2015.5208","title":"Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNA","year":2015,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":343,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Germline; Genetics; Medicine; Germline mutation; Gene; Cancer; Allele; Mendelian inheritance; Exome sequencing; Biology; Phenotype; Mutation","score_opus":0.030588858083084876,"score_gpt":0.2934010566878006,"score_spread":0.2628121986047157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2190282709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953589,0.00042080868,0.00077510095,0.0003493575,0.00053356733,0.00014471344,0.000031051055,0.000009255305,0.0023772563],"genre_scores_gemma":[0.99138,0.000044498076,0.00587193,0.0018286363,0.0006590788,0.000013898174,0.00009120495,0.000024745696,0.000086026055],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99891335,0.00008243241,0.00028981623,0.0002929701,0.000082129496,0.00033929283],"domain_scores_gemma":[0.99936014,0.00003092765,0.00011572242,0.00023542452,0.00011018418,0.00014759695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039046342,0.00013651937,0.00023104947,0.000068578775,0.00003084424,0.000021699874,0.00016174038,0.00022505042,0.000026277647],"category_scores_gemma":[0.00038895183,0.00014672222,0.00004746864,0.00011668875,0.00005558148,0.0000060707625,0.00017243865,0.00014054062,0.000015880005],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036621053,0.00011826432,0.007550385,0.000011475887,0.000036790574,0.00028861733,0.00028644892,0.003552652,0.98243034,0.00013556734,0.0033035674,0.0019196534],"study_design_scores_gemma":[0.02127841,0.0041133123,0.03527277,0.00008183128,0.00015924753,0.0015778884,0.0025793307,0.030096512,0.5887988,0.0022313348,0.3118471,0.0019634664],"about_ca_topic_score_codex":0.0005053219,"about_ca_topic_score_gemma":0.000750998,"teacher_disagreement_score":0.39363158,"about_ca_system_score_codex":0.00032335462,"about_ca_system_score_gemma":0.0010931471,"threshold_uncertainty_score":0.59831583},"labels":[],"label_agreement":null},{"id":"W2228606564","doi":"10.1001/jamaoncol.2015.5076","title":"Translational Childhood Cancer Genomics","year":2016,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Otorhinolaryngology; Family medicine; MEDLINE; Neurology; Psychiatry","score_opus":0.010100925778794421,"score_gpt":0.26591677338671055,"score_spread":0.25581584760791615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2228606564","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0049646473,0.004463565,0.000514498,0.9726369,0.0023541148,0.00039497312,0.0023519944,0.00001923861,0.012300084],"genre_scores_gemma":[0.0018536734,0.0067307474,0.00068991655,0.93496126,0.048496637,0.00019898172,0.0024395129,0.0001250679,0.004504232],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983307,0.00007686366,0.0003376865,0.00061717303,0.00014638432,0.0004912047],"domain_scores_gemma":[0.9990199,0.00010883688,0.00022051275,0.00044499116,0.00012826233,0.000077471006],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0001202351,0.00032061737,0.00036782998,0.00007457986,0.00007609711,0.0000349866,0.0003970486,0.0020197984,0.00040780893],"category_scores_gemma":[0.0000615654,0.00029071132,0.00023370986,0.000041284606,0.00013515445,0.0000025250683,0.00012539366,0.00065997,0.00008509357],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004535483,0.000026842657,0.00011559799,0.000019023042,0.00017201682,0.000055379325,0.00003364389,0.000017701746,0.007034904,0.000043578602,0.93670547,0.055730484],"study_design_scores_gemma":[0.0011333571,0.00027685193,0.00046597235,0.000021173317,0.00007690581,0.000051279778,0.0000030949852,0.000003197336,0.0022137805,0.00049283827,0.9948605,0.0004011002],"about_ca_topic_score_codex":0.00005589091,"about_ca_topic_score_gemma":0.00019047035,"teacher_disagreement_score":0.058154974,"about_ca_system_score_codex":0.00018086396,"about_ca_system_score_gemma":0.0015810548,"threshold_uncertainty_score":0.9999545},"labels":[],"label_agreement":null},{"id":"W2255009384","doi":"10.1001/jamaoncol.2015.4395","title":"Differing Perspectives on Breast Cancer Chemoprevention—Reply","year":2016,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Medicine; Otorhinolaryngology; Family medicine; Breast cancer; Internal medicine; Psychiatry; Cancer","score_opus":0.006445882364539007,"score_gpt":0.2700140490861776,"score_spread":0.2635681667216386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2255009384","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07120571,0.0038425922,0.00005158067,0.9077432,0.0015133345,0.00049417984,0.00027485847,0.00006415467,0.014810374],"genre_scores_gemma":[0.050202042,0.006993491,0.00015871461,0.85426706,0.043590065,0.0004804686,0.00066460535,0.000275051,0.0433685],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980516,0.00021805167,0.00024281791,0.00078659615,0.0001738101,0.00052712334],"domain_scores_gemma":[0.999013,0.000060603612,0.00022201928,0.0005128993,0.00011282457,0.000078624245],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00013668806,0.00038955687,0.00040941895,0.000097420474,0.00009824677,0.00002812678,0.00032746862,0.002118402,0.00026804217],"category_scores_gemma":[0.00004457621,0.00029040079,0.00031706152,0.00005924265,0.0001730802,0.0000038440494,0.0001596187,0.0011920568,0.00014179664],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022157337,0.000068523055,0.00007024877,0.000045752375,0.00040993167,0.00021158787,0.00006192779,0.0000017154687,0.07503099,0.000022610215,0.8947153,0.029139837],"study_design_scores_gemma":[0.0010809612,0.00066286227,0.0004992311,0.00013315541,0.000085319836,0.00027475815,0.00003635315,0.000001956972,0.011345428,0.00004078618,0.98543864,0.0004005565],"about_ca_topic_score_codex":0.00003016179,"about_ca_topic_score_gemma":0.0000034191464,"teacher_disagreement_score":0.09072333,"about_ca_system_score_codex":0.00024755226,"about_ca_system_score_gemma":0.00024070904,"threshold_uncertainty_score":0.9999548},"labels":[],"label_agreement":null},{"id":"W2283816551","doi":"10.1001/jamaoncol.2015.6113","title":"Association of Pathologic Complete Response to Neoadjuvant Therapy in HER2-Positive Breast Cancer With Long-Term Outcomes","year":2016,"lang":"en","type":"review","venue":"JAMA Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":375,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University; University of Ottawa; BC Cancer Agency; McGill University; University of Calgary; St. Michael's Hospital","funders":"National Cancer Institute","keywords":"Medicine; Breast cancer; Oncology; Internal medicine; Hazard ratio; Neoadjuvant therapy; Randomized controlled trial; Cancer; Clinical trial; Lapatinib; Trastuzumab; Confidence interval","score_opus":0.03141613759811938,"score_gpt":0.362242651247462,"score_spread":0.3308265136493426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2283816551","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.032618694,0.9574559,0.000025601994,0.00525138,0.0002898706,0.0014087601,0.002763915,0.000015536143,0.00017037641],"genre_scores_gemma":[0.0060668453,0.9915193,0.000100036945,0.00063553633,0.00018926042,0.0007927859,0.00017710465,0.00005192591,0.00046725917],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9973752,0.00095538,0.0005005348,0.00059927953,0.000169324,0.00040029368],"domain_scores_gemma":[0.998336,0.00032847282,0.0006799243,0.00036759724,0.00021820047,0.00006980389],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004415181,0.00044639863,0.001699132,0.00015132503,0.00004339144,0.000010005927,0.00026652424,0.0006248417,0.00004373565],"category_scores_gemma":[0.00009381583,0.00026899856,0.0002540635,0.00017643909,0.00010739133,0.000004519847,0.00017044015,0.00018464173,0.000018359668],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026530824,0.00028442268,0.062781446,0.0002611467,0.0011182076,0.0001276324,0.000116532756,8.756306e-7,0.00029316137,0.0000028181616,0.0005588829,0.9318018],"study_design_scores_gemma":[0.0033315518,0.0018040263,0.57900023,0.002861033,0.0002915158,0.00016627541,0.000017020713,2.5951904e-8,0.000052243173,0.000003485925,0.4120407,0.00043190076],"about_ca_topic_score_codex":0.00014489266,"about_ca_topic_score_gemma":0.0011434094,"teacher_disagreement_score":0.9313699,"about_ca_system_score_codex":0.00095868425,"about_ca_system_score_gemma":0.0005932845,"threshold_uncertainty_score":0.9999762},"labels":[],"label_agreement":null},{"id":"W2290458471","doi":"10.1001/jamaoncol.2015.6479","title":"Oncologic Drugs Advisory Committee Recommendations and Approval of Cancer Drugs by the US Food and Drug Administration","year":2016,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Pharmaceutical industry and healthcare","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Advisory committee; Food and drug administration; Family medicine; Drug approval; Clinical trial; Drug; Pharmacology; Internal medicine","score_opus":0.23354803218996642,"score_gpt":0.5189264427589264,"score_spread":0.28537841056895996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2290458471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.76005334,0.0027915195,0.00001804232,0.2298549,0.00070447533,0.0005740212,0.00049301976,0.000045457215,0.005465267],"genre_scores_gemma":[0.9799434,0.004732253,0.00008522976,0.013113769,0.00030991688,0.00024393934,0.00002649934,0.00001686806,0.0015281347],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968093,0.0016689003,0.0005417725,0.00038461472,0.00012679001,0.000468613],"domain_scores_gemma":[0.9961267,0.0028599903,0.00033292748,0.00018985254,0.00014050356,0.00035000892],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015867344,0.00023023326,0.00039034753,0.00006398225,0.0004490213,0.000017300303,0.00025958207,0.00078264193,0.0010104147],"category_scores_gemma":[0.0001728477,0.00014814355,0.000059236627,0.00015645206,0.0010410531,0.00018819499,0.0001675498,0.0012916768,0.000014317976],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009756962,0.0005661633,0.018676518,0.00010909067,0.00023727147,0.0000060747843,0.00227419,0.0000030156455,0.009515736,0.0055427765,0.13726455,0.8248289],"study_design_scores_gemma":[0.0039572516,0.0010206555,0.003382148,0.000042794534,0.00022296137,0.000044549066,0.0014224319,0.00016198333,0.022601081,0.0018792974,0.9650243,0.00024056004],"about_ca_topic_score_codex":0.00009747757,"about_ca_topic_score_gemma":0.00033099833,"teacher_disagreement_score":0.82775974,"about_ca_system_score_codex":0.00018821668,"about_ca_system_score_gemma":0.0003792316,"threshold_uncertainty_score":0.9999028},"labels":[],"label_agreement":null},{"id":"W2395076114","doi":"10.1001/jamaoncol.2016.0732","title":"Analysis of Body Mass Index and Mortality in Patients With Colorectal Cancer Using Causal Diagrams","year":2016,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":184,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Underweight; Body mass index; Colorectal cancer; Population; Hazard ratio; Retrospective cohort study; Internal medicine; Cancer; Cohort study; Surgery; Overweight; Confidence interval","score_opus":0.018779623621373136,"score_gpt":0.3317732007112069,"score_spread":0.3129935770898338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2395076114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992733,0.000035338944,0.00007351685,0.00013513674,0.000076446326,0.00018660803,0.00006345985,0.000005967935,0.00015025274],"genre_scores_gemma":[0.99976397,0.000040430637,0.00003351978,0.000079497346,0.000038453672,0.000013512884,0.0000100656625,0.0000074864683,0.000013077351],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99927,0.000042936095,0.00020279906,0.00018479693,0.00013778801,0.0001616379],"domain_scores_gemma":[0.99954,0.000073120245,0.0001278588,0.00010188229,0.00008221758,0.000074957345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010209009,0.00008412952,0.00046735085,0.00018510559,0.0000134206875,0.0000029498142,0.000028509594,0.00012473017,0.00011889479],"category_scores_gemma":[0.000031702748,0.000050001196,0.000041025083,0.00035768573,0.00014386648,0.00005262073,0.000021991289,0.00008549878,2.3886784e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094090804,0.0001463698,0.9851211,0.000011734603,0.0005545807,0.000015074989,0.000120102006,0.000020202511,0.001617615,0.000008048657,0.000011945958,0.0114323385],"study_design_scores_gemma":[0.003965344,0.0006396867,0.9936852,0.00003243512,0.00073268585,7.2378543e-7,0.0000327975,0.00045225304,0.00021635384,0.000007694,0.0001663606,0.00006845905],"about_ca_topic_score_codex":0.0077125235,"about_ca_topic_score_gemma":0.0152726825,"teacher_disagreement_score":0.01136388,"about_ca_system_score_codex":0.0003514202,"about_ca_system_score_gemma":0.00017887336,"threshold_uncertainty_score":0.9988952},"labels":[],"label_agreement":null},{"id":"W2403998898","doi":"10.1001/jamaoncol.2016.0494","title":"Genomic Alterations in Cell-Free DNA and Enzalutamide Resistance in Castration-Resistant Prostate Cancer","year":2016,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":384,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"National Cancer Institute","keywords":"Enzalutamide; Prostate cancer; Medicine; Interquartile range; Oncology; Internal medicine; Cell-free fetal DNA; Prostate-specific antigen; Cancer; Androgen deprivation therapy; Androgen receptor; Biology; Genetics","score_opus":0.02452938334777873,"score_gpt":0.3308476599576475,"score_spread":0.30631827660986877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2403998898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9604585,0.0033534465,0.0000034559052,0.028866606,0.000088207256,0.00067015487,0.00007924946,0.000014497164,0.006465864],"genre_scores_gemma":[0.986956,0.0025592167,0.0004726403,0.00035006108,0.00010653377,0.00036221877,0.000012959095,0.00001591288,0.009164471],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988305,0.00010402432,0.0002962807,0.0003035322,0.00012514855,0.0003405103],"domain_scores_gemma":[0.99934804,0.00019162262,0.00006382632,0.00022748577,0.00006505114,0.000103996324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002550051,0.00011591332,0.0002565492,0.00019641366,0.0000496671,0.000017999195,0.00007663265,0.000115742,0.00010202865],"category_scores_gemma":[0.000088406356,0.000078222525,0.000023186065,0.00017915937,0.00014267948,0.0001196049,0.000052013103,0.00016475239,0.000011940381],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061733183,0.00044613553,0.17738406,0.00019719337,0.000040657196,0.0011748499,0.00353038,0.0000062859654,0.78191745,0.0011946228,0.0057993177,0.022135701],"study_design_scores_gemma":[0.025833787,0.0008780787,0.88901657,0.0004739781,0.00003775886,0.000022570332,0.00042029304,0.00002667756,0.028409828,0.003397026,0.051241044,0.00024241502],"about_ca_topic_score_codex":0.0005483668,"about_ca_topic_score_gemma":0.03588338,"teacher_disagreement_score":0.7535076,"about_ca_system_score_codex":0.0010308244,"about_ca_system_score_gemma":0.0007970233,"threshold_uncertainty_score":0.98170924},"labels":[],"label_agreement":null},{"id":"W2409177147","doi":"10.1001/jamaoncol.2016.0149","title":"Radical Cystectomy and the Multidisciplinary Management of Muscle-Invasive Bladder Cancer","year":2016,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Otorhinolaryngology; Family medicine; MEDLINE; Neurology; Psychiatry","score_opus":0.019787550496334384,"score_gpt":0.3232224669575325,"score_spread":0.3034349164611981,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2409177147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92035294,0.002742863,0.00015113721,0.04985446,0.00036937091,0.0011681988,0.000041164643,0.000035747264,0.025284138],"genre_scores_gemma":[0.9933621,0.0027743082,0.00052676356,0.000806572,0.00019192071,0.00025811372,0.0000018796259,0.000015119071,0.0020631682],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9991326,0.000099224606,0.0002091622,0.00021977497,0.00014892904,0.00019035439],"domain_scores_gemma":[0.9992385,0.00031417498,0.000085862375,0.00022177442,0.000052492054,0.00008720273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016456927,0.000114720206,0.00033479102,0.000041168892,0.00005356077,0.0000032886956,0.0000783939,0.00011039569,0.00037189364],"category_scores_gemma":[0.000024585614,0.00005172252,0.00007863291,0.00007457325,0.0005547454,0.00003854718,0.00011505584,0.000087902714,0.000017807042],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073457547,0.00076529244,0.02856492,0.00041548695,0.0023370336,0.0008034024,0.002585624,0.0000011445551,0.0069349664,0.005669785,0.0076624183,0.93691415],"study_design_scores_gemma":[0.12140664,0.0029448243,0.75305164,0.0010000269,0.0021440834,0.0003347614,0.001757665,0.000036513375,0.007917595,0.0027447357,0.10634501,0.0003165287],"about_ca_topic_score_codex":0.0001727622,"about_ca_topic_score_gemma":0.000077510726,"teacher_disagreement_score":0.93659765,"about_ca_system_score_codex":0.00013630332,"about_ca_system_score_gemma":0.000155069,"threshold_uncertainty_score":0.40719745},"labels":[],"label_agreement":null},{"id":"W2540613192","doi":"10.1001/jamaoncol.2016.4877","title":"Systemic Therapy for Previously Untreated Advanced <i>BRAF</i>-Mutated Melanoma","year":2016,"lang":"en","type":"review","venue":"JAMA Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University","funders":"","keywords":"Medicine; Hazard ratio; Oncology; Internal medicine; Melanoma; Randomized controlled trial; Meta-analysis; Odds ratio; Confidence interval; Adverse effect; MEK inhibitor; Progression-free survival; Overall survival; Cancer research; MAPK/ERK pathway","score_opus":0.028164773284773216,"score_gpt":0.3337088176855344,"score_spread":0.30554404440076116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2540613192","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007530202,0.9909684,0.00045217815,0.00007403677,0.0009962165,0.0034859183,0.00047481267,0.000076553006,0.0027188715],"genre_scores_gemma":[0.00023328826,0.98971057,0.0004505884,0.00030353453,0.0012252844,0.0021124186,0.0024054989,0.0001673709,0.003391421],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99661624,0.00053572597,0.000913229,0.0010510294,0.00012540157,0.00075836724],"domain_scores_gemma":[0.9976537,0.00024094836,0.0007962295,0.00087017304,0.00023214107,0.00020678276],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00043784516,0.0007244161,0.0020652332,0.00013875026,0.00011177474,0.000034302426,0.00065974455,0.0018404031,0.00006110517],"category_scores_gemma":[0.000213983,0.00049164065,0.0007975041,0.00014768816,0.00010870433,0.0000063590705,0.00014956143,0.00023733685,0.00015529025],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031355736,0.00010214195,0.0000036043382,0.0027655554,0.0004911676,0.00004459466,0.000019172816,2.8906393e-7,0.004647917,0.00011447895,0.009938022,0.9815595],"study_design_scores_gemma":[0.0033322342,0.0034469413,0.0000011759797,0.00270763,0.00025891722,0.0007181592,0.000009556439,7.0186127e-7,0.0011208737,0.000036297344,0.98776436,0.0006031745],"about_ca_topic_score_codex":0.0000066016814,"about_ca_topic_score_gemma":0.000015627398,"teacher_disagreement_score":0.9809563,"about_ca_system_score_codex":0.000190478,"about_ca_system_score_gemma":0.0012295922,"threshold_uncertainty_score":0.99975353},"labels":[],"label_agreement":null},{"id":"W2546973056","doi":"10.1001/jamaoncol.2016.4884","title":"Association of Polymorphisms in <i>FCGR2A</i> and <i>FCGR3A</i> With Degree of Trastuzumab Benefit in the Adjuvant Treatment of ERBB2/HER2–Positive Breast Cancer","year":2016,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute; U.S. Department of Health and Human Services","keywords":"Medicine; Trastuzumab; Internal medicine; Oncology; Breast cancer; Regimen; Cyclophosphamide; Cohort; Cancer; Chemotherapy","score_opus":0.02793474528304624,"score_gpt":0.3318939157411339,"score_spread":0.3039591704580877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2546973056","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9711885,0.0010631984,0.0000065199306,0.024313819,0.000044535118,0.0007416399,0.00032716163,0.0000044635185,0.002310183],"genre_scores_gemma":[0.9976174,0.0014483844,0.000116197865,0.00025389215,0.00006672521,0.00015947058,0.00000618041,0.000017626375,0.0003140823],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982821,0.00024522466,0.00047320852,0.00024829133,0.00042789977,0.00032327182],"domain_scores_gemma":[0.99829406,0.00083710474,0.0003322582,0.00023957816,0.00023269931,0.00006432464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005692937,0.00014942966,0.0007055716,0.00018542317,0.00001528827,0.000002735006,0.000116298936,0.0001997057,0.00009169342],"category_scores_gemma":[0.00006718426,0.000079240825,0.000057062527,0.0003580609,0.0002414685,0.000064724096,0.000027204445,0.00014680577,0.000001267809],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024980595,0.0010770693,0.61506015,0.000062503954,0.00014647689,0.0000697398,0.003012909,0.000003652409,0.023773814,0.000102970414,0.00038248353,0.35381016],"study_design_scores_gemma":[0.0099445665,0.0058112727,0.9570828,0.00058071624,0.0001170373,0.000098436474,0.0004956083,0.000012027896,0.024562027,0.00007899087,0.0011316946,0.0000848032],"about_ca_topic_score_codex":0.010088302,"about_ca_topic_score_gemma":0.024033098,"teacher_disagreement_score":0.35372534,"about_ca_system_score_codex":0.001727168,"about_ca_system_score_gemma":0.0006964933,"threshold_uncertainty_score":0.9965036},"labels":[],"label_agreement":null},{"id":"W2560322684","doi":"10.1001/jamaoncol.2016.5688","title":"Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015","year":2016,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":6310,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Ottawa Hospital; University of British Columbia","funders":"National Heart, Lung, and Blood Institute; Medical Research Council; Audrey and Theodor Geisel School of Medicine at Dartmouth; Norris Cotton Cancer Center; University of California, Irvine; Tehran University of Medical Sciences and Health Services; National Institutes of Health; Western Sydney University; Mekelle University; Universität Ulm; Addis Ababa University; Northumbria University; University of Gondar; National Research University Higher School of Economics; Seoul National University; Universidade do Porto; Universitetet i Tromsø; Baqiyatallah University of Medical Sciences; University of Haifa; Jimma University; Haramaya University; Universitetet i Bergen; Samfundet Folkhälsan; Shiraz University of Medical Sciences; University Of Nigeria Nsukka; Inyuvesi Yakwazulu-Natali; Massachusetts General Hospital; Universidade Federal de Minas Gerais; Wuhan University; National Center for Chronic Disease Prevention and Health Promotion; Jordan University of Science and Technology; Ahmadu Bello University; Fudan University; Universität Bielefeld; Kosin University; Umweltbundesamt; Newcastle University; United Nations Population Fund; Karolinska Institutet; Yonsei University; Pacific Institute for Research and Evaluation; Birzeit University; Trường Đại học Duy Tân; Iran University of Medical Sciences; Curtin University of Technology; Dartmouth College; Centers for Disease Control and Prevention; National Institute on Minority Health and Health Disparities; Jackson State University; Johns Hopkins University; Alborz University of Medical Sciences; National Institute for Health and Care Research; World Health Organization; Shiraz University","keywords":"Medicine; Years of potential life lost; Demography; Cancer; Life expectancy; Population; Cancer registry; Incidence (geometry); Lung cancer; Mortality rate; Gerontology; Environmental health; Surgery; Oncology; Internal medicine","score_opus":0.11305784042264108,"score_gpt":0.4077724964717964,"score_spread":0.29471465604915537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560322684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97828275,0.0014047071,0.000094967516,0.018534502,0.00016743253,0.0009136659,0.00040707548,0.000028082442,0.00016683427],"genre_scores_gemma":[0.9929683,0.0005280027,0.001062868,0.004569413,0.0005190069,0.00024711926,0.00001655396,0.000021050628,0.00006764969],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997791,0.000106120766,0.00048204287,0.0006145502,0.00061206496,0.0003942394],"domain_scores_gemma":[0.99802953,0.00051398634,0.0002236723,0.00028998696,0.0004225204,0.00052029843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061486766,0.00020489324,0.00065222336,0.00005388084,0.00004848005,0.000021576456,0.00017359434,0.00024887524,0.00015044014],"category_scores_gemma":[0.0009174267,0.00016387657,0.00008025169,0.00033573763,0.0009850713,0.0002322253,0.0001875825,0.0001317676,0.0000052591513],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024260012,0.00017344521,0.95561945,0.00012637838,0.0001982391,0.000019072515,0.00024913615,0.00003789976,0.0001758148,0.0005469729,0.020248378,0.0201792],"study_design_scores_gemma":[0.003669052,0.0013556607,0.97501785,0.00034362142,0.00017584497,0.00004111292,0.00031454707,0.000060885824,0.000010473791,0.00072472787,0.018076904,0.00020934567],"about_ca_topic_score_codex":0.009832742,"about_ca_topic_score_gemma":0.017195733,"teacher_disagreement_score":0.019969855,"about_ca_system_score_codex":0.0009233357,"about_ca_system_score_gemma":0.0011665835,"threshold_uncertainty_score":0.99676085},"labels":[],"label_agreement":null},{"id":"W2566317011","doi":"10.1001/jamaoncol.2016.5478","title":"The <i>KRAS</i>-Variant and Cetuximab Response in Head and Neck Squamous Cell Cancer","year":2016,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Institute of Dental and Craniofacial Research; National Cancer Institute","keywords":"Cetuximab; KRAS; Medicine; Oncology; Internal medicine; Head and neck squamous-cell carcinoma; Head and neck cancer; Cancer; Colorectal cancer; Radiation therapy","score_opus":0.020109965153768745,"score_gpt":0.3258279171779345,"score_spread":0.3057179520241658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566317011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88767976,0.00839635,0.0000037978782,0.09817082,0.00021150979,0.00022119135,0.000009613099,0.000016861864,0.005290082],"genre_scores_gemma":[0.98817736,0.005741993,0.000099015226,0.003389878,0.00016723598,0.00008771564,2.8693526e-7,0.00001234607,0.002324199],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99898237,0.00018620523,0.00020088008,0.0002366661,0.00008607933,0.00030780717],"domain_scores_gemma":[0.9983898,0.0012490404,0.000050659128,0.00016118321,0.00004527156,0.00010408973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005346621,0.00011060101,0.00034799168,0.000049188486,0.00011457441,0.0000105673835,0.000047181074,0.0001300239,0.000030337556],"category_scores_gemma":[0.00035333377,0.00005594609,0.000021780665,0.00008580559,0.00023731701,0.000042846157,0.000083584535,0.00015893183,0.0000087435365],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.039281692,0.000590892,0.1188784,0.0001714208,0.000071086266,0.0015848817,0.0060241683,4.2450847e-7,0.068078615,0.00061534496,0.06333679,0.7013663],"study_design_scores_gemma":[0.0108878305,0.0025712687,0.35107332,0.00010021079,0.0000299194,0.00014573749,0.00026671003,0.0000130740455,0.00083316705,0.00012488863,0.6338577,0.00009613742],"about_ca_topic_score_codex":0.00037830893,"about_ca_topic_score_gemma":0.0024928523,"teacher_disagreement_score":0.70127016,"about_ca_system_score_codex":0.00020134554,"about_ca_system_score_gemma":0.00030800115,"threshold_uncertainty_score":0.22814153},"labels":[],"label_agreement":null},{"id":"W2574800639","doi":"10.1001/jamaoncol.2016.6020","title":"Molecular-Based Recursive Partitioning Analysis Model for Glioblastoma in the Temozolomide Era","year":2017,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; University of Calgary","funders":"National Cancer Institute","keywords":"Medicine; Temozolomide; Recursive partitioning; Oncology; Hazard ratio; Proportional hazards model; Internal medicine; Survivin; Immunohistochemistry; Glioblastoma; Multivariate analysis; Glioma; Confidence interval; Cancer research; Radiation therapy; Cancer","score_opus":0.03271598446077441,"score_gpt":0.3546530358862001,"score_spread":0.3219370514254257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2574800639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9519391,0.000097014534,0.0028850017,0.042463806,0.00004995532,0.00060453435,0.00002216423,0.000012762227,0.0019256407],"genre_scores_gemma":[0.9931302,0.000007804854,0.0025733132,0.0034838014,0.00005524047,0.0006779239,0.00004130866,0.000010476668,0.000019894047],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99909943,0.000077945086,0.00020868397,0.00024355832,0.00012485617,0.00024551473],"domain_scores_gemma":[0.9988047,0.00032160908,0.00018045348,0.00052870717,0.000102257516,0.000062312734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034117576,0.00011252736,0.00036558375,0.00018324477,0.00021125928,0.000053803204,0.00016393655,0.00014012933,0.000019291832],"category_scores_gemma":[0.00043341104,0.000077908975,0.00024767395,0.00014484135,0.00008693951,0.000055327946,0.000023004448,0.00013697393,0.000008427744],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007425009,0.01097824,0.46570814,0.00018215376,0.0050898013,0.006116928,0.0064236233,0.2803237,0.009135046,0.043912876,0.024116479,0.14058797],"study_design_scores_gemma":[0.01536273,0.0027651219,0.20051765,0.00008270997,0.0035425061,0.000034995956,0.00033061064,0.7558296,0.011412601,0.0043260874,0.0055498984,0.0002454917],"about_ca_topic_score_codex":0.00007680195,"about_ca_topic_score_gemma":0.0010928012,"teacher_disagreement_score":0.47550586,"about_ca_system_score_codex":0.00017850599,"about_ca_system_score_gemma":0.00017956927,"threshold_uncertainty_score":0.31770357},"labels":[],"label_agreement":null},{"id":"W2586519388","doi":"10.1001/jamaoncol.2016.6728","title":"Correlation of Long-term Results of Imatinib in Advanced Gastrointestinal Stromal Tumors With Next-Generation Sequencing Results","year":2017,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":126,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"National Cancer Institute; U.S. Department of Veterans Affairs","keywords":"Medicine; GiST; Imatinib mesylate; Internal medicine; Imatinib; Oncology; Clinical trial; Clinical endpoint; PDGFRA; Randomized controlled trial; Survival rate; Gastroenterology; Stromal cell","score_opus":0.08707842160318213,"score_gpt":0.35515958213784143,"score_spread":0.2680811605346593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586519388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939097,0.000015816084,0.0005828777,0.0009746283,0.000034910816,0.0005689126,0.000047467056,0.000014514842,0.0038511613],"genre_scores_gemma":[0.97497934,0.000004887431,0.024547022,0.00001355443,0.00008019709,0.000024958168,0.0001929111,0.000014181847,0.0001429541],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982295,0.000115649156,0.000694498,0.0003155184,0.0003180027,0.00032683255],"domain_scores_gemma":[0.99793273,0.00023046213,0.0008659635,0.00047029258,0.00036218826,0.00013838192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054523494,0.00015650717,0.00046613754,0.00017541267,0.00007882694,0.000019835636,0.00013817618,0.00004904779,0.000010853374],"category_scores_gemma":[0.0026454665,0.00012403193,0.0000552947,0.000093952396,0.000260291,0.00024316851,0.000059751495,0.00030789286,0.00000482123],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02813953,0.0007566554,0.75612766,0.0001838463,0.00003687194,0.0041808574,0.0003605748,0.0013544966,0.17595135,0.00009418712,0.00007058214,0.03274338],"study_design_scores_gemma":[0.018041987,0.01737135,0.93659073,0.0014867481,0.00003900506,0.0028760594,0.00020822106,0.008089599,0.015195822,0.00001680594,0.000003338511,0.000080342616],"about_ca_topic_score_codex":0.000676003,"about_ca_topic_score_gemma":0.0015735987,"teacher_disagreement_score":0.18046305,"about_ca_system_score_codex":0.00040727432,"about_ca_system_score_gemma":0.0006650946,"threshold_uncertainty_score":0.5057875},"labels":[],"label_agreement":null},{"id":"W2592294322","doi":"10.1001/jamaoncol.2016.5945","title":"Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases","year":2017,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":529,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Public Health Ontario; University of Toronto; Mount Sinai Hospital","funders":"National Institute of General Medical Sciences; National Human Genome Research Institute; National Health and Medical Research Council; National Center for Advancing Translational Sciences; Medical Research Council; National Heart, Lung, and Blood Institute; Anschutz Medical Campus, University of Colorado; Health Research Council of New Zealand; University of Texas Health Science Center at San Antonio; University of California, San Diego; National Institutes of Health; Bundesministerium für Bildung und Forschung; National Institute for Health and Care Research; Vincent Fairfax Family Foundation; World Health Organization; Wellcome Trust; Cancer Research UK; Morehouse School of Medicine; Johns Hopkins University; National Jewish Health; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; National Institute of Neurological Disorders and Stroke; British Heart Foundation; University of Pittsburgh; University of Minnesota; Brigham and Women's Hospital; Canadian Institutes of Health Research; Cancerfonden; NHLBI Division of Intramural Research; Motor Neurone Disease Association; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Diabetes and Digestive and Kidney Diseases; Temple University; South London and Maudsley NHS Foundation Trust; Deutsche Forschungsgemeinschaft; National Cancer Institute; University of Bristol; GlaxoSmithKline; King's College London; World Cancer Research Fund; American Heart Association","keywords":"Medicine; Telomere; Cancer; Oncology; Internal medicine; Genetics; DNA; Biology","score_opus":0.014487709622223592,"score_gpt":0.3185083507505348,"score_spread":0.30402064112831123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592294322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99544644,0.0012951398,0.0000118247535,0.001774033,0.00020323833,0.00019837634,0.00017058456,0.000018185683,0.00088214834],"genre_scores_gemma":[0.99293786,0.0057364115,0.00017765591,0.00012247752,0.0004348602,0.000016453732,0.000010335466,0.0000126060695,0.0005513226],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991029,0.000056144687,0.00022539195,0.00023697037,0.00016011749,0.00021847291],"domain_scores_gemma":[0.99838555,0.0006301088,0.00044838924,0.00024436327,0.000116951254,0.00017466194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019636488,0.00012062134,0.0004930815,0.00007357159,0.00020522614,0.000026701875,0.00008328213,0.00021187271,0.00003770372],"category_scores_gemma":[0.0014025227,0.00010165732,0.000041432777,0.000040106097,0.00020059188,0.0001200121,0.00008337881,0.00021566018,0.0000053145313],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001198643,0.000054337914,0.8726654,0.000106127,0.00023948353,0.000017047789,0.00022058327,3.2808848e-7,0.00035450872,0.000010986427,0.0012683177,0.12494303],"study_design_scores_gemma":[0.002332053,0.00041151184,0.9873432,0.00008387933,0.00087151886,0.000006100528,0.00010077822,0.00007372987,0.00046593355,0.00009744408,0.008114906,0.00009894622],"about_ca_topic_score_codex":0.0016534311,"about_ca_topic_score_gemma":0.001056332,"teacher_disagreement_score":0.12484408,"about_ca_system_score_codex":0.00012680172,"about_ca_system_score_gemma":0.00017954205,"threshold_uncertainty_score":0.41454655},"labels":[],"label_agreement":null},{"id":"W2607785336","doi":"10.1001/jamaoncol.2017.0502","title":"Association Between <i>SLC16A5</i> Genetic Variation and Cisplatin-Induced Ototoxic Effects in Adult Patients With Testicular Cancer","year":2017,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Hearing, Cochlea, Tinnitus, Genetics","field":"Neuroscience","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency; Princess Margaret Cancer Centre; University of Toronto; BC Children's Hospital; University Health Network; University of British Columbia","funders":"","keywords":"Medicine; Testicular cancer; Interquartile range; Cisplatin; Pharmacogenomics; Internal medicine; Oncology; Odds ratio; Ototoxicity; Chemotherapy; Cancer; Pharmacogenetics; Bioinformatics; Genotype; Pharmacology; Genetics; Biology; Gene","score_opus":0.01883450593665139,"score_gpt":0.29155629906533276,"score_spread":0.2727217931286814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2607785336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972068,0.000008914873,0.0001375199,0.00085936044,0.00031592994,0.00084539445,0.000015356369,0.000034047305,0.0005766919],"genre_scores_gemma":[0.99732435,0.000025916212,0.0013685888,0.00085722323,0.00019738328,0.00011926023,0.000003789367,0.000031185868,0.00007231011],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99796504,0.00036356976,0.00031791962,0.00052817713,0.0003782402,0.0004470329],"domain_scores_gemma":[0.99773204,0.0009778737,0.0005888238,0.00040234937,0.00017261777,0.00012631985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029513935,0.00019209093,0.00033490162,0.00011069406,0.00028751147,0.00014416194,0.00027419053,0.0003525694,0.000010524495],"category_scores_gemma":[0.0063627297,0.0001834958,0.000022698781,0.00014713073,0.00006988159,0.0002036912,0.00015716601,0.00036567464,0.000026227848],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039519582,0.000096977434,0.9350018,0.00003794002,0.000013187395,0.000025683798,0.00044358522,0.00005418006,0.04274465,0.000021716234,0.000054062617,0.021466695],"study_design_scores_gemma":[0.0034756497,0.0006509741,0.97810954,0.00006835034,0.000066785935,0.0000022678294,0.0000033531103,0.0008015897,0.016140638,0.000151558,0.0003227668,0.00020650862],"about_ca_topic_score_codex":0.0005454489,"about_ca_topic_score_gemma":0.00062554155,"teacher_disagreement_score":0.04310776,"about_ca_system_score_codex":0.0005485748,"about_ca_system_score_gemma":0.00020168444,"threshold_uncertainty_score":0.7617242},"labels":[],"label_agreement":null},{"id":"W2613162682","doi":"10.1001/jamaoncol.2017.0751","title":"Associations of Luminal and Basal Subtyping of Prostate Cancer With Prognosis and Response to Androgen Deprivation Therapy","year":2017,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":317,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Genome British Columbia","funders":"","keywords":"Medicine; Prostate cancer; Retrospective cohort study; Androgen deprivation therapy; Oncology; Internal medicine; Prospective cohort study; Prostate; Subtyping; Metastasis; Cancer; Pathology","score_opus":0.03806270671449913,"score_gpt":0.35084125963257196,"score_spread":0.3127785529180728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2613162682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984664,0.0006282078,0.0000035061614,0.013853326,0.000029384488,0.0006427049,0.00007863211,0.0000049777727,0.000095239644],"genre_scores_gemma":[0.99741435,0.0012250636,0.0007928165,0.00028436896,0.000032825086,0.0002064103,0.000008506226,0.000008114595,0.000027530225],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999465,0.000048676888,0.00015130907,0.0001462533,0.000084744184,0.00010403671],"domain_scores_gemma":[0.9992665,0.00012837656,0.00024026229,0.00013039018,0.00017067888,0.00006376565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025390767,0.00006820288,0.0002588202,0.000056610777,0.00008452228,0.000012485518,0.000030896448,0.00005784862,0.0000066910106],"category_scores_gemma":[0.00014299949,0.00005054535,0.000015789608,0.00004405766,0.000112014364,0.000071538685,0.000029018576,0.000047015266,1.743443e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038874778,0.00017278243,0.91514146,0.000027735352,0.00013811282,0.000011318659,0.0016712768,0.0000011139201,0.0071881358,0.00002306335,0.00014735824,0.07159013],"study_design_scores_gemma":[0.0037568037,0.0030737715,0.94922775,0.0001229487,0.00007700391,0.0000070863657,0.000106493804,0.000011580283,0.0419611,0.000034076176,0.001575633,0.00004577271],"about_ca_topic_score_codex":0.0005380592,"about_ca_topic_score_gemma":0.00042479497,"teacher_disagreement_score":0.071544364,"about_ca_system_score_codex":0.00012289858,"about_ca_system_score_gemma":0.0002593177,"threshold_uncertainty_score":0.20611794},"labels":[],"label_agreement":null},{"id":"W2740476111","doi":"10.1001/jamaoncol.2017.2085","title":"Role of Cytotoxic Tumor-Infiltrating Lymphocytes in Predicting Outcomes in Metastatic HER2-Positive Breast Cancer","year":2017,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; University of Ottawa; Ottawa Hospital; Queen's University; University of British Columbia","funders":"","keywords":"Medicine; Lapatinib; Taxane; Trastuzumab; Oncology; Internal medicine; Metastatic breast cancer; Breast cancer; Docetaxel; Tumor-infiltrating lymphocytes; Cancer; Immunotherapy","score_opus":0.01663913112658683,"score_gpt":0.33253364601581675,"score_spread":0.3158945148892299,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740476111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927795,0.0005762086,0.0000019103475,0.0025740208,0.00014477562,0.00041322282,0.00006894592,0.000014440392,0.003427002],"genre_scores_gemma":[0.99854314,0.00012747038,0.00037209902,0.0006858682,0.000077160985,0.00009784082,0.0000053650347,0.000017135215,0.00007389035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99869233,0.000119753066,0.00051156024,0.000231362,0.00015031666,0.00029468417],"domain_scores_gemma":[0.99888694,0.00029029502,0.000429493,0.0002764745,0.00006514405,0.00005162822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052143197,0.00014833857,0.00062918494,0.0001634029,0.0000762401,0.000020761487,0.00016579774,0.000097492295,0.00013696271],"category_scores_gemma":[0.00023215234,0.00012471939,0.0000999939,0.00011011987,0.00019809179,0.0001659065,0.000057186975,0.00021303922,0.000002369192],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019413896,0.0002687596,0.85499644,0.000062851876,0.00013893483,0.0001326975,0.0012517144,0.000012198312,0.082985334,0.000020607671,0.000023462011,0.058165584],"study_design_scores_gemma":[0.00752886,0.0004252565,0.97399235,0.00044826992,0.00004880557,0.00019828691,0.0017211296,0.0006851727,0.014638801,0.00004758206,0.00015833454,0.00010717437],"about_ca_topic_score_codex":0.015794577,"about_ca_topic_score_gemma":0.008967754,"teacher_disagreement_score":0.11899587,"about_ca_system_score_codex":0.00071725284,"about_ca_system_score_gemma":0.0006085735,"threshold_uncertainty_score":0.9907593},"labels":[],"label_agreement":null},{"id":"W2740889547","doi":"10.1001/jamaoncol.2017.2023","title":"Demonstrating Noninferiority of Accelerated Radiotherapy With Panitumumab vs Standard Radiotherapy With Cisplatin in Locoregionally Advanced Squamous Cell Head and Neck Carcinoma—Reply","year":2017,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Oncology; Radiation therapy; Internal medicine; Cisplatin; Panitumumab; Head and neck squamous-cell carcinoma; Head and neck; Stage (stratigraphy); Head and neck cancer; Overall survival; Cetuximab; Chemotherapy; Surgery; Cancer","score_opus":0.02526348135416973,"score_gpt":0.3141709108334444,"score_spread":0.28890742947927467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740889547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8417302,0.0044566765,0.00018368068,0.14809133,0.0001737866,0.0016998085,0.000102858576,0.00005974865,0.0035019168],"genre_scores_gemma":[0.78872496,0.0019945505,0.02413632,0.181631,0.0019003677,0.00032445605,0.0001783012,0.0002504137,0.00085965765],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967702,0.00024250615,0.0007801828,0.0009097332,0.0005387925,0.0007586113],"domain_scores_gemma":[0.9972494,0.0005213899,0.000940347,0.0007047129,0.00043262093,0.00015149274],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034477675,0.00070738356,0.0028682116,0.0002996077,0.00022112242,0.00005542325,0.00026300192,0.0009156655,0.000059850398],"category_scores_gemma":[0.00006498737,0.0005246867,0.000110955494,0.00022351986,0.0007885117,0.00017362999,0.000044653396,0.0022487384,7.856792e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.057464316,0.00077054667,0.67277586,0.003465853,0.0008581932,0.018493578,0.005789285,0.00006828321,0.0061722226,0.000016187176,0.14990398,0.08422171],"study_design_scores_gemma":[0.07255882,0.052259356,0.2623841,0.0022129207,0.00033493523,0.0020099443,0.00031781627,0.00029279903,0.00095377775,0.000014698634,0.6054235,0.0012373254],"about_ca_topic_score_codex":0.0009744629,"about_ca_topic_score_gemma":0.0020225188,"teacher_disagreement_score":0.45551956,"about_ca_system_score_codex":0.00088904187,"about_ca_system_score_gemma":0.0028300544,"threshold_uncertainty_score":0.99972045},"labels":[],"label_agreement":null},{"id":"W2743199111","doi":"10.1001/jamaoncol.2017.2319","title":"Association of Systemic Inflammation and Sarcopenia With Survival in Nonmetastatic Colorectal Cancer","year":2017,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":424,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute","keywords":"Medicine; Sarcopenia; Internal medicine; Body mass index; Cancer; Colorectal cancer; Systemic inflammation; Overweight; Oncology; Inflammation; Surrogate endpoint; Prospective cohort study; Gastroenterology","score_opus":0.029169919706434427,"score_gpt":0.3635976434972987,"score_spread":0.3344277237908643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2743199111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858078,0.00010507478,0.000016386977,0.011420774,0.00014725568,0.0003383208,0.0000061916408,0.00000721871,0.0021510182],"genre_scores_gemma":[0.9986448,0.00025265716,0.0006418735,0.000113759765,0.00009971299,0.00004513643,0.0000056378813,0.000005656412,0.00019074949],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99936914,0.00009184447,0.00021632753,0.00009286767,0.00011442391,0.000115418836],"domain_scores_gemma":[0.9992818,0.00014266395,0.00035371454,0.0000778527,0.000100029036,0.00004388921],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057540566,0.00004773327,0.00028659552,0.000073635834,0.000059126403,0.000011685497,0.0000339064,0.000092566996,0.000035412613],"category_scores_gemma":[0.00021587993,0.00004019846,0.000010302055,0.00003692409,0.000043087464,0.00008852954,0.000016773165,0.00013753802,0.0000034501777],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006162873,0.000043323686,0.97083366,0.00048008986,0.000030207262,0.000025321046,0.0007123105,0.000003145575,0.011498963,0.00020475658,0.00020575132,0.015346165],"study_design_scores_gemma":[0.005814784,0.00041542205,0.9897037,0.0004995582,0.000048327496,0.000040402505,0.0002750057,0.00037683683,0.0013653192,0.000059775706,0.0013559246,0.000044930413],"about_ca_topic_score_codex":0.00054180657,"about_ca_topic_score_gemma":0.003686657,"teacher_disagreement_score":0.018870035,"about_ca_system_score_codex":0.00038791992,"about_ca_system_score_gemma":0.00021118036,"threshold_uncertainty_score":0.20572412},"labels":[],"label_agreement":null},{"id":"W2753140990","doi":"10.1001/jamaoncol.2017.2579","title":"Effect of Modified Vaccinia Ankara–5T4 and Low-Dose Cyclophosphamide on Antitumor Immunity in Metastatic Colorectal Cancer","year":2017,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Academy of Medical Sciences; Cancer Research UK; Wellcome Trust","keywords":"Medicine; Cyclophosphamide; Colorectal cancer; Randomized controlled trial; Internal medicine; Clinical endpoint; Modified vaccinia Ankara; Chemotherapy; Oncology; Vaccinia; Cancer; Gastroenterology","score_opus":0.013369444290487666,"score_gpt":0.3174498981780427,"score_spread":0.30408045388755506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2753140990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897088,0.006631159,0.0000015924973,0.0005055391,0.0009408806,0.00059850886,0.000053028874,0.00002623813,0.0015342786],"genre_scores_gemma":[0.9974082,0.0017728033,0.000014857837,0.00017969907,0.00001909154,0.00012945279,0.000022524544,0.000024263903,0.0004290685],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99708474,0.0015747708,0.0004971115,0.0003348252,0.000042956086,0.00046560372],"domain_scores_gemma":[0.99719507,0.0016753536,0.00048761067,0.00055983046,0.000057760833,0.000024364448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012785681,0.00029654393,0.0009470396,0.00021187901,0.00038055133,0.000030300946,0.0004995245,0.00037520117,0.00025282553],"category_scores_gemma":[0.0008235909,0.00024159237,0.000120102,0.00008918857,0.00062009593,0.00019621375,0.00018926691,0.0006674719,0.000057147558],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03644943,0.00052896945,0.019787837,0.00012472528,0.00040663712,0.00009473136,0.0008479897,0.000019811858,0.8268906,0.00039711402,0.00027742694,0.11417474],"study_design_scores_gemma":[0.011610676,0.0056857523,0.47522274,0.00014425011,0.0000700535,0.000088636225,0.00007086655,0.000022131344,0.50402576,0.00007727658,0.002756984,0.00022486119],"about_ca_topic_score_codex":0.0025980335,"about_ca_topic_score_gemma":0.00030705013,"teacher_disagreement_score":0.4554349,"about_ca_system_score_codex":0.0001276976,"about_ca_system_score_gemma":0.00022544365,"threshold_uncertainty_score":0.9851851},"labels":[],"label_agreement":null},{"id":"W2761031851","doi":"10.1001/jamaoncol.2017.3055","title":"The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level","year":2017,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":2020,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Hospital for Sick Children; SickKids Foundation; University of Manitoba","funders":"Department of Global Health and Population, Harvard T.H. Chan School of Public Health; Johns Hopkins Bloomberg School of Public Health; Rede de Química e Tecnologia; Western Sydney University; Ingham Institute for Applied Medical Research; Uniwersytet Medyczny im. Piastów Slaskich we Wroclawiu; Universität Ulm; Laboratório Associado para a Química Verde; Golestan University of Medical Sciences; National Research University Higher School of Economics; Texas Children's Hospital; Universitetet i Oslo; Universitetet i Bergen; Jimma University; Haramaya University; Seoul National University; Alborz University of Medical Sciences; Mekelle University; Queensland University of Technology; Universität Bielefeld; Public Health Foundation of India; Karolinska Institutet; Yonsei University; All-India Institute of Medical Sciences; Iran University of Medical Sciences; Wuhan University; Jordan University of Science and Technology; Johns Hopkins University; University of Washington; Imperial College London; Inyuvesi Yakwazulu-Natali; Fogarty International Center; Universidade do Porto; Uniwersytet Jagielloński Collegium Medicum; Case Western Reserve University; Tehran University of Medical Sciences and Health Services; Norwegian Institute of Public Health; Centers for Disease Control and Prevention; Jackson State University; Universitetet i Tromsø; Universität Basel; College of Medicine, Seoul National University; Sabin Vaccine Institute","keywords":"Medicine; Years of potential life lost; Life expectancy; Liver cancer; Cancer; Incidence (geometry); Mortality rate; Demography; Disease burden; Standardized mortality ratio; Population; Environmental health; Internal medicine","score_opus":0.1713678529679771,"score_gpt":0.40534369956053434,"score_spread":0.23397584659255724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2761031851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8629529,0.011435789,0.0000016910225,0.1228009,0.00009280803,0.00025577363,0.00018831565,0.0000053131057,0.0022665132],"genre_scores_gemma":[0.9895787,0.006829811,0.00019046223,0.0026899613,0.00019753457,0.000090835194,0.00002423583,0.0000040711816,0.00039436962],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99944836,0.000042815365,0.00010182209,0.00015993412,0.00014516756,0.00010190525],"domain_scores_gemma":[0.99895066,0.0005813185,0.00010660978,0.00018879194,0.00010862908,0.00006398822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013191954,0.00007259749,0.00016534317,0.000009935497,0.0003492121,0.000029074086,0.00009817317,0.000069891605,0.000032780554],"category_scores_gemma":[0.0001510629,0.000037516307,0.000030315408,0.000014912325,0.00035593015,0.000044410797,0.00021644936,0.00005032092,0.000006854925],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011528957,0.00022075872,0.46170446,0.00004446945,0.0009075732,0.00006846393,0.0014101969,0.00001987674,0.0003612829,0.003790879,0.35578072,0.17453842],"study_design_scores_gemma":[0.00111142,0.00016687062,0.88411176,0.000039491555,0.00011878211,0.000011887255,0.00025177829,0.000023392511,0.000021129568,0.0011820595,0.11292454,0.000036908114],"about_ca_topic_score_codex":0.0062020672,"about_ca_topic_score_gemma":0.0015272029,"teacher_disagreement_score":0.4224073,"about_ca_system_score_codex":0.00035576939,"about_ca_system_score_gemma":0.00024234333,"threshold_uncertainty_score":0.93757117},"labels":[],"label_agreement":null},{"id":"W2765953690","doi":"10.1001/jamaoncol.2017.3290","title":"Dose-Response Association of CD8<sup>+</sup> Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer","year":2017,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":404,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Royal Alexandra Hospital; Vancouver General Hospital; Alberta Health Services; University of British Columbia; University of Calgary","funders":"National Center for Advancing Translational Sciences; Cancer Research UK; National Cancer Institute; National Center for Research Resources; Fogarty International Center; Francis Crick Institute","keywords":"Medicine; Tumor-infiltrating lymphocytes; Serous fluid; Oncology; CD8; Internal medicine; Ovarian cancer; Survival analysis; Immunotherapy; Cancer; Immune system; Immunology","score_opus":0.01761508240589437,"score_gpt":0.30840041665345425,"score_spread":0.29078533424755987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765953690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98590386,0.00031879888,0.0000023202956,0.012013783,0.00024759688,0.00028180686,0.00003819201,0.000023476196,0.0011701739],"genre_scores_gemma":[0.9972073,0.00017523304,0.0003315283,0.00078569585,0.00025158483,0.00003643701,0.000010088385,0.000019100431,0.0011830349],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99852836,0.00034475545,0.00039795038,0.00024283651,0.00019909134,0.0002870345],"domain_scores_gemma":[0.99838966,0.00067914446,0.00048646692,0.0002879552,0.000090013156,0.000066763765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015424142,0.00014405132,0.00052534643,0.00011614193,0.00013205007,0.000037953334,0.00013238957,0.0002567724,0.00021109458],"category_scores_gemma":[0.0008054337,0.00013202784,0.00006783303,0.00009780839,0.00013780234,0.00013739019,0.00005221096,0.0001916708,0.000007010498],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034301277,0.00038378083,0.6150511,0.00012464833,0.0004555301,0.00024528604,0.0028564602,0.000057898225,0.26804054,0.000079175305,0.002484518,0.07591982],"study_design_scores_gemma":[0.017487414,0.0008719851,0.9647395,0.00015055823,0.00007792734,0.000056793506,0.00028201964,0.0012657479,0.0059139924,0.00005129246,0.008947015,0.00015575538],"about_ca_topic_score_codex":0.008452123,"about_ca_topic_score_gemma":0.0014236955,"teacher_disagreement_score":0.3496884,"about_ca_system_score_codex":0.001156443,"about_ca_system_score_gemma":0.00071654125,"threshold_uncertainty_score":0.9981507},"labels":[],"label_agreement":null},{"id":"W2770798942","doi":"10.1001/jamaoncol.2017.3776","title":"Association of Ipilimumab With Safety and Antitumor Activity in Women With Metastatic or Recurrent Human Papillomavirus–Related Cervical Carcinoma","year":2017,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":162,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Drug Research and Development; University Hospital; Juravinski Cancer Centre; Princess Margaret Cancer Centre; BC Cancer Agency; Ottawa Hospital; University Health Network","funders":"","keywords":"Medicine; Ipilimumab; Response Evaluation Criteria in Solid Tumors; Internal medicine; Cervical cancer; Oncology; Cancer; Immunotherapy; Clinical trial; Phases of clinical research","score_opus":0.022603644146138538,"score_gpt":0.31995943085534284,"score_spread":0.2973557867092043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2770798942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946479,0.000087289154,0.000005019642,0.0032138124,0.00006216668,0.00041060185,0.000016243137,0.000012097575,0.0015448426],"genre_scores_gemma":[0.99896216,0.0001454032,0.00014467954,0.00016866667,0.000024246621,0.000030597177,0.000005884184,0.000013315704,0.00050507183],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99891335,0.00015466115,0.00027419836,0.00022716697,0.00018291995,0.00024767802],"domain_scores_gemma":[0.99896646,0.00014015671,0.00048116787,0.00026532545,0.00007639725,0.000070478476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061899563,0.00012907459,0.00055990147,0.000086124615,0.00012601638,0.000018054734,0.00008288405,0.00012623983,0.00017120088],"category_scores_gemma":[0.000083013314,0.00008209154,0.000026200662,0.00010540371,0.0002078733,0.00013147332,0.00003692803,0.00025728706,0.0000013034729],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2178663,0.0013579007,0.54520136,0.00037775206,0.0010220879,0.0005090098,0.0033606796,0.0000013396136,0.037417073,0.000065291824,0.00018969072,0.19263148],"study_design_scores_gemma":[0.022023087,0.0074533154,0.9656861,0.00014081788,0.00011990077,0.000080717145,0.0002797508,0.000033663644,0.00093639083,0.000020460822,0.0031180612,0.000107730775],"about_ca_topic_score_codex":0.00069549534,"about_ca_topic_score_gemma":0.0030153892,"teacher_disagreement_score":0.42048472,"about_ca_system_score_codex":0.00085910957,"about_ca_system_score_gemma":0.00030945917,"threshold_uncertainty_score":0.3347596},"labels":[],"label_agreement":null},{"id":"W2770975168","doi":"10.1001/jamaoncol.2017.5029","title":"Vemurafenib for <i>BRAF</i> V600–Mutant Erdheim-Chester Disease and Langerhans Cell Histiocytosis","year":2017,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":405,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"National Cancer Institute","keywords":"Vemurafenib; Medicine; V600E; Langerhans cell histiocytosis; Internal medicine; Progression-free survival; Melanoma; Oncology; Adverse effect; Positron emission tomography; Dermatology; Cancer research; Radiology; Chemotherapy; Disease; Mutation; Metastatic melanoma","score_opus":0.030770526430371405,"score_gpt":0.3246722442241393,"score_spread":0.2939017177937679,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2770975168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.948798,0.00083889614,0.00021196797,0.017315093,0.00043456224,0.00091951346,0.00016819438,0.00005569261,0.031258058],"genre_scores_gemma":[0.9897346,0.000161866,0.0011184496,0.0023465813,0.0002430956,0.00019119638,0.000069597605,0.000030519746,0.006104101],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99907136,0.000023345518,0.00018722608,0.00032534616,0.00010620634,0.00028651083],"domain_scores_gemma":[0.9988885,0.00012198123,0.00014655564,0.0004631882,0.00007062799,0.0003091822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010242762,0.0001653706,0.00036515936,0.000049246708,0.00031266283,0.00005447945,0.00011009636,0.00014968567,0.000084210566],"category_scores_gemma":[0.00020134034,0.0001358591,0.00010368644,0.000020079515,0.00019506394,0.00009742996,0.00006457149,0.0001044044,0.00006529544],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007134652,0.005110798,0.14962932,0.0010974824,0.00076881575,0.0027966287,0.0018899145,0.0000024666015,0.006887501,0.00219223,0.0808091,0.7416811],"study_design_scores_gemma":[0.015906988,0.0014336433,0.07934411,0.000072400944,0.0009927317,0.000062016006,0.000110939785,0.00023927793,0.0008826839,0.00087885186,0.8998377,0.00023869544],"about_ca_topic_score_codex":0.000086939384,"about_ca_topic_score_gemma":0.000076658485,"teacher_disagreement_score":0.81902856,"about_ca_system_score_codex":0.00017927574,"about_ca_system_score_gemma":0.00023059375,"threshold_uncertainty_score":0.5540173},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W2793000264","doi":"10.1001/jamaoncol.2017.5808","title":"Radiographic Progression-Free Survival as a Clinically Meaningful End Point in Metastatic Castration-Resistant Prostate Cancer","year":2018,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health; Active Biotech; Astellas Pharma; Eisai; Ipsen; Clovis Oncology; Advanced Accelerator Applications; Endocyte; Gilead Sciences; Genentech; Valeant Pharmaceuticals International; Sanofi; GlaxoSmithKline; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Prostate cancer; Enzalutamide; Oncology; Internal medicine; Progression-free survival; Clinical endpoint; Clinical trial; Placebo; Discontinuation; Cancer; Chemotherapy; Pathology","score_opus":0.04999381704449428,"score_gpt":0.4252381961655681,"score_spread":0.37524437912107383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793000264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.952628,0.0019436366,0.000008834462,0.027199034,0.00060678954,0.0018158967,0.00006186935,0.000077116034,0.015658788],"genre_scores_gemma":[0.99195313,0.0013984842,0.0027909717,0.001049849,0.00049673615,0.0006364164,0.000065785985,0.000042346743,0.0015663003],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9970662,0.00041114926,0.0007183699,0.000542425,0.0006000032,0.0006618743],"domain_scores_gemma":[0.99808383,0.00049636763,0.00022206317,0.0004789762,0.00040617006,0.00031261402],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001573546,0.00023776774,0.000646412,0.00037312205,0.0001293205,0.000044957753,0.00022545493,0.00019033934,0.0010792601],"category_scores_gemma":[0.0008012327,0.00016959872,0.00014153082,0.00071420544,0.00067721884,0.00014960687,0.00012938539,0.0005333129,0.00007283432],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.053955954,0.0045281844,0.4186831,0.0006048815,0.0015502234,0.00956274,0.01128526,0.000006428438,0.026260927,0.002692898,0.017238934,0.45363045],"study_design_scores_gemma":[0.08998401,0.056817994,0.6564928,0.0019281213,0.0009979408,0.0006874314,0.005782302,0.0007936364,0.009656895,0.016910328,0.15872104,0.0012275028],"about_ca_topic_score_codex":0.00107868,"about_ca_topic_score_gemma":0.004806214,"teacher_disagreement_score":0.45240295,"about_ca_system_score_codex":0.00048020607,"about_ca_system_score_gemma":0.002134392,"threshold_uncertainty_score":0.9998339},"labels":[],"label_agreement":null},{"id":"W2793364080","doi":"10.1001/jamaoncol.2018.0013","title":"Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer","year":2018,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":1812,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"Genentech; Daiichi Sankyo Europe; Gilead Sciences; National Cancer Institute; Sirtex Medical; Five Prime Therapeutics; Ipsen; Eli Lilly and Company; Ono Pharmaceutical; Astellas Pharma; Yakult Honsha; Sanofi; Kyowa Hakko Kirin; MacroGenics; Arog Pharmaceuticals; Pfizer; Incyte; Halozyme; Amgen; Celgene; Bristol-Myers Squibb; AstraZeneca; Chugai Pharmaceutical; Agios Pharmaceuticals","keywords":"Medicine; Pembrolizumab; Internal medicine; Cancer; Cohort; Response Evaluation Criteria in Solid Tumors; Progressive disease; Clinical endpoint; Gastroenterology; Surgery; Disease; Immunotherapy; Clinical trial","score_opus":0.008114240074526269,"score_gpt":0.2647737009068763,"score_spread":0.25665946083235003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793364080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9472523,0.0007408746,0.000051973097,0.048917614,0.00026498473,0.0019453655,0.000031661777,0.000039881554,0.0007553876],"genre_scores_gemma":[0.61172664,0.009715768,0.003272549,0.35600856,0.005303301,0.00053474365,0.0017241603,0.0003761218,0.011338192],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99833256,0.00010343838,0.00044202476,0.00048717202,0.00024321706,0.00039155953],"domain_scores_gemma":[0.99905556,0.00012026269,0.00039224216,0.00024318819,0.000119468605,0.00006930292],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00010743886,0.00032141685,0.0009671493,0.0005404492,0.000034232955,0.000011425886,0.00007450511,0.00042735162,0.00012442187],"category_scores_gemma":[0.00002723762,0.00024600013,0.000055439737,0.00035911982,0.00019835781,0.000083157145,0.000048750877,0.0006185137,0.0000012957374],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018797606,0.00019686694,0.61209023,0.00033537514,0.00029883612,0.00013962046,0.00017557357,0.000008329628,0.0000047284407,0.0000012144988,0.08128508,0.2866665],"study_design_scores_gemma":[0.037586067,0.0054301214,0.77383536,0.0002103228,0.00034109602,0.000015333288,0.000009313161,0.000016659353,0.000003931162,0.0000019843458,0.18242243,0.00012736411],"about_ca_topic_score_codex":0.00023695688,"about_ca_topic_score_gemma":0.00013503706,"teacher_disagreement_score":0.33552563,"about_ca_system_score_codex":0.00047700419,"about_ca_system_score_gemma":0.0001499189,"threshold_uncertainty_score":0.9999992},"labels":[],"label_agreement":null},{"id":"W2800412330","doi":"10.1001/jamaoncol.2018.0211","title":"Hormone Replacement Therapy After Oophorectomy and Breast Cancer Risk Among <i>BRCA1</i> Mutation Carriers","year":2018,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":172,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Sunnybrook Health Science Centre; University of Toronto; Women's College Hospital; Public Health Ontario","funders":"","keywords":"Medicine; Breast cancer; Hazard ratio; Oophorectomy; Ovarian cancer; Prospective cohort study; Internal medicine; Hormone replacement therapy (female-to-male); Gynecology; Family history; Cancer; Proportional hazards model; Oncology; BRCA mutation; Cohort; Cohort study; Obstetrics; Surgery; Hysterectomy; Confidence interval","score_opus":0.006555885125884231,"score_gpt":0.27597025544227166,"score_spread":0.26941437031638743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800412330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931433,0.00334529,0.00031101046,0.0010465893,0.00047972536,0.00030728133,0.00013750985,0.00001737311,0.0012118708],"genre_scores_gemma":[0.99253166,0.0032585722,0.0007586291,0.0016327521,0.001032968,0.0004101332,0.000046461,0.00003115752,0.00029768463],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99879277,0.00014961371,0.00021316051,0.00047032916,0.00011058839,0.00026351633],"domain_scores_gemma":[0.9991971,0.000021180824,0.00015717236,0.0003089134,0.00021642767,0.00009920933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026246835,0.00016767679,0.00016047119,0.000054086457,0.00012920781,0.000031450123,0.00011075796,0.0002895971,0.00017462048],"category_scores_gemma":[0.00003626305,0.00015655112,0.00004963302,0.00011670833,0.00043816218,0.000009885847,0.00008332292,0.00013537545,0.000010552454],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008848138,0.00022702306,0.24689369,0.000020224334,0.000863409,0.00003624618,0.0034274575,0.00010009024,0.19620663,0.000022789076,0.09273612,0.45061818],"study_design_scores_gemma":[0.0054408526,0.0021575554,0.620205,0.0000112070275,0.00007807695,0.00012126877,0.00044988494,0.00017217592,0.07133625,0.00013192641,0.299493,0.0004028009],"about_ca_topic_score_codex":0.00046409373,"about_ca_topic_score_gemma":0.0011071007,"teacher_disagreement_score":0.4502154,"about_ca_system_score_codex":0.00020197885,"about_ca_system_score_gemma":0.000294363,"threshold_uncertainty_score":0.638397},"labels":[],"label_agreement":null},{"id":"W2805212882","doi":"10.1001/jamaoncol.2018.2254","title":"Association of Exercise With Mortality in Adult Survivors of Childhood Cancer","year":2018,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":155,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; University of Alberta","funders":"National Cancer Institute","keywords":"Medicine; Interquartile range; Cancer; National Death Index; Population; Cohort study; Internal medicine; Hazard ratio; Incidence (geometry); Mortality rate; Pediatrics; Confidence interval","score_opus":0.018558042344005526,"score_gpt":0.33453772707503426,"score_spread":0.3159796847310287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2805212882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879553,0.00013643579,0.000016755177,0.005911215,0.00032305875,0.00048545163,0.000051095365,0.00002639689,0.005094341],"genre_scores_gemma":[0.9976777,0.00022494828,0.0005002502,0.0009766442,0.00030361576,0.00004597189,0.000016561331,0.000021664377,0.00023264224],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980048,0.00022856226,0.00068979594,0.00028880645,0.00050336204,0.00028465377],"domain_scores_gemma":[0.9979084,0.00025343813,0.00069696864,0.00036015417,0.0006828562,0.000098163175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010730693,0.00014944207,0.00087124977,0.00015809423,0.000022209199,0.0000031772743,0.0001292318,0.0003012605,0.0002705536],"category_scores_gemma":[0.0005577089,0.00013117549,0.000085797874,0.00046156242,0.00020524979,0.00009242499,0.00004609007,0.00027260266,0.000008114118],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007308076,0.0009158122,0.9824528,0.0002621648,0.00021521447,0.000008169316,0.0071512344,0.00000516899,0.00037081286,0.000120462406,0.001661152,0.006106208],"study_design_scores_gemma":[0.0047449307,0.0013994866,0.9846377,0.0006074903,0.00021812765,0.0000050888602,0.00088164,0.000025838624,0.006008901,0.00011368131,0.0012327447,0.00012439849],"about_ca_topic_score_codex":0.027740903,"about_ca_topic_score_gemma":0.11441385,"teacher_disagreement_score":0.08667295,"about_ca_system_score_codex":0.0004481927,"about_ca_system_score_gemma":0.00075406604,"threshold_uncertainty_score":0.9787335},"labels":[],"label_agreement":null},{"id":"W2808333976","doi":"10.1001/jamaoncol.2018.0775","title":"Association of <i>ERBB</i> Mutations With Clinical Outcomes of Afatinib- or Erlotinib-Treated Patients With Lung Squamous Cell Carcinoma","year":2018,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Afatinib; Medicine; Erlotinib; Oncology; Internal medicine; Lung cancer; Gefitinib; Basal cell; Carcinoma; ErbB; Epidermal growth factor receptor; Cancer","score_opus":0.015937738691310308,"score_gpt":0.3583568929958549,"score_spread":0.34241915430454456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808333976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98722863,0.000015306787,0.00005997767,0.000864293,0.00015616007,0.00086802343,0.000119839024,0.000030148272,0.010657592],"genre_scores_gemma":[0.99317497,0.000003102651,0.003302239,0.00044292214,0.00009352096,0.0000439254,0.00020806675,0.00002664396,0.0027045927],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985223,0.0001295501,0.0005896013,0.00024880876,0.00029123123,0.00021855095],"domain_scores_gemma":[0.9971304,0.0007498606,0.0007366261,0.00024534707,0.0010305145,0.00010728734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017894969,0.00015529181,0.00061097683,0.00010455301,0.00006716441,0.000005461965,0.00006761937,0.0002000631,0.00018793624],"category_scores_gemma":[0.00029294577,0.00009214702,0.00008414437,0.00029517457,0.00020078699,0.00008317002,0.000019985759,0.0001443469,0.000011190565],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018286767,0.0021262502,0.98992604,0.000061371946,0.000395127,0.0000175142,0.001246719,0.000004064389,0.000032473843,0.000020947535,0.0024102498,0.0019305603],"study_design_scores_gemma":[0.018597769,0.011923151,0.9645764,0.000029023166,0.0016983756,0.0000047748854,0.00035050846,0.00003526133,0.0008175279,0.000005263507,0.0018652932,0.00009664866],"about_ca_topic_score_codex":0.0003720424,"about_ca_topic_score_gemma":0.0007850256,"teacher_disagreement_score":0.025349641,"about_ca_system_score_codex":0.00032250426,"about_ca_system_score_gemma":0.0007398013,"threshold_uncertainty_score":0.37576464},"labels":[],"label_agreement":null},{"id":"W2809263049","doi":"10.1001/jamaoncol.2018.1771","title":"Association of Body Mass Index and Age With Subsequent Breast Cancer Risk in Premenopausal Women","year":2018,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":369,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto","funders":"National Institutes of Health; Hellenic Health Foundation; Division of Cancer Epidemiology and Genetics, National Cancer Institute; Umeå Universitet; Medical Research Council; Samfundet Folkhälsan; Graduate School of Public Health, University of Pittsburgh; Karolinska Institutet; National Cancer Institute; University of Toronto; National University of Singapore; University of Oxford; Norges Teknisk-Naturvitenskapelige Universitet; Deutsches Krebsforschungszentrum; University of Pittsburgh; Duke-NUS Medical School; Imperial College London; Universitetet i Oslo; Helsingin Yliopisto; Universiteit Utrecht; World Health Organization; Aarhus Universitet; University of Southern California","keywords":"Medicine; Body mass index; Breast cancer; Oncology; Gynecology; Cancer; Association (psychology); Internal medicine; Obstetrics; Gerontology","score_opus":0.009468008879487547,"score_gpt":0.2933573706393742,"score_spread":0.28388936175988666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809263049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99639106,0.000049199887,0.000016409855,0.0014040391,0.00011283233,0.00021633995,0.000053242093,0.0000104935525,0.0017464102],"genre_scores_gemma":[0.9987009,0.00023100681,0.000059587714,0.00024538575,0.00025346674,0.00004921035,0.0000045075626,0.0000103324,0.00044557115],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99924225,0.000061990315,0.00017678239,0.00015674168,0.00014448004,0.00021777517],"domain_scores_gemma":[0.9994735,0.000051276787,0.00020094002,0.00009599761,0.00010282317,0.000075477365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030466667,0.00007773485,0.000298324,0.000081330065,0.000020397798,0.000005770923,0.00003198494,0.00015131476,0.0002757304],"category_scores_gemma":[0.000033082193,0.000059843023,0.000010930842,0.00013100835,0.00009619576,0.00004894443,0.000018692761,0.00018962259,0.0000021930623],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016025174,0.00009960225,0.9802364,0.000026585047,0.00010096817,0.000030593867,0.0014150521,0.000002271843,0.0039661536,0.000015124203,0.00074284076,0.011761869],"study_design_scores_gemma":[0.0040702876,0.0017161324,0.98246205,0.00003884565,0.000046142522,0.000014991293,0.00026390716,0.00007736305,0.00027094054,0.00006821543,0.010908261,0.000062893865],"about_ca_topic_score_codex":0.0058079874,"about_ca_topic_score_gemma":0.011665659,"teacher_disagreement_score":0.011698975,"about_ca_system_score_codex":0.00138318,"about_ca_system_score_gemma":0.0002532354,"threshold_uncertainty_score":0.8779978},"labels":[],"label_agreement":null},{"id":"W2810247444","doi":"10.1001/jamaoncol.2018.1977","title":"Association of<i>MGMT</i>Promoter Methylation Status With Survival Outcomes in Patients With High-Risk Glioma Treated With Radiotherapy and Temozolomide","year":2018,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":202,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Notre-Dame; Toronto General Hospital; Cancer Care Ontario","funders":"National Cancer Institute","keywords":"Temozolomide; Medicine; Oncology; Glioma; Radiation therapy; Internal medicine; Glioblastoma; Methylation; Cancer research; Gene","score_opus":0.007310149578843544,"score_gpt":0.26220942388373286,"score_spread":0.25489927430488935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810247444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99783164,0.0000440132,0.000032024345,0.0010324767,0.000047551654,0.00073015527,0.000038489557,0.000025618356,0.00021805495],"genre_scores_gemma":[0.99699116,0.00003541797,0.002623274,0.000114748866,0.00004407387,0.00005032193,0.00007287444,0.000027699703,0.000040416886],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986757,0.00021392162,0.00026034383,0.0002887972,0.00028184432,0.00027938795],"domain_scores_gemma":[0.99872833,0.0003092107,0.00037803233,0.00018536704,0.0003073072,0.00009176753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023712944,0.00019144095,0.00064678193,0.00021843884,0.000045722853,0.000014392653,0.0000307763,0.00017589175,0.00003279939],"category_scores_gemma":[0.0000699956,0.00010837551,0.000025112136,0.0003143581,0.0001109748,0.00011851985,0.000010637749,0.00012331514,0.0000022490967],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004285759,0.0012095191,0.9806817,0.000012194468,0.00077209546,0.000044326494,0.00040823233,0.0000052753667,0.00038847895,0.000021648675,0.00006324301,0.012107536],"study_design_scores_gemma":[0.033319924,0.016622802,0.9451328,0.000042803447,0.00035852406,0.000005073616,0.000054477525,0.000027696291,0.0039003014,0.000014162581,0.00040374076,0.00011770857],"about_ca_topic_score_codex":0.0015559457,"about_ca_topic_score_gemma":0.003850252,"teacher_disagreement_score":0.035548903,"about_ca_system_score_codex":0.00057163625,"about_ca_system_score_gemma":0.00009610477,"threshold_uncertainty_score":0.4419425},"labels":[],"label_agreement":null},{"id":"W2810342468","doi":"10.1001/jamaoncol.2018.1812","title":"Tucatinib Combined With Ado-Trastuzumab Emtansine in Advanced <i>ERBB2/HER2</i>-Positive Metastatic Breast Cancer","year":2018,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":165,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Bausch Health (Canada); London Health Sciences Centre; Jewish General Hospital","funders":"","keywords":"Medicine; Trastuzumab emtansine; Trastuzumab; Metastatic breast cancer; Taxane; Internal medicine; Adverse effect; Breast cancer; Pharmacokinetics; Oncology; Pertuzumab; Cancer; Response Evaluation Criteria in Solid Tumors; Capecitabine; Gastroenterology; Pharmacology; Progressive disease; Chemotherapy; Colorectal cancer","score_opus":0.025182949452053863,"score_gpt":0.39367988303731133,"score_spread":0.3684969335852575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810342468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.932335,0.00040425564,0.0001684881,0.03979486,0.0005104773,0.0019408838,0.00019647439,0.00010961136,0.024539918],"genre_scores_gemma":[0.9876527,0.00018845411,0.004045174,0.005353951,0.0005134426,0.00056333054,0.00005509436,0.000086782275,0.0015410371],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9969932,0.00036976812,0.00052181503,0.0006676789,0.0005530389,0.0008945319],"domain_scores_gemma":[0.9976542,0.00052411464,0.00018283055,0.0005234793,0.0007594021,0.0003559607],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000597553,0.00032375872,0.0008998061,0.00029993473,0.00010190244,0.000027153705,0.00025946417,0.00019381143,0.0020930823],"category_scores_gemma":[0.00024414787,0.0002570119,0.00007123583,0.0010043958,0.00072909123,0.00017950199,0.00010457508,0.0008035024,0.00019737238],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06176285,0.0073985797,0.12509087,0.0010619501,0.00126712,0.00644448,0.011533351,0.00008649291,0.03291227,0.0012425234,0.04656032,0.7046392],"study_design_scores_gemma":[0.03933163,0.034757126,0.82554257,0.002024311,0.00040053684,0.0025084186,0.002980037,0.0008116039,0.009208158,0.0003481608,0.08122258,0.0008648823],"about_ca_topic_score_codex":0.001896861,"about_ca_topic_score_gemma":0.012250034,"teacher_disagreement_score":0.70377433,"about_ca_system_score_codex":0.0018917193,"about_ca_system_score_gemma":0.0032712289,"threshold_uncertainty_score":0.9999882},"labels":[],"label_agreement":null},{"id":"W2884733293","doi":"10.1001/jamaoncol.2018.2428","title":"Follow-up Recommendations for Completely Resected Gastroenteropancreatic Neuroendocrine Tumors","year":2018,"lang":"en","type":"review","venue":"JAMA Oncology","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Ottawa; University of Toronto; Health Sciences Centre; Mount Sinai Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Neuroendocrine tumors; MEDLINE; Multidisciplinary approach; General surgery; Oncology; Internal medicine; Intensive care medicine","score_opus":0.14259627281744186,"score_gpt":0.44755826398915516,"score_spread":0.3049619911717133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884733293","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020939638,0.97156644,0.00012536073,0.011349763,0.002425834,0.009242349,0.0009528141,0.00042002098,0.0037080296],"genre_scores_gemma":[0.000027931306,0.9769591,0.0054838555,0.0012772197,0.0018643095,0.002697318,0.0022478292,0.0002732024,0.009169253],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9941619,0.0010251122,0.0016079282,0.0012225795,0.00045772517,0.0015247728],"domain_scores_gemma":[0.99445665,0.002283609,0.00086822815,0.0011617151,0.00060108694,0.0006286988],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032880524,0.00079179456,0.0041069137,0.0009024323,0.00025544723,0.00007558186,0.0007320637,0.000060235598,0.0006542521],"category_scores_gemma":[0.004255167,0.0006579446,0.0010951248,0.00071828935,0.00042806796,0.00017600619,0.00044281184,0.0013837478,0.00043005546],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010409437,0.0004403674,0.000022006827,0.016827518,0.0004483876,0.0045123883,0.000014854954,5.6151666e-8,0.000009893784,0.0001391426,0.40993214,0.5666123],"study_design_scores_gemma":[0.0047572204,0.009044637,0.000011339181,0.006596215,0.0012375871,0.018144535,0.00003304237,0.000016098731,0.000013025579,0.00009846775,0.95974106,0.00030679887],"about_ca_topic_score_codex":0.00004531575,"about_ca_topic_score_gemma":0.00014787655,"teacher_disagreement_score":0.5663055,"about_ca_system_score_codex":0.00082393346,"about_ca_system_score_gemma":0.0013003056,"threshold_uncertainty_score":0.9995872},"labels":[],"label_agreement":null},{"id":"W2893903454","doi":"10.1001/jamaoncol.2018.4039","title":"Tenofovir vs Entecavir for Hepatocellular Carcinoma Prevention in Patients With Chronic Hepatitis B","year":2018,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Otorhinolaryngology; Family medicine; Neurology; Internal medicine; Psychiatry","score_opus":0.019552385490580828,"score_gpt":0.27654457821241896,"score_spread":0.25699219272183815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2893903454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7217835,0.0006123313,0.0003190914,0.2669247,0.0012718879,0.0068583055,0.00037977417,0.00012745635,0.0017229217],"genre_scores_gemma":[0.57559603,0.00047660092,0.0030183173,0.3871949,0.013928902,0.0040874793,0.0063048024,0.00037111767,0.009021838],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964697,0.00027899834,0.0008081455,0.00092934165,0.0005375359,0.00097630016],"domain_scores_gemma":[0.9978303,0.0002814271,0.00051890465,0.0006720869,0.00059290073,0.000104417864],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00033307073,0.00058498076,0.0015404387,0.0004858632,0.00013166414,0.00002566281,0.0002588946,0.0017322697,0.00025495325],"category_scores_gemma":[0.00026816753,0.0005036141,0.00025475363,0.00025830494,0.0003511926,0.00013396709,0.00016449919,0.0015223554,0.00017333007],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053083565,0.00022740917,0.5415275,0.000571478,0.00016717208,0.00045880297,0.00010949571,1.0110725e-7,0.0000071781387,0.0000027580934,0.45154724,0.004850002],"study_design_scores_gemma":[0.0070598563,0.012560683,0.35691038,0.00044936486,0.00029481898,0.000019975309,0.0000019055636,0.0000639437,0.00005587726,0.000055277964,0.62220997,0.00031794672],"about_ca_topic_score_codex":0.0034848629,"about_ca_topic_score_gemma":0.010895706,"teacher_disagreement_score":0.18461715,"about_ca_system_score_codex":0.003150885,"about_ca_system_score_gemma":0.001154991,"threshold_uncertainty_score":0.99974155},"labels":[],"label_agreement":null},{"id":"W2898717093","doi":"10.1001/jamaoncol.2018.4628","title":"Safety and Efficacy of Durvalumab With or Without Tremelimumab in Patients With PD-L1–Low/Negative Recurrent or Metastatic HNSCC","year":2018,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":310,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; National Institute for Health and Care Research","keywords":"Tremelimumab; Durvalumab; Medicine; Internal medicine; Head and neck squamous-cell carcinoma; Tolerability; Oncology; Immunotherapy; Adverse effect; Cancer; Head and neck cancer; Nivolumab; Ipilimumab","score_opus":0.021322078231398343,"score_gpt":0.31950666701340313,"score_spread":0.29818458878200477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898717093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966209,0.00010806427,0.000057017412,0.0006608581,0.000120522025,0.0012154214,0.000028830724,0.0000198761,0.0011685198],"genre_scores_gemma":[0.99587494,0.00014138862,0.0028569961,0.0005764759,0.00006775508,0.00003689537,0.000022582526,0.000028781207,0.0003941987],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99841535,0.0002023527,0.00047427506,0.00034797884,0.0002712812,0.00028877315],"domain_scores_gemma":[0.99870604,0.00037728355,0.00030434428,0.00026178005,0.00025392257,0.00009661275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033815016,0.00021768505,0.00074977416,0.00017163489,0.00005588786,0.00000836715,0.00008500717,0.00010429966,0.00042714656],"category_scores_gemma":[0.00019404537,0.00011458164,0.000039515056,0.0004533385,0.0006617668,0.00009258524,0.000033472734,0.00020296055,0.0000052214978],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6839135,0.0018215758,0.06570114,0.00016255524,0.00057768327,0.00005617364,0.004288066,9.669344e-7,0.000185074,0.000011388111,0.00030684326,0.24297498],"study_design_scores_gemma":[0.11300598,0.059897553,0.8158235,0.00090785895,0.0003147213,0.000081240316,0.0008846591,0.00009561415,0.0008349899,0.0000076280053,0.007909201,0.0002370408],"about_ca_topic_score_codex":0.00025309226,"about_ca_topic_score_gemma":0.0036327613,"teacher_disagreement_score":0.75012237,"about_ca_system_score_codex":0.00032035704,"about_ca_system_score_gemma":0.00066287105,"threshold_uncertainty_score":0.46769553},"labels":[],"label_agreement":null},{"id":"W2904240523","doi":"10.1001/jamaoncol.2018.6012","title":"Assessment of<i>ERBB2</i>/<i>HER2</i>Status in<i>HER2</i>-Equivocal Breast Cancers by FISH and 2013/2014 ASCO-CAP Guidelines","year":2018,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute","keywords":"Medicine; Breast cancer; Oncology; Internal medicine; Fluorescence in situ hybridization; Clinical trial; Cohort; Clinical Oncology; Fish <Actinopterygii>; Cancer; Chromosome; Gene","score_opus":0.013110897557483323,"score_gpt":0.3339736071521035,"score_spread":0.32086270959462015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904240523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9685004,0.0036262267,0.00036140418,0.013054773,0.0009797491,0.00050856307,0.00075704535,0.000034345387,0.01217754],"genre_scores_gemma":[0.98591506,0.0047816546,0.0026935614,0.0051043197,0.00084712025,0.00013199123,0.0002164089,0.000045273315,0.00026459357],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99779105,0.000171379,0.0005566405,0.00067481294,0.0001974357,0.00060868775],"domain_scores_gemma":[0.9987315,0.0000573491,0.0002623367,0.00041656088,0.00036720268,0.00016504098],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032743876,0.00033014143,0.00054272794,0.0000763137,0.00009825833,0.000021166954,0.00022352196,0.00033863238,0.000080843136],"category_scores_gemma":[0.00007653761,0.00030641575,0.0000943744,0.00014466516,0.00065963564,0.000015597552,0.0003112571,0.00016909614,0.000008824533],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006021563,0.0004099425,0.14745525,0.00006466171,0.00044176274,0.000019896588,0.00022666708,0.00003100133,0.07141969,0.00009429008,0.7216908,0.057543922],"study_design_scores_gemma":[0.004933993,0.0016756792,0.3010314,0.00006424749,0.00010594409,0.00014369657,0.00035967538,0.00012412075,0.008590459,0.000072133,0.6824298,0.00046885613],"about_ca_topic_score_codex":0.0057608606,"about_ca_topic_score_gemma":0.013546988,"teacher_disagreement_score":0.15357618,"about_ca_system_score_codex":0.0002953976,"about_ca_system_score_gemma":0.0005875669,"threshold_uncertainty_score":0.9999388},"labels":[],"label_agreement":null},{"id":"W2905463162","doi":"10.1001/jamaoncol.2018.5877","title":"Assessment of Frequency and Reporting of Changes in Cancer Trial Design After Initiation of Patient Accrual","year":2018,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"Vetenskapsrådet; National Natural Science Foundation of China","keywords":"Medicine; Accrual; Clinical trial; Research design; Clinical study design; Oncology; Drug trial; Internal medicine; Statistics; Accounting","score_opus":0.665240267925091,"score_gpt":0.6166713619402905,"score_spread":0.04856890598480046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905463162","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7580357,0.00043122808,0.06208118,0.15052435,0.010227724,0.011623716,0.0015178975,0.000060799342,0.0054974067],"genre_scores_gemma":[0.03180657,0.000114389724,0.9494696,0.015372397,0.002481508,0.00068400556,0.000009361879,0.0000461256,0.000016030584],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9912366,0.003156659,0.004551787,0.00037923126,0.0004305436,0.0002451585],"domain_scores_gemma":[0.94331837,0.046183422,0.009697133,0.00034125333,0.0004291068,0.00003070449],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0070863534,0.00020796513,0.0021730817,0.00022183612,0.000009795385,0.000005087312,0.0001462221,0.0013596485,0.00042699516],"category_scores_gemma":[0.108159445,0.00017519835,0.00011198264,0.00014592282,0.00033426264,0.00003341585,0.00012851348,0.0008049577,2.4465058e-7],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.052616835,0.0063202768,0.02961885,0.02656145,0.0027158153,0.0026895471,0.008801878,0.000010745222,0.006869098,0.012670404,0.42034745,0.43077764],"study_design_scores_gemma":[0.029999496,0.021433398,0.010477248,0.0026796784,0.0010094288,0.00001752275,0.00014570296,0.00010863872,0.005943565,0.92240703,0.005146874,0.0006314178],"about_ca_topic_score_codex":0.00012627235,"about_ca_topic_score_gemma":0.00010516895,"teacher_disagreement_score":0.90973663,"about_ca_system_score_codex":0.00021205882,"about_ca_system_score_gemma":0.00058327534,"threshold_uncertainty_score":0.9999368},"labels":[],"label_agreement":null},{"id":"W2907028960","doi":"10.1001/jamaoncol.2018.5904","title":"Association of Patient Sex With Efficacy of Immune Checkpoint Inhibitors and Overall Survival in Advanced Cancers","year":2019,"lang":"en","type":"review","venue":"JAMA Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":302,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Immunotherapy; Hazard ratio; Meta-analysis; Internal medicine; Randomized controlled trial; Observational study; Clinical trial; Oncology; MEDLINE; Cancer; Confidence interval","score_opus":0.018362684288729527,"score_gpt":0.32044378403258034,"score_spread":0.30208109974385083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907028960","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10541496,0.8919026,4.3649297e-7,0.00016348466,0.00039215595,0.001293661,0.000032333934,0.000007763476,0.00079258654],"genre_scores_gemma":[0.0043141367,0.9949275,0.00009621368,0.000048778522,0.00006547457,0.000052303905,0.0000699898,0.000031667445,0.0003938835],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979614,0.00022080034,0.0010735898,0.00028497103,0.0002457956,0.00021344543],"domain_scores_gemma":[0.997556,0.0004669578,0.001596261,0.0002443887,0.00009767197,0.00003874293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005513769,0.0002397163,0.0022938724,0.00020443599,0.0000102833965,0.0000023898954,0.00006943511,0.00048821108,0.0000379687],"category_scores_gemma":[0.00012792276,0.00017612067,0.00024376798,0.00025307914,0.00008600824,0.00003975018,0.00004229608,0.00037342843,0.000001139509],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025807025,0.00020490366,0.0017510263,0.008724434,0.00069025025,0.00001124707,0.00048573266,0.000004697609,0.00026172405,0.0000048213706,0.0000987222,0.98518175],"study_design_scores_gemma":[0.012374331,0.005002797,0.008336536,0.012592192,0.0008556556,0.000026903954,0.00023885498,0.000003137284,0.00022673454,0.0000020530708,0.96008635,0.00025445595],"about_ca_topic_score_codex":0.0012903893,"about_ca_topic_score_gemma":0.0003978213,"teacher_disagreement_score":0.9849273,"about_ca_system_score_codex":0.0021682358,"about_ca_system_score_gemma":0.0013489731,"threshold_uncertainty_score":0.71819925},"labels":[],"label_agreement":null},{"id":"W2909664909","doi":"10.1001/jamaoncol.2018.6908","title":"Association Between Invasive Lobular Breast Cancer and Mutations in the Mismatch Repair Gene <i>MSH6</i>","year":2019,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Medicine; Otorhinolaryngology; Family medicine; Breast cancer; MEDLINE; Internal medicine; Psychiatry; Cancer","score_opus":0.02186519730483698,"score_gpt":0.29666452917169733,"score_spread":0.27479933186686034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909664909","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3000163,0.0005932431,0.0000025436955,0.69519305,0.00074623746,0.0011183068,0.00041900235,0.000040663843,0.0018706763],"genre_scores_gemma":[0.06698717,0.0007690044,0.0005727473,0.917181,0.008082888,0.00060200936,0.0009862133,0.00009016333,0.004728795],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974686,0.00047201582,0.00049019314,0.00055048615,0.00053536793,0.00048333546],"domain_scores_gemma":[0.99638826,0.002414446,0.0004361862,0.00044302674,0.0002686699,0.000049395527],"candidate_categories":["research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0006337816,0.00030790092,0.0008112788,0.00018822716,0.00006542264,0.00003226591,0.00022328636,0.0020014518,0.00023803937],"category_scores_gemma":[0.00043028465,0.00023971559,0.00015760222,0.00028408034,0.00011279999,0.00005190974,0.00009200557,0.002393598,0.000067402354],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041148825,0.000029567787,0.21221693,0.00020157052,0.00032303907,0.00028002038,0.00080876716,0.0000062857916,0.00017840364,6.842109e-7,0.78413093,0.0017826416],"study_design_scores_gemma":[0.0017344052,0.00040456082,0.30956507,0.0001411223,0.0008314401,0.00028020874,0.00012427196,0.00001146887,0.0001374694,0.00012102963,0.6864148,0.00023417102],"about_ca_topic_score_codex":0.0008614805,"about_ca_topic_score_gemma":0.0008867175,"teacher_disagreement_score":0.23302913,"about_ca_system_score_codex":0.002250146,"about_ca_system_score_gemma":0.0013065363,"threshold_uncertainty_score":0.9999079},"labels":[],"label_agreement":null},{"id":"W2914132252","doi":"10.1001/jamaoncol.2018.6631","title":"Methodology Flaws and Implications of a Complementary Medicine Study","year":2019,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"Complementary and Alternative Medicine Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; University of Calgary","funders":"","keywords":"Medicine; Otorhinolaryngology; Family medicine; MEDLINE; Psychiatry; Law","score_opus":0.2537361593006372,"score_gpt":0.47629790789540294,"score_spread":0.22256174859476574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914132252","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04732265,0.0009360092,0.00019254207,0.936954,0.00091239676,0.0022834218,0.00015317333,0.000032570635,0.011213232],"genre_scores_gemma":[0.039425652,0.00041026564,0.0034339137,0.940438,0.012127216,0.00026543878,0.0013463257,0.00006764567,0.002485593],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968119,0.0008825102,0.0009497594,0.0006409841,0.00032249463,0.0003922989],"domain_scores_gemma":[0.9943552,0.004126672,0.000554506,0.00061542745,0.0002814269,0.000066756176],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009923426,0.00038234194,0.0021882122,0.00044326758,0.000089058114,0.0000027996186,0.0002521077,0.00016739388,0.0016042322],"category_scores_gemma":[0.00045925178,0.00028366767,0.00011309615,0.00019579243,0.0007135377,0.000036677844,0.00041634895,0.0014579963,0.00001438228],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018232247,0.0002701649,0.07822501,0.0003872609,0.0013636086,0.0003274064,0.0020141269,6.600223e-8,0.00034296798,0.00013350429,0.8849847,0.031768885],"study_design_scores_gemma":[0.0068505174,0.014246205,0.12445629,0.00014538568,0.0014440661,0.00032573633,0.0037960813,0.00000253341,0.000014360943,0.0006191469,0.84793293,0.00016676539],"about_ca_topic_score_codex":0.000987097,"about_ca_topic_score_gemma":0.00021301875,"teacher_disagreement_score":0.046231274,"about_ca_system_score_codex":0.00016953245,"about_ca_system_score_gemma":0.0001661548,"threshold_uncertainty_score":0.99996156},"labels":[],"label_agreement":null},{"id":"W2918886543","doi":"10.1001/jamaoncol.2019.0022","title":"<i>CHEK2</i> Alleles Predispose to Renal Cancer in Poland","year":2019,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Otorhinolaryngology; Family medicine; Neurology; Psychiatry","score_opus":0.012722114216908269,"score_gpt":0.3065758528575868,"score_spread":0.29385373864067854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2918886543","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.038456287,0.0031149462,0.00019807905,0.9409167,0.002816594,0.0011022702,0.00093001034,0.000025810583,0.012439271],"genre_scores_gemma":[0.008867863,0.000755857,0.0010241631,0.95903397,0.012407716,0.00067019364,0.00140903,0.00012679255,0.015704444],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99781007,0.00020532131,0.00039245372,0.00083027955,0.00019928777,0.0005626091],"domain_scores_gemma":[0.99891615,0.000072363786,0.00017788015,0.00064107217,0.00013181046,0.000060723603],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.000221006,0.0003370189,0.00046146955,0.00018659586,0.00003429912,0.000032852302,0.0005298433,0.0021426422,0.0002444294],"category_scores_gemma":[0.00011366062,0.00034197635,0.00012711142,0.00016435789,0.000085392836,0.0000039907377,0.00029649524,0.0010506604,0.00012167933],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015800804,0.000032906468,0.0009150266,0.000054506847,0.00010729436,0.00010898973,0.00011731849,0.00063172396,0.027385818,0.0000023391412,0.9608119,0.009674162],"study_design_scores_gemma":[0.0010262041,0.00046178463,0.0012059482,0.000052457606,0.00003720211,0.000040331073,0.000017657123,0.000016181555,0.004076583,0.000027608805,0.99264324,0.0003948014],"about_ca_topic_score_codex":0.0002524849,"about_ca_topic_score_gemma":0.002417822,"teacher_disagreement_score":0.031831335,"about_ca_system_score_codex":0.0005918809,"about_ca_system_score_gemma":0.0015560592,"threshold_uncertainty_score":0.9999032},"labels":[],"label_agreement":null},{"id":"W2925055605","doi":"10.1001/jamaoncol.2019.0054","title":"The Role of Disease Label in Patient Perceptions and Treatment Decisions in the Setting of Low-Risk Malignant Neoplasms","year":2019,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Patient-Provider Communication in Healthcare","field":"Health Professions","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University Health Network; Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Disease; MEDLINE; Malignant disease; Intensive care medicine; Oncology; Internal medicine; Cancer","score_opus":0.0632828586419593,"score_gpt":0.3961007150998496,"score_spread":0.3328178564578903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2925055605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873707,0.0014906162,0.0000014731512,0.008003794,0.00016628874,0.0018455993,0.00010377254,0.000007683525,0.0010100642],"genre_scores_gemma":[0.99673,0.0017200836,0.00040668013,0.00040692586,0.000016302034,0.000656897,0.000018666145,0.00001030831,0.000034115135],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99543077,0.0030528172,0.0008463045,0.0001887023,0.00016953488,0.00031189673],"domain_scores_gemma":[0.9896772,0.008815094,0.0005073212,0.0007802482,0.00014082529,0.00007934969],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006107507,0.000105696345,0.0002760487,0.00011501553,0.00036172115,0.000003836753,0.00029625144,0.00015083632,0.00003571885],"category_scores_gemma":[0.0009309335,0.000060853417,0.000041614414,0.0002554373,0.00010488034,0.00005935049,0.00021952226,0.00046110118,0.00002778487],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025437176,0.00037409575,0.84348965,0.000033639593,0.000007857168,0.0000013934927,0.06428449,0.000070780836,0.000118083684,0.0014147052,0.000095781645,0.08985513],"study_design_scores_gemma":[0.0020099524,0.00077687186,0.8344205,0.00033049585,0.000017318453,0.0000011483354,0.14802091,0.002828846,0.000009466438,0.0021614952,0.009353056,0.000069937676],"about_ca_topic_score_codex":0.0025402058,"about_ca_topic_score_gemma":0.013940477,"teacher_disagreement_score":0.08978519,"about_ca_system_score_codex":0.0003622983,"about_ca_system_score_gemma":0.0006199285,"threshold_uncertainty_score":0.7779113},"labels":[],"label_agreement":null},{"id":"W2937981811","doi":"10.1001/jamaoncol.2018.7147","title":"Current Landscape of Immunotherapy in Breast Cancer","year":2019,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":409,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Institutes of Health","keywords":"Medicine; Breast cancer; Immunotherapy; Oncology; Clinical trial; Cancer; Immune checkpoint; Internal medicine; Tumor microenvironment","score_opus":0.012827140362133293,"score_gpt":0.32467049464520614,"score_spread":0.31184335428307286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2937981811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9792,0.009159363,0.0000026491452,0.0061060446,0.00071263075,0.00029592143,0.000022333414,0.000013150488,0.004487924],"genre_scores_gemma":[0.9918062,0.00650137,0.000043922864,0.0011981933,0.00013528149,0.000031109725,0.00000904205,0.000012946428,0.000261915],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992593,0.00004538501,0.000268013,0.00014963366,0.00010561682,0.0001720428],"domain_scores_gemma":[0.99956936,0.000053468342,0.00010579581,0.00018802803,0.00005413671,0.000029224042],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020656608,0.000085636224,0.00033621976,0.00012808247,0.0000075829053,0.0000030309493,0.00007654126,0.00011996035,0.0031275086],"category_scores_gemma":[0.0000038769404,0.000067631685,0.00009071302,0.00020841154,0.00004922587,0.000041460946,0.000015377831,0.00017950842,0.000030132027],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006561253,0.00031253207,0.47334376,0.00007298115,0.00007101614,0.0000069397947,0.0003341161,0.0000026902858,0.051098526,0.00004397737,0.0032867165,0.4648655],"study_design_scores_gemma":[0.009262769,0.00043030758,0.7766059,0.0002042342,0.00001154214,0.000062108666,0.00010719391,0.000057381272,0.00095931726,0.00001948226,0.2122051,0.00007466418],"about_ca_topic_score_codex":0.0004515188,"about_ca_topic_score_gemma":0.00011158523,"teacher_disagreement_score":0.46479085,"about_ca_system_score_codex":0.00018518629,"about_ca_system_score_gemma":0.0003271179,"threshold_uncertainty_score":0.9977838},"labels":[],"label_agreement":null},{"id":"W2955638704","doi":"10.1001/jamaoncol.2019.1867","title":"Looking Forward, Not Backward, on Watch and Wait for Rectal Cancer","year":2019,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Otorhinolaryngology; Family medicine; MEDLINE; Neurology; Psychiatry","score_opus":0.024328073687890535,"score_gpt":0.345970239144727,"score_spread":0.3216421654568365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955638704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9563364,0.00019682077,0.000013318007,0.013304433,0.00082095683,0.0011489126,0.000039177055,0.000050430917,0.02808958],"genre_scores_gemma":[0.9880596,0.000169714,0.00056445046,0.003726448,0.00040868006,0.0003607602,0.000021850623,0.000033209202,0.0066553126],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99881166,0.000042459058,0.00020693173,0.0004172878,0.00016758645,0.00035407319],"domain_scores_gemma":[0.9989368,0.0005420632,0.00008052169,0.00019422903,0.00009037326,0.00015606594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018421837,0.00016976423,0.000513385,0.000054888616,0.00004769102,0.000013383956,0.00006067928,0.00024935039,0.00070345844],"category_scores_gemma":[0.00011233829,0.00013296398,0.00012115279,0.00009579723,0.000055197863,0.000057721543,0.00005957254,0.00021727927,0.00012527805],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022028655,0.0006584655,0.1764206,0.00031166064,0.00062004983,0.00023484623,0.000955119,0.000024396299,0.00765694,0.0009982059,0.01530176,0.7747893],"study_design_scores_gemma":[0.018085841,0.010999156,0.11468402,0.00019854096,0.0002596411,0.00015364055,0.00014760812,0.0006165816,0.01250183,0.00033375848,0.8417212,0.0002981962],"about_ca_topic_score_codex":0.00017316952,"about_ca_topic_score_gemma":0.00016027244,"teacher_disagreement_score":0.8264194,"about_ca_system_score_codex":0.00066299736,"about_ca_system_score_gemma":0.00018605497,"threshold_uncertainty_score":0.7702376},"labels":[],"label_agreement":null},{"id":"W2959096163","doi":"10.1001/jamaoncol.2019.1588","title":"Durvalumab With or Without Tremelimumab for Patients With Metastatic Pancreatic Ductal Adenocarcinoma","year":2019,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":765,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; AstraZeneca","keywords":"Durvalumab; Medicine; Tremelimumab; Gemcitabine; Internal medicine; Population; Combination therapy; Oncology; Surgery; Cancer; Immunotherapy; Ipilimumab; Nivolumab","score_opus":0.031134347711250843,"score_gpt":0.3374684671745833,"score_spread":0.30633411946333244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2959096163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849966,0.00013624,0.0005196723,0.0014801398,0.00010758856,0.0044144457,0.00003765801,0.00007738941,0.008230265],"genre_scores_gemma":[0.9660481,0.000030452768,0.022485431,0.000959584,0.0001626792,0.0006446024,0.00015332023,0.00008552009,0.009430312],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99728316,0.00022541228,0.0004774306,0.000639767,0.0005701918,0.00080401695],"domain_scores_gemma":[0.99715763,0.0010689142,0.00025340117,0.00059984805,0.0005828161,0.00033736252],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00047589437,0.00035647504,0.0016009252,0.00023503786,0.000128957,0.000027633729,0.00020298731,0.00023437459,0.0011570989],"category_scores_gemma":[0.0003592836,0.0002017207,0.00010519497,0.00032977955,0.00033900025,0.00017771215,0.000059907023,0.00040483437,0.00025400738],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03719622,0.0012845411,0.9550898,0.0004116548,0.0010046825,0.00023441097,0.00056090916,0.000003173404,0.000078604244,0.0002030884,0.0012380284,0.002694875],"study_design_scores_gemma":[0.061219122,0.0594485,0.86410916,0.00023889329,0.0022727288,0.00086512923,0.001035669,0.0020147136,0.00003810411,0.00008721192,0.008291462,0.00037927885],"about_ca_topic_score_codex":0.000103717735,"about_ca_topic_score_gemma":0.00019901693,"teacher_disagreement_score":0.09098063,"about_ca_system_score_codex":0.0005016271,"about_ca_system_score_gemma":0.0019109846,"threshold_uncertainty_score":0.999756},"labels":[],"label_agreement":null},{"id":"W2976453465","doi":"10.1001/jamaoncol.2019.3338","title":"The Value of Progression-Free Survival as a Treatment End Point Among Patients With Advanced Cancer","year":2019,"lang":"en","type":"review","venue":"JAMA Oncology","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Surrogate endpoint; MEDLINE; Progression-free survival; Cancer; Meta-analysis; Oncology; Internal medicine; Intensive care medicine; Overall survival","score_opus":0.11490236358128177,"score_gpt":0.48394285602300235,"score_spread":0.3690404924417206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2976453465","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0059101474,0.98316354,0.0000020918778,0.0002492518,0.0006355303,0.0022778139,0.00015506225,0.000016013408,0.0075905723],"genre_scores_gemma":[0.00023530793,0.9974169,0.00050627254,0.000049102444,0.00017877894,0.00053262216,0.00015467149,0.000047034402,0.00087927136],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979606,0.00032933577,0.0006272741,0.000350769,0.00042871502,0.00030326564],"domain_scores_gemma":[0.99646395,0.0013998885,0.0010026677,0.00068574416,0.00034103336,0.000106723295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022787674,0.00036553995,0.0024266613,0.00009182127,0.000043501714,0.0000051941747,0.00026156605,0.00036536265,0.00009290117],"category_scores_gemma":[0.00046200276,0.00016792459,0.00034765425,0.00018960291,0.00029811726,0.000042773176,0.000109980945,0.0002783569,0.000013664034],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004927177,0.00038366756,0.012159057,0.0035441997,0.00088822644,0.000029033092,0.0003706095,9.622178e-7,2.7856905e-7,0.00011814711,0.000436428,0.9815767],"study_design_scores_gemma":[0.0040378943,0.0060249353,0.00278151,0.024674509,0.0017878889,0.000004467704,0.000154171,0.0000012489004,0.000016133117,0.000019595687,0.9603422,0.00015542188],"about_ca_topic_score_codex":0.0004185872,"about_ca_topic_score_gemma":0.0003161455,"teacher_disagreement_score":0.98142123,"about_ca_system_score_codex":0.0007240577,"about_ca_system_score_gemma":0.0015811027,"threshold_uncertainty_score":0.6847766},"labels":[],"label_agreement":null},{"id":"W2989825979","doi":"10.1001/jamaoncol.2019.5098","title":"<i>Listeria</i> Susceptibility in Patients With Multiple Myeloma Receiving Daratumumab-Based Therapy","year":2019,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Daratumumab; Listeria; Multiple myeloma; Listeria monocytogenes; Oncology; Internal medicine; MEDLINE; Bortezomib","score_opus":0.019006791030601954,"score_gpt":0.2983351776100454,"score_spread":0.2793283865794435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989825979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913629,0.000045638168,0.0000110436895,0.0009146531,0.0001640048,0.0018159566,0.000025516565,0.000055202257,0.005605048],"genre_scores_gemma":[0.99691844,0.0000106545995,0.0014159428,0.0009361411,0.000057446578,0.00009665284,0.00022499177,0.00003444212,0.000305272],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979571,0.00026934108,0.00031824937,0.0005228251,0.0003813568,0.00055111054],"domain_scores_gemma":[0.99847865,0.0004046349,0.00011109522,0.0005886781,0.00020257379,0.00021437238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000342964,0.00022368951,0.00053556816,0.0001766955,0.00005724132,0.000025343243,0.00013744073,0.00022450801,0.00061760336],"category_scores_gemma":[0.00022626873,0.00015782543,0.000076186385,0.0002833838,0.00011211661,0.0001391515,0.000049645587,0.00037493245,0.00022050108],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013093088,0.0018421792,0.91566205,0.000052113428,0.000057075897,0.00009724601,0.000139524,0.000009226432,0.0014385405,0.000003745506,0.00023835682,0.06736684],"study_design_scores_gemma":[0.045478087,0.005736723,0.9373704,0.000078531324,0.000009785413,0.0000045846123,0.000050521307,0.00045980318,0.0010764058,0.000006720847,0.009584305,0.00014411696],"about_ca_topic_score_codex":0.00035371364,"about_ca_topic_score_gemma":0.0012619213,"teacher_disagreement_score":0.067222714,"about_ca_system_score_codex":0.00060290267,"about_ca_system_score_gemma":0.0003886741,"threshold_uncertainty_score":0.6762324},"labels":[],"label_agreement":null},{"id":"W2991564522","doi":"10.1001/jamaoncol.2018.2706","title":"Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016","year":2018,"lang":"en","type":"review","venue":"JAMA Oncology","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":1542,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Ottawa Hospital; University of Manitoba","funders":"Medical Research Council; College of Medicine, Seoul National University; University of California, Irvine; Laboratório Associado para a Química Verde; Western Sydney University; Alborz University of Medical Sciences; Fakultet Medicinskih Nauka, Univerziteta U Kragujevcu; University of Peradeniya; Helsingin Yliopisto; National Research University Higher School of Economics; Christian Medical College, Vellore; Tampereen Yliopisto; University of Haifa; Universitair Medisch Centrum Groningen; Haramaya University; Inyuvesi Yakwazulu-Natali; University of Gondar; Universidade Federal de Minas Gerais; Golestan University of Medical Sciences; Tehran University of Medical Sciences and Health Services; Mazandaran University of Medical Sciences; Samara University; United Nations Population Fund; Karolinska Institutet; Universidade do Porto; Seoul National University; Rijksuniversiteit Groningen; National Institute for Health and Care Research; Jordan University of Science and Technology; University of Oxford; Samfundet Folkhälsan; Maragheh University of Medical Sciences; Fudan University; Ahmadu Bello University; Uniwersytet Medyczny im. Piastów Slaskich we Wroclawiu; Trường Đại học Duy Tân; Iran University of Medical Sciences; Rede de Química e Tecnologia; University of West Florida; National Cancer Institute; University College London; Mekelle University; Arabian Gulf University; Case Western Reserve University; Universitetet i Tromsø; Baqiyatallah University of Medical Sciences; Imperial College London; Johns Hopkins University; Curtin University of Technology; University of Washington; Aarhus Universitet; United Arab Emirates University; Jackson State University; Korea University; South African Medical Research Council; King's College London; Public Health Foundation of India; Universität Bielefeld; Kosin University; Ball State University; Uniwersytet Jagielloński Collegium Medicum","keywords":"Medicine; Years of potential life lost; Cancer; Population; Disease burden; Global health; Demography; Epidemiology; Incidence (geometry); Environmental health; Gerontology; Public health; Life expectancy; Pathology; Internal medicine","score_opus":0.1869459352406655,"score_gpt":0.4487672438435223,"score_spread":0.2618213086028568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991564522","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.234617,0.7586049,0.000023765137,0.0019515923,0.00038099216,0.0028600064,0.0012703829,0.000037999805,0.00025340103],"genre_scores_gemma":[0.028867025,0.9628008,0.0013818903,0.003429735,0.002049878,0.0010806995,0.00019600325,0.00007591432,0.000118040625],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.996194,0.00025918966,0.001053787,0.0011037991,0.0008319871,0.00055720395],"domain_scores_gemma":[0.9967417,0.000789488,0.00068349123,0.0005109907,0.0005835298,0.0006907855],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009894061,0.00048033937,0.0024463353,0.00011207724,0.00007310073,0.000045222325,0.00035430628,0.0007286083,0.00014881871],"category_scores_gemma":[0.0011314723,0.00041746386,0.00028765836,0.00065786234,0.0015671778,0.00019606168,0.00037008815,0.00038748703,0.000011600635],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025692747,0.0005809585,0.250778,0.014550373,0.0019593157,0.00008118415,0.0004451314,0.00002413443,0.0000012708368,0.0005769697,0.09957705,0.62885636],"study_design_scores_gemma":[0.0018816204,0.0016621726,0.28247127,0.0075597675,0.0015026369,0.00011083764,0.00014562775,0.00002044297,1.3352432e-7,0.00021587143,0.70399225,0.00043738776],"about_ca_topic_score_codex":0.010417423,"about_ca_topic_score_gemma":0.013101098,"teacher_disagreement_score":0.628419,"about_ca_system_score_codex":0.0017327586,"about_ca_system_score_gemma":0.0042356765,"threshold_uncertainty_score":0.99982774},"labels":[],"label_agreement":null},{"id":"W2997720498","doi":"10.1001/jamaoncol.2019.5570","title":"Association Between Immune-Related Adverse Events and Recurrence-Free Survival Among Patients With Stage III Melanoma Randomized to Receive Pembrolizumab or Placebo","year":2020,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":436,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Pharmacyclics; Genentech; Merck Canada; Deutschen Konsortium für Translationale Krebsforschung; Radboud Universitair Medisch Centrum; Melanoma Institute Australia; Amgen; Radboud Universiteit; Universitat de Barcelona; Astellas Pharma; Les Laboratories Pierre Fabre; European Organisation for Research and Treatment of Cancer; SkylineDx; Sun Pharma; Peter MacCallum Cancer Centre; Syndax Pharmaceuticals; Regeneron Pharmaceuticals; Endocyte; Array BioPharma; Aix-Marseille Université; InflaRx; Pfizer; Incyte; F. Hoffmann-La Roche; Sanofi; GlaxoSmithKline; NeraCare; University of Sydney; Medizinischen Hochschule Hannover; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Pembrolizumab; Internal medicine; Adverse effect; Placebo; Randomized controlled trial; Clinical trial; Melanoma; Oncology; Surgery; Cancer; Immunotherapy; Pathology","score_opus":0.014428608379705823,"score_gpt":0.2701461534137153,"score_spread":0.25571754503400945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2997720498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98826694,0.00008076887,0.00006082262,0.0063334564,0.00036369427,0.0022857527,0.00011627829,0.000065593245,0.0024267011],"genre_scores_gemma":[0.9958522,0.00014579482,0.00025427315,0.0008584603,0.00014026815,0.00012031416,0.00019962472,0.000032290638,0.0023968308],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99757797,0.0006024794,0.00067551085,0.00039823187,0.0004016485,0.0003441372],"domain_scores_gemma":[0.9978319,0.0009342015,0.00054669596,0.0002357995,0.00020832547,0.00024309046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000988694,0.00023627475,0.0010889282,0.00010579202,0.00009885826,0.0000108767235,0.00014018142,0.00035878044,0.00041975066],"category_scores_gemma":[0.0014868836,0.0001679179,0.00014344086,0.0003713865,0.00011485334,0.00014360313,0.00010370825,0.00037652132,0.000022979331],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5861143,0.00012118685,0.3975838,0.000043286916,0.0015398607,0.000036449495,0.0026006699,0.0000031562581,0.00006455532,0.000004970158,0.0018195531,0.0100681735],"study_design_scores_gemma":[0.43638495,0.0031452444,0.5519953,0.00011062636,0.000448348,0.0000026547643,0.00030672713,0.00004619257,0.000072304116,0.000010516167,0.007286671,0.00019046891],"about_ca_topic_score_codex":0.00041672218,"about_ca_topic_score_gemma":0.00025696808,"teacher_disagreement_score":0.15441146,"about_ca_system_score_codex":0.00062298635,"about_ca_system_score_gemma":0.00029817072,"threshold_uncertainty_score":0.6847493},"labels":[],"label_agreement":null},{"id":"W3000043704","doi":"10.1001/jamaoncol.2019.5559","title":"Association Between 21-Gene Assay Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast Cancer","year":2020,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Cancer Institute; National Institutes of Health; Genomic Health","keywords":"Medicine; Breast cancer; Oncology; Internal medicine; Cancer recurrence; Cancer","score_opus":0.013472572159005458,"score_gpt":0.26638401579031185,"score_spread":0.2529114436313064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3000043704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98626035,0.00043713383,0.00007193794,0.011957559,0.00008875234,0.0002742959,0.0007382327,0.000008431193,0.00016327365],"genre_scores_gemma":[0.9974223,0.00028292782,0.00026676749,0.0011233739,0.00031477836,0.00009455562,0.0004650927,0.000014049224,0.000016178636],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99879384,0.00014983906,0.0001796303,0.00046348624,0.00015203831,0.0002611458],"domain_scores_gemma":[0.99929273,0.00009112725,0.00019505383,0.000094276904,0.00023335223,0.000093456096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001180273,0.00018327235,0.00027116478,0.000028565057,0.0000674934,0.000016215034,0.000104945815,0.00020188853,0.000012017132],"category_scores_gemma":[0.000103772545,0.00015855383,0.000028061386,0.00015675048,0.00010872719,0.000013290536,0.00012091844,0.00016643766,0.0000041595526],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063106365,0.00009332777,0.97119224,0.000012272824,0.000189463,0.0000033174024,0.00019996421,0.000009329823,0.00028567706,0.0000051920047,0.0018813021,0.025496848],"study_design_scores_gemma":[0.0025783775,0.00047619498,0.99324006,0.000050663246,0.000065951586,0.0000029393198,0.00003223153,0.000008333872,0.0017614509,0.0000145634995,0.001589032,0.00018019971],"about_ca_topic_score_codex":0.00015560356,"about_ca_topic_score_gemma":0.0002799528,"teacher_disagreement_score":0.025316648,"about_ca_system_score_codex":0.00024483583,"about_ca_system_score_gemma":0.00019067455,"threshold_uncertainty_score":0.6465637},"labels":[],"label_agreement":null},{"id":"W3008735477","doi":"10.1001/jamaoncol.2019.6716","title":"Global Retinoblastoma Presentation and Analysis by National Income Level","year":2020,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Ocular Oncology and Treatments","field":"Medicine","cited_by":369,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; Hospital for Sick Children","funders":"Cliniques Universitaires Saint-Luc; Emory Eye Center; NIH Clinical Center; National Cancer Institute; Faculty of Medicine and Health, University of Sydney; School of Medicine, Shanghai Jiao Tong University; College of Medicine, University of Cincinnati; Université de Paris; Servicio Andaluz de Salud; Universitas Andalas; Centre hospitalier universitaire Sainte-Justine; Masarykova Univerzita; Dali University; Universitas Airlangga; University of Cape Town; Hospital for Sick Children; Addis Ababa University; Anna University; Université Mohammed V de Rabat; Aarhus Universitet; University of Ghana; Prince of Songkla University; Jimma University; Hospital Infantil de México Federico Gómez; Università degli Studi di Padova; Universitas Udayana; Shanghai Jiao Tong University; Hacettepe Üniversitesi; Tel Aviv University; Seoul National University Hospital; Faculdade de Medicina da Universidade de São Paulo; Mahidol University; Hebrew University of Jerusalem; Universitätsklinikum Hamburg-Eppendorf; Universiteit Stellenbosch; Universidade de São Paulo; Chulalongkorn University; Centre Hospitalier Universitaire Vaudois; Northwestern University; Seoul National University; Helsingin Yliopisto; Semmelweis Egyetem; University of Cincinnati; Amsterdam University Medical Centers; Universitätsklinikum Essen; Birmingham Women's and Children's NHS Foundation Trust; Leonard M. Miller School of Medicine; Indus Hospital; University of Southern California; Children's Hospital Colorado; Cleveland Clinic; Hadassah Medical Organization; Guangxi Medical University; Iran University of Medical Sciences; Tehran University of Medical Sciences and Health Services; Universidade de Coimbra; University of Miami; University of South Carolina; University of Louisville; Johns Hopkins University; Feinberg School of Medicine; Ankara Universitesi; Ege Üniversitesi; Università degli Studi di Siena; Chang Gung Medical Foundation; Children's Hospital Los Angeles; St. Jude Children's Research Hospital; Aarhus Universitetshospital; Universidad de Chile; Emory University; Inyuvesi Yakwazulu-Natali; University of Otago; Consejo Nacional de Investigaciones Científicas y Técnicas; Uniwersytet Jagielloński Collegium Medicum","keywords":"Medicine; Retinoblastoma; Interquartile range; Pediatrics; Cohort; Strabismus; Referral; Surgery; Internal medicine; Family medicine","score_opus":0.03398779889015197,"score_gpt":0.3545768754051521,"score_spread":0.3205890765150001,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008735477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9485743,0.00020277592,0.000998358,0.034673344,0.000059958642,0.00021535504,0.00015662232,0.00004410898,0.015075184],"genre_scores_gemma":[0.9919922,0.000021089825,0.0021098105,0.0052176104,0.00010762413,0.000017414823,0.00026469238,0.0000046870246,0.00026490106],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99919057,0.00010076631,0.00016986481,0.0002370632,0.00017471689,0.00012703327],"domain_scores_gemma":[0.99950606,0.00009725537,0.0000775978,0.0000615046,0.00010439833,0.00015318015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001041071,0.000087347726,0.00028471067,0.000053397394,0.00005330804,0.000008448712,0.000039706138,0.00020377262,0.0001811411],"category_scores_gemma":[0.00022993957,0.00007839328,0.00007001771,0.00042041388,0.00009210328,0.000067453344,0.000045352874,0.000100417776,0.0000520972],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006209526,0.00022700157,0.96867615,0.000017796794,0.0013274736,0.00015445692,0.00017415028,0.000010673742,0.00028456052,0.0005871649,0.016099442,0.011820172],"study_design_scores_gemma":[0.0039206943,0.0012874454,0.96569437,0.0000031148168,0.00093621254,0.00007865395,0.000059020775,0.0015726795,0.00013628598,0.00031642057,0.02592483,0.0000702438],"about_ca_topic_score_codex":0.00003803365,"about_ca_topic_score_gemma":0.00005884029,"teacher_disagreement_score":0.04341788,"about_ca_system_score_codex":0.0002202885,"about_ca_system_score_gemma":0.00015778554,"threshold_uncertainty_score":0.31967852},"labels":[],"label_agreement":null},{"id":"W30128482","doi":"10.1001/jamaoncol.2018.4091","title":"Using circles of support and accountability in China: prospects and problems","year":2010,"lang":"en","type":"dissertation","venue":"JAMA Oncology","topic":"Homelessness and Social Issues","field":"Health Professions","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Accountability; China; Political science; Law","score_opus":0.055439473072147256,"score_gpt":0.4587338958495721,"score_spread":0.40329442277742483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W30128482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98678964,0.0003747949,6.427946e-7,0.0000966884,0.0007449569,0.0010687663,0.000026533824,0.00001729335,0.010880679],"genre_scores_gemma":[0.998688,0.00032963,0.0001752865,0.000026791275,0.00019541182,0.00012895858,0.00011445306,0.000026677923,0.00031480013],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983606,0.00029781682,0.00060486596,0.0003131308,0.00011804336,0.00030555468],"domain_scores_gemma":[0.998858,0.0002628422,0.00050124055,0.00014638968,0.00016320145,0.00006833917],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0008940573,0.0001632392,0.00093256694,0.00013278624,0.00020657382,0.000008545743,0.00008560762,0.0015998689,0.00013801052],"category_scores_gemma":[0.00022200601,0.0001539478,0.000029603272,0.000117470045,0.000122070145,0.00010709962,0.00005780206,0.0012689172,0.0000024529336],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022308719,0.00021867211,0.7215588,0.00477611,0.000026131858,0.000011574969,0.2351916,3.8131628e-7,0.003531121,0.0019299797,0.000014001771,0.032518562],"study_design_scores_gemma":[0.000851809,0.00013597269,0.92888135,0.00032299262,0.000033656706,5.032557e-7,0.06464742,0.000015890486,0.00006746126,0.0034270105,0.0014677993,0.00014814285],"about_ca_topic_score_codex":0.010918618,"about_ca_topic_score_gemma":0.26653174,"teacher_disagreement_score":0.25561312,"about_ca_system_score_codex":0.00014884485,"about_ca_system_score_gemma":0.0008122498,"threshold_uncertainty_score":0.99969625},"labels":[],"label_agreement":null},{"id":"W3013690193","doi":"10.1001/jamaoncol.2020.0167","title":"Double Counting of Patients in Meta-analyses of Observational Studies","year":2020,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Otorhinolaryngology; Family medicine; MEDLINE; Neurology; Psychiatry","score_opus":0.4692503425462964,"score_gpt":0.4781352585005708,"score_spread":0.00888491595427443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013690193","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08670594,0.0023355314,0.00000586515,0.9081428,0.0005045543,0.00059584645,0.0001976604,0.000020459487,0.0014913342],"genre_scores_gemma":[0.0326657,0.00020807267,0.0020784868,0.9612151,0.0021275752,0.00009872227,0.0010985098,0.000053206186,0.0004546738],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964119,0.00039212225,0.0016469515,0.00042474837,0.00087457465,0.0002496783],"domain_scores_gemma":[0.99536985,0.001835186,0.0015335997,0.00034885606,0.00087226246,0.00004023901],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070907397,0.0002898886,0.003404007,0.00027195513,0.000020931173,0.0000043027294,0.00022612567,0.000573865,0.00024536584],"category_scores_gemma":[0.0017430307,0.00023682564,0.00057363266,0.0003962111,0.00024129037,0.00007775701,0.00017079391,0.001202243,0.000009329312],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041591874,0.0002675811,0.044567324,0.002368628,0.010607356,0.00011428028,0.0020052588,0.000010841953,0.00004328066,0.000039789153,0.93935776,0.00020197382],"study_design_scores_gemma":[0.0065253046,0.0011626927,0.06611604,0.0002783968,0.011203396,0.0000047420594,0.00049053726,0.000012331877,0.00062966085,0.00041021412,0.9128756,0.0002910778],"about_ca_topic_score_codex":0.001218132,"about_ca_topic_score_gemma":0.00051289273,"teacher_disagreement_score":0.05404024,"about_ca_system_score_codex":0.0002960302,"about_ca_system_score_gemma":0.0006741403,"threshold_uncertainty_score":0.96574694},"labels":[],"label_agreement":null},{"id":"W3014602666","doi":"10.1001/jamaoncol.2020.0249","title":"Effect of Delayed Targeted Intraoperative Radiotherapy vs Whole-Breast Radiotherapy on Local Recurrence and Survival","year":2020,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"St. Olavs Hospital Universitetssykehuset i Trondheim; Uniwersytet Medyczny w Lublinie; Universität des Saarlandes; University College London; University of Southern California; National Institute for Health and Care Research; Universitätsspital Zürich; Norges Teknisk-Naturvitenskapelige Universitet; University of Oxford","keywords":"Medicine; Lumpectomy; Radiation therapy; Mastectomy; Breast cancer; Randomized controlled trial; External beam radiotherapy; Surgery; Intraoperative radiotherapy; Cancer; Radiology; Brachytherapy; Internal medicine","score_opus":0.007730415757261636,"score_gpt":0.2830973617822725,"score_spread":0.2753669460250109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014602666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9809078,0.004107992,0.0034207515,0.010263215,0.0002762034,0.00044692762,0.0002124782,0.000023502984,0.0003411496],"genre_scores_gemma":[0.9958715,0.0010835676,0.00052062346,0.00189201,0.00043568324,0.000059015503,0.00009354503,0.00002745424,0.000016640257],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985858,0.00038682495,0.00021754716,0.00045884392,0.00011165593,0.00023933104],"domain_scores_gemma":[0.9993531,0.00016387079,0.000113114394,0.00017818242,0.0000736401,0.00011807262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019348114,0.00025580692,0.00050491333,0.000029947052,0.000064976244,0.000009909197,0.00014311256,0.00023433895,0.00003375504],"category_scores_gemma":[0.000060495262,0.00020308346,0.00008159293,0.000111309935,0.00036417998,0.000005483785,0.00005309087,0.0001595383,0.0000035314054],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038546044,0.0003633772,0.014766037,0.00009951325,0.0016051935,0.000051154355,0.0019276923,0.00027347862,0.3798101,0.00022415532,0.009094876,0.5532384],"study_design_scores_gemma":[0.042911418,0.10292276,0.053934228,0.00011248899,0.00030461338,0.00035176985,0.0005880682,0.0020373533,0.611119,0.000036209294,0.18432738,0.0013547501],"about_ca_topic_score_codex":0.000059971404,"about_ca_topic_score_gemma":0.000036290974,"teacher_disagreement_score":0.55188364,"about_ca_system_score_codex":0.00009353585,"about_ca_system_score_gemma":0.000100864556,"threshold_uncertainty_score":0.82815033},"labels":[],"label_agreement":null},{"id":"W3016210953","doi":"10.1001/jamaoncol.2020.0237","title":"Durvalumab With or Without Tremelimumab vs Standard Chemotherapy in First-line Treatment of Metastatic Non–Small Cell Lung Cancer","year":2020,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":628,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"National Center for Advancing Translational Sciences; AstraZeneca","keywords":"Durvalumab; Tremelimumab; Medicine; Internal medicine; Oncology; Lung cancer; Chemotherapy; Cancer; Immunotherapy; Nivolumab; Ipilimumab","score_opus":0.03414082962539107,"score_gpt":0.3314500925352575,"score_spread":0.2973092629098664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016210953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9744195,0.0021061804,0.00040029088,0.020396817,0.000101444,0.0015022506,0.00006585765,0.00003492863,0.00097276137],"genre_scores_gemma":[0.9860825,0.0052388464,0.0032426298,0.004136979,0.000179675,0.00024665205,0.000021405163,0.00005449259,0.0007968526],"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","domain_scores_codex":[0.99853706,0.00007907631,0.00049393356,0.00036255503,0.00021070022,0.00031664516],"domain_scores_gemma":[0.99915165,0.00012792899,0.00024705232,0.00023546252,0.00010379839,0.0001341108],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015070083,0.00026319677,0.0010567284,0.00010545621,0.0000345368,0.000009013141,0.00009870582,0.00012741814,0.0010418498],"category_scores_gemma":[0.000016007249,0.00016589886,0.00012829788,0.00039770504,0.00012728486,0.00004628982,0.000012839403,0.00013786671,0.0000030765425],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5245523,0.0030307143,0.14861462,0.0013998372,0.0018760574,0.0008613258,0.021279743,0.00027869176,0.019946782,0.000004544504,0.0030059603,0.27514946],"study_design_scores_gemma":[0.32727534,0.1354826,0.053165708,0.0008410638,0.001802518,0.00019056712,0.0026115389,0.0104360655,0.09792966,0.00000934141,0.36939946,0.0008561562],"about_ca_topic_score_codex":0.0014528974,"about_ca_topic_score_gemma":0.007146713,"teacher_disagreement_score":0.3663935,"about_ca_system_score_codex":0.0009495113,"about_ca_system_score_gemma":0.0012695658,"threshold_uncertainty_score":0.9998713},"labels":[],"label_agreement":null},{"id":"W3021442601","doi":"10.1001/jamaoncol.2020.0910","title":"Effect of Combined Immune Checkpoint Inhibition vs Best Supportive Care Alone in Patients With Advanced Colorectal Cancer","year":2020,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":398,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal; Canadian Red Cross Society; Dalhousie University; Moncton Hospital; Juravinski Cancer Centre; Ottawa Hospital; Saskatchewan Cancer Agency; St. John’s Health Sciences Centre; Université de Sherbrooke; Queen's University; Princess Margaret Cancer Centre; Centre Hospitalier de l’Université de Montréal; Université Laval","funders":"Ipsen; Eisai; Celgene; Amgen","keywords":"Medicine; Microsatellite instability; Internal medicine; Colorectal cancer; Oncology; Cetuximab; Regorafenib; Tremelimumab; Irinotecan; Cancer; Ipilimumab; Immunotherapy","score_opus":0.005834023752853325,"score_gpt":0.27359923073120196,"score_spread":0.26776520697834866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3021442601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954535,0.00048397025,0.0000026880757,0.0021177176,0.00014072697,0.0012068184,0.000053599662,0.00002195056,0.0005190678],"genre_scores_gemma":[0.9988055,0.00008197123,0.00006415942,0.00058933353,0.000046691606,0.00015907122,0.0002200053,0.000021240463,0.000012013083],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99883705,0.00013338038,0.00040060282,0.00024238674,0.00017387114,0.0002126759],"domain_scores_gemma":[0.9993144,0.00009583288,0.00024735864,0.00009943737,0.00016605011,0.00007689828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013597148,0.00016124094,0.00063370896,0.00007342676,0.000024097897,0.0000032970756,0.000048617356,0.00016304103,0.00017496668],"category_scores_gemma":[0.00007670848,0.00012272273,0.000092632836,0.0003072475,0.00015271096,0.000074322925,0.000032004813,0.00023503204,0.000005453295],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3485377,0.00066222856,0.37223306,0.00066023954,0.00024552902,0.00010662332,0.0047585755,0.000016989929,0.1504605,0.0000023645296,0.00017467559,0.1221415],"study_design_scores_gemma":[0.05409076,0.068993114,0.5277138,0.0003072621,0.00011163126,0.000004110177,0.00046953122,0.000017247623,0.34739587,7.850723e-7,0.0007630623,0.00013288678],"about_ca_topic_score_codex":0.000345431,"about_ca_topic_score_gemma":0.0002855156,"teacher_disagreement_score":0.29444695,"about_ca_system_score_codex":0.0005025812,"about_ca_system_score_gemma":0.0002551678,"threshold_uncertainty_score":0.50044876},"labels":[],"label_agreement":null},{"id":"W3030472743","doi":"10.1001/jamaoncol.2020.2218","title":"Efficacy of Savolitinib vs Sunitinib in Patients With<i>MET</i>-Driven Papillary Renal Cell Carcinoma","year":2020,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":179,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Sunitinib; Tolerability; Internal medicine; Renal cell carcinoma; Population; Oncology; Clinical endpoint; Cabozantinib; Expanded access; Clinical trial; Urology; Surgery; Adverse effect","score_opus":0.023545140243513205,"score_gpt":0.25515136495276947,"score_spread":0.23160622470925626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3030472743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98058134,0.00015171664,0.0000053623035,0.0020699492,0.00006636912,0.00094469334,0.000036622285,0.000035912042,0.016108008],"genre_scores_gemma":[0.99558455,0.000012905247,0.0016926625,0.0021146806,0.00020468306,0.0000347752,0.00022071581,0.000045668374,0.00008933664],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978889,0.00024465966,0.0005887757,0.00045899977,0.0003781378,0.000440499],"domain_scores_gemma":[0.99845356,0.00035604747,0.00026160153,0.00035419056,0.00021857386,0.0003560233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012316574,0.0002685994,0.00084325776,0.00016516107,0.000031367246,0.000007029443,0.00016645202,0.00025002565,0.00024061895],"category_scores_gemma":[0.00015873085,0.00021679584,0.00013932651,0.0003749072,0.00017226678,0.00007014907,0.0001132275,0.000434984,0.000063514985],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011037271,0.0018616013,0.9694324,0.00026395026,0.0000768705,0.0012630016,0.0015937942,0.000035647972,0.0041467426,0.00006240573,0.0018153854,0.008410908],"study_design_scores_gemma":[0.025903314,0.018469075,0.9320972,0.000068360074,0.00018099218,0.00002535037,0.00018198283,0.000033454657,0.014148635,0.0000071217273,0.00869983,0.00018469417],"about_ca_topic_score_codex":0.00011793095,"about_ca_topic_score_gemma":0.000022121447,"teacher_disagreement_score":0.037335232,"about_ca_system_score_codex":0.0003049785,"about_ca_system_score_gemma":0.0004581036,"threshold_uncertainty_score":0.8840678},"labels":[],"label_agreement":null},{"id":"W3030999222","doi":"10.1001/jamaoncol.2020.1271","title":"Evaluation of First-line Radiosurgery vs Whole-Brain Radiotherapy for Small Cell Lung Cancer Brain Metastases","year":2020,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":215,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Université de Sherbrooke","funders":"National Center for Advancing Translational Sciences; National Institute of General Medical Sciences","keywords":"Medicine; Radiosurgery; Interquartile range; Lung cancer; Radiation therapy; Brain metastasis; Internal medicine; Prophylactic cranial irradiation; Oncology; Cohort; Retrospective cohort study; Cancer; Metastasis; Conventional PCI","score_opus":0.09586448013135285,"score_gpt":0.42618148420825736,"score_spread":0.3303170040769045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3030999222","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24557509,0.034004845,0.003082583,0.7101889,0.00048297175,0.0046427194,0.000932708,0.00009288054,0.0009972929],"genre_scores_gemma":[0.91080827,0.003017512,0.009882783,0.061408833,0.0055783144,0.0058667245,0.0007765747,0.0002197363,0.002441268],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99751824,0.00053293083,0.00047105542,0.00041330638,0.0006454981,0.000418981],"domain_scores_gemma":[0.9958144,0.002590252,0.00025630998,0.00025011934,0.00087942457,0.00020948655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028217633,0.00020148208,0.00084928935,0.00014310238,0.00008395426,0.000011970469,0.00015170325,0.00016080304,0.0008393807],"category_scores_gemma":[0.004848471,0.0001708646,0.00022304567,0.00032716035,0.00013423458,0.00007746834,0.0000625632,0.00024449878,0.000004691682],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032107003,0.00033942354,0.007380934,0.0014474477,0.0011612448,0.000032227006,0.0023340564,0.0010332379,0.022894375,0.00002783545,0.855301,0.10483748],"study_design_scores_gemma":[0.019762186,0.0038978711,0.003889667,0.00018400417,0.0010697771,0.000012132986,0.00025450694,0.05200739,0.012900832,0.00006061726,0.90573555,0.00022543588],"about_ca_topic_score_codex":0.00018714939,"about_ca_topic_score_gemma":0.00038229986,"teacher_disagreement_score":0.6652332,"about_ca_system_score_codex":0.0010514456,"about_ca_system_score_gemma":0.0016808683,"threshold_uncertainty_score":0.91906303},"labels":[],"label_agreement":null},{"id":"W3032917453","doi":"10.1001/jamaoncol.2020.1694","title":"Survival After Minimally Invasive vs Open Radical Hysterectomy for Early-Stage Cervical Cancer","year":2020,"lang":"en","type":"review","venue":"JAMA Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":209,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute","keywords":"Medicine; Cervical cancer; Observational study; Hysterectomy; Randomized controlled trial; Meta-analysis; Radical Hysterectomy; Confounding; Stage (stratigraphy); Surgery; Cancer; Internal medicine","score_opus":0.10949079119001927,"score_gpt":0.42479862671239965,"score_spread":0.3153078355223804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3032917453","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00030167677,0.9758266,0.000012193578,0.005386582,0.0016719692,0.006855459,0.0014248297,0.000071838826,0.008448843],"genre_scores_gemma":[0.00018947832,0.97738856,0.0011330197,0.0044983015,0.0036097046,0.008575133,0.00051776227,0.00016600653,0.0039220303],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958947,0.0005985778,0.0011538488,0.0011738591,0.00042671693,0.0007522984],"domain_scores_gemma":[0.9954701,0.0025265526,0.00052172784,0.00049222074,0.0001966621,0.00079274393],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00038507037,0.0007423896,0.00564289,0.00021689282,0.000080095924,0.00011535944,0.00082825095,0.0013462291,0.0037158295],"category_scores_gemma":[0.0007892549,0.0005274242,0.0011702289,0.0006538673,0.0001908749,0.00012733684,0.0007510942,0.0010103582,0.00039005937],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007918804,0.0005247192,0.00051643467,0.016908178,0.0018689766,0.0017899375,0.00010712576,2.168287e-8,9.1523214e-7,0.00008926381,0.0033026258,0.966973],"study_design_scores_gemma":[0.014140629,0.005077075,0.0009622777,0.004257352,0.0041616727,0.00008002645,0.000018256169,7.7259807e-7,0.0000046677246,0.000033286844,0.9708013,0.00046266124],"about_ca_topic_score_codex":0.0008406164,"about_ca_topic_score_gemma":0.0009999287,"teacher_disagreement_score":0.9674987,"about_ca_system_score_codex":0.001665294,"about_ca_system_score_gemma":0.004380254,"threshold_uncertainty_score":0.99995023},"labels":[],"label_agreement":null},{"id":"W3037873371","doi":"10.1001/jamaoncol.2020.1796","title":"Efficacy and Safety of Trastuzumab Emtansine Plus Capecitabine vs Trastuzumab Emtansine Alone in Patients With Previously Treated ERBB2 (HER2)-Positive Metastatic Breast Cancer","year":2020,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Capecitabine; Medicine; Metastatic breast cancer; Trastuzumab emtansine; Internal medicine; Trastuzumab; Oncology; Phases of clinical research; Breast cancer; Cancer; Gastroenterology; Chemotherapy","score_opus":0.019962352137295275,"score_gpt":0.31567226766944956,"score_spread":0.2957099155321543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3037873371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.976393,0.00080430525,0.00013056574,0.018006684,0.000071432914,0.0031326425,0.00062936515,0.00006430553,0.0007677307],"genre_scores_gemma":[0.99639094,0.0005926936,0.00088032836,0.0013284737,0.0001713966,0.00016013208,0.0002610987,0.00010176206,0.0001131734],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961264,0.00047616241,0.0009826928,0.0008417552,0.0007511175,0.0008218833],"domain_scores_gemma":[0.997464,0.00065154635,0.0003153099,0.00037579058,0.0006153281,0.0005780063],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00038127328,0.00047855603,0.0018430821,0.00028588687,0.000077606106,0.000021623693,0.00021454626,0.0002473359,0.00067594467],"category_scores_gemma":[0.00038842633,0.00037951165,0.00009172335,0.0012499149,0.00053699047,0.00017890136,0.00011295895,0.00079636154,0.000014466671],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2847766,0.009736181,0.35574818,0.0036019057,0.0031813455,0.0044986173,0.023660978,0.0007460331,0.0042304303,0.000100291894,0.005845745,0.30387372],"study_design_scores_gemma":[0.06494399,0.016027534,0.9139944,0.0009316159,0.0006164306,0.00019106014,0.00039416552,0.0006532123,0.0005233336,0.000005931086,0.0013503291,0.00036804576],"about_ca_topic_score_codex":0.0022298105,"about_ca_topic_score_gemma":0.0031778095,"teacher_disagreement_score":0.5582462,"about_ca_system_score_codex":0.00209347,"about_ca_system_score_gemma":0.0022096252,"threshold_uncertainty_score":0.99986565},"labels":[],"label_agreement":null},{"id":"W3038137802","doi":"10.1001/jamaoncol.2020.2404","title":"Covid-19 Pandemic—An Opportunity to Reduce and Eliminate Low-Value Practices in Oncology?","year":2020,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Cancer Care Ontario","funders":"","keywords":"Medicine; Coronavirus disease 2019 (COVID-19); Pandemic; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Value (mathematics); MEDLINE; Betacoronavirus; Oncology; Coronavirus Infections; Internal medicine; Virology; Intensive care medicine; Outbreak; Infectious disease (medical specialty); Statistics","score_opus":0.35086257480534905,"score_gpt":0.5370751771833544,"score_spread":0.18621260237800535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3038137802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5831397,0.00014698395,0.00003690346,0.41270804,0.00015334196,0.0006615377,0.000013009038,0.00009071474,0.0030497555],"genre_scores_gemma":[0.65130293,0.00046686272,0.0008674911,0.3467241,0.00044257002,0.00004535922,0.00002347328,0.00001983973,0.00010739412],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99720997,0.000813748,0.000551405,0.0006335116,0.00022688114,0.00056450325],"domain_scores_gemma":[0.9918518,0.0018873981,0.00043065887,0.00033359035,0.00014037266,0.0053561865],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0019082213,0.0002192032,0.0007539523,0.00023823857,0.00011133962,0.000024955567,0.00018316621,0.00059959764,0.00039046849],"category_scores_gemma":[0.048115943,0.00020527611,0.000048118913,0.00041535305,0.00015175539,0.00026385233,0.00018565445,0.001019183,0.000055242817],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016248485,0.0017599823,0.15433452,0.0018133913,0.000102271006,0.00801235,0.041444853,0.000076318334,0.026857017,0.0011464518,0.04905688,0.69914746],"study_design_scores_gemma":[0.0058748615,0.010916981,0.103202865,0.00007161743,0.00010230241,0.0008242328,0.0039871642,0.0005591986,0.00019721285,0.00026271926,0.8737459,0.00025493358],"about_ca_topic_score_codex":0.003693229,"about_ca_topic_score_gemma":0.0036648058,"teacher_disagreement_score":0.82468903,"about_ca_system_score_codex":0.00183752,"about_ca_system_score_gemma":0.013428397,"threshold_uncertainty_score":0.99216455},"labels":[],"label_agreement":null},{"id":"W3038926436","doi":"10.1001/jamaoncol.2020.2134","title":"Characterization of the Cancer Spectrum in Men With Germline<i>BRCA1</i>and<i>BRCA2</i>Pathogenic Variants","year":2020,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; University of Toronto; University Health Network; Centre hospitalier universitaire de Québec; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"Klinisk Institut, Aalborg Universitet; Servicio Gallego de Salud; Lee Kong Chian School of Medicine, Nanyang Technological University; European Regional Development Fund; Medical Research Council; Canadian Institutes of Health Research; Manchester Biomedical Research Centre; Fox Chase Cancer Center; National Institutes of Health; Centro de Investigación Biomédica en Red de Cáncer; National Cancer Institute; Liga Portuguesa Contra o Cancro; National Institute of General Medical Sciences; Institut National Du Cancer; Tel Aviv University; Ministerio de Economía y Competitividad; Landspítali Háskólasjúkrahús; Aalborg Universitetshospital; Fondation ARC pour la Recherche sur le Cancer; Medizinische Universität Wien; Karolinska Institutet; Hungarian Scientific Research Fund; Gentofte Hospital; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Ministero della Salute; Generalitat de Catalunya; Associazione Italiana per la Ricerca sul Cancro; Aalborg Universitet; Deutsche Krebshilfe; National Breast Cancer Foundation; Seoul National University; Universität Wien; Cancer Australia; National Institute for Health and Care Research; Georgetown University; Nanyang Technological University; Centre Hospitalier Universitaire de Québec; Istituto Oncologico Veneto; Helsingin Yliopisto; Université Laval; Centres de Recerca de Catalunya; KWF Kankerbestrijding; Cancer Research UK; Memorial Sloan-Kettering Cancer Center; Wellcome Trust; College of Medicine, Seoul National University; Susan G. Komen for the Cure; National Cancer Centre of Singapore; Deutsches Krebsforschungszentrum; Università degli Studi di Firenze; Instituto de Investigación Sanitaria de Santiago de Compostela; Ministério da Ciência, Tecnologia e Inovação; Kansas Bioscience Authority; University of Chicago; Cancer Research Institute; Dr. Ralph and Marian Falk Medical Research Trust; Cancer Center, University of Kansas; Cancerfonden; Fundación Mutua Madrileña; Rigshospitalet; National Health and Medical Research Council; Fisher Center for Alzheimer's Research Foundation; Instituto de Salud Carlos III; Ohio State University; Institut Català de la Salut; University of Pennsylvania; European Commission; Breast Cancer Research Foundation","keywords":"Medicine; Germline; Cancer; BRCA2 Protein; Germline mutation; Oncology; Genetics; Mutation; Internal medicine; Gene; Biology","score_opus":0.01058025025450346,"score_gpt":0.2567594755809587,"score_spread":0.24617922532645523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3038926436","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9796134,0.00029391775,0.00046350536,0.018097926,0.00012221816,0.000281385,0.000056542456,0.000005991114,0.0010650735],"genre_scores_gemma":[0.99590075,0.0003823306,0.0003073886,0.0028874453,0.00029384866,0.00007157353,0.000036154746,0.00001957344,0.00010094688],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991114,0.00010961217,0.00021550407,0.00031397335,0.000086898166,0.00016260814],"domain_scores_gemma":[0.9995125,0.000011689075,0.00015911943,0.00022062898,0.000049542177,0.000046548754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000119992554,0.000108308166,0.00017042253,0.00002474459,0.000033975106,0.000008860315,0.00020738838,0.000164047,0.000041334646],"category_scores_gemma":[0.000041328112,0.00008156986,0.000033076005,0.00021423833,0.00013889906,0.0000060069965,0.00014141294,0.00012819936,0.0000019079705],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023502066,0.00003836772,0.013901113,0.000020239739,0.00004891157,0.000004046476,0.0005241572,0.00013405942,0.97948676,0.00010484159,0.000391451,0.0051110317],"study_design_scores_gemma":[0.0029580928,0.0007203933,0.42620066,0.000031270683,0.000065373526,0.00004224763,0.00013686213,0.00081862445,0.5040743,0.00009411553,0.06460635,0.00025170765],"about_ca_topic_score_codex":0.000046868467,"about_ca_topic_score_gemma":0.0003784586,"teacher_disagreement_score":0.47541246,"about_ca_system_score_codex":0.00007856843,"about_ca_system_score_gemma":0.00046638676,"threshold_uncertainty_score":0.3326322},"labels":[],"label_agreement":null},{"id":"W3044088237","doi":"10.1001/jamaoncol.2020.2485","title":"Development and Validation of a Deep Learning Algorithm for Gleason Grading of Prostate Cancer From Biopsy Specimens","year":2020,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":225,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"U.S. Department of Defense","keywords":"Medicine; Grading (engineering); Biopsy; Prostate cancer; Prostate; Second opinion; Prostate biopsy; Radiology; Tumor grade; Medical physics; Cancer; Pathology; Internal medicine","score_opus":0.033228661469353424,"score_gpt":0.31262632328907225,"score_spread":0.2793976618197188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3044088237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99312395,0.0017536767,0.0013253452,0.0029205424,0.00007879642,0.0005875886,0.000059725317,0.000014202986,0.00013615351],"genre_scores_gemma":[0.91688275,0.00078392343,0.08148539,0.00026146785,0.00014362742,0.00023969378,0.00016083026,0.000016558042,0.000025733212],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99931186,0.00002494779,0.0002571051,0.00019503875,0.00008532014,0.00012572658],"domain_scores_gemma":[0.9994537,0.00012467639,0.00020201762,0.000046538342,0.00008898485,0.00008404563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000081417325,0.000087814515,0.00035011917,0.000034793466,0.000030384103,0.00000433423,0.000023711296,0.000065779765,0.000054393],"category_scores_gemma":[0.000047047106,0.00007554644,0.00003533855,0.0000683017,0.00003895242,0.000037066173,0.000026352422,0.00007128893,0.0000011973502],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035112066,0.00015031711,0.050593946,0.00015011866,0.0002713214,0.000019443269,0.007137123,0.000017659646,0.015567653,0.0000371452,0.00017522184,0.92552894],"study_design_scores_gemma":[0.009698225,0.0029750983,0.10470783,0.00029388597,0.0004326189,0.000009685631,0.0019004295,0.005258931,0.7691957,0.00010059274,0.10524854,0.00017851075],"about_ca_topic_score_codex":0.00014286692,"about_ca_topic_score_gemma":0.000016700495,"teacher_disagreement_score":0.9253504,"about_ca_system_score_codex":0.00018166089,"about_ca_system_score_gemma":0.00014054096,"threshold_uncertainty_score":0.30806947},"labels":[],"label_agreement":null},{"id":"W3089997034","doi":"10.1001/jamaoncol.2020.3949","title":"Survival and Outcomes After Noncompletion of Treatment for Anal Cancer","year":2020,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"Colorectal and Anal Carcinomas","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Otorhinolaryngology; Family medicine; MEDLINE; Neurology; Psychiatry","score_opus":0.05276631449055629,"score_gpt":0.3421484084919138,"score_spread":0.2893820940013575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3089997034","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11469815,0.00048231188,0.000017919996,0.88188535,0.00049859384,0.000611353,0.0004027414,0.000018385348,0.0013851745],"genre_scores_gemma":[0.26812094,0.00030395706,0.00053748634,0.7168478,0.007814389,0.00077679654,0.0006903318,0.000060134636,0.0048481836],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99906725,0.000055642246,0.00026488275,0.0002965725,0.00011367215,0.00020196148],"domain_scores_gemma":[0.9992957,0.00029059316,0.0001399359,0.00010776667,0.00009641759,0.00006955735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000043965283,0.000207929,0.0009570975,0.00008704778,0.000022344655,0.0000056498243,0.000041883693,0.00042461566,0.00021913146],"category_scores_gemma":[0.000037443966,0.00014675138,0.0002536947,0.000055905995,0.000101170386,0.000017242575,0.000037146907,0.00032852578,0.000004372202],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003882784,0.00017511389,0.15760125,0.00118787,0.0009189691,0.0015904525,0.0004751781,4.1015412e-7,0.0005466867,0.000035094214,0.77339756,0.0601886],"study_design_scores_gemma":[0.0028120303,0.0043113744,0.11323801,0.00004474695,0.0005795208,0.000032015316,0.000030729003,0.00005298969,0.00004215576,0.000071417315,0.8786632,0.00012182104],"about_ca_topic_score_codex":0.00047994722,"about_ca_topic_score_gemma":0.0005894471,"teacher_disagreement_score":0.16503759,"about_ca_system_score_codex":0.00039775483,"about_ca_system_score_gemma":0.00032174436,"threshold_uncertainty_score":0.59843475},"labels":[],"label_agreement":null},{"id":"W3090413519","doi":"10.1001/jamaoncol.2020.4564","title":"Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib","year":2020,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":1212,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Nivolumab; Ipilimumab; Tolerability; Internal medicine; Sorafenib; Hepatocellular carcinoma; Adverse effect; Randomized controlled trial; Surgery; Gastroenterology; Oncology; Cancer; Immunotherapy","score_opus":0.023995485520901996,"score_gpt":0.2317533058969982,"score_spread":0.2077578203760962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3090413519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99478865,0.0006169438,0.00002658973,0.0010666591,0.000015259495,0.0024042693,0.000017883904,0.000055067172,0.0010086526],"genre_scores_gemma":[0.9980942,0.00006523076,0.0011188077,0.00030950154,0.00003762009,0.00008594119,0.00018482827,0.000049313378,0.000054546992],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99820703,0.00016034067,0.00045235152,0.0005227741,0.00026145176,0.00039605048],"domain_scores_gemma":[0.99891,0.00013316888,0.00020878071,0.00027701474,0.00017239891,0.0002986274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000110262794,0.00030675536,0.0009543969,0.00012755714,0.000048894308,0.000009243133,0.00009365212,0.00022301158,0.000055682653],"category_scores_gemma":[0.00006113968,0.00022216536,0.000063466,0.00044875356,0.00018641942,0.000115415816,0.000056231438,0.0002813768,0.000008907393],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034831136,0.0006886204,0.9416983,0.00019808217,0.00015620572,0.00065510545,0.0013297186,0.0000060157367,0.00026756222,0.000018650062,0.000041387568,0.020109173],"study_design_scores_gemma":[0.09243507,0.023879226,0.8758689,0.00019294309,0.00046978207,0.000033433716,0.00015599426,0.0019177011,0.002480461,0.0000023439457,0.0022882049,0.0002759427],"about_ca_topic_score_codex":0.00014467706,"about_ca_topic_score_gemma":0.000050041428,"teacher_disagreement_score":0.06582944,"about_ca_system_score_codex":0.00028928727,"about_ca_system_score_gemma":0.0003720966,"threshold_uncertainty_score":0.905964},"labels":[],"label_agreement":null},{"id":"W3091620172","doi":"10.1001/jamaoncol.2020.3963","title":"Survival and Outcomes After Noncompletion of Treatment for Anal Cancer—Reply","year":2020,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"Colorectal and Anal Carcinomas","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Queen's University","funders":"","keywords":"Medicine; Anal cancer; MEDLINE; Oncology; Cancer; Gynecology; Internal medicine","score_opus":0.0495800179343163,"score_gpt":0.33570046823075805,"score_spread":0.28612045029644173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3091620172","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09817462,0.00049381756,0.000019589637,0.89827794,0.0005348825,0.0006759344,0.00041993623,0.000023129667,0.0013801336],"genre_scores_gemma":[0.1796642,0.00024592396,0.00045567862,0.8088282,0.0061631096,0.0006297916,0.00060361286,0.00005232626,0.0033571685],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99890614,0.00006601944,0.000316873,0.00035198487,0.00013031838,0.0002286704],"domain_scores_gemma":[0.9991466,0.000350768,0.00017470017,0.00013519106,0.000111405156,0.00008132921],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000055690387,0.0002358065,0.00107389,0.00009996491,0.000026773867,0.0000069989046,0.000051022354,0.0003751602,0.00018316411],"category_scores_gemma":[0.000053075375,0.0001702894,0.00028680408,0.00006618312,0.00011466054,0.000019606428,0.000043668668,0.0003578845,0.0000046970413],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004087848,0.00017160761,0.1284104,0.0011691882,0.0009174952,0.0017468325,0.0004808777,4.3580147e-7,0.00047131418,0.000032431835,0.806961,0.055550575],"study_design_scores_gemma":[0.003006064,0.005440989,0.096972585,0.00005091367,0.0006298564,0.00004381309,0.000037680253,0.000058633497,0.00004692635,0.00008066385,0.89349484,0.00013705854],"about_ca_topic_score_codex":0.0007705032,"about_ca_topic_score_gemma":0.0005804818,"teacher_disagreement_score":0.08944976,"about_ca_system_score_codex":0.00046042987,"about_ca_system_score_gemma":0.00038921495,"threshold_uncertainty_score":0.69442},"labels":[],"label_agreement":null},{"id":"W3093123863","doi":"10.1001/jamaoncol.2020.4630","title":"Multi-institutional Analysis of Prognostic Factors and Outcomes After Hypofractionated Stereotactic Radiotherapy to the Resection Cavity in Patients With Brain Metastases","year":2020,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Radiosurgery; Radiation therapy; Interquartile range; Cohort; Retrospective cohort study; Dose fractionation; Surgery; Internal medicine","score_opus":0.025677227916149986,"score_gpt":0.3126175125691195,"score_spread":0.2869402846529695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093123863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98478395,0.00007224037,0.00042197455,0.013749313,0.000043419113,0.00073882274,0.00017301578,0.000010959266,0.0000062898403],"genre_scores_gemma":[0.99484706,0.00000614979,0.0020462272,0.0028485018,0.000015447695,0.00006766868,0.00014748376,0.000007750801,0.000013683603],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989711,0.00023973171,0.00022787658,0.00023635133,0.0001946645,0.00013029434],"domain_scores_gemma":[0.99901515,0.0005541389,0.00010156637,0.00012551808,0.00009569404,0.000107908665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018145889,0.00013545086,0.00047943293,0.00021810444,0.000044245295,0.000009877027,0.00003559602,0.00005855392,0.00009744613],"category_scores_gemma":[0.00050456234,0.000068221605,0.00008419551,0.0006550694,0.00007651949,0.00009851985,0.000020710952,0.00014200994,0.0000018123396],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023474104,0.0007479367,0.98986125,0.00001785236,0.002007004,0.000038197108,0.0005005287,0.00023852628,0.00004851674,0.000009436941,0.00006564434,0.004117673],"study_design_scores_gemma":[0.0048082424,0.0020262904,0.98857087,0.000010118424,0.0011003598,0.000003536631,0.00012083184,0.00049762323,0.00003757404,5.5802707e-7,0.0027614683,0.00006251058],"about_ca_topic_score_codex":0.0004506077,"about_ca_topic_score_gemma":0.0014827381,"teacher_disagreement_score":0.01090081,"about_ca_system_score_codex":0.00017779892,"about_ca_system_score_gemma":0.00009293227,"threshold_uncertainty_score":0.27819964},"labels":[],"label_agreement":null},{"id":"W3096193621","doi":"10.1001/jamaoncol.2020.5745","title":"Serial Screening for COVID-19 in Asymptomatic Patients Receiving Anticancer Therapy in the United Arab Emirates","year":2020,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Pacira BioSciences; Northwestern University; Intuitive Foundation; Pacira Pharmaceuticals; National Cancer Institute; Agency for Healthcare Research and Quality; Intuitive Surgical; American College of Surgeons","keywords":"Medicine; Coronavirus disease 2019 (COVID-19); Asymptomatic; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); 2019-20 coronavirus outbreak; Cohort study; Betacoronavirus; MEDLINE; Cohort; Pandemic; Family medicine; Internal medicine; Virology; Outbreak; Disease; Infectious disease (medical specialty)","score_opus":0.15245498208069533,"score_gpt":0.4405189808179583,"score_spread":0.28806399873726296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096193621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8435329,0.00006819799,0.0003825616,0.15425348,0.00013755425,0.0014117776,0.0000110824485,0.000039117534,0.0001632965],"genre_scores_gemma":[0.8296967,0.00011381022,0.0005120712,0.1691252,0.00034473083,0.00012043156,0.000064314554,0.000016749507,0.000005967538],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983525,0.0003818048,0.00043239203,0.00025668036,0.00018270199,0.00039387774],"domain_scores_gemma":[0.9972076,0.0021584325,0.00014140224,0.00016425586,0.00009207006,0.00023624543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008297416,0.00013976598,0.0004231633,0.00021339934,0.0000763268,0.000023059332,0.00015379606,0.00021699171,0.000067845554],"category_scores_gemma":[0.005392193,0.00010030189,0.000056408884,0.00071644154,0.000057773468,0.000079499296,0.00002939112,0.00036983466,0.000005575234],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065203705,0.0004455737,0.822001,0.0005395609,0.000040601884,0.0001010371,0.02807224,0.00022343973,0.00066248904,0.00015099814,0.0077185403,0.13352415],"study_design_scores_gemma":[0.020032974,0.004681244,0.8486049,0.00015497235,0.000022804448,0.000008411943,0.0017217788,0.0048608473,0.00007006073,0.00023692838,0.11944622,0.00015881531],"about_ca_topic_score_codex":0.001436077,"about_ca_topic_score_gemma":0.0014061562,"teacher_disagreement_score":0.13336533,"about_ca_system_score_codex":0.0005027903,"about_ca_system_score_gemma":0.0011427463,"threshold_uncertainty_score":0.6455348},"labels":[],"label_agreement":null},{"id":"W3118701973","doi":"10.1001/jamaoncol.2020.6789","title":"Frequency of and Factors Associated With Nonmedical Opioid Use Behavior Among Patients With Cancer Receiving Opioids for Cancer Pain","year":2021,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences","keywords":"Medicine; Interquartile range; Cancer; Opioid; Internal medicine; Cancer pain; Inclusion and exclusion criteria; Physical therapy; Alternative medicine","score_opus":0.02420105981240075,"score_gpt":0.306094218075656,"score_spread":0.2818931582632553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3118701973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973287,0.0003865597,0.000057594894,0.00059964537,0.00016320596,0.0010377974,0.00034374298,0.000030861476,0.000051905645],"genre_scores_gemma":[0.99663997,0.00018770722,0.0011968579,0.000395417,0.00005139918,0.000784155,0.00047279862,0.000048226342,0.00022346602],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99851125,0.00014576424,0.0003093569,0.00039387506,0.0002894886,0.00035024836],"domain_scores_gemma":[0.99827784,0.0005961096,0.00023929257,0.00020664185,0.0004873939,0.00019272193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016337779,0.0002220768,0.0006160456,0.00007231949,0.000070938004,0.000015063364,0.000056595698,0.0002823395,0.00020873388],"category_scores_gemma":[0.00065529335,0.00015582365,0.000057568577,0.0002049674,0.0002171076,0.00012239322,0.0000362199,0.0002242904,2.018712e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001676088,0.0013299865,0.97936404,0.00010584735,0.00040916807,0.000053129268,0.0015419726,0.0000035048106,0.00022327811,0.000012178617,0.0003529629,0.016436346],"study_design_scores_gemma":[0.0076851104,0.0019201796,0.98692507,0.0005095993,0.0007969792,0.000001329564,0.0005319169,0.000049230996,0.00069431943,0.000006539714,0.00071084924,0.00016885599],"about_ca_topic_score_codex":0.002900945,"about_ca_topic_score_gemma":0.010321687,"teacher_disagreement_score":0.01626749,"about_ca_system_score_codex":0.0006022685,"about_ca_system_score_gemma":0.0010757847,"threshold_uncertainty_score":0.6354304},"labels":[],"label_agreement":null},{"id":"W3128013781","doi":"10.1001/jamaoncol.2020.8017","title":"Evaluation of Efficacy and Safety of Nab-Paclitaxel vs Paclitaxel in Platinum-Refractory Metastatic Urothelial Cancer—Reply","year":2021,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Queen's University; University Health Network","funders":"","keywords":"Medicine; Otorhinolaryngology; Neurology; Family medicine; Internal medicine; Psychiatry","score_opus":0.06340154576612089,"score_gpt":0.37241622273889274,"score_spread":0.30901467697277185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3128013781","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.461554,0.027725384,0.000046020756,0.48102492,0.0025052025,0.007010313,0.0028386535,0.00006299136,0.017232511],"genre_scores_gemma":[0.57237905,0.0059139687,0.0022851613,0.40825394,0.0049788146,0.0013741754,0.0018366708,0.00031835306,0.0026598605],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953073,0.0013024088,0.0011715551,0.0006619499,0.0011350617,0.00042172073],"domain_scores_gemma":[0.9966679,0.001090463,0.0007891837,0.0005546933,0.0007996349,0.000098111785],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015205499,0.00042180778,0.0018615262,0.00037704984,0.000034749006,0.000009452944,0.00014382292,0.0007861961,0.0011526527],"category_scores_gemma":[0.0011105612,0.00037439898,0.00021281267,0.00030132922,0.00029670596,0.00008538097,0.00008539968,0.0013071194,0.0000065565496],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011116678,0.003406589,0.012354505,0.0050924416,0.006311351,0.00201491,0.007445246,0.0000952639,0.0060506007,0.000058729907,0.42690882,0.5191449],"study_design_scores_gemma":[0.06747582,0.008329066,0.09381558,0.0027044371,0.010485044,0.00026119113,0.00058831245,0.0002591765,0.001908403,0.00072306505,0.812718,0.0007319275],"about_ca_topic_score_codex":0.0028775504,"about_ca_topic_score_gemma":0.000594578,"teacher_disagreement_score":0.51841295,"about_ca_system_score_codex":0.0012131348,"about_ca_system_score_gemma":0.0045822356,"threshold_uncertainty_score":0.9998708},"labels":[],"label_agreement":null},{"id":"W3129029771","doi":"10.1001/jamaoncol.2020.6752","title":"Why Not Adore ADAURA?—The Trial We Need vs the Trial We Got","year":2021,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Otorhinolaryngology; Family medicine; Neurology; MEDLINE; Psychiatry","score_opus":0.04064746612541352,"score_gpt":0.3827713780327475,"score_spread":0.342123911907334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129029771","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13546228,0.0014827934,0.000052620686,0.8314322,0.0054394533,0.0022035548,0.00004723659,0.0000677382,0.023812097],"genre_scores_gemma":[0.8293935,0.0017798735,0.00078659644,0.10348087,0.01565355,0.0015741893,0.00026544262,0.00008649894,0.046979465],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99851507,0.00032607128,0.00034926986,0.0002757444,0.00024532923,0.00028849047],"domain_scores_gemma":[0.998339,0.00080071803,0.00014099105,0.00046563824,0.00015064531,0.00010301406],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00028388674,0.00015656516,0.000418481,0.0000433028,0.00023840724,0.00004211245,0.00015029688,0.00022258867,0.001128953],"category_scores_gemma":[0.00044353874,0.0000815793,0.0002234686,0.00026328999,0.00014316,0.0000535586,0.00006912429,0.0003790488,0.000114400544],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2618894,0.0011637125,0.00006970509,0.000029435978,0.0008001324,0.0005090541,0.0038912138,0.000008365832,0.000424839,0.0024853202,0.59548587,0.13324293],"study_design_scores_gemma":[0.23411997,0.0027404139,0.00029487506,0.000024844134,0.0006925922,0.00009812177,0.0015381061,0.00002906047,0.00023300799,0.00025071576,0.75990975,0.0000685359],"about_ca_topic_score_codex":0.00023468884,"about_ca_topic_score_gemma":0.0005489291,"teacher_disagreement_score":0.72795135,"about_ca_system_score_codex":0.00033560334,"about_ca_system_score_gemma":0.0013610993,"threshold_uncertainty_score":0.9997842},"labels":[],"label_agreement":null},{"id":"W3133576100","doi":"10.1001/jamaoncol.2021.0019","title":"Assessment of Immune Checkpoint Inhibitors and Genomic Alterations by Body Mass Index in Advanced Renal Cell Carcinoma","year":2021,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"William Osler Health System; Juravinski Cancer Centre","funders":"Genentech; Ipsen; Pfizer; Bristol-Myers Squibb","keywords":"Medicine; Renal cell carcinoma; Body mass index; Clear cell renal cell carcinoma; Internal medicine; Oncology; Vascular endothelial growth factor; Immune checkpoint; Immune system; Carcinoma; Cancer research; Cancer; Immunotherapy; VEGF receptors; Immunology","score_opus":0.01056701007371909,"score_gpt":0.28577121943876493,"score_spread":0.27520420936504586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3133576100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98623633,0.0017950736,0.00012337421,0.001578098,0.00014475205,0.00042291937,0.000020683266,0.000011195537,0.00966755],"genre_scores_gemma":[0.9945807,0.0001272024,0.0039941627,0.00016658807,0.00007483884,0.00008149892,0.00017072994,0.000022254702,0.00078202784],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983542,0.00017078042,0.00066506147,0.00036999176,0.00017452,0.0002654785],"domain_scores_gemma":[0.999093,0.0001294882,0.00021439663,0.0003116051,0.00012251292,0.0001289953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024380416,0.00017654592,0.0005627507,0.000145287,0.000037181573,0.000011893761,0.000055053588,0.00018793954,0.00011515861],"category_scores_gemma":[0.0000405679,0.00016688473,0.00010338976,0.00018660612,0.00008642785,0.00006862073,0.000092332106,0.00033097505,0.00000418019],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012629674,0.0004931507,0.18397936,0.00008181997,0.000031379153,0.0005459907,0.00015550952,0.00004929614,0.8123216,0.00004764144,0.00023693926,0.0019309883],"study_design_scores_gemma":[0.004965572,0.0010949797,0.6482171,0.000031254727,0.00006034257,0.00011583784,0.0002963664,0.0004687862,0.34260932,0.000041767424,0.0020032353,0.000095434734],"about_ca_topic_score_codex":0.000185459,"about_ca_topic_score_gemma":0.00008196175,"teacher_disagreement_score":0.46971232,"about_ca_system_score_codex":0.0008060309,"about_ca_system_score_gemma":0.0007217546,"threshold_uncertainty_score":0.6805362},"labels":[],"label_agreement":null},{"id":"W3137427440","doi":"10.1001/jamaoncol.2021.0379","title":"Evolution of the Randomized Clinical Trial in the Era of Precision Oncology","year":2021,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":202,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; NOSM University; Kingston Health Sciences Centre; Thunder Bay Regional Health Sciences Centre","funders":"","keywords":"Medicine; Randomized controlled trial; Internal medicine; Surrogate endpoint; Breast cancer; Oncology; Clinical endpoint; Colorectal cancer; Cohort; Lung cancer; Cancer","score_opus":0.5062045424251019,"score_gpt":0.6209226704404257,"score_spread":0.11471812801532377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3137427440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83963454,0.0003715813,0.08502742,0.026179377,0.011927771,0.0062959855,0.000067591216,0.000032271426,0.030463452],"genre_scores_gemma":[0.5210251,0.00020166356,0.47635272,0.00096374034,0.0010998411,0.00021237669,0.0000013460326,0.00002051707,0.00012268499],"study_design_codex":"randomized_trial","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9402244,0.05465157,0.003985956,0.000373084,0.0005025108,0.0002624496],"domain_scores_gemma":[0.49803796,0.4993135,0.0014771716,0.000783174,0.00034338536,0.00004478564],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.05315469,0.00013246945,0.0022340522,0.00004143551,0.000038874234,0.0000070851142,0.00061336113,0.0008016671,0.00029630575],"category_scores_gemma":[0.63886446,0.000068504414,0.0007018838,0.00044375102,0.0010423915,0.00003077283,0.0002822258,0.0011719987,0.000006891917],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4461532,0.0035255328,0.00029784345,0.00006444454,0.00013709738,0.000030624473,0.0005928125,0.0000060487214,0.00021824005,0.36191893,0.005017311,0.1820379],"study_design_scores_gemma":[0.33916354,0.0009580592,0.0010836303,0.000059987717,0.0001985243,0.000011948933,0.00021166934,0.00022992946,0.00021460709,0.6550515,0.0027654222,0.000051152998],"about_ca_topic_score_codex":0.000032311462,"about_ca_topic_score_gemma":0.00011364509,"teacher_disagreement_score":0.58570975,"about_ca_system_score_codex":0.00018518619,"about_ca_system_score_gemma":0.001152006,"threshold_uncertainty_score":0.9749765},"labels":[],"label_agreement":null},{"id":"W3162414274","doi":"10.1001/jamaoncol.2021.1359","title":"Central Nervous System–Specific Outcomes of Phase 3 Randomized Clinical Trials in Patients With Advanced Breast Cancer, Lung Cancer, and Melanoma","year":2021,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Sunnybrook Health Science Centre; Juravinski Hospital; McMaster University; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Lung cancer; Melanoma; Oncology; Cancer; Internal medicine; Clinical trial; Central nervous system; Metastatic breast cancer; Randomized controlled trial; Cancer research","score_opus":0.034853460795665675,"score_gpt":0.41050362783154726,"score_spread":0.3756501670358816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3162414274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875385,0.0058824713,0.00008556025,0.003387024,0.00077557407,0.0017165296,0.00046009524,0.000018286599,0.00013595847],"genre_scores_gemma":[0.99565214,0.0020814354,0.0012740048,0.00035762374,0.00016760372,0.00027074091,0.000107715365,0.000021357635,0.00006736821],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9953721,0.002297902,0.0014086608,0.0003927353,0.00021169522,0.00031690786],"domain_scores_gemma":[0.9959126,0.002769955,0.000644197,0.00025192136,0.00021629065,0.00020500828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024541966,0.00020673726,0.0033263636,0.000084716914,0.00003061896,0.000010135136,0.00005098882,0.00017348507,0.00016387524],"category_scores_gemma":[0.0007010798,0.0001279226,0.00028196463,0.00016273136,0.00017282063,0.000055940804,0.000038223232,0.00021493444,5.742538e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14859729,0.0021825864,0.53751934,0.00019366092,0.001192997,0.00039531104,0.00012410415,0.00001845474,0.000018492816,0.00021638266,0.0003525434,0.30918887],"study_design_scores_gemma":[0.51824987,0.00084401865,0.47805578,0.00027463445,0.00095491833,0.000044232827,0.00017645495,0.00018900774,0.00004032695,0.000004032166,0.0010708725,0.00009585936],"about_ca_topic_score_codex":0.0004713238,"about_ca_topic_score_gemma":0.00034603578,"teacher_disagreement_score":0.36965257,"about_ca_system_score_codex":0.00038243813,"about_ca_system_score_gemma":0.00057760865,"threshold_uncertainty_score":0.52165323},"labels":[],"label_agreement":null},{"id":"W3164251373","doi":"10.1001/jamaoncol.2021.1463","title":"Association of Molecular Subtypes With Differential Outcome to Apalutamide Treatment in Nonmetastatic Castration-Resistant Prostate Cancer","year":2021,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Hazard ratio; Prostate cancer; Internal medicine; Oncology; Proportional hazards model; Enzalutamide; Cohort; Confidence interval; Cancer; Androgen receptor","score_opus":0.02506877602564506,"score_gpt":0.3563358219363845,"score_spread":0.33126704591073947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164251373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884149,0.0003287112,0.000038157144,0.009774921,0.00007728592,0.00071892847,0.00007211354,0.0000101334945,0.00056484557],"genre_scores_gemma":[0.9925085,0.00017281281,0.0011818296,0.0002224098,0.000036627596,0.00030720027,0.00009307771,0.000016092936,0.0054614614],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987533,0.00013554894,0.00030433276,0.0002464675,0.00027687833,0.00028349183],"domain_scores_gemma":[0.9992972,0.00011242747,0.00011383314,0.00015029115,0.00022014903,0.00010608063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011768876,0.00012764064,0.00044668617,0.00012650232,0.000024399773,0.0000137550005,0.000034001507,0.00008652722,0.00018781592],"category_scores_gemma":[0.0000833237,0.00008898809,0.000057299447,0.00030287917,0.000031430394,0.0000397457,0.000020856118,0.00011350901,0.00000861469],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004729493,0.0013692706,0.71260977,0.00019079114,0.0007216824,0.002268237,0.0021950952,0.0002177776,0.24849476,0.0000918217,0.000170261,0.026941026],"study_design_scores_gemma":[0.017307622,0.005518838,0.7840358,0.0001665558,0.0005384517,0.000029069262,0.0007950696,0.00009987216,0.18681198,0.000089843066,0.0044103893,0.00019653217],"about_ca_topic_score_codex":0.0009467433,"about_ca_topic_score_gemma":0.008058852,"teacher_disagreement_score":0.07142599,"about_ca_system_score_codex":0.0017726549,"about_ca_system_score_gemma":0.0009867896,"threshold_uncertainty_score":0.46354312},"labels":[],"label_agreement":null},{"id":"W3176726648","doi":"10.1001/jamaoncol.2021.1516","title":"Adjuvant Zoledronate Therapy for Women With Breast Cancer—Effective Treatment or Fool’s Gold?","year":2021,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Adjuvant; Breast cancer; MEDLINE; Adjuvant therapy; Oncology; Medical physics; Cancer; Intensive care medicine; Internal medicine","score_opus":0.028488919355201585,"score_gpt":0.34469385056623747,"score_spread":0.3162049312110359,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3176726648","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05161044,0.0034789373,0.000013024341,0.9305061,0.0011539826,0.008090705,0.0017949096,0.00014022757,0.0032116345],"genre_scores_gemma":[0.012786684,0.004331355,0.0007124902,0.853433,0.0056365677,0.035232063,0.0015896169,0.00028430016,0.08599394],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970705,0.00024491115,0.00040925373,0.00087705057,0.00027033806,0.0011279327],"domain_scores_gemma":[0.9978612,0.0006228457,0.0003461545,0.0005094765,0.00033491713,0.00032537637],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00012866734,0.0006553869,0.0018556729,0.00017186523,0.00011028747,0.0000244367,0.0001079041,0.0013262356,0.0007115579],"category_scores_gemma":[0.00001993166,0.00037356763,0.00019759336,0.00021384424,0.00012543329,0.000055193992,0.00002810381,0.0008841798,0.000034954417],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020643422,0.0009248413,0.0019615514,0.0004380884,0.0026176693,0.006950826,0.00060895685,7.9477945e-7,0.000012217166,0.0000023140772,0.38600558,0.57983375],"study_design_scores_gemma":[0.031518836,0.02845633,0.034447823,0.000283786,0.00051484903,0.0020522452,0.000102211714,0.0000087992,0.00005808469,0.000025056728,0.90221256,0.00031943928],"about_ca_topic_score_codex":0.0022106275,"about_ca_topic_score_gemma":0.0028862373,"teacher_disagreement_score":0.57951427,"about_ca_system_score_codex":0.0061531896,"about_ca_system_score_gemma":0.003759067,"threshold_uncertainty_score":0.99997026},"labels":[],"label_agreement":null},{"id":"W3180426532","doi":"10.1001/jamaoncol.2021.2140","title":"Practice Patterns and Outcomes of Novel Targeted Agents for the Treatment of <i>ERBB2</i>-Positive Metastatic Breast Cancer","year":2021,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; CancerCare Manitoba; Queen's University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Metastatic breast cancer; Oncology; Breast cancer; Cancer; Internal medicine; Intensive care medicine","score_opus":0.08597336018157553,"score_gpt":0.4605725266895825,"score_spread":0.37459916650800695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3180426532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86272746,0.0041381097,0.0018324855,0.123783715,0.00053126283,0.0025136317,0.0033695046,0.000015505859,0.0010883246],"genre_scores_gemma":[0.98594284,0.0040941346,0.0045574517,0.003389159,0.0001404586,0.0005413147,0.0000563248,0.00003133233,0.0012469703],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998875,0.00015052974,0.0002985591,0.00021666811,0.0002357739,0.0002234708],"domain_scores_gemma":[0.99631894,0.0025676885,0.00019014985,0.00024150853,0.0005974944,0.00008420957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028217872,0.000115506715,0.00052380055,0.00004851344,0.000040808703,0.0000069466237,0.00006574087,0.000071373375,0.00024574515],"category_scores_gemma":[0.0004215123,0.00007213205,0.0001029985,0.00013435434,0.0001357646,0.000051600673,0.000040648913,0.000103675084,0.000001117466],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057470165,0.014228267,0.32354346,0.0012473973,0.009413215,0.00057286536,0.012842532,0.00007210813,0.034840614,0.00071778253,0.006771328,0.59000343],"study_design_scores_gemma":[0.016225064,0.004542766,0.8159953,0.00014880692,0.0019928447,0.000498781,0.0042687696,0.0008143598,0.026843775,0.000021989075,0.12851158,0.00013601576],"about_ca_topic_score_codex":0.00240499,"about_ca_topic_score_gemma":0.00074652705,"teacher_disagreement_score":0.5898674,"about_ca_system_score_codex":0.000348127,"about_ca_system_score_gemma":0.0007587509,"threshold_uncertainty_score":0.36356413},"labels":[],"label_agreement":null},{"id":"W3186969757","doi":"10.1001/jamaoncol.2021.2318","title":"Addition of Metformin to Concurrent Chemoradiation in Patients With Locally Advanced Non–Small Cell Lung Cancer","year":2021,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Hamilton Health Sciences","funders":"National Cancer Institute","keywords":"Medicine; Internal medicine; Interquartile range; Hazard ratio; Metformin; Common Terminology Criteria for Adverse Events; Lung cancer; Chemoradiotherapy; Oncology; Clinical endpoint; Cancer; Surgery; Clinical trial; Confidence interval","score_opus":0.004354965336468148,"score_gpt":0.2483650140380045,"score_spread":0.24401004870153636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3186969757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9818167,0.016110176,0.0006144448,0.000047905178,0.00032265828,0.00033092074,0.00010640853,0.0000031979296,0.0006476003],"genre_scores_gemma":[0.9930035,0.0035856396,0.0012694778,0.0010600619,0.00017561608,0.00022560924,0.00054326514,0.000018712111,0.000118148775],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990936,0.000059606336,0.00023800727,0.00029137914,0.00010352216,0.00021388901],"domain_scores_gemma":[0.9993006,0.000014393037,0.00014461362,0.00017606215,0.00028940925,0.0000749094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009789421,0.0001179098,0.00025346878,0.00004690663,0.000016721127,0.0000059645904,0.00009133884,0.00016077966,0.000114772905],"category_scores_gemma":[0.000051451658,0.00011155332,0.000041125182,0.00015914359,0.00002670266,0.0000071307004,0.000052188054,0.0000857778,0.000002610722],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050811935,0.0005017664,0.031272966,0.00013736448,0.00005552614,0.0000053327744,0.00025017795,0.0012988184,0.052470516,0.000025999565,0.004197465,0.90927595],"study_design_scores_gemma":[0.007955349,0.0010944693,0.07626023,0.00007900083,0.00006753355,8.513406e-7,0.00012846378,0.00016419037,0.6000224,0.0000091947,0.3139265,0.000291858],"about_ca_topic_score_codex":0.0000309406,"about_ca_topic_score_gemma":0.0006323164,"teacher_disagreement_score":0.90898407,"about_ca_system_score_codex":0.000099288816,"about_ca_system_score_gemma":0.00048151502,"threshold_uncertainty_score":0.45490125},"labels":[],"label_agreement":null},{"id":"W3191105813","doi":"10.1001/jamaoncol.2021.2697","title":"Recommendations for Age-Appropriate Testing, Timing, and Frequency of Audiologic Monitoring During Childhood Cancer Treatment","year":2021,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Hearing, Cochlea, Tinnitus, Genetics","field":"Neuroscience","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; SickKids Foundation; Hospital for Sick Children; BC Children's Hospital; University of British Columbia","funders":"Cancer Research UK","keywords":"Medicine; Context (archaeology); Ototoxicity; Hearing loss; Tinnitus; Intensive care medicine; Cancer; Clinical trial; Pediatric cancer; Audiology; Surgery; Internal medicine; Chemotherapy; Cisplatin","score_opus":0.1561833292756699,"score_gpt":0.3740810340462203,"score_spread":0.21789770477055037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3191105813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952597,0.00029006036,0.0000869562,0.0016630773,0.00057287567,0.0003738702,0.000044344957,0.00006375553,0.0016453685],"genre_scores_gemma":[0.9620694,0.0009333926,0.035595044,0.00019439895,0.0003638527,0.0002286968,0.0000053036556,0.000028545326,0.00058135146],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99844015,0.00020361581,0.0003776205,0.0005071607,0.00008961823,0.00038186548],"domain_scores_gemma":[0.99838,0.00089354,0.000245292,0.0002620668,0.0001234444,0.00009564464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000159838,0.00016791046,0.0003348002,0.00008261269,0.00023766441,0.000034051154,0.00013970901,0.0001668059,0.000047044578],"category_scores_gemma":[0.002526466,0.0001620911,0.00005362108,0.00024115399,0.000109000866,0.000071372386,0.00013799511,0.00016230113,0.00000461719],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001704364,0.00032141912,0.045509897,0.00006853101,0.000028423281,0.00008348944,0.0015550769,0.00016451882,0.86062235,0.00019161361,0.000069047965,0.09136858],"study_design_scores_gemma":[0.0024035198,0.0009179816,0.21494277,0.0001234989,0.00007946505,0.00016711428,0.0002616798,0.00016063522,0.7739042,0.0015166027,0.0052475757,0.00027497456],"about_ca_topic_score_codex":0.00019928225,"about_ca_topic_score_gemma":0.00014201106,"teacher_disagreement_score":0.16943288,"about_ca_system_score_codex":0.0003148016,"about_ca_system_score_gemma":0.00043653086,"threshold_uncertainty_score":0.6609884},"labels":[],"label_agreement":null},{"id":"W3195999920","doi":"10.1001/jamaoncol.2021.3338","title":"Randomized Clinical Trials in the Era of Precision Oncology—The Role of End Points, Industry Funding, and Medical Writing Integrity","year":2021,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Otorhinolaryngology; Family medicine; MEDLINE; Neurology; Internal medicine; Psychiatry","score_opus":0.1383174984120795,"score_gpt":0.4000104798995828,"score_spread":0.2616929814875033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3195999920","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12088325,0.017962782,0.00016855303,0.7976475,0.002286664,0.0014669015,0.00037285572,0.00001061294,0.059200894],"genre_scores_gemma":[0.5097533,0.020804122,0.0009716225,0.45708662,0.010424032,0.0003191768,0.0001624894,0.00008200833,0.00039665936],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98572963,0.006155013,0.006731543,0.00070631393,0.00015293118,0.0005245463],"domain_scores_gemma":[0.9476413,0.04641255,0.0051325657,0.0005892253,0.00012322115,0.00010110375],"candidate_categories":["metaresearch","research_integrity","insufficient_payload"],"consensus_categories":["metaresearch","research_integrity"],"category_scores_codex":[0.091011226,0.00031065108,0.0055099023,0.00024665392,0.00007235707,0.00006174237,0.00089098717,0.006129751,0.0014875932],"category_scores_gemma":[0.0687851,0.00021811687,0.000814785,0.0002164669,0.0013103837,0.00015307756,0.0003211356,0.010841102,0.000016567055],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009188872,0.0005037805,0.023507237,0.00016941887,0.00065022154,0.00020137636,0.0019334614,0.0000018653324,0.000001792396,0.050808646,0.35166737,0.56136596],"study_design_scores_gemma":[0.038252767,0.00034180595,0.004612488,0.00026261565,0.00009066138,0.000064698244,0.0006048525,0.00024922233,0.000007962122,0.040045585,0.91524315,0.00022416528],"about_ca_topic_score_codex":0.0011819304,"about_ca_topic_score_gemma":0.00032670933,"teacher_disagreement_score":0.5635758,"about_ca_system_score_codex":0.00030077834,"about_ca_system_score_gemma":0.0010861758,"threshold_uncertainty_score":0.9994252},"labels":[],"label_agreement":null},{"id":"W3201585333","doi":"10.1001/jamaoncol.2021.3987","title":"Prognosis Associated With Luminal and Basal Subtypes of Metastatic Prostate Cancer","year":2021,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Medicine; Prostate cancer; Basal (medicine); Internal medicine; Oncology; Prostate; Pathology; Cancer; Biopsy","score_opus":0.03329409438283301,"score_gpt":0.352235723384815,"score_spread":0.318941629001982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201585333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98520905,0.0029567264,0.0000019670615,0.009739414,0.000055474196,0.00037164093,0.00004768451,0.000015515187,0.0016025357],"genre_scores_gemma":[0.99422634,0.0010440577,0.00055541476,0.000342859,0.000048589827,0.00016036052,0.00007231681,0.000015275731,0.0035347776],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991079,0.00011273784,0.00015572253,0.00020328941,0.00018634388,0.00023401278],"domain_scores_gemma":[0.99919575,0.00016799671,0.00008696786,0.00008670747,0.00036150345,0.0001010479],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017739489,0.000093137336,0.0003602061,0.000060288625,0.00003819469,0.000009928409,0.000027364851,0.00006634025,0.00017386218],"category_scores_gemma":[0.00014684311,0.00006222629,0.00003160512,0.0002524024,0.00021953118,0.000051988845,0.000036209076,0.00016017794,0.0000021248447],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031842324,0.001240638,0.9247697,0.00043653906,0.0014291024,0.0022462714,0.0017779005,0.0000026497348,0.012953426,0.00008451222,0.003887746,0.04798729],"study_design_scores_gemma":[0.015829861,0.0057631214,0.8671627,0.0005280608,0.0010235184,0.00018599445,0.0014998824,0.00014602473,0.096189864,0.00022466213,0.011252323,0.00019396875],"about_ca_topic_score_codex":0.0001238449,"about_ca_topic_score_gemma":0.00049820996,"teacher_disagreement_score":0.08323643,"about_ca_system_score_codex":0.00016640921,"about_ca_system_score_gemma":0.0011305374,"threshold_uncertainty_score":0.25375143},"labels":[],"label_agreement":null},{"id":"W3202966447","doi":"10.1001/jamaoncol.2021.4531","title":"Incidence and Predictors of Second Primary Cancers in Patients With Neuroendocrine Tumors","year":2021,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Incidence (geometry); Oncology; Internal medicine; Neuroendocrine tumors; Primary (astronomy)","score_opus":0.009036331980940648,"score_gpt":0.28587309050649645,"score_spread":0.2768367585255558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3202966447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99464726,0.00022710346,6.910288e-7,0.001303584,0.000090807,0.00037043038,0.000019543868,0.000017242319,0.003323312],"genre_scores_gemma":[0.99777776,0.00010588665,0.00042724004,0.0010596736,0.000047675476,0.000030970023,0.00002337225,0.000019793095,0.0005076146],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99856335,0.00013380499,0.00029824843,0.00034144562,0.0003163508,0.0003467784],"domain_scores_gemma":[0.99904555,0.0002358714,0.00011444926,0.00023587368,0.00019791756,0.00017032807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000060775146,0.00012792592,0.00046571635,0.00016129107,0.000019710516,0.000006214699,0.00008237279,0.000009511652,0.00016102415],"category_scores_gemma":[0.0004605771,0.00010704464,0.00002471714,0.0003507673,0.00026111037,0.000166697,0.0001574445,0.00038108925,0.0000019481356],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001286868,0.00024450454,0.9807057,0.00026649822,0.00002409129,0.010894507,0.00005972793,0.00001152415,0.0017744299,0.000020058767,0.000763884,0.003948243],"study_design_scores_gemma":[0.0057532177,0.0030450353,0.975515,0.00010604843,0.000017554787,0.0010412631,0.00008403719,0.0000073872943,0.005029583,0.000025453175,0.009299309,0.00007609161],"about_ca_topic_score_codex":0.00008961954,"about_ca_topic_score_gemma":0.0011450191,"teacher_disagreement_score":0.009853244,"about_ca_system_score_codex":0.00028166594,"about_ca_system_score_gemma":0.00093700556,"threshold_uncertainty_score":0.43651536},"labels":[],"label_agreement":null},{"id":"W3209267706","doi":"10.1001/jamaoncol.2021.5153","title":"Implications of Selection Bias Due to Delayed Study Entry in Clinical Genomic Studies","year":2021,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Genetic Associations and Epidemiology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Medicine; Milestone; Truncation (statistics); Lung cancer; Data set; Cancer; Survival analysis; Oncology; Internal medicine; Statistics","score_opus":0.07599562025519879,"score_gpt":0.41817460537246715,"score_spread":0.34217898511726835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209267706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99430454,0.0005435545,0.0005138402,0.003201408,0.00023530089,0.0002711175,0.000012878928,0.00000515402,0.00091221894],"genre_scores_gemma":[0.994658,0.00044892405,0.0030554873,0.0012263408,0.00021269398,0.00009361258,0.00004186422,0.0000096127305,0.0002534442],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99790436,0.00079506455,0.0006775381,0.00037119442,0.00004185448,0.00021000735],"domain_scores_gemma":[0.9989434,0.00025431582,0.00019198026,0.00025540302,0.00029499998,0.000059885762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010870575,0.00009416925,0.00040395246,0.000061398634,0.00004666986,0.0000037408222,0.0001172606,0.00026599035,0.000026440266],"category_scores_gemma":[0.0020367028,0.000095388976,0.00008704345,0.00022281491,0.000049803362,0.0000016024449,0.00019528782,0.00013417902,0.000012684297],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009923638,0.0008728832,0.9162363,0.0000051382253,0.00028034573,0.000007718999,0.00031523657,0.00046491544,0.047711376,0.00008768431,0.00865756,0.02526161],"study_design_scores_gemma":[0.000938836,0.0015069969,0.9802385,0.0000026592486,0.000037349295,0.00003137664,0.0015195644,0.000022363121,0.001198668,0.0002495242,0.014165548,0.000088603825],"about_ca_topic_score_codex":0.00007275819,"about_ca_topic_score_gemma":0.0042371736,"teacher_disagreement_score":0.064002216,"about_ca_system_score_codex":0.000088600216,"about_ca_system_score_gemma":0.0003268313,"threshold_uncertainty_score":0.38898495},"labels":[],"label_agreement":null},{"id":"W3210203927","doi":"10.1001/jamaoncol.2021.4398","title":"Analysis of the Li-Fraumeni Spectrum Based on an International Germline <i>TP53</i> Variant Data Set","year":2021,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":146,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute","keywords":"Li–Fraumeni syndrome; Germline; Genetics; Phenotype; Cancer; Medicine; Germline mutation; Biology; Gene; Mutation","score_opus":0.03520636438146082,"score_gpt":0.3412794353095997,"score_spread":0.3060730709281389,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3210203927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7618376,0.00028421354,0.0118735805,0.15664941,0.0041290433,0.0008450885,0.0031808703,0.00013247403,0.061067715],"genre_scores_gemma":[0.98514456,0.000041953488,0.0014256652,0.010090775,0.00035759318,0.000009566926,0.002500116,0.000022022588,0.0004077324],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99838114,0.00024871703,0.00035183423,0.00046276083,0.00036918273,0.00018633802],"domain_scores_gemma":[0.99766505,0.00016446966,0.00019677855,0.0017276785,0.00014935958,0.00009666035],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004502365,0.00012281566,0.00042562812,0.00021524014,0.000037340964,0.000014066302,0.00048667318,0.00020501454,0.001255323],"category_scores_gemma":[0.0004905131,0.000095653115,0.00017827177,0.00087230594,0.000081299986,0.00006586788,0.00027230216,0.00038716313,0.000014394841],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010333094,0.017591944,0.071536615,0.0002840133,0.029002514,0.01912333,0.0027835907,0.07929838,0.48240727,0.0155486455,0.10667856,0.16541204],"study_design_scores_gemma":[0.0069034747,0.0012996305,0.09398179,0.00009769927,0.004873795,0.00035041166,0.00013265073,0.4436319,0.023199001,0.00012261927,0.4251522,0.00025484458],"about_ca_topic_score_codex":0.00014137411,"about_ca_topic_score_gemma":0.0010014696,"teacher_disagreement_score":0.45920828,"about_ca_system_score_codex":0.00028539315,"about_ca_system_score_gemma":0.0009067114,"threshold_uncertainty_score":0.9996577},"labels":[],"label_agreement":null},{"id":"W3211488171","doi":"10.1001/jamaoncol.2019.2996","title":"Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017","year":2019,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":2665,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Alberta; University of British Columbia; University of Toronto; Public Health Agency of Canada; Ottawa Hospital; University of Manitoba; Impact; McGill University; University of Calgary","funders":"Division of Cancer Epidemiology and Genetics, National Cancer Institute; National Cancer Institute; Dipartimento di Medicina e Chirurgia, Università degli Studi di Milano-Bicocca; Invasive Fungi Research Center, Mazandaran University of Medical Sciences; Department of Medicine, Ottawa Hospital; Center for International Health; Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences; College of Medicine and Health Sciences, United Arab Emirates University; Gastrointestinal and Liver Diseases Research Center; Drug Applied Research Center, Tabriz University of Medical Sciences; Medical Research Council; Đại học Quốc gia Hà Nội; School of Public Health and Family Medicine, University of Cape Town; Comprehensive Cancer Center, University of Alabama at Birmingham; Injury Prevention Research Center; Wolkite University; Directorate for Biological Sciences; Debre Markos University; Damietta University; Universitair Ziekenhuis Antwerpen; Moscow Institute of Physics and Technology; Imam Abdulrahman Bin Faisal University; Shahroud University of Medical Sciences; Babol University of Medical Sciences; Menzies Institute for Medical Research; Kurdistan University Of Medical Sciences; Lorestan University of Medical Sciences; Kwame Nkrumah University of Science and Technology; Universitas Hasanuddin; Savitribai Phule Pune University; McGill University; Alexandria University; Mansoura University; University of Peradeniya; Xiamen University; Universitas Airlangga; Universidad Autónoma de Sinaloa; Shahid Beheshti University of Medical Sciences; Universitatea de Medicină şi Farmacie \"Carol Davila\" Bucureşti; Golestan University of Medical Sciences; Western Sydney University; Tartu Ülikool; College of Science and Engineering, University of Minnesota; Shiraz University of Medical Sciences; Fakultet Medicinskih Nauka, Univerziteta U Kragujevcu; Università degli Studi di Milano; Pomorski Uniwersytet Medyczny W Szczecinie; Qatar Foundation; Universidade Federal de Minas Gerais; University of Hail; Universidade do Porto; Virginia Commonwealth University; Università di Bologna; Baqiyatallah University of Medical Sciences; Shahrekord University of Medical Sciences; Chungnam National University Hospital; Universidad Nacional Autónoma de México; University of New South Wales; Kermanshah University of Medical Sciences; Birjand University of Medical Sciences; University of South Carolina; Pacific Institute for Research and Evaluation; Qazvin University of Medical Sciences; Guilan University of Medical Sciences; Universitair Medisch Centrum Groningen; University of Gondar; United Arab Emirates University; Instituto De Saúde Pública, Universidade do Porto; Ahvaz Jundishapur University of Medical Sciences; Mazandaran University of Medical Sciences; Shahrekord University; Ministry of Health and Medical Education; Haramaya University; National Center of Neurology and Psychiatry; Mashhad University of Medical Sciences; Taipei Medical University; Tanta University; World Health Organization; Urmia University; Babol Noshirvani University of Technology; Hamadan University of Medical Sciences; Institute for Research in Fundamental Sciences; Inyuvesi Yakwazulu-Natali; Semmelweis Egyetem; University College London; Universiti Kebangsaan Malaysia; Hawassa University; Kuwait University; Tampereen Yliopisto; Tabriz University of Medical Sciences; Seoul National University Hospital; Tsinghua University; University of Cape Town; Khalifa University of Science, Technology and Research; Student Research Committee, Tabriz University of Medical Sciences; La Trobe University; Frankfurt University of Applied Sciences; Kashan University of Medical Sciences; Karolinska Institutet; Kerman University of Medical Sciences; Public Health Agency of Canada; Madda Walabu University; Universidade Federal de Juiz de Fora; Institució Catalana de Recerca i Estudis Avançats; Rafsanjan University of Medical Sciences; United Nations Population Fund; Bushehr University of Medical Sciences; Kyung Hee University; Tarbiat Modares University; Hacettepe Üniversitesi; U.S. Department of Veterans Affairs; Kosin University; Sun Yat-sen University; Yonsei University; Rijksuniversiteit Groningen; Sharif University of Technology; Adigrat University; Morgan State University; Universitätsklinikum Heidelberg; Ottawa Hospital Research Institute; King Saud University; Ain Shams University; Cochrane South Africa; University of Toronto; Imperial College London; Public Health England; Queensland University of Technology; Cairo University; Laboratório Associado para a Química Verde; University of Health Sciences Lahore; Oklahoma State University; Flinders University; Monash University; Wuhan University; University of Washington; South African Medical Research Council; Universitas Negeri Semarang; Sydney Medical School; Newcastle University; Universitat de València; Helsingin Yliopisto; Delhi Technological University; Uniwersytet Jagielloński Collegium Medicum; Shiraz University; King's College London; McMaster University; University of Leicester; Sanjay Gandhi Postgraduate Institute of Medical Sciences; Krishna Institute Of Medical Sciences Deemed To Be University; Universität Ulm; University of Embu; Health Services Management Research Center; Dilla University; Maragheh University of Medical Sciences; Mekelle University; National Institutes of Health; Banaras Hindu University; Wollega University; University of Tabriz; Ahmadu Bello University; Brigham and Women's Hospital; Arak University of Medical Sciences; Rede de Química e Tecnologia; Radboud Universiteit; Aksum University; Islamic Azad University; West Virginia University; University of Health and Allied Sciences; A.T. Still University; Christian Medical College, Vellore; Curtin University of Technology; Universidade Federal de Santa Catarina; Amirkabir University of Technology; Applied Molecular Biosciences Unit; Iran University of Medical Sciences; Ekiti State University; Bahir Dar University; National Center for Child Health and Development; Sheffield Hallam University; Universidade Federal do Rio Grande do Sul; Arabian Gulf University; Seattle Children's Research Institute; Deakin University; Public Health Agency; Eli Lilly and Company; Syddansk Universitet; Jimma University; Harvard University; Postgraduate Institute of Medical Education and Research, Chandigarh; Sveučilište u Zagrebu; Seoul National University; Tehran University of Medical Sciences and Health Services; University of Technology Sydney; Division of Cardiothoracic Surgery, University of Colorado School of Medicine, Anschutz Medical Campus; University of Jiroft; Durban University of Technology; University of Texas at Austin; Bournemouth University; Trường Đại học Nguyễn Tất Thành; Chungnam National University; Addis Ababa University; Ball State University; Samara University; Jordan University of Science and Technology; Hamad Bin Khalifa University; University of Oklahoma; Wellcome Trust; Johns Hopkins University; Westfälische Wilhelms-Universität Münster; St. Jude Children's Research Hospital; Trường Đại học Duy Tân; Universidade de Brasília; Case Western Reserve University; Hamad Medical Corporation; Birmingham City University; School of Medicine, Boston University; Jackson State University; University of Tasmania; Alborz University of Medical Sciences; Northwestern University; University of West Florida; Isfahan University of Medical Sciences; Instituto de Salud Carlos III; San Diego State University","keywords":"Medicine; Cancer; Incidence (geometry); Cancer incidence; Years of potential life lost; Demography; Gerontology; Life expectancy; Population; Environmental health; Internal medicine","score_opus":0.10922435704668773,"score_gpt":0.40194005345103223,"score_spread":0.29271569640434447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211488171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98965925,0.0013717368,0.000023969553,0.006668442,0.0002248951,0.0012793858,0.00029781967,0.000024925215,0.0004495758],"genre_scores_gemma":[0.99286497,0.0003795654,0.0009757796,0.005038355,0.0004134067,0.00019171016,0.0000353889,0.000020393136,0.00008044013],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978005,0.00009345339,0.00046420243,0.0006406009,0.0006169617,0.00038427112],"domain_scores_gemma":[0.9982333,0.00038687114,0.00024012972,0.0003339292,0.0003646903,0.00044108083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058130495,0.00020708473,0.0007179337,0.000054279204,0.000046886886,0.000029964878,0.0001899591,0.00026142734,0.00014977356],"category_scores_gemma":[0.00054380414,0.00019821242,0.00008673852,0.0003397031,0.00067457196,0.00022412914,0.0001978196,0.00020186548,0.000009029368],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022549802,0.00017379811,0.9777948,0.0002281956,0.00020445805,0.000016481681,0.00036106867,0.0002533791,0.00009183074,0.00051880674,0.011549177,0.0065530087],"study_design_scores_gemma":[0.0032643403,0.0014780498,0.9799229,0.0002659407,0.00017432425,0.000043603563,0.0005574602,0.00028067685,0.0000062447707,0.0004076788,0.013382502,0.000216291],"about_ca_topic_score_codex":0.013294134,"about_ca_topic_score_gemma":0.014366062,"teacher_disagreement_score":0.006336718,"about_ca_system_score_codex":0.0007440561,"about_ca_system_score_gemma":0.0011336126,"threshold_uncertainty_score":0.9932764},"labels":[],"label_agreement":null},{"id":"W3212351387","doi":"10.1001/jamaoncol.2021.4337","title":"Treatment Selection in First-line Metastatic Renal Cell Carcinoma—The Contemporary Treatment Paradigm in the Age of Combination Therapy","year":2021,"lang":"en","type":"review","venue":"JAMA Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Renal cell carcinoma; Oncology; Clear cell renal cell carcinoma; Internal medicine; Targeted therapy; Immune checkpoint; Blockade; Biomarker; Immunotherapy; Cancer; Receptor","score_opus":0.14141519839767608,"score_gpt":0.3723387328481768,"score_spread":0.23092353445050073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212351387","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.028264329,0.9615571,0.000006754947,0.0018115998,0.00013028391,0.005457582,0.000035701618,0.000014408388,0.0027222363],"genre_scores_gemma":[0.15859301,0.8371383,0.00007826799,0.00014363088,0.00012136236,0.002191394,0.0010943675,0.000050435832,0.0005892613],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949685,0.0023941817,0.0013226476,0.0005977512,0.0003410013,0.00037593648],"domain_scores_gemma":[0.9967977,0.001803089,0.00071101665,0.00054783304,0.000071056886,0.000069307236],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006216821,0.0006530584,0.0030992222,0.00044901835,0.00007420346,0.00002533315,0.0002142315,0.00038741663,0.000056365046],"category_scores_gemma":[0.000042051986,0.00031861893,0.0007708483,0.00086221227,0.00013837029,0.000053046013,0.000029113608,0.00046934988,0.000013770915],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059552654,0.010989787,0.0021452107,0.0023557888,0.0008520947,0.0073585487,0.0033208176,0.0000194869,0.000024286712,0.00027844426,0.00046713455,0.97159284],"study_design_scores_gemma":[0.013082867,0.018301297,0.004435483,0.0011569428,0.0016678219,0.0010034299,0.00022401825,0.00003864092,0.00019774261,0.00006155198,0.9595832,0.0002470042],"about_ca_topic_score_codex":0.0024962663,"about_ca_topic_score_gemma":0.0017158398,"teacher_disagreement_score":0.97134584,"about_ca_system_score_codex":0.004157181,"about_ca_system_score_gemma":0.0020866357,"threshold_uncertainty_score":0.99992657},"labels":[],"label_agreement":null},{"id":"W4200584507","doi":"10.1001/jamaoncol.2021.6987","title":"Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019","year":2021,"lang":"en","type":"review","venue":"JAMA Oncology","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":2009,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University of Calgary; University of Alberta; Alberta Health Services; McMaster University; Ottawa Hospital; Research Canada; University of British Columbia; University of Waterloo; University of Toronto","funders":"European and Developing Countries Clinical Trials Partnership; Division of Cancer Epidemiology and Genetics, National Cancer Institute; Division of Human Resource Development; Division of Mathematical Sciences; National Cancer Institute; National Heart, Lung, and Blood Institute; Dipartimento di Medicina e Chirurgia, Università degli Studi di Milano-Bicocca; Erasmus Universitair Medisch Centrum Rotterdam; Amity Institute of Biotechnology, Amity University; Department of Medicine, University of Toronto; Gastrointestinal and Liver Diseases Research Center; Instituto de Salud Carlos III; Sydney Medical School; Medical Research Council; School of Public Health and Family Medicine, University of Cape Town; Lerner Research Institute, Cleveland Clinic; School of Medicine, University of Alabama at Birmingham; University of Texas Health Science Center at San Antonio; University of Oklahoma Health Sciences Center; University of Veterinary and Animal Sciences; Liverpool University Hospitals NHS Foundation Trust; George Institute for Global Health; King Faisal University; Université de Versailles Saint-Quentin-en-Yvelines; Ajman University; Laboratório Associado para a Química Verde; Cancer Research Center, Tehran University of Medical Sciences; Universidad Autónoma de Sinaloa; Department of Global Health and Population, Harvard T.H. Chan School of Public Health; Imam Abdulrahman Bin Faisal University; Centro de Desarrollo Urbano Sustentable; Alborz University of Medical Sciences; Alzahra University; Peking Union Medical College; University Of Nigeria Nsukka; Kurdistan University Of Medical Sciences; Walailak University; Novo Nordisk Fonden; National Center of Neurology and Psychiatry; Menofia University; Mekelle University; Universitas Airlangga; Tartu Ülikool; Universidad de Chile; University of Sulaimani; Universidade Federal de Minas Gerais; Universidad Nacional Autónoma de México; National Research University Higher School of Economics; Eastern Virginia Medical School; Amirkabir University of Technology; Universidade Federal de Santa Catarina; Ajou University; Technische Universität Berlin; Trakya Üniversitesi; Universidade do Porto; University of Tsukuba; University of Dhaka; Oulun Yliopisto; Biotechnology Research Center, Tabriz University of Medical Sciences; Hokkaido University; Università di Bologna; Universitatea de Medicină şi Farmacie \"Carol Davila\" Bucureşti; Golestan University of Medical Sciences; Shahid Beheshti University of Medical Sciences; Universitat de Barcelona; Göteborgs Universitet; Shahrekord University of Medical Sciences; Shahroud University of Medical Sciences; Babol University of Medical Sciences; Universitetet i Oslo; Rajshahi University; Autoritatea Natională pentru Cercetare Stiintifică; Kermanshah University of Medical Sciences; Faculdade de Medicina do ABC; Pacific Institute for Research and Evaluation; Gazi Üniversitesi; Qazvin University of Medical Sciences; Guilan University of Medical Sciences; Universitair Medisch Centrum Groningen; Shahrekord University; Ministry of Health and Medical Education; Haramaya University; Hamadan University of Medical Sciences; Moscow Institute of Physics and Technology; Emory University; Università di Catania; Zanjan University of Medical Sciences; United Arab Emirates University; University of Gondar; Harokopio University; University of Waterloo; Tabriz University of Medical Sciences; King Abdulaziz University; European Regional Development Fund; Karolinska Institutet; Federation University Australia; Bill and Melinda Gates Foundation; Institució Catalana de Recerca i Estudis Avançats; University of Alabama at Birmingham; Imperial College London; University of Toronto; Universitat de València; Inyuvesi Yakwazulu-Natali; Delhi Technological University; Cambridge University Hospitals; Universidad Nacional de Colombia; Gachon University; Seoul National University; University of Jordan; Tarbiat Modares University; Hacettepe Üniversitesi; U.S. Department of Veterans Affairs; Kosin University; Yonsei University; Rijksuniversiteit Groningen; Sharif University of Technology; Instituto Politécnico do Porto; University of Pennsylvania; National Taiwan Normal University; Cairo University; Université de Lausanne; Ottawa Hospital Research Institute; King Saud University; College of Science and Engineering, University of Minnesota; Maurice Wilkins Centre for Molecular Biodiscovery; Shiraz University of Medical Sciences; Ain Shams University; Universiti Sains Malaysia; Curtin University of Technology; Nankai University; Debre Tabor University; Universiteit Utrecht; Flinders University; Wuhan University; Alberta Health Services; University of Zanjan; University of Washington; Institut National de la Santé et de la Recherche Médicale; Deutsche Forschungsgemeinschaft; Amity University; Queensland University of Technology; Middlesex University; London South Bank University; Westfälische Wilhelms-Universität Münster; Indian Council of Medical Research; Uniwersytet Jagielloński Collegium Medicum; American Lebanese Syrian Associated Charities; Semmelweis Egyetem; University College London; Shiraz University; King's College London; University of Queensland; National Institute for Health and Care Research; Macquarie University; Katolicki Uniwersytet Lubelski Jana Pawla II; Student Research Committee, Tabriz University of Medical Sciences; La Trobe University; Università degli Studi di Napoli Federico II; World Health Organization; Ekiti State University; University of Alberta; Jordan University of Science and Technology; Hamad Bin Khalifa University; University of Cambridge; Kasturba Medical College, Manipal; Maragheh University of Medical Sciences; Tehran University of Medical Sciences and Health Services; University of Technology Sydney; University of Arkansas for Medical Sciences; South Eastern Sydney Local Health District; Mongolian National University of Medical Sciences; South African Medical Research Council; Mashhad University of Medical Sciences; Alexander von Humboldt-Stiftung; University of Southern California; Tribhuvan University; National Institutes of Health; Banaras Hindu University; National University of Singapore; Trường Đại học Nguyễn Tất Thành; University of Tabriz; Baki Dövlət Universiteti; European Commission; Ahmadu Bello University; James Cook University; Nord universitet; Public Health Foundation of India; Australian Catholic University; University of Cape Town; Khalifa University of Science, Technology and Research; University of Ottawa; National Institute for Medical Research Development; University of Alabama; National Authority for Scientific Research and Innovation; Barts Charity; Washington University in St. Louis; Monash University; University of Texas Health Science Center at Houston; China Medical University; Anglia Ruskin University; Jackson State University; Universidade de São Paulo; Universitatea din București; Universitas Ahmad Dahlan; Islamic Azad University; Technische Universität München; University of Colombo; Universidade Federal do Rio Grande do Sul; Arabian Gulf University; King Abdullah University of Science and Technology; Sanofi; University of Oxford; McMaster University; Deakin University; Universidade de Lisboa; Jazan University; University of Baghdad; University of Glasgow; Umeå Universitet; Moffitt Cancer Center; Taipei Medical University; Cleveland Clinic; London School of Hygiene and Tropical Medicine; Sveučilište u Zagrebu; Centre Hospitalier Universitaire Vaudois; Johns Hopkins University; Ohio State University; Alexandria University; Rush University; Bournemouth University; Case Western Reserve University; University of Central Florida; Wellcome Trust; Pomorski Uniwersytet Medyczny W Szczecinie; Università degli Studi di Milano; Universiti Brunei Darussalam; Coventry University; Bahir Dar University; National Center for Child Health and Development; Salahaddin University-Erbil; Durban University of Technology; Krishna Institute Of Medical Sciences Deemed To Be University; Fundação para a Ciência e a Tecnologia; Universidad de Antioquia; Xiamen University; Children's Hospital of Philadelphia; Wayne State University; Jimma University; Harvard University; Boston College; Iran University of Medical Sciences; Tulane University; Western Sydney University; Brown University; United Nations Population Fund; University of Oklahoma; Ochsner Health; Kerman University of Medical Sciences; Trường Đại học Duy Tân; Isfahan University of Medical Sciences","keywords":"Medicine; Cancer; Incidence (geometry); Cancer incidence; Gerontology; Demography; Years of potential life lost; Life expectancy; Internal medicine; Population; Environmental health","score_opus":0.15698928027793474,"score_gpt":0.4699616461180795,"score_spread":0.31297236584014476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200584507","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2939914,0.69432217,0.000012273248,0.0049800873,0.0009283509,0.0035802221,0.0021153118,0.00003962476,0.000030552994],"genre_scores_gemma":[0.014420377,0.97625405,0.0004975055,0.0049854307,0.0020245512,0.00088727666,0.0005104981,0.00014512283,0.0002751634],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99568063,0.0005132846,0.0013298009,0.0011981595,0.00056479836,0.0007133396],"domain_scores_gemma":[0.99399495,0.0026465792,0.00071011315,0.0010890438,0.00035204095,0.0012073015],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00080604956,0.0005394698,0.0043536094,0.00015942428,0.000048051555,0.000039136536,0.00035664596,0.0011624296,0.0006544982],"category_scores_gemma":[0.002467851,0.00048262664,0.00045865038,0.0006482601,0.0006702932,0.00011480728,0.00042253354,0.0010024294,0.000026990056],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077526196,0.0006486831,0.10807572,0.018180432,0.0012016285,0.00011554619,0.0010726523,0.000009229855,0.000003587446,0.00003056342,0.019508371,0.85037833],"study_design_scores_gemma":[0.0018581457,0.0011685083,0.42416808,0.0074236416,0.002121061,0.000013982639,0.0001593004,0.000007834905,5.925731e-7,0.00002554702,0.5626661,0.00038717611],"about_ca_topic_score_codex":0.06539118,"about_ca_topic_score_gemma":0.051388897,"teacher_disagreement_score":0.84999114,"about_ca_system_score_codex":0.0018164046,"about_ca_system_score_gemma":0.009377749,"threshold_uncertainty_score":0.99976254},"labels":[],"label_agreement":null},{"id":"W4205157273","doi":"10.1001/jamaoncol.2021.7148","title":"Evidence-Based Clinical Practice Guidelines for Extramammary Paget Disease","year":2022,"lang":"en","type":"review","venue":"JAMA Oncology","topic":"Cancer and Skin Lesions","field":"Medicine","cited_by":138,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Medicine; Extramammary Paget's disease; Biopsy; Radiation therapy; Dermatology; Disease; Surgery; Radiology; Internal medicine","score_opus":0.6527709803475009,"score_gpt":0.6188556866096045,"score_spread":0.03391529373789637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205157273","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[4.336122e-7,0.9471779,0.00055108214,0.043813944,0.002711442,0.0029188571,0.0002735349,0.00009140297,0.0024614434],"genre_scores_gemma":[2.291027e-7,0.92587715,0.017418237,0.04567168,0.0055423626,0.0026229,0.0008065349,0.000091491784,0.001969431],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949411,0.0012681861,0.0020612266,0.00084988505,0.0004507573,0.00042885268],"domain_scores_gemma":[0.97110766,0.025465496,0.00096001686,0.0009894113,0.0008649864,0.00061240175],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0038501532,0.00041469434,0.0027666546,0.00021727355,0.00017618151,0.000030016272,0.00037820768,0.0006775047,0.002134652],"category_scores_gemma":[0.09514148,0.00032333302,0.0019006438,0.0003304533,0.00016501058,0.00014152715,0.00019393959,0.0013640119,0.00007413825],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008274297,0.00037867276,0.0000062020717,0.00644296,0.00014839934,0.00105838,0.0000039839456,8.0558686e-7,2.2019012e-8,0.000067661946,0.38649407,0.6045714],"study_design_scores_gemma":[0.0017059791,0.0016640759,0.000027095575,0.009765025,0.008514116,0.00044639947,0.000032769047,0.000062637904,1.3462239e-8,0.000046083333,0.9774414,0.00029440963],"about_ca_topic_score_codex":0.000025409132,"about_ca_topic_score_gemma":0.000008401082,"teacher_disagreement_score":0.604277,"about_ca_system_score_codex":0.0008482655,"about_ca_system_score_gemma":0.01413284,"threshold_uncertainty_score":0.99992186},"labels":[],"label_agreement":null},{"id":"W4205452388","doi":"10.1001/jamaoncol.2021.6871","title":"Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer","year":2022,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Medicine; Androgen deprivation therapy; Brachytherapy; External beam radiotherapy; Prostate cancer; Radiation therapy; Retrospective cohort study; Randomized controlled trial; Cohort; Internal medicine; Oncology; Urology; Surgery; Cancer","score_opus":0.02436716679589874,"score_gpt":0.3398482702062112,"score_spread":0.3154811034103125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205452388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902947,0.004312552,0.0010228899,0.0013319948,0.00006800281,0.0024841302,0.00046453564,0.000015353044,0.0000058214346],"genre_scores_gemma":[0.9750781,0.01460964,0.0071926955,0.00022204893,0.0001423552,0.002493089,0.00012872154,0.0000334226,0.00009991076],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99890226,0.00008781346,0.0003972429,0.00028495974,0.00015344477,0.0001742589],"domain_scores_gemma":[0.9989281,0.00021880968,0.0005118641,0.00016428363,0.00011148617,0.00006545506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016143113,0.00017385356,0.00062380644,0.00010091637,0.00009573754,0.0000086032005,0.000045724617,0.00006201104,0.000094567455],"category_scores_gemma":[0.000008250304,0.00011179734,0.00006517073,0.00011328096,0.00009704459,0.00007686904,0.000012801594,0.000071881615,7.57168e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02177409,0.00075144833,0.57988924,0.000032513246,0.00074945734,0.000011647925,0.003427794,0.00017417561,0.003987534,0.000016678745,0.00005493893,0.3891305],"study_design_scores_gemma":[0.08337525,0.17961128,0.496946,0.00015425339,0.00071224605,0.00018026932,0.00068788615,0.0011133436,0.19601083,0.00011381745,0.040775776,0.00031901523],"about_ca_topic_score_codex":0.0009959757,"about_ca_topic_score_gemma":0.00014368207,"teacher_disagreement_score":0.3888115,"about_ca_system_score_codex":0.0005924123,"about_ca_system_score_gemma":0.000418719,"threshold_uncertainty_score":0.4558963},"labels":[],"label_agreement":null},{"id":"W4205809226","doi":"10.1001/jamaoncol.2021.6590","title":"Association of Daily Sitting Time and Leisure-Time Physical Activity With Survival Among US Cancer Survivors","year":2022,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":251,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Medicine; Sitting; Population; Cohort study; Cohort; National Health and Nutrition Examination Survey; Gerontology; Cancer; Cancer survivor; Demography; Physical therapy; Internal medicine; Environmental health","score_opus":0.009966207491442652,"score_gpt":0.2778777303757237,"score_spread":0.26791152288428105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205809226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99222744,0.00005469192,0.0000053754966,0.0022655656,0.0002896688,0.0002610552,0.00009130217,0.000045571414,0.0047593475],"genre_scores_gemma":[0.9952751,0.000011563992,0.000017991943,0.00014315674,0.0003302256,0.000070520735,0.000029760697,0.00002552303,0.0040961965],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99840826,0.00042727636,0.00015021981,0.00029533717,0.0004475229,0.00027139907],"domain_scores_gemma":[0.99876696,0.0005279856,0.0003028464,0.00016390046,0.00014323101,0.00009505151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066805194,0.0001416433,0.00066262163,0.000072602954,0.00012723217,0.00001055905,0.00007553911,0.00012041658,0.00041452027],"category_scores_gemma":[0.0000807388,0.00012920187,0.00007882518,0.0002860718,0.000091230206,0.00009831618,0.00012620562,0.00046779786,0.0000057841735],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013263522,0.00042849648,0.9547934,0.0000661365,0.0002963427,0.000045434903,0.0028318618,0.00011835921,0.015278631,0.0000149294965,0.0010225835,0.023777507],"study_design_scores_gemma":[0.0026905828,0.0016301133,0.9757978,0.000028801818,0.0003452676,0.000018407547,0.0007541847,0.0023148048,0.0018067821,0.000011875332,0.014398591,0.00020279229],"about_ca_topic_score_codex":0.014684892,"about_ca_topic_score_gemma":0.012751958,"teacher_disagreement_score":0.023574714,"about_ca_system_score_codex":0.0007413056,"about_ca_system_score_gemma":0.00032332024,"threshold_uncertainty_score":0.9918764},"labels":[],"label_agreement":null},{"id":"W4210639134","doi":"10.1001/jamaoncol.2021.7639","title":"Development of an Open Database of Genes Included in Hereditary Cancer Genetic Testing Panels Available From Major Sources in the US","year":2022,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Genomics and Rare Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Institute of Mental Health; Canadian Institutes of Health Research; National Institutes of Health; Wellcome Trust","keywords":"Medicine; Hereditary Cancer; Genetic testing; Gene; Cancer; Database; Genetics; Bioinformatics; Computational biology; Internal medicine; Biology; Computer science","score_opus":0.042722726313453314,"score_gpt":0.3039056119699771,"score_spread":0.2611828856565238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210639134","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960725,0.0028753458,0.0000040141567,0.00008671245,0.00008574071,0.000285839,0.00036761924,0.0000014578751,0.00022079096],"genre_scores_gemma":[0.9893018,0.00007809859,0.009391581,0.00044684592,0.00008282398,0.00021389418,0.00044783272,0.000012160279,0.000024984485],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988355,0.00025361942,0.00036001366,0.00027848515,0.00010278193,0.00016962111],"domain_scores_gemma":[0.99941087,0.000060352308,0.0001728255,0.00028240486,0.0000398068,0.000033749395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004124662,0.000094524854,0.000204466,0.000051554278,0.00007977407,0.000009673917,0.0007023058,0.0000651951,0.00017374699],"category_scores_gemma":[0.000056279623,0.00008042415,0.000019824533,0.00013400326,0.000051654257,0.0000053515555,0.0010335958,0.00009453764,9.04999e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038202747,0.0008016588,0.084254384,0.000037945993,0.000056134293,0.00014714281,0.0016128469,0.002274663,0.87937325,0.0000030807141,0.0006440468,0.030412812],"study_design_scores_gemma":[0.0053235414,0.0015423257,0.64235,0.000064483494,0.000079041296,0.000083194165,0.011200327,0.0010354802,0.19389996,0.00018837754,0.14367707,0.00055615953],"about_ca_topic_score_codex":0.008869165,"about_ca_topic_score_gemma":0.009501156,"teacher_disagreement_score":0.6854733,"about_ca_system_score_codex":0.000048141977,"about_ca_system_score_gemma":0.0007918713,"threshold_uncertainty_score":0.99773085},"labels":[{"model":"gemma","categories":["open_science"],"domain":null,"study_design":"not_applicable","genre":"dataset","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"gpt","categories":[],"domain":null,"study_design":"not_applicable","genre":"dataset","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"split"},{"id":"W4210689349","doi":"10.1001/jamaoncol.2021.6744","title":"Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes","year":2022,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":190,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"Medical Research and Materiel Command; David Geffen School of Medicine, University of California, Los Angeles; European Regional Development Fund; National Cancer Institute; Medisinske fakultet, Universitetet i Oslo; Servicio Gallego de Salud; Universitätsklinikum Hamburg-Eppendorf; Scottish Government; KWF Kankerbestrijding; Det Sundhedsvidenskabelige Fakultet, Københavns Universitet; Instituto de Salud Carlos III; Freistaat Sachsen; Russian Academy of Sciences; Medical Research Council; European Commission; Canadian Institutes of Health Research; Directorate for Biological Sciences; National Institutes of Health; Université de Versailles Saint-Quentin-en-Yvelines; Universitätsklinikum Köln; Akershus Universitetssykehus; National University Health System; Agency for Science, Technology and Research; Universidad de La Sabana; Pomorski Uniwersytet Medyczny W Szczecinie; Institut Gustave-Roussy; Universität zu Köln; Fondazione Italiana per la Ricerca sul Cancro; Medizinischen Hochschule Hannover; Kreftforeningen; Institut National Du Cancer; Leids Universitair Medisch Centrum; Karolinska Institutet; Associazione Italiana per la Ricerca sul Cancro; Deutsche Krebshilfe; National Health and Medical Research Council; Universiti Malaya; Norges Forskningsråd; National Medical Research Council; Stockholms Läns Landsting; Sundhed og Sygdom, Det Frie Forskningsråd; Saint Petersburg State University; Kuopion Yliopistollinen Sairaala; University of Toronto; Pontificia Universidad Javeriana; King's College London; Gentofte Hospital; Deutsche Forschungsgemeinschaft; Deutsche Gesetzliche Unfallversicherung; Alexander von Humboldt-Stiftung; Cancerfonden; Cancer Council Victoria; University of Melbourne; Robert Bosch Stiftung; Programme Grants for Applied Research; Manchester Biomedical Research Centre; Monash University; Itä-Suomen Yliopisto; Eberhard Karls Universität Tübingen; Universiteit Leiden; Cancer Research Institute; University of Crete; Institut National de la Santé et de la Recherche Médicale; Institute of Genetics; Wellcome Trust; Agence Nationale de la Recherche; Lunds Universitet; Faculty of Health and Medical Sciences, University of Western Australia; Cancer Research UK; National University of Singapore; National Research Foundation Singapore; National Institute for Health and Care Research; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; National Research Foundation; Chief Scientist Office, Scottish Government Health and Social Care Directorate; Bundesministerium für Bildung und Forschung; Genome Institute of Singapore; National Breast Cancer Foundation; QIMR Berghofer Medical Research Institute; Research Promotion Foundation; Engineering and Physical Sciences Research Council; Fondation de France; University of Cambridge; Government of Canada; Breast Cancer Research Trust; Fondation du cancer du sein du Québec; Duke-NUS Medical School; Huntsman Cancer Institute; Scottish Funding Council; Instituto de Investigación Sanitaria de Santiago de Compostela; Deutsches Krebsforschungszentrum; Helsingin Yliopisto; Genome Canada; University of California, San Diego; Universitetet i Oslo; University of Oxford; Cancer Council NSW; Susan G. Komen for the Cure","keywords":"Medicine; Germline; Breast cancer; Gene; Germline mutation; Cancer; Pathology; Oncology; Genetics; Internal medicine; Mutation; Biology","score_opus":0.011167600553947346,"score_gpt":0.2814819573539547,"score_spread":0.27031435680000737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210689349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961916,0.00082714576,0.000059439284,0.0014046525,0.00025241787,0.00025207782,0.0007109829,0.000010214311,0.0002914282],"genre_scores_gemma":[0.99798524,0.00013030562,0.00033721226,0.0006856595,0.000116811716,0.00031590267,0.0002414119,0.000027744349,0.00015970628],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980927,0.0005786116,0.00037988843,0.00048058943,0.00015414359,0.00031405495],"domain_scores_gemma":[0.9990799,0.00005381616,0.0002814053,0.00036809765,0.00016897434,0.000047801805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068787625,0.0001506456,0.00032491187,0.00009969007,0.000081608996,0.0000041286175,0.00027371416,0.00019764915,0.00047395434],"category_scores_gemma":[0.00008923937,0.00014967745,0.00006798443,0.0003482142,0.00020089319,0.0000043290634,0.00027361605,0.00024798527,0.000001279642],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096811255,0.0007974157,0.23283578,0.000019153262,0.0001412628,0.00017660923,0.00034641262,0.0061952267,0.7343971,0.000050405153,0.001472562,0.02259994],"study_design_scores_gemma":[0.0035379676,0.0014710521,0.97479266,0.000013354996,0.000055681256,0.00046970896,0.00055475754,0.00026190598,0.011655478,0.0001373829,0.00673685,0.00031318836],"about_ca_topic_score_codex":0.0001968023,"about_ca_topic_score_gemma":0.0028723285,"teacher_disagreement_score":0.7419569,"about_ca_system_score_codex":0.00053860864,"about_ca_system_score_gemma":0.0012388305,"threshold_uncertainty_score":0.61036694},"labels":[],"label_agreement":null},{"id":"W4211142194","doi":"10.1001/jamaoncol.2021.7643","title":"Effect of a Symptom Monitoring Intervention for Patients Hospitalized With Advanced Cancer","year":2022,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute","keywords":"Medicine; Psychological intervention; Randomized controlled trial; Intervention (counseling); Population; Emergency medicine; Clinical trial; MEDLINE; Physical therapy; Internal medicine; Psychiatry","score_opus":0.006983832577466542,"score_gpt":0.32910184091148187,"score_spread":0.3221180083340153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211142194","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969073,0.0002656496,0.00005874491,0.00023969215,0.0012292423,0.0008584086,0.000045025783,0.000024166771,0.00037179518],"genre_scores_gemma":[0.99754214,0.000023030298,0.00009033817,0.00006829989,0.000118494114,0.0018855386,0.00004368622,0.000018175842,0.00021027896],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992593,0.00011296708,0.00016400954,0.00016154819,0.00015956035,0.00014264788],"domain_scores_gemma":[0.9994553,0.00012519394,0.00014391117,0.00011738067,0.00011667111,0.000041585048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020480849,0.00008355036,0.00031134632,0.00006178226,0.000051504303,0.0000026257524,0.000058721052,0.000045191082,0.00010897554],"category_scores_gemma":[0.000054127882,0.00006783565,0.00011340769,0.00012535733,0.00002510804,0.000039336486,0.000047921912,0.00012206889,4.196167e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01405356,0.00032819607,0.52646405,0.00049642206,0.00013555393,0.000007697867,0.0010100126,0.00003801239,0.00069321634,0.000016474314,0.0003153968,0.45644143],"study_design_scores_gemma":[0.08857414,0.20188333,0.5262658,0.0007914277,0.0010557022,0.000023373608,0.0014696857,0.00017310453,0.03278115,0.00004711272,0.14649855,0.00043665667],"about_ca_topic_score_codex":0.00035532244,"about_ca_topic_score_gemma":0.000058636157,"teacher_disagreement_score":0.4560048,"about_ca_system_score_codex":0.0004539996,"about_ca_system_score_gemma":0.0000723637,"threshold_uncertainty_score":0.27662575},"labels":[],"label_agreement":null},{"id":"W4213378853","doi":"10.1001/jamaoncol.2021.6204","title":"Breast Cancer Screening Strategies for Women With <i>ATM, CHEK2</i>, and <i>PALB2</i> Pathogenic Variants","year":2022,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute","keywords":"CHEK2; PALB2; Medicine; Breast cancer; Mammography; Cancer; Oncology; Population; Breast cancer screening; Internal medicine; Gynecology; Environmental health; Genetics; Biology","score_opus":0.011540693307698349,"score_gpt":0.27602070455708827,"score_spread":0.2644800112493899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213378853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98678666,0.0013495538,0.004315532,0.0036733693,0.00032075282,0.00052691443,0.0009888995,0.00002583189,0.0020124791],"genre_scores_gemma":[0.9904482,0.00017463711,0.003964315,0.002291421,0.000386601,0.0019936007,0.00009708869,0.000041353753,0.0006027942],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988151,0.0001008034,0.00016648519,0.00043887435,0.00011183441,0.00036685393],"domain_scores_gemma":[0.99943614,0.000031936914,0.000121457204,0.00022983277,0.00009898595,0.00008163254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002914845,0.00015431398,0.00018834944,0.000042056985,0.0002834528,0.000040666764,0.00018717912,0.00012361347,0.00015230317],"category_scores_gemma":[0.000007876882,0.0001499514,0.000033702185,0.00012441912,0.00014897795,0.0000103231605,0.000214002,0.00015223032,6.740558e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007303326,0.0003941903,0.007014954,0.00016302905,0.0009582309,0.00006141209,0.0030315786,0.010494221,0.56832045,0.0013937985,0.03508321,0.3657816],"study_design_scores_gemma":[0.008051007,0.004321741,0.030128222,0.000014565146,0.00013032649,0.0016603641,0.011719247,0.0006428466,0.004138182,0.0012396452,0.93717635,0.0007775082],"about_ca_topic_score_codex":0.000055322645,"about_ca_topic_score_gemma":0.00022437242,"teacher_disagreement_score":0.9020931,"about_ca_system_score_codex":0.00022167995,"about_ca_system_score_gemma":0.0009939097,"threshold_uncertainty_score":0.61148405},"labels":[],"label_agreement":null},{"id":"W4214616073","doi":"10.1001/jamaoncol.2021.8049","title":"Cost-effectiveness Analysis of Pertuzumab With Trastuzumab in Patients With Metastatic Breast Cancer","year":2022,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; Canadian Centre for Applied Research in Cancer Control; Public Health Ontario; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Pertuzumab; Medicine; Trastuzumab; Metastatic breast cancer; Breast cancer; Oncology; Internal medicine; Cost effectiveness; Population; Chemotherapy; Cancer; Environmental health","score_opus":0.048287472551245374,"score_gpt":0.3967369460307583,"score_spread":0.34844947347951294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214616073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99581474,0.00009842639,0.000085503794,0.0011348247,0.000056943292,0.0014940875,0.0004028268,0.000015816784,0.0008968488],"genre_scores_gemma":[0.99764377,0.0000142050385,0.00021682656,0.0003316331,0.000019278916,0.0015482854,0.000114058465,0.000028381924,0.00008356092],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99736995,0.000733299,0.00030570937,0.0004034756,0.0007877576,0.0003997878],"domain_scores_gemma":[0.9986073,0.00043816163,0.00016000628,0.00033762303,0.00032520713,0.00013171276],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000687716,0.00016417728,0.0009398167,0.0007859421,0.00007025062,0.000006910883,0.00017055744,0.000053761763,0.0021835114],"category_scores_gemma":[0.000051403807,0.0001199648,0.00008649702,0.0026026778,0.00019162496,0.00006515582,0.0000985568,0.00055436714,0.0000023223301],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013920778,0.0020145047,0.91100687,0.00016817052,0.0021877403,0.00023546946,0.0010516606,0.00644254,0.00007288745,0.00003542304,0.00016925411,0.06269471],"study_design_scores_gemma":[0.011779701,0.0062904563,0.97514284,0.00006515715,0.0013558378,0.00004538129,0.0007508266,0.0011172774,0.00005740611,0.0000041906696,0.003259597,0.00013135893],"about_ca_topic_score_codex":0.0037557501,"about_ca_topic_score_gemma":0.0030265118,"teacher_disagreement_score":0.06413595,"about_ca_system_score_codex":0.003990684,"about_ca_system_score_gemma":0.0017596497,"threshold_uncertainty_score":0.9998328},"labels":[],"label_agreement":null},{"id":"W4224213206","doi":"10.1001/jamaoncol.2022.0373","title":"Association of Pathogenic Variants in Hereditary Cancer Genes With Multiple Diseases","year":2022,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"U.S. National Library of Medicine; National Institute of Allergy and Infectious Diseases; National Human Genome Research Institute; Medical Research Council","keywords":"Medicine; Phenome; Biobank; Cohort; Cancer; Genome-wide association study; Medical record; Disease; Cohort study; Internal medicine; Bioinformatics; Genetics; Genotype; Single-nucleotide polymorphism; Phenotype; Gene; Biology","score_opus":0.00853701586686538,"score_gpt":0.269700235275418,"score_spread":0.2611632194085526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224213206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99422497,0.0029224134,0.000065473214,0.001442335,0.00040546258,0.00018515634,0.00045871708,0.0000061587507,0.00028930992],"genre_scores_gemma":[0.99751973,0.00023033058,0.00054607244,0.00046838462,0.00022715567,0.00041306534,0.00018630049,0.000016176706,0.00039280998],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990841,0.0002012653,0.00017611147,0.00023316029,0.00014008375,0.00016528199],"domain_scores_gemma":[0.9995066,0.000050294908,0.00016740485,0.00016922397,0.000077172954,0.00002932675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017529265,0.00007812821,0.00014546272,0.000053692558,0.00005694875,0.000003428161,0.0001410876,0.00009832295,0.00019134706],"category_scores_gemma":[0.00007074386,0.00007959922,0.000039589326,0.00016139902,0.000040599625,0.000003817066,0.00013187708,0.000103386505,0.000001075676],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073160906,0.00042943744,0.7431123,0.000024275983,0.00022859257,0.000047857982,0.00026202112,0.016330777,0.1837439,0.000018496825,0.018165486,0.036905203],"study_design_scores_gemma":[0.0047869575,0.0014354929,0.7346376,0.0000098165765,0.00011670175,0.00004436028,0.00089016795,0.00069742434,0.018267902,0.00012915123,0.23867835,0.0003060283],"about_ca_topic_score_codex":0.00024687778,"about_ca_topic_score_gemma":0.002479057,"teacher_disagreement_score":0.22051287,"about_ca_system_score_codex":0.00052457,"about_ca_system_score_gemma":0.00071906345,"threshold_uncertainty_score":0.32459617},"labels":[],"label_agreement":null},{"id":"W4224288628","doi":"10.1001/jamaoncol.2022.0177","title":"Enabling the Sharing of Single-Dose Vials Through Risk Mitigation to Decrease Financial Toxicity","year":2022,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Otorhinolaryngology; Family medicine; Neurology; MEDLINE; Psychiatry","score_opus":0.046409613462392904,"score_gpt":0.27278634441819033,"score_spread":0.2263767309557974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224288628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.967019,0.00088253454,0.002094376,0.0042620674,0.001029871,0.0003991918,0.0004018363,0.000025186317,0.02388594],"genre_scores_gemma":[0.99091405,0.00012046688,0.00092275516,0.0071655624,0.00044678655,0.000121277444,0.000012534461,0.000022249822,0.00027430907],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99832016,0.000063637,0.0008047788,0.00040934279,0.000045601206,0.00035646034],"domain_scores_gemma":[0.998352,0.00024961098,0.00081669807,0.0003730119,0.00004892197,0.00015976612],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014260807,0.00014184228,0.0005290058,0.00014091941,0.00039557187,0.00004460961,0.00047522984,0.00012261227,0.0013907278],"category_scores_gemma":[0.0036751537,0.00015273206,0.0001555079,0.0003163821,0.00008934799,0.0003068326,0.0003500241,0.00032876286,0.00008213985],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014315312,0.0013781328,0.08218003,0.00007024209,0.00017624482,0.000036616566,0.015847009,0.016421217,0.0038675386,0.7229145,0.03030239,0.12537453],"study_design_scores_gemma":[0.0014932341,0.0010343287,0.03418959,0.000011481066,0.00002174525,0.000013023937,0.00044912266,0.0006440959,0.0021028975,0.14534312,0.8143556,0.0003417348],"about_ca_topic_score_codex":0.001720684,"about_ca_topic_score_gemma":0.00032225795,"teacher_disagreement_score":0.7840532,"about_ca_system_score_codex":0.0006616234,"about_ca_system_score_gemma":0.0002522569,"threshold_uncertainty_score":0.99952215},"labels":[],"label_agreement":null},{"id":"W4225081539","doi":"10.1001/jamaoncol.2022.0874","title":"Concerns Remain Regarding the Association of Sitting Time and Physical Activity With Cancer Survivorship—Reply","year":2022,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Medicine; Otorhinolaryngology; Family medicine; MEDLINE; Psychiatry","score_opus":0.021177923124891192,"score_gpt":0.3038195449455537,"score_spread":0.2826416218206625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225081539","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.42896026,0.00018029854,0.000004155202,0.5617329,0.0005954711,0.0004528674,0.00016138321,0.000042206335,0.007870455],"genre_scores_gemma":[0.534906,0.0001641693,0.000027821621,0.43060794,0.011932585,0.00035206432,0.00024886444,0.00013118703,0.021629315],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974245,0.0008895966,0.00021676486,0.00046096861,0.00062700483,0.00038119266],"domain_scores_gemma":[0.99628454,0.0023465678,0.0007385779,0.0003675445,0.00021165154,0.000051129897],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0009861869,0.00025589002,0.0009586309,0.00008366244,0.0001520984,0.000024389243,0.00015551769,0.00051620556,0.00032243357],"category_scores_gemma":[0.0002926612,0.0001800633,0.00016391677,0.0002570254,0.00015210579,0.00006804153,0.00015212718,0.002664188,0.0000038608514],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014738145,0.00012089107,0.025499225,0.0005639749,0.0010053187,0.00039850274,0.008114313,0.000012743638,0.0009349428,0.00002662393,0.9379009,0.023948774],"study_design_scores_gemma":[0.0014316337,0.0009582622,0.0055085104,0.00017740173,0.0007506113,0.000052582036,0.0006222552,0.00014286494,0.00024587053,0.000023884704,0.98985213,0.00023396744],"about_ca_topic_score_codex":0.011250013,"about_ca_topic_score_gemma":0.004620879,"teacher_disagreement_score":0.13112496,"about_ca_system_score_codex":0.0015962924,"about_ca_system_score_gemma":0.00064413773,"threshold_uncertainty_score":0.9996367},"labels":[],"label_agreement":null},{"id":"W4225104640","doi":"10.1001/jamaoncol.2022.0615","title":"Assessment of Toxic Effects and Survival in Treatment Deescalation With Radiotherapy vs Transoral Surgery for HPV-Associated Oropharyngeal Squamous Cell Carcinoma","year":2022,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; University of Ottawa; University of Calgary; McGill University; Princess Margaret Cancer Centre; University Health Network; University of Toronto; Health Sciences Centre; University of British Columbia; Sunnybrook Health Science Centre; Western University","funders":"","keywords":"Medicine; Clinical endpoint; Neck dissection; Radiation therapy; Internal medicine; Randomized controlled trial; Surrogate endpoint; Oncology; Quality of life (healthcare); Head and neck squamous-cell carcinoma; Chemoradiotherapy; Surgery; Cancer; Head and neck cancer","score_opus":0.020760217377520252,"score_gpt":0.3136201558589964,"score_spread":0.2928599384814761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225104640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99593127,0.0008940258,0.000073537405,0.0014210457,0.00019781673,0.0009142618,0.000032696265,0.00001569226,0.0005196591],"genre_scores_gemma":[0.99858993,0.0001150574,0.0003724006,0.00024183579,0.000058910005,0.00045603813,0.000050387236,0.000019882033,0.00009555936],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99885553,0.00029111805,0.0002477421,0.00022101383,0.00014976444,0.0002348542],"domain_scores_gemma":[0.998559,0.0011506955,0.00010698634,0.000085006366,0.00003948423,0.00005881423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003662836,0.00013175322,0.0008854674,0.00012625985,0.00008027991,0.0000029059274,0.000025517611,0.000075662065,0.00003677816],"category_scores_gemma":[0.000020989899,0.00010554687,0.00007526996,0.00016154256,0.00004860227,0.000027721253,0.000010292865,0.00011718007,6.11346e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041901534,0.0019693153,0.9488102,0.00031888223,0.00009997821,0.00018755377,0.0018353534,0.00007115035,0.006108722,0.000026064203,0.00033858602,0.036044046],"study_design_scores_gemma":[0.01749735,0.025613884,0.9525885,0.00001193466,0.00011813893,0.000016285461,0.00023364225,0.0011845874,0.0010271362,0.000005485682,0.0016046361,0.000098397366],"about_ca_topic_score_codex":0.00039117734,"about_ca_topic_score_gemma":0.0008516778,"teacher_disagreement_score":0.035945646,"about_ca_system_score_codex":0.001155396,"about_ca_system_score_gemma":0.00048280405,"threshold_uncertainty_score":0.43040764},"labels":[],"label_agreement":null},{"id":"W4233885426","doi":"10.1001/jamaoncol.2019.6921","title":"Error in Table 2","year":2020,"lang":"en","type":"erratum","venue":"JAMA Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; Public Health Ontario; University of Toronto","funders":"","keywords":"Medicine; Oncology; MEDLINE; Internal medicine","score_opus":0.031382739229008964,"score_gpt":0.3340743508320977,"score_spread":0.3026916116030887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233885426","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003914452,0.009763068,0.00000390086,0.061220065,0.038516697,0.00068754115,0.000054693293,0.00009125417,0.8892713],"genre_scores_gemma":[0.0013107593,0.0056949356,0.00043600035,0.04729475,0.009150896,0.00015924954,0.0015260761,0.00011140031,0.9343159],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986209,0.000092610746,0.00040271046,0.0003746746,0.00017684323,0.00033221042],"domain_scores_gemma":[0.9993396,0.0000716436,0.00017000675,0.00026855015,0.000045030367,0.00010521766],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023282526,0.00021710311,0.0008144235,0.00017435507,0.00002390605,0.000013004546,0.00015832095,0.0015655833,0.0022259383],"category_scores_gemma":[0.00014594069,0.00019278639,0.00013735826,0.00035588726,0.00010149055,0.00003627169,0.00005976475,0.001869569,0.00019717216],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026644403,0.0001384306,0.00015770059,0.00020749068,0.00012433567,0.00093767996,0.00022407401,1.4635066e-7,0.0004342793,0.000018518784,0.9543231,0.04076981],"study_design_scores_gemma":[0.00429933,0.0013573978,0.0025262847,0.00022244333,0.000075216165,0.00013555834,0.0001357034,0.000047409325,0.00003407884,0.000038916547,0.9909524,0.00017528988],"about_ca_topic_score_codex":0.0006132523,"about_ca_topic_score_gemma":0.00085322396,"teacher_disagreement_score":0.045044594,"about_ca_system_score_codex":0.0007624381,"about_ca_system_score_gemma":0.0020741436,"threshold_uncertainty_score":0.9997306},"labels":[],"label_agreement":null},{"id":"W4234731965","doi":"10.1001/jamaoncol.2019.6210","title":"Errors in Table","year":2019,"lang":"en","type":"erratum","venue":"JAMA Oncology","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Public Health Ontario; Women's College Hospital","funders":"","keywords":"Medicine","score_opus":0.026722874466928444,"score_gpt":0.33993577877378944,"score_spread":0.313212904306861,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234731965","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010446042,0.00250862,5.6472305e-7,0.004645429,0.030172788,0.00092414534,0.000039175215,0.000064790285,0.95119846],"genre_scores_gemma":[0.012434909,0.0010700151,0.00022658514,0.003342862,0.002337689,0.00024681576,0.00076736906,0.000089372195,0.9794844],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980811,0.0001225762,0.00040527878,0.000570895,0.00029744385,0.0005227443],"domain_scores_gemma":[0.99889106,0.00020175228,0.00018707674,0.0004659344,0.00009140186,0.00016277323],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00021408893,0.0003131348,0.0013144433,0.00030568615,0.000018966863,0.000011156104,0.00016754471,0.0017666004,0.002993725],"category_scores_gemma":[0.0002617422,0.0002678088,0.00017469552,0.0004199767,0.00008091156,0.00005352177,0.00014964998,0.00182681,0.0013262688],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081965403,0.0004414476,0.008420629,0.00020038012,0.000119362514,0.0022787526,0.0000898939,0.0000020128386,0.000012077178,0.000040870607,0.96814096,0.01943393],"study_design_scores_gemma":[0.004300856,0.0021444275,0.026794191,0.0002986364,0.0001236338,0.00017752312,0.00003827127,0.000057288165,0.000013798565,0.00010983255,0.96574116,0.00020039309],"about_ca_topic_score_codex":0.0006575603,"about_ca_topic_score_gemma":0.0010966052,"teacher_disagreement_score":0.028285936,"about_ca_system_score_codex":0.0025877357,"about_ca_system_score_gemma":0.0021877647,"threshold_uncertainty_score":0.9999774},"labels":[],"label_agreement":null},{"id":"W4253427595","doi":"10.1001/jamaoncol.2019.6477","title":"Errors in Figure 3","year":2020,"lang":"en","type":"erratum","venue":"JAMA Oncology","topic":"Diverse Scientific and Economic Studies","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto; Women's College Hospital","funders":"","keywords":"Medicine; MEDLINE; Medical physics","score_opus":0.05283207734295908,"score_gpt":0.25011337010485657,"score_spread":0.1972812927618975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253427595","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000704689,0.0038019014,0.000005929599,0.007996249,0.08460714,0.00018096226,0.00061835017,0.0000365428,0.9026825],"genre_scores_gemma":[0.0004718546,0.0019065617,0.0001629348,0.0031776908,0.0017416034,0.000047944686,0.00021207472,0.000036654616,0.9922427],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99774516,0.000024308763,0.0008356444,0.00089372555,0.000029240995,0.00047192958],"domain_scores_gemma":[0.99888355,0.000062872175,0.00058395125,0.00033935969,0.000020396621,0.00010988563],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000514441,0.00027153565,0.0012318899,0.0004048256,0.000068236324,0.000071679286,0.00053936796,0.0009921979,0.021116178],"category_scores_gemma":[0.0003560151,0.00033267765,0.00021541236,0.00028554458,0.00015139038,0.00014997287,0.00030230364,0.0011431475,0.06844223],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001535566,0.00005326551,0.0007007416,0.00004653332,0.00006861998,0.00007948356,0.0007004473,0.000008399504,7.825177e-8,0.0245217,0.972785,0.0010203503],"study_design_scores_gemma":[0.000631392,0.00008743509,0.0013245702,0.000024188937,0.0000073590713,0.0000026719163,0.00043079746,0.00032578476,1.8256377e-7,0.0033154872,0.9935229,0.0003272218],"about_ca_topic_score_codex":0.00033108154,"about_ca_topic_score_gemma":0.00027979558,"teacher_disagreement_score":0.08956022,"about_ca_system_score_codex":0.00061598327,"about_ca_system_score_gemma":0.00015599809,"threshold_uncertainty_score":0.9999125},"labels":[],"label_agreement":null},{"id":"W4256052490","doi":"10.1001/jamaoncol.2019.6910","title":"Missing Panels in Figure 1","year":2020,"lang":"en","type":"erratum","venue":"JAMA Oncology","topic":"Diverse Scientific and Economic Studies","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto; Women's College Hospital","funders":"","keywords":"Medicine; MEDLINE","score_opus":0.07311079861610739,"score_gpt":0.2581189166740233,"score_spread":0.18500811805791592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4256052490","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000479066,0.004362453,0.000022942457,0.0102297235,0.066733636,0.00017133993,0.00048525594,0.000037020276,0.91790974],"genre_scores_gemma":[0.0005953907,0.0017394336,0.00027047592,0.0032623878,0.0021363702,0.00003198392,0.00017968622,0.000039909864,0.99174434],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976923,0.000028807213,0.00086782983,0.00089205895,0.000029857838,0.0004891708],"domain_scores_gemma":[0.9988225,0.00009471608,0.0006183955,0.0003247597,0.000021217298,0.00011837316],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00056898955,0.00027501883,0.0012566808,0.00036823298,0.000089627916,0.00012224817,0.00048230228,0.00095287047,0.014259514],"category_scores_gemma":[0.0004191181,0.00033814512,0.00020367758,0.00025769626,0.00014267302,0.0001646741,0.00027138533,0.0010776682,0.036122486],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013913255,0.000049793496,0.0004484587,0.00006211497,0.00006629518,0.00009840013,0.0010200406,0.000005776343,3.6772124e-7,0.011565872,0.9823111,0.0043578492],"study_design_scores_gemma":[0.0005917131,0.000068506175,0.001330432,0.00004361748,0.000008574049,0.000004142591,0.00040883143,0.0004596063,5.2556294e-7,0.004621026,0.9921268,0.00033622354],"about_ca_topic_score_codex":0.0002544857,"about_ca_topic_score_gemma":0.000058999696,"teacher_disagreement_score":0.07383464,"about_ca_system_score_codex":0.00060761726,"about_ca_system_score_gemma":0.00017362449,"threshold_uncertainty_score":0.9999071},"labels":[],"label_agreement":null},{"id":"W4281554826","doi":"10.1001/jamaoncol.2022.1479","title":"Effect of Supine vs Prone Breast Radiotherapy on Acute Toxic Effects of the Skin Among Women With Large Breast Size","year":2022,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Royal Victoria Regional Health Centre; University of British Columbia; Health Sciences Centre; Southlake Regional Health Center; Dalhousie University; Regional Municipality of Durham; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Supine position; Prone position; Randomized controlled trial; Breast cancer; Randomization; Regimen; Internal medicine; Surgery; Cancer","score_opus":0.002107120532603353,"score_gpt":0.23317745572687618,"score_spread":0.23107033519427284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281554826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963205,0.00004048854,0.000009150581,0.0013945188,0.0005006131,0.0011777843,0.00011881718,0.000029065079,0.00040907977],"genre_scores_gemma":[0.99876523,0.000008872913,0.000053832577,0.00021206492,0.00022482024,0.00021476866,0.000013361508,0.000028856259,0.00047821965],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99827707,0.00060238974,0.0002589978,0.00023153731,0.0002931173,0.0003368928],"domain_scores_gemma":[0.9987216,0.0005483578,0.00028961812,0.0003042893,0.000046541732,0.00008960938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005617343,0.00018493341,0.0006924073,0.00010711845,0.000107817985,0.000003618197,0.00015302458,0.00014054691,0.0003722528],"category_scores_gemma":[0.000017817267,0.000105600964,0.000104928426,0.00033679287,0.00023188324,0.0000442605,0.00007047393,0.00044627814,0.000001878479],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06787036,0.0020629326,0.15919164,0.0012038639,0.0018477584,0.00030813922,0.0024303105,0.000028670132,0.067324825,0.00013426488,0.0017170014,0.69588023],"study_design_scores_gemma":[0.023690855,0.02705804,0.82832694,0.0002312912,0.00035747603,0.09329097,0.0001709972,0.00008760403,0.025547845,0.000010535691,0.0010497652,0.00017766513],"about_ca_topic_score_codex":0.000051920946,"about_ca_topic_score_gemma":0.000019175817,"teacher_disagreement_score":0.69570255,"about_ca_system_score_codex":0.0003868571,"about_ca_system_score_gemma":0.00018218573,"threshold_uncertainty_score":0.43062824},"labels":[],"label_agreement":null},{"id":"W4283314661","doi":"10.1001/jamaoncol.2022.2059","title":"Prophylactic Antibiotic Regimens in Tumor Resection Surgery Involving a Prosthesis—Reply","year":2022,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"Surgical site infection prevention","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Otorhinolaryngology; Family medicine; MEDLINE; Neurology; General surgery; Psychiatry","score_opus":0.036911608158457856,"score_gpt":0.3031570249962175,"score_spread":0.26624541683775965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283314661","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30701038,0.0004754091,0.000005184343,0.6784331,0.0029206634,0.0021853328,0.000008954802,0.0002817306,0.008679194],"genre_scores_gemma":[0.237113,0.000102405924,0.00014455816,0.7463091,0.0053110993,0.0004954656,0.00056424044,0.0001810179,0.009779127],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953934,0.001659229,0.0008934462,0.0008402293,0.00058549334,0.00062820566],"domain_scores_gemma":[0.9966657,0.0018389988,0.00068923197,0.00056255027,0.00015150475,0.00009201199],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019036726,0.000347904,0.0011290701,0.0012483955,0.00013319902,0.000044446693,0.00012207488,0.00093947345,0.0052762423],"category_scores_gemma":[0.0023466172,0.00034051962,0.00039519527,0.0009887335,0.00011700319,0.0001746077,0.0001465026,0.004594917,0.0001790168],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019972508,0.0008844142,0.057976086,0.002277652,0.00015230653,0.029699896,0.00017672709,0.0000066082403,0.001022556,0.000016146283,0.8894586,0.01633174],"study_design_scores_gemma":[0.0014304991,0.0016694098,0.033653826,0.00033607078,0.00018182395,0.0034602878,0.00005600615,0.00003299223,0.00024859494,0.00013501503,0.9584673,0.00032816466],"about_ca_topic_score_codex":0.0005394919,"about_ca_topic_score_gemma":0.00008315799,"teacher_disagreement_score":0.06989739,"about_ca_system_score_codex":0.003139131,"about_ca_system_score_gemma":0.0009510913,"threshold_uncertainty_score":0.9999047},"labels":[],"label_agreement":null},{"id":"W4292213007","doi":"10.1001/jamaoncol.2022.3467","title":"Caution Regarding Assessment of Toxic Effects and Survival in Treatment De-escalation With Radiotherapy vs Transoral Surgery for Human Papillomavirus–Associated Oropharyngeal Cancer—Reply","year":2022,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Otorhinolaryngology; Neurology; Family medicine; MEDLINE; General surgery; Psychiatry","score_opus":0.037005986957889855,"score_gpt":0.3658940959846155,"score_spread":0.3288881090267256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292213007","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8111902,0.0020080206,0.00014004359,0.18347803,0.00068679696,0.0020145013,0.0001322748,0.00004492628,0.00030520663],"genre_scores_gemma":[0.87753594,0.005876407,0.0006871861,0.10740088,0.0022249115,0.003903698,0.0013276815,0.00016663522,0.000876649],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977841,0.00058989244,0.00046982316,0.00044863034,0.00026636838,0.0004411995],"domain_scores_gemma":[0.99808276,0.001288316,0.00034078493,0.00015464293,0.0000766379,0.000056868932],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006341215,0.00031030184,0.00204366,0.00027743663,0.0001415593,0.000009391872,0.0000461157,0.0004582877,0.000053029573],"category_scores_gemma":[0.00004199559,0.00025537494,0.0001772463,0.00019128266,0.00010076167,0.000049719838,0.000012445232,0.0005950574,4.671285e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009431647,0.0016118496,0.62628686,0.004683748,0.004121512,0.0026071155,0.00410357,0.00008557516,0.010468644,0.000052495343,0.22330064,0.11324637],"study_design_scores_gemma":[0.024182923,0.02669013,0.6464563,0.0009909647,0.0011145278,0.00005174076,0.00012500132,0.00041900566,0.000454671,0.000031050986,0.29898754,0.000496171],"about_ca_topic_score_codex":0.00288492,"about_ca_topic_score_gemma":0.0028056942,"teacher_disagreement_score":0.112750195,"about_ca_system_score_codex":0.0052055465,"about_ca_system_score_gemma":0.0010193954,"threshold_uncertainty_score":0.99998987},"labels":[],"label_agreement":null},{"id":"W4292249484","doi":"10.1001/jamaoncol.2022.3737","title":"Error in Figure 2","year":2022,"lang":"en","type":"erratum","venue":"JAMA Oncology","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Government of Ontario; Pfizer","keywords":"Medicine","score_opus":0.027383103168801007,"score_gpt":0.34826074588494066,"score_spread":0.32087764271613967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292249484","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01054579,0.001599269,5.7504235e-7,0.006086798,0.02745759,0.00080231624,0.00015454124,0.00008532402,0.9532678],"genre_scores_gemma":[0.043719232,0.0002712763,0.00025623682,0.004195506,0.0018595584,0.00031024904,0.0044138664,0.00007480859,0.94489926],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983108,0.00016564944,0.00033813075,0.0004454666,0.00030179764,0.00043816658],"domain_scores_gemma":[0.9991716,0.000090667076,0.0001641996,0.00038394073,0.00003740392,0.00015217751],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018031412,0.00027288054,0.000862102,0.00031673696,0.00005075433,0.000008185933,0.0001602385,0.001024579,0.012159887],"category_scores_gemma":[0.00019699194,0.00023655272,0.00015622408,0.00021386448,0.000053052532,0.000031675223,0.00014308353,0.002662548,0.00047006938],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014257783,0.0006363108,0.007139738,0.000104378996,0.00012407519,0.027646696,0.00013222398,9.3655626e-7,0.000002452963,0.000039002534,0.94753003,0.016501598],"study_design_scores_gemma":[0.0031232499,0.0021733334,0.076256424,0.000046399342,0.00015544488,0.00030659488,0.000048800157,0.000011565419,0.0000015937803,0.00006776112,0.9177377,0.00007110396],"about_ca_topic_score_codex":0.00008247073,"about_ca_topic_score_gemma":0.00009985045,"teacher_disagreement_score":0.06911668,"about_ca_system_score_codex":0.0012847722,"about_ca_system_score_gemma":0.0011294367,"threshold_uncertainty_score":0.9996384},"labels":[],"label_agreement":null},{"id":"W4293105208","doi":"10.1001/jamaoncol.2022.3524","title":"Analysis of Quality-of-Life Outcomes by Drug Class in Cancer Clinical Trials—Reply","year":2022,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Otorhinolaryngology; Family medicine; MEDLINE; Neurology; Psychiatry","score_opus":0.2685709622888784,"score_gpt":0.554625176787541,"score_spread":0.2860542144986626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293105208","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.070462875,0.0019851523,0.000023553273,0.9197756,0.0023890776,0.00083040126,0.002118737,0.000034883647,0.002379703],"genre_scores_gemma":[0.007363953,0.0018304395,0.00014190422,0.9821467,0.0019454876,0.00060426316,0.0015887453,0.00006511653,0.0043134303],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9834784,0.008849445,0.005540027,0.00079006725,0.0009145847,0.00042745494],"domain_scores_gemma":[0.978719,0.015744284,0.0041624797,0.00097508787,0.0002641238,0.0001350436],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.012042762,0.00037562265,0.0077411365,0.0011952452,0.000031653242,0.000006342073,0.0004201478,0.001423461,0.0110547645],"category_scores_gemma":[0.0052876095,0.00032939587,0.0020434014,0.0013127562,0.00044932723,0.00004423262,0.00012856773,0.0038351943,0.000008353767],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002011741,0.00046318135,0.19217739,0.0002039057,0.0059221955,0.00008335229,0.00026606137,0.00002858863,0.00007662056,0.000021378264,0.79427075,0.0044748555],"study_design_scores_gemma":[0.010652301,0.00057137565,0.03062802,0.00006131143,0.0027264182,0.0000015704177,0.00015034224,0.000041607942,0.00003569888,0.000056877034,0.9548258,0.00024866042],"about_ca_topic_score_codex":0.0051214476,"about_ca_topic_score_gemma":0.0010464577,"teacher_disagreement_score":0.16154937,"about_ca_system_score_codex":0.0012724246,"about_ca_system_score_gemma":0.0023893877,"threshold_uncertainty_score":0.99991584},"labels":[],"label_agreement":null},{"id":"W4293105406","doi":"10.1001/jamaoncol.2022.4054","title":"Change of Article Status to Open Access","year":2022,"lang":"en","type":"erratum","venue":"JAMA Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Government of Ontario; Pfizer","keywords":"Medicine; Gerontology; Family medicine","score_opus":0.07316993465775118,"score_gpt":0.41230582663671117,"score_spread":0.33913589197896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293105406","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.085639715,0.02316128,0.000055116132,0.045751367,0.06875433,0.006236619,0.00736783,0.00006814054,0.7629656],"genre_scores_gemma":[0.41714904,0.023963979,0.0034873965,0.07391232,0.026764242,0.01937057,0.022595884,0.0007416274,0.41201493],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985004,0.0001490681,0.00026057032,0.00053559773,0.00015192849,0.00040244273],"domain_scores_gemma":[0.9989542,0.000027240652,0.00024005826,0.0005401085,0.00011958686,0.00011883966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015108315,0.00022853597,0.0005146927,0.00008367027,0.00008957331,0.00005297775,0.0012170287,0.00038377574,0.0006219517],"category_scores_gemma":[0.00012995624,0.00022544574,0.0000958107,0.00018972685,0.000077519886,0.0000101418555,0.0056064,0.0002748402,0.000020069328],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045942268,0.00025453678,0.0026849639,0.0000415074,0.00027908463,0.000023803364,0.0002745025,0.0000026463326,0.00075493415,0.000028917706,0.95503527,0.04016044],"study_design_scores_gemma":[0.0009318193,0.00096775254,0.03957555,0.000018075192,0.00007705533,0.00000812704,0.0001999659,6.692287e-7,0.0011620078,0.0000409716,0.9568136,0.00020443588],"about_ca_topic_score_codex":0.0029333343,"about_ca_topic_score_gemma":0.0027568648,"teacher_disagreement_score":0.35095066,"about_ca_system_score_codex":0.00024899514,"about_ca_system_score_gemma":0.0006336514,"threshold_uncertainty_score":0.919341},"labels":[],"label_agreement":null},{"id":"W4294001434","doi":"10.1001/jamaoncol.2022.4267","title":"Errors in Abstract and Affiliations","year":2022,"lang":"en","type":"erratum","venue":"JAMA Oncology","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Government of Ontario; Pfizer","keywords":"Medicine; George (robot); Gerontology; Art history; Art","score_opus":0.02248534637367638,"score_gpt":0.34299221898329635,"score_spread":0.32050687260961996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294001434","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.039580822,0.012044929,2.9378495e-7,0.08368224,0.02683508,0.0013595095,0.0002477917,0.0000842751,0.8361651],"genre_scores_gemma":[0.2764999,0.042050324,0.0008557803,0.016776437,0.006393345,0.0034731345,0.006483368,0.00023306429,0.6472346],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989657,0.00004625146,0.00026105574,0.00034606186,0.00016457363,0.00021640575],"domain_scores_gemma":[0.99934024,0.0001675813,0.00013733709,0.00023016975,0.00002952116,0.000095141026],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001537695,0.00016794291,0.00053743727,0.00021708776,0.000060037433,0.000010091097,0.000059570782,0.00046419373,0.0032998926],"category_scores_gemma":[0.00009261796,0.00015025024,0.00007883855,0.00013724297,0.00005213686,0.000029797291,0.00007882428,0.0010215007,0.000031422172],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000066854904,0.0005689007,0.009293906,0.00014972415,0.00011679979,0.0008792084,0.00034698492,0.0000026662867,0.0000015158571,0.000112531096,0.9705524,0.017908508],"study_design_scores_gemma":[0.0015830845,0.00064133084,0.2498189,0.00009643469,0.0001484022,0.00006446976,0.00015085516,0.000009885983,0.0000012771762,0.000054946453,0.7473457,0.000084736464],"about_ca_topic_score_codex":0.00071535644,"about_ca_topic_score_gemma":0.0031380854,"teacher_disagreement_score":0.240525,"about_ca_system_score_codex":0.0020757993,"about_ca_system_score_gemma":0.0009923063,"threshold_uncertainty_score":0.9976112},"labels":[],"label_agreement":null},{"id":"W4294001741","doi":"10.1001/jamaoncol.2022.3829","title":"Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer","year":2022,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":324,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University; Canadian Partnership Against Cancer; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Gemcitabine; FOLFIRINOX; Pancreatic cancer; Oncology; Internal medicine; Adjuvant; Adjuvant therapy; Cancer; Irinotecan; Colorectal cancer","score_opus":0.04120636559404846,"score_gpt":0.39803146526592575,"score_spread":0.3568250996718773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294001741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96675694,0.0014106738,0.000050138056,0.019404814,0.00033064449,0.0016191397,0.00010918846,0.00003989544,0.010278557],"genre_scores_gemma":[0.97014683,0.0012692737,0.0020251898,0.0055546723,0.0002456406,0.0024138785,0.00006932471,0.00004458189,0.018230585],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980475,0.00024368615,0.0004911909,0.00033893037,0.00039278428,0.00048595836],"domain_scores_gemma":[0.9979708,0.0010502985,0.0002195666,0.0003825375,0.0002358835,0.00014091046],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007989455,0.00018063711,0.0012978724,0.00019704264,0.00018388951,0.000005032902,0.0002402585,0.00017100111,0.0048525054],"category_scores_gemma":[0.0005054429,0.0001424939,0.00022768392,0.00022892423,0.00021177104,0.00004325623,0.00015982994,0.00039295343,0.000032309177],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008274058,0.0012910933,0.9000044,0.00014607815,0.0010276147,0.00012122571,0.001233893,0.000014767559,0.0021805353,0.0023122896,0.036620185,0.04677389],"study_design_scores_gemma":[0.020333217,0.014317051,0.70720756,0.000026216825,0.00043717626,0.000095794676,0.0013812445,0.0006148028,0.00040931383,0.001256555,0.25373822,0.00018285352],"about_ca_topic_score_codex":0.0008688227,"about_ca_topic_score_gemma":0.00007447028,"teacher_disagreement_score":0.21711805,"about_ca_system_score_codex":0.0005009296,"about_ca_system_score_gemma":0.0012422217,"threshold_uncertainty_score":0.9960572},"labels":[],"label_agreement":null},{"id":"W4294958444","doi":"10.1001/jamaoncol.2022.3766","title":"Ensuring High-Quality Shared Decision-making for Lung Cancer Screening","year":2022,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Decision aids; Quality (philosophy); Cancer; Lung cancer; Lung cancer screening; MEDLINE; Intensive care medicine; Family medicine; Alternative medicine; Oncology; Pathology; Internal medicine","score_opus":0.19054147670657437,"score_gpt":0.5235302621303454,"score_spread":0.33298878542377097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294958444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9689503,0.004117908,0.019516176,0.003320155,0.0008736095,0.0005696752,0.00025507482,0.00006701628,0.0023300971],"genre_scores_gemma":[0.9461947,0.00011890342,0.05065952,0.0019326335,0.00047826092,0.00031751435,0.000050302548,0.000024482397,0.00022367333],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986659,0.00012916562,0.0003968093,0.00027382353,0.00026039788,0.0002738722],"domain_scores_gemma":[0.99707127,0.0022469542,0.00022958507,0.00019832922,0.00018585521,0.000068028174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000691757,0.00011186203,0.00050190784,0.00012420726,0.00017742676,0.0000074223644,0.00013596567,0.000096471194,0.00089725177],"category_scores_gemma":[0.0012662506,0.00010893316,0.00013867312,0.0001892715,0.000040848587,0.000060901504,0.00018566918,0.00026279708,0.0000011575489],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050786748,0.00029945068,0.23843557,0.0004537995,0.0005394414,0.0001937065,0.0064294613,0.0026292936,0.0068641827,0.0019117716,0.036292803,0.7008718],"study_design_scores_gemma":[0.009842447,0.0014219302,0.1636687,0.0014883805,0.0003898897,0.000043349188,0.004499159,0.007116475,0.0025513784,0.001185366,0.8073702,0.00042270022],"about_ca_topic_score_codex":0.0003528906,"about_ca_topic_score_gemma":0.000099798635,"teacher_disagreement_score":0.7710774,"about_ca_system_score_codex":0.00046177732,"about_ca_system_score_gemma":0.00023149623,"threshold_uncertainty_score":0.9824278},"labels":[],"label_agreement":null},{"id":"W4297964923","doi":"10.1001/jamaoncol.2022.4394","title":"Treatment With Stereotactic Ablative Radiotherapy for Up to 5 Oligometastases in Patients With Cancer","year":2022,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Positive Living North; Kelowna General Hospital; University of British Columbia","funders":"","keywords":"SABR volatility model; Medicine; Population; Prostate cancer; Radiation therapy; Cancer; Ablative case; Breast cancer; Lung cancer; Cohort; Oncology; Internal medicine; Surgery","score_opus":0.023676599289634816,"score_gpt":0.332461060624334,"score_spread":0.30878446133469917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297964923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880668,0.00013923249,0.00035455913,0.0064267777,0.000152421,0.003743965,0.00027493693,0.000024856408,0.0008164685],"genre_scores_gemma":[0.9780395,0.00002368572,0.0061818752,0.006601722,0.000048848484,0.0050432114,0.00017010338,0.00005002492,0.0038410018],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987821,0.00013827179,0.00019716959,0.00032425104,0.00027242868,0.0002857543],"domain_scores_gemma":[0.9992521,0.00017974357,0.000119704775,0.00022837747,0.00007727156,0.00014281551],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012961161,0.00016836678,0.00044517877,0.00025644724,0.00006794816,0.000009865494,0.000070837166,0.000020554866,0.0012997777],"category_scores_gemma":[0.00002668562,0.000116799245,0.00004182271,0.00031294927,0.000034612054,0.000061707295,0.000030521755,0.000090374495,0.0000030127092],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12564458,0.0072376602,0.61445415,0.00019159453,0.0031134267,0.00053553504,0.0082513355,0.0012230242,0.00003640347,0.00037975624,0.013048251,0.22588424],"study_design_scores_gemma":[0.07016448,0.08270432,0.38812944,0.00004159453,0.0007956101,0.000012955995,0.0022893401,0.00034030064,0.000038673035,0.000021031068,0.4551667,0.0002955776],"about_ca_topic_score_codex":0.00023894306,"about_ca_topic_score_gemma":0.00027785276,"teacher_disagreement_score":0.44211844,"about_ca_system_score_codex":0.0014422437,"about_ca_system_score_gemma":0.0003395466,"threshold_uncertainty_score":0.99961317},"labels":[],"label_agreement":null},{"id":"W4304989346","doi":"10.1001/jamaoncol.2022.4445","title":"Comparing Trial and Real-world Adjuvant Oxaliplatin Delivery in Patients With Stage III Colon Cancer Using a Longitudinal Cumulative Dose","year":2022,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Oxaliplatin; Medicine; FOLFOX; Oncology; Regimen; Internal medicine; Colorectal cancer; Chemotherapy regimen; Fluorouracil; Stage (stratigraphy); Randomized controlled trial; Clinical trial; Cancer","score_opus":0.07246552915765818,"score_gpt":0.36321377675170163,"score_spread":0.29074824759404344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4304989346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99583673,0.00030414885,0.0000013936756,0.0002405324,0.0002455627,0.0011769714,0.000045372046,0.000018154653,0.0021311257],"genre_scores_gemma":[0.99887115,0.00006323876,0.0001574303,0.0001710177,0.00009032252,0.00026671024,0.000030176554,0.000015506199,0.00033443526],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987409,0.00013399262,0.00028969382,0.00032713372,0.00023934648,0.00026893668],"domain_scores_gemma":[0.9994102,0.0001557708,0.00018517833,0.00010019697,0.000077946206,0.00007068735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016812004,0.00016308823,0.00065883587,0.00017881487,0.00023950059,0.000010499578,0.00004116613,0.000042835025,0.00016188677],"category_scores_gemma":[0.00001719698,0.0001310652,0.0000360724,0.00029285657,0.000100671656,0.00007197828,0.00020916451,0.00028478474,4.4106116e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1425795,0.00066459336,0.84840983,0.000020351137,0.00019600173,0.00020095959,0.0017264552,0.0006104414,0.000020470452,0.000030351728,0.00012441944,0.0054166084],"study_design_scores_gemma":[0.11483242,0.0064840633,0.8738661,0.00004809223,0.00017711766,0.0000047157987,0.0006547735,0.0016014379,0.000006931115,0.0000057529314,0.0021916118,0.00012700302],"about_ca_topic_score_codex":0.018308412,"about_ca_topic_score_gemma":0.040064085,"teacher_disagreement_score":0.02774707,"about_ca_system_score_codex":0.0019415462,"about_ca_system_score_gemma":0.00031582895,"threshold_uncertainty_score":0.98822874},"labels":[],"label_agreement":null},{"id":"W4304990118","doi":"10.1001/jamaoncol.2022.4649","title":"Association of Changes in Cancer Therapy Over 3 Decades With Risk of Subsequent Breast Cancer Among Female Childhood Cancer Survivors","year":2022,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Alberta","funders":"National Cancer Institute","keywords":"Medicine; Breast cancer; Cancer; Cumulative incidence; Internal medicine; Radiation therapy; Anthracycline; Population; Oncology; Cancer registry; Incidence (geometry); Retrospective cohort study; Cohort","score_opus":0.021371245718769395,"score_gpt":0.32633524515083273,"score_spread":0.3049639994320633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4304990118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9775431,0.003962876,0.0000023587854,0.015327486,0.00058239297,0.0009149197,0.0012732084,0.00003677826,0.0003568905],"genre_scores_gemma":[0.9886059,0.0073657515,0.000050289254,0.0020362912,0.00045195423,0.0010132355,0.00003516795,0.00005947684,0.00038191443],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965575,0.00086619443,0.0006682247,0.0004916566,0.00092082913,0.0004956259],"domain_scores_gemma":[0.9973725,0.00045183906,0.0013943709,0.0003588215,0.00029053004,0.00013193644],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015537157,0.00027772374,0.0010884687,0.00032532198,0.00010387373,0.000007789081,0.00024382019,0.00024571858,0.0023559597],"category_scores_gemma":[0.000094654824,0.0002462871,0.00014359676,0.00082930416,0.00017300855,0.00011509059,0.00011534973,0.00077842304,6.202729e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015791696,0.0010484315,0.9585065,0.00013424312,0.0008209164,0.00001451219,0.014549969,0.0010009818,0.0006574628,0.000020144087,0.00092284265,0.020744776],"study_design_scores_gemma":[0.0066974736,0.001286151,0.9791157,0.00023934302,0.00020216414,0.000011484831,0.0022004417,0.0000491233,0.002343875,0.000023197685,0.007588101,0.00024293574],"about_ca_topic_score_codex":0.30526954,"about_ca_topic_score_gemma":0.6228158,"teacher_disagreement_score":0.31754625,"about_ca_system_score_codex":0.0025970843,"about_ca_system_score_gemma":0.0014418256,"threshold_uncertainty_score":0.9999989},"labels":[],"label_agreement":null},{"id":"W4306913474","doi":"10.1001/jamaoncol.2022.5068","title":"Methodologic Concerns in Secondary Analysis of KEYNOTE-048","year":2022,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Otorhinolaryngology; Family medicine; Neurology; MEDLINE; Psychiatry","score_opus":0.07565656600452525,"score_gpt":0.44372764315129026,"score_spread":0.368071077146765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306913474","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010289067,0.0017597405,0.00017417855,0.85292983,0.0009637071,0.00087214424,0.00090199814,0.000051078645,0.13205823],"genre_scores_gemma":[0.010264204,0.00042246087,0.005146768,0.9595993,0.0013176549,0.0004826892,0.006650987,0.000055111228,0.01606079],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978161,0.00062714814,0.00055363605,0.00045876263,0.0002449497,0.0002994142],"domain_scores_gemma":[0.99785894,0.00115454,0.00040242483,0.00044690576,0.00009024509,0.000046951503],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00043114158,0.00021677266,0.0015373244,0.0010855105,0.000038724538,0.000007799812,0.00018112478,0.00083134865,0.009356834],"category_scores_gemma":[0.00020372709,0.00018467581,0.0004278977,0.0010358067,0.00012882175,0.00005973486,0.00010582864,0.0018538124,0.000009049632],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003505746,0.0002949044,0.007205834,0.00022879151,0.009273388,0.005055371,0.0014236629,0.000112222966,0.00007757247,0.00016594386,0.9412599,0.03455184],"study_design_scores_gemma":[0.0024048758,0.0012134211,0.020284276,0.000018334362,0.00948042,0.000040339146,0.00026530505,0.000037633272,0.000018307832,0.0001344474,0.9659656,0.00013698303],"about_ca_topic_score_codex":0.0012216993,"about_ca_topic_score_gemma":0.00031768024,"teacher_disagreement_score":0.11599744,"about_ca_system_score_codex":0.0013401996,"about_ca_system_score_gemma":0.0013227087,"threshold_uncertainty_score":0.9915488},"labels":[],"label_agreement":null},{"id":"W4306915041","doi":"10.1001/jamaoncol.2022.5049","title":"Association of Long-term Outcomes With Stereotactic Radiosurgery vs Whole-Brain Radiotherapy for Resected Brain Metastasis","year":2022,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Juravinski Cancer Centre","funders":"National Cancer Institute","keywords":"Medicine; Radiosurgery; Quality of life (healthcare); Brain metastasis; Radiation therapy; Randomization; Randomized controlled trial; Internal medicine; Oncology; Surgery; Metastasis; Cancer","score_opus":0.032032689934869414,"score_gpt":0.339230455043574,"score_spread":0.3071977651087046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306915041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8241219,0.00044655823,0.00058571127,0.1719682,0.00030985288,0.0015852547,0.00078036083,0.00005903372,0.0001431525],"genre_scores_gemma":[0.96201634,0.000028922374,0.006957518,0.016598795,0.00025936245,0.0013522086,0.0016642468,0.000108038366,0.011014579],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99750316,0.0008098729,0.00047909564,0.00036034835,0.00044669598,0.00040082666],"domain_scores_gemma":[0.9945422,0.004214754,0.00058543205,0.0003750529,0.00016184297,0.000120707286],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015755061,0.0002181709,0.0009960664,0.00027046714,0.00015560353,0.000017491668,0.00011619493,0.000123634,0.0012036454],"category_scores_gemma":[0.0008329939,0.0001693978,0.0003007735,0.00035105358,0.00004732658,0.000087765286,0.00004729645,0.0002921966,0.0000037503453],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0105944015,0.0028758408,0.6416138,0.00030003558,0.008462434,0.00086500915,0.0009880846,0.00006045633,0.003167252,0.00022977358,0.22969134,0.101151615],"study_design_scores_gemma":[0.030241817,0.015906343,0.62547183,0.000048027265,0.0012723143,0.0005275387,0.00029916366,0.000110176734,0.0009524224,0.000053413685,0.324815,0.0003019483],"about_ca_topic_score_codex":0.000054522032,"about_ca_topic_score_gemma":0.00010335768,"teacher_disagreement_score":0.15536942,"about_ca_system_score_codex":0.0013919094,"about_ca_system_score_gemma":0.00043052956,"threshold_uncertainty_score":0.99970937},"labels":[],"label_agreement":null},{"id":"W4308027679","doi":"10.1001/jamaoncol.2022.5357","title":"Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19","year":2022,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; McGill University Health Centre","funders":"National Center for Advancing Translational Sciences; National Institute of Allergy and Infectious Diseases; National Heart, Lung, and Blood Institute; National Institute on Aging; Loxo Oncology; EMD Serono; Genentech; Bausch Health; Ipsen; European Society for Medical Oncology; Astellas Pharma; Eisai; National Institutes of Health; Regeneron Pharmaceuticals; Natera; National Geographic Society; UroGen Pharma; ECOG-ACRIN Cancer Research Group; Seagen; Hope Foundation; Flatiron Health; Vanderbilt University; Advanced Accelerator Applications; National Cancer Institute; Gilead Sciences; Pfizer; Incyte; American Cancer Society; American College of Radiology Imaging Network; Exelixis; Sanofi; American Association for Cancer Research; Amgen; Bristol-Myers Squibb; AstraZeneca","keywords":"Medicine; Interquartile range; Immunosuppression; Cytokine storm; Internal medicine; Cancer; Intensive care unit; Regimen; Retrospective cohort study; Nivolumab; Immunotherapy; Coronavirus disease 2019 (COVID-19)","score_opus":0.021758550648267143,"score_gpt":0.39032240771732324,"score_spread":0.3685638570690561,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308027679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98756075,0.001368003,0.000029493112,0.010151154,0.00013346359,0.00043526877,0.00005061701,0.000017108303,0.0002541318],"genre_scores_gemma":[0.988865,0.00046615943,0.00007917796,0.010262062,0.00003267952,0.000069629365,0.00002375361,0.000014182451,0.0001873434],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99916756,0.000116491814,0.00019988653,0.00018364578,0.0001618999,0.00017052161],"domain_scores_gemma":[0.999192,0.0002591397,0.00015346995,0.00015119754,0.0000621696,0.00018200827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021176344,0.000092917646,0.0003122123,0.000118041025,0.00013666258,0.0000053547046,0.000051356034,0.00007973484,0.0005108491],"category_scores_gemma":[0.00012319989,0.00006991211,0.000020265545,0.0001035562,0.00016712766,0.000056885405,0.00011188596,0.00027238196,2.670954e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051173284,0.0002680049,0.90255094,0.00020751236,0.00006831551,0.000033139022,0.004718921,0.000009200845,0.0012635483,0.000029093597,0.0033528693,0.0823811],"study_design_scores_gemma":[0.008103858,0.0049098413,0.8526096,0.00005586208,0.000032835767,0.000034428733,0.00057056645,0.000050874234,0.00010607525,0.000036781377,0.13341385,0.00007547155],"about_ca_topic_score_codex":0.004811901,"about_ca_topic_score_gemma":0.0004386071,"teacher_disagreement_score":0.13006097,"about_ca_system_score_codex":0.00048283258,"about_ca_system_score_gemma":0.0008596563,"threshold_uncertainty_score":0.7274187},"labels":[],"label_agreement":null},{"id":"W4309183974","doi":"10.1001/jamaoncol.2022.5370","title":"Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma","year":2022,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":405,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital; Université de Sherbrooke","funders":"Houston Methodist Research Institute; University of California, San Diego; Saint Luke's Health System; Northwell Health; National Cancer Institute; University College London; Kaiser Permanente; Université de Sherbrooke; Moffitt Cancer Center; Houston Methodist Hospital; Montreal Neurological Institute and Hospital; University of California, Los Angeles; University of South Carolina; McGill University; Sylvester Comprehensive Cancer Center, University of Miami Health Systems; Tufts Medical Center; University of Miami; Hollings Cancer Center, Medical University of South Carolina; Brown University","keywords":"Medicine; Temozolomide; Internal medicine; Clinical endpoint; Placebo; Clinical trial; Oncology; Hazard ratio; Glioblastoma; Randomization; Chemotherapy; Surgery; Confidence interval; Pathology","score_opus":0.007123232567838385,"score_gpt":0.23840523519058587,"score_spread":0.23128200262274748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309183974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981126,0.000085663276,0.0000052000682,0.0006672767,0.00016698119,0.000705308,0.000037494672,0.000021553977,0.00019791561],"genre_scores_gemma":[0.99937993,0.000016503724,0.00024596526,0.00007511433,0.000018272201,0.00013939383,0.0000746955,0.000018642819,0.000031477583],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99851954,0.0002630764,0.00032461397,0.0002657567,0.0004272575,0.00019973199],"domain_scores_gemma":[0.998373,0.0004538337,0.0005736155,0.00016291434,0.00035718837,0.000079460566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024482334,0.00014083883,0.0005151963,0.00019214924,0.00008009662,0.000005397383,0.00004935056,0.00007871163,0.000077062796],"category_scores_gemma":[0.00014621299,0.000098849225,0.000043960597,0.0002684041,0.000038974056,0.000063344516,0.000065280205,0.00017487572,9.649016e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026233434,0.003907113,0.97737706,0.000103289756,0.00015632322,0.00022134141,0.0005184027,0.000060447725,0.0014666542,0.000024871142,0.00060085725,0.0129403155],"study_design_scores_gemma":[0.017521733,0.017166654,0.9573804,0.00005655763,0.00042556226,0.000019031782,0.00038667768,0.00019319843,0.0064564073,0.000013266638,0.00028375295,0.00009673466],"about_ca_topic_score_codex":0.00012126244,"about_ca_topic_score_gemma":0.00042777273,"teacher_disagreement_score":0.019996617,"about_ca_system_score_codex":0.00050963,"about_ca_system_score_gemma":0.00012787055,"threshold_uncertainty_score":0.40309545},"labels":[],"label_agreement":null},{"id":"W4309184100","doi":"10.1001/jamaoncol.2022.5228","title":"Avelumab Plus Talazoparib in Patients With Advanced Solid Tumors","year":2022,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute; Foundation Medicine; Genentech; Astellas Pharma; Incyte; National Center for Advancing Translational Sciences; Seagen; Gilead Sciences; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Symphogen; GlaxoSmithKline; Amgen; Pfizer","keywords":"Medicine; Prostate cancer; Oncology; Internal medicine; Avelumab; Cancer; Lung cancer; Breast cancer; Immunogenicity; Response Evaluation Criteria in Solid Tumors; Clinical endpoint; Immunotherapy; Antigen; Immunology; Phases of clinical research; Chemotherapy; Clinical trial; Pembrolizumab","score_opus":0.014103020392398594,"score_gpt":0.3020944315400396,"score_spread":0.28799141114764104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309184100","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15403104,0.00030676898,0.00003196989,0.8054116,0.0023650408,0.0030624582,0.00036725012,0.00021850194,0.034205403],"genre_scores_gemma":[0.032218438,0.00006208402,0.0007676162,0.95588523,0.0023799404,0.0013180091,0.0031092162,0.00019014698,0.004069345],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968657,0.00029241008,0.00066951034,0.0007494724,0.0007162527,0.0007066612],"domain_scores_gemma":[0.9983276,0.00023737141,0.0005235491,0.0006334197,0.00017562209,0.00010244524],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021355163,0.00043284893,0.0013273166,0.00047628145,0.00008546004,0.000015091807,0.00027268525,0.00088252284,0.0040303287],"category_scores_gemma":[0.00007917117,0.0003964938,0.00013255134,0.00040301553,0.00021117326,0.00010338382,0.00012617331,0.004193044,0.00009882074],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049360413,0.00034867055,0.0053549088,0.00017771262,0.00013551426,0.0039659827,0.00043847243,0.00011437732,0.000018716277,0.000012152413,0.974759,0.009738456],"study_design_scores_gemma":[0.024968948,0.0058961427,0.01473311,0.00025707652,0.00006880415,0.00014527973,0.00005910091,0.000015296244,0.000046476045,0.000072022245,0.953338,0.00039974472],"about_ca_topic_score_codex":0.00006531122,"about_ca_topic_score_gemma":0.000042039766,"teacher_disagreement_score":0.15047362,"about_ca_system_score_codex":0.0047968747,"about_ca_system_score_gemma":0.0016630451,"threshold_uncertainty_score":0.9998487},"labels":[],"label_agreement":null},{"id":"W4309827972","doi":"10.1001/jamaoncol.2022.5486","title":"Effectiveness of Adjuvant Pembrolizumab vs High-Dose Interferon or Ipilimumab for Quality-of-Life Outcomes in Patients With Resected Melanoma","year":2022,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute","keywords":"Medicine; Ipilimumab; Pembrolizumab; Internal medicine; Quality of life (healthcare); Clinical endpoint; Oncology; Randomized controlled trial; Randomization; Clinical trial; Adjuvant therapy; Cancer; Immunotherapy","score_opus":0.02678739375407324,"score_gpt":0.33753905426309,"score_spread":0.31075166050901676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309827972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971039,0.00010512924,0.00003419381,0.00051060144,0.00036610907,0.0015937624,0.0001685571,0.000018213357,0.00009947971],"genre_scores_gemma":[0.99882126,0.000008475603,0.00018876427,0.00028035292,0.000019259865,0.0004022778,0.0001403545,0.000026476939,0.00011275981],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9977738,0.0007829145,0.0006419367,0.00027750636,0.00028214508,0.00024167255],"domain_scores_gemma":[0.99766356,0.0014338858,0.00037365963,0.00029778862,0.0001773948,0.00005373392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009796151,0.00015785011,0.0010327224,0.00025065464,0.000048448263,0.0000027250237,0.00016059361,0.000118394215,0.0002475966],"category_scores_gemma":[0.00038896757,0.00011019471,0.00012487019,0.00031668702,0.0001343668,0.000049822367,0.00009710444,0.00022725547,5.785569e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6178963,0.001864783,0.3641977,0.00069782534,0.0003920752,0.000010666505,0.0004862874,0.000011939715,0.0046561314,0.000087291985,0.00013872891,0.009560276],"study_design_scores_gemma":[0.08601483,0.037958965,0.872549,0.000118372074,0.000058529757,0.000004684658,0.00030863646,0.000013687991,0.0017595587,0.00003007495,0.0010672547,0.00011639931],"about_ca_topic_score_codex":0.0010749161,"about_ca_topic_score_gemma":0.0004685927,"teacher_disagreement_score":0.53188145,"about_ca_system_score_codex":0.0006720874,"about_ca_system_score_gemma":0.00062942033,"threshold_uncertainty_score":0.449361},"labels":[],"label_agreement":null},{"id":"W4310566600","doi":"10.1001/jamaoncol.2022.5610","title":"Tucatinib vs Placebo, Both in Combination With Trastuzumab and Capecitabine, for Previously Treated ERBB2 (HER2)-Positive Metastatic Breast Cancer in Patients With Brain Metastases","year":2022,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":197,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Aptitude Health; Eisai; National Breast Cancer Foundation; Seagen; G1 Therapeutics; Daiichi-Sankyo; MacroGenics; Silverback Therapeutics; Puma Biotechnology; Medac; Ipsen; OncoSec Medical; Syndax Pharmaceuticals; BioMarin Pharmaceutical; Mylan; Ionis Pharmaceuticals; National Center for Advancing Translational Sciences; Teva Pharmaceutical Industries; Les Laboratories Pierre Fabre; Vertex Pharmaceuticals; Foundation Medicine; Genomic Health; Breast Cancer Research Foundation; Jounce Therapeutics; Celgene; Genentech; Veracyte; Amgen; Radius Health; Daiichi Sankyo Europe; National Cancer Institute; Gilead Sciences; Yale University; Sanofi; GlaxoSmithKline; Carrick Therapeutics; Samsung; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Pfizer","keywords":"Capecitabine; Medicine; Trastuzumab; Internal medicine; Metastatic breast cancer; Placebo; Oncology; Breast cancer; Pertuzumab; Cancer; Colorectal cancer; Pathology","score_opus":0.009678729924896167,"score_gpt":0.28176592373884174,"score_spread":0.2720871938139456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310566600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845714,0.00023173237,0.00013931224,0.008986842,0.000044956425,0.0040242197,0.0018240303,0.000024396519,0.00015313373],"genre_scores_gemma":[0.99286133,0.000021484211,0.0019952294,0.0011583122,0.000019848172,0.003015317,0.00068320555,0.00004865134,0.00019663738],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99782354,0.0005835888,0.00038589715,0.00049939135,0.00028118322,0.00042637408],"domain_scores_gemma":[0.9985288,0.00081057387,0.00023102116,0.00017795493,0.00012303313,0.00012862052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053155934,0.00028275873,0.0007541502,0.000311913,0.000110904395,0.000016846714,0.0000692821,0.00005067558,0.00027604005],"category_scores_gemma":[0.000061937666,0.00019226961,0.000049119422,0.00043981988,0.0001173421,0.00013478713,0.00004242034,0.0002242774,8.965692e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06097251,0.0130641,0.71696025,0.0002841293,0.0013821705,0.0005911545,0.003549921,0.00030721095,0.00006379022,0.0008314272,0.0021569785,0.19983634],"study_design_scores_gemma":[0.08634218,0.023138775,0.88567317,0.00017586657,0.00065926265,0.00022376297,0.0011270449,0.0002548317,0.00005056886,0.00006979308,0.002019831,0.00026492146],"about_ca_topic_score_codex":0.0012151937,"about_ca_topic_score_gemma":0.003783721,"teacher_disagreement_score":0.19957142,"about_ca_system_score_codex":0.001278129,"about_ca_system_score_gemma":0.00046337312,"threshold_uncertainty_score":0.7840527},"labels":[],"label_agreement":null},{"id":"W4313278417","doi":"10.1001/jamaoncol.2022.6815","title":"Association of COVID-19 Vaccination With Breakthrough Infections and Complications in Patients With Cancer","year":2022,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; St. Michael's Hospital; Institute for Clinical Evaluative Sciences; Princess Margaret Cancer Centre; University of Toronto; University Health Network; Public Health Ontario","funders":"","keywords":"Medicine; Cancer; Hazard ratio; Internal medicine; Vaccination; Retrospective cohort study; Incidence (geometry); Population; Cohort; Cohort study; Immunology; Confidence interval","score_opus":0.03142714794451472,"score_gpt":0.39453593245238017,"score_spread":0.36310878450786543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313278417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9146067,0.000042414344,0.0001993873,0.08331597,0.000052895633,0.0006582659,0.00007534678,0.000020983607,0.0010280525],"genre_scores_gemma":[0.9921099,0.00003811438,0.0001228605,0.0072511076,0.000024032528,0.00021966104,0.00008858434,0.000007981728,0.00013774031],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992273,0.00012877017,0.0001758816,0.00014600783,0.0001892095,0.00013282846],"domain_scores_gemma":[0.9990441,0.0003378734,0.00021735934,0.00010390409,0.00019471672,0.00010199802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002353108,0.00006029702,0.0001993577,0.00017731372,0.00014148014,0.0000039102615,0.000027308773,0.00006486345,0.00024185814],"category_scores_gemma":[0.00027991142,0.00005186122,0.000011727996,0.000411545,0.000020058209,0.00007053518,0.000029564217,0.00022510218,7.239287e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046026678,0.0005672256,0.9863467,0.00009016607,0.000037507474,0.0000023771586,0.0012973251,0.00030911207,0.000010987384,0.0002810514,0.00264813,0.007949106],"study_design_scores_gemma":[0.00578855,0.0024759562,0.92955434,0.000012311027,0.000054967088,0.000009767363,0.00019634792,0.000063993175,0.0000034090183,0.000083181534,0.06170874,0.00004845048],"about_ca_topic_score_codex":0.006339945,"about_ca_topic_score_gemma":0.016514385,"teacher_disagreement_score":0.07750323,"about_ca_system_score_codex":0.0029187954,"about_ca_system_score_gemma":0.0014376333,"threshold_uncertainty_score":0.9584142},"labels":[],"label_agreement":null},{"id":"W4317436361","doi":"10.1001/jamaoncol.2022.6881","title":"Long-term Trajectories of Physical Function Decline in Women With and Without Cancer","year":2023,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; Cancer; Breast cancer; Colorectal cancer; Cohort; Prospective cohort study; Cohort study; Endometrial cancer; Lung cancer; Internal medicine; Gerontology","score_opus":0.01936109449623488,"score_gpt":0.32873183478697526,"score_spread":0.3093707402907404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317436361","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973291,0.00015084137,0.000016243735,0.0016096943,0.00018721321,0.00014181879,0.000006772068,0.000032548265,0.000525753],"genre_scores_gemma":[0.9986747,0.00011705847,0.000007643379,0.00051606743,0.0002918962,0.00011270412,0.000008429545,0.000011373076,0.00026012817],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99944127,0.000033014632,0.00010743981,0.00014739513,0.00010775166,0.00016312265],"domain_scores_gemma":[0.9996859,0.00006781387,0.000045165994,0.00008918239,0.000054000742,0.000057979134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001150131,0.00007225114,0.00030096617,0.00008905501,0.000012819161,0.0000035074304,0.000025012812,0.00007723798,0.00004678739],"category_scores_gemma":[0.000019612451,0.000054188262,0.000015976297,0.00030227762,0.00009826111,0.000040144372,0.000025997359,0.00013253251,0.000002727875],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045882976,0.00009825518,0.87892514,0.00015732105,0.000050237526,0.000034502882,0.005780739,0.0000075248195,0.0027440505,0.000045901706,0.00013858208,0.107429415],"study_design_scores_gemma":[0.0027327703,0.002169173,0.9903531,0.000081027145,0.000044399127,0.000012558238,0.0010325483,0.000045322995,0.00047424983,0.0000643102,0.0029318894,0.00005865228],"about_ca_topic_score_codex":0.00078330276,"about_ca_topic_score_gemma":0.018989557,"teacher_disagreement_score":0.111427926,"about_ca_system_score_codex":0.00014776933,"about_ca_system_score_gemma":0.00017330733,"threshold_uncertainty_score":0.9989113},"labels":[],"label_agreement":null},{"id":"W4318070812","doi":"10.1001/jamaoncol.2022.6911","title":"Association of Inflammatory Biomarkers With Survival Among Patients With Stage III Colon Cancer","year":2023,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec","funders":"National Cancer Institute","keywords":"Medicine; Internal medicine; Hazard ratio; Colorectal cancer; Proportional hazards model; Cancer; Oncology; Biomarker; Prospective cohort study; Cohort; Confidence interval","score_opus":0.00977426076898849,"score_gpt":0.2715399056885958,"score_spread":0.2617656449196073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318070812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99307376,0.000021869026,0.000004977849,0.0010630225,0.00034887658,0.0009555955,0.00009464844,0.00016247095,0.0042747804],"genre_scores_gemma":[0.9975673,0.000032000764,0.0002017168,0.00018586495,0.00011072261,0.00028700972,0.00015412833,0.000049204893,0.0014120729],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99800533,0.000206796,0.00040281078,0.0003211361,0.0006400184,0.0004239267],"domain_scores_gemma":[0.99807703,0.0003130989,0.0005955234,0.00027393748,0.0005673205,0.00017310679],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006917984,0.00020066217,0.00050572254,0.00028274787,0.000080456186,0.000012019545,0.00011960335,0.00032992396,0.00022922904],"category_scores_gemma":[0.00020987332,0.00015719679,0.0000747016,0.0006474783,0.00024825815,0.00015376021,0.00007402587,0.00020969249,0.00002760623],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057630907,0.00022153136,0.97931635,0.00024119571,0.0012573864,0.00014466491,0.00029269847,0.000017905182,0.00043059755,0.00002359888,0.009000008,0.0032909624],"study_design_scores_gemma":[0.009646877,0.00091868616,0.9754139,0.00016721981,0.00038866609,8.5233063e-7,0.00033140552,0.000116403535,0.00097457867,0.0000039628435,0.011859105,0.00017831889],"about_ca_topic_score_codex":0.00016617651,"about_ca_topic_score_gemma":0.0010811138,"teacher_disagreement_score":0.00449352,"about_ca_system_score_codex":0.00093315635,"about_ca_system_score_gemma":0.0006492064,"threshold_uncertainty_score":0.6410299},"labels":[],"label_agreement":null},{"id":"W4318916194","doi":"10.1001/jamaoncol.2022.7143","title":"Different Ways of Traveling the Cancer Road—Daytime Running Lights at Night?","year":2023,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Cancer; Oncology; Daytime; Internal medicine","score_opus":0.24392723444079104,"score_gpt":0.4474011985879096,"score_spread":0.20347396414711857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318916194","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9618525,0.0012147111,0.00003654843,0.027369235,0.0003596775,0.00018577423,0.000010978713,0.000047437057,0.008923137],"genre_scores_gemma":[0.9925296,0.0015916936,0.0001933554,0.003094916,0.00060510123,0.000043825392,0.000024804933,0.000019560901,0.0018971801],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99896663,0.00005975045,0.0003239104,0.00018743458,0.00020495246,0.00025730883],"domain_scores_gemma":[0.9989658,0.00047145554,0.00015918033,0.0002237998,0.00011972531,0.00006005934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002155514,0.00012032241,0.00047965278,0.00007692024,0.000067554065,0.0000030629128,0.00013775799,0.00018343149,0.00032450637],"category_scores_gemma":[0.00016146731,0.000070328264,0.00012215652,0.00021694903,0.00012335833,0.00002338987,0.00009104733,0.00023446996,0.000064650856],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014777353,0.00042022913,0.27187023,0.0007741645,0.0013163701,0.00075200666,0.069497705,0.0002473671,0.27861682,0.0023643249,0.23298772,0.13967532],"study_design_scores_gemma":[0.0030535406,0.00093472295,0.22340895,0.00089303363,0.00030651776,0.000022123797,0.0020116516,0.0018841634,0.14782643,0.00046207925,0.61900145,0.00019535076],"about_ca_topic_score_codex":0.00029959105,"about_ca_topic_score_gemma":0.00017410758,"teacher_disagreement_score":0.38601372,"about_ca_system_score_codex":0.00019456093,"about_ca_system_score_gemma":0.00010951323,"threshold_uncertainty_score":0.35531172},"labels":[],"label_agreement":null},{"id":"W4319657006","doi":"10.1001/jamaoncol.2022.7364","title":"Assessment of Phase 3 Randomized Clinical Trials Including Patients With Leptomeningeal Disease","year":2023,"lang":"en","type":"review","venue":"JAMA Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; St. Michael's Hospital; University of Calgary; University of Toronto; McMaster University","funders":"","keywords":"Medicine; Randomized controlled trial; Breast cancer; Lung cancer; Disease; Clinical trial; Melanoma; Cancer; Internal medicine; Oncology","score_opus":0.3602542693905168,"score_gpt":0.6070659847269417,"score_spread":0.24681171533642493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319657006","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014376543,0.98239547,0.00031000673,0.0004732722,0.0011996893,0.012118667,0.00091864745,0.000103596474,0.0010429759],"genre_scores_gemma":[0.0004568811,0.99147856,0.0030906072,0.00017316832,0.0006490264,0.0012940494,0.0025061741,0.00009783991,0.00025368913],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98438954,0.0103587825,0.003695736,0.00064702664,0.00054127374,0.00036764727],"domain_scores_gemma":[0.97414476,0.021323133,0.003181528,0.0005874397,0.00023667315,0.0005264514],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.018020349,0.0005115754,0.013596588,0.00037122009,0.000061774976,0.000016910817,0.00016270706,0.00049003493,0.00026241006],"category_scores_gemma":[0.009106854,0.00027635228,0.0024640728,0.00036608227,0.00032664486,0.000041412768,0.00018327976,0.000730115,0.000035051817],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03460689,0.004329638,0.00035824534,0.008716734,0.0060137967,0.0005461904,0.000012704359,2.94571e-7,1.6225794e-8,0.0002555929,0.0012939663,0.94386595],"study_design_scores_gemma":[0.3805556,0.0031906925,0.0002070105,0.007666764,0.02908662,0.000008837798,0.000008707327,0.000024189958,3.3405257e-8,0.000025628698,0.5790419,0.00018399417],"about_ca_topic_score_codex":0.000012679146,"about_ca_topic_score_gemma":0.000002504164,"teacher_disagreement_score":0.94368196,"about_ca_system_score_codex":0.00049514335,"about_ca_system_score_gemma":0.0030016117,"threshold_uncertainty_score":0.9999689},"labels":[],"label_agreement":null},{"id":"W4321612529","doi":"10.1001/jamaoncol.2022.7770","title":"Exposure to US Cancer Drugs With Lack of Confirmed Benefit After US Food and Drug Administration Accelerated Approval","year":2023,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Canadian Institutes of Health Research; National Institutes of Health; Astellas Pharma; Seagen; Flatiron Health; Emerson Collective; National Palliative Care Research Center; Eisai; National Comprehensive Cancer Network; F. Hoffmann-La Roche; University of Pennsylvania; Myriad Genetics; Prostate Cancer Foundation; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb; Cancer Care Ontario; Pfizer; Amgen; Conquer Cancer Foundation","keywords":"Medicine; Food and drug administration; Cancer drugs; Drug approval; Drug; Drug administration; Administration (probate law); Cancer; Pharmacology; Intensive care medicine; Oncology; Family medicine; Internal medicine","score_opus":0.28424878318026425,"score_gpt":0.43793605879494996,"score_spread":0.1536872756146857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321612529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9494123,0.00040611764,0.000052688138,0.04642891,0.00035802813,0.00083196553,0.0005053091,0.000051757717,0.0019529228],"genre_scores_gemma":[0.98765635,0.00009640224,0.00072601135,0.009602171,0.00026200362,0.0005933497,0.00005797771,0.000030674702,0.00097503554],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99694103,0.0001613335,0.0019233538,0.0005241155,0.00008293973,0.00036723417],"domain_scores_gemma":[0.99774694,0.0005550955,0.001065913,0.0003032918,0.00013302045,0.00019575667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00392802,0.0001755682,0.000892332,0.000311666,0.00008213097,0.000055516368,0.00015489038,0.00022248515,0.000339601],"category_scores_gemma":[0.00042787092,0.00019936719,0.000048266895,0.00036728042,0.00008993584,0.00025095895,0.000057567435,0.00016160736,0.00030841393],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001696073,0.00049993314,0.85044646,0.0015412995,0.00064213475,0.00002483365,0.027845915,0.0019251889,0.00009663466,0.045507226,0.05851382,0.01126048],"study_design_scores_gemma":[0.004058588,0.002556226,0.8309781,0.00012297959,0.000028657116,0.000015277046,0.002798947,0.0014851133,0.00021425463,0.0023421466,0.15485549,0.00054424535],"about_ca_topic_score_codex":0.0011011922,"about_ca_topic_score_gemma":0.005966334,"teacher_disagreement_score":0.09634167,"about_ca_system_score_codex":0.0003427919,"about_ca_system_score_gemma":0.00039476005,"threshold_uncertainty_score":0.8129958},"labels":[],"label_agreement":null},{"id":"W4360601141","doi":"10.1001/jamaoncol.2023.0239","title":"Subcutaneous vs Intravenous Administration of Medications and Fluids for Patients With Cancer in the US and Canada","year":2023,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Ottawa Hospital; Princess Margaret Cancer Centre; University of Ottawa","funders":"","keywords":"Medicine; Intravenous fluid; Administration (probate law); Cancer; Palliative care; Intensive care medicine; Intravenous drug; Emergency medicine; Anesthesia; Internal medicine; Family medicine; Nursing","score_opus":0.017500671534278495,"score_gpt":0.3596588544290456,"score_spread":0.3421581828947671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4360601141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987438,0.000024568619,0.000025096188,0.011111524,0.00028095726,0.00061749166,0.00013049267,0.000009409136,0.00036242016],"genre_scores_gemma":[0.9984982,0.000083717314,0.00014488834,0.0008575801,0.000072650946,0.00019668289,0.000048844497,0.0000072319885,0.000090227295],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992247,0.000121068224,0.00023546387,0.00011650287,0.00011396893,0.00018827387],"domain_scores_gemma":[0.99730736,0.0023369766,0.00011716398,0.00008411776,0.00011466826,0.000039700386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029950822,0.000056697783,0.00015469435,0.000048426176,0.0001632988,0.0000023138557,0.00006426675,0.00009589891,0.000020297908],"category_scores_gemma":[0.00033634438,0.00003838935,0.0000049081846,0.00011773446,0.00007583237,0.000019551884,0.000020287494,0.00015346851,7.972796e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001798933,0.00017551208,0.9410083,0.00041944542,0.000057742516,0.000066740715,0.011182525,0.0000263554,0.00006048614,0.0014187149,0.019313473,0.02447172],"study_design_scores_gemma":[0.0018956262,0.0011363906,0.9746106,0.00008974558,0.000039877847,0.000011348127,0.0020436842,0.0004319936,0.000005882744,0.00012420815,0.019549916,0.000060705894],"about_ca_topic_score_codex":0.14324239,"about_ca_topic_score_gemma":0.8670649,"teacher_disagreement_score":0.72382253,"about_ca_system_score_codex":0.00008614668,"about_ca_system_score_gemma":0.002829258,"threshold_uncertainty_score":0.8624628},"labels":[],"label_agreement":null},{"id":"W4361270506","doi":"10.1001/jamaoncol.2023.0042","title":"Pathologic Complete Response and Clinical Outcomes in Patients With Localized Soft Tissue Sarcoma Treated With Neoadjuvant Chemoradiotherapy or Radiotherapy","year":2023,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; McGill University","funders":"National Cancer Institute","keywords":"Medicine; Soft tissue sarcoma; Chemoradiotherapy; Radiation therapy; Internal medicine; Hazard ratio; Proportional hazards model; Oncology; Clinical trial; Sarcoma; Surgery; Soft tissue; Confidence interval; Pathology","score_opus":0.03960588045100155,"score_gpt":0.3626036190392862,"score_spread":0.3229977385882846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361270506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912842,0.0002508788,0.000033155364,0.0067603597,0.00006186795,0.0013659433,0.000034964603,0.00015639566,0.00005225441],"genre_scores_gemma":[0.98929197,0.00059181754,0.0048044636,0.0045061307,0.000058572507,0.0002076697,0.00010071839,0.000070171955,0.0003685],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975371,0.0006119949,0.0005370632,0.0005992257,0.00025271424,0.00046190995],"domain_scores_gemma":[0.9971581,0.0019371869,0.00017797177,0.00042786726,0.00008634505,0.00021250061],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006355381,0.00032892582,0.001406514,0.00026911116,0.00006794875,0.000023641443,0.000100572026,0.00029481392,0.0001497131],"category_scores_gemma":[0.0002001073,0.00017474196,0.000076255295,0.00049805944,0.00034838854,0.00005821382,0.0000317337,0.00027870393,0.000028089584],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.052530684,0.0023626823,0.8168621,0.000012700131,0.0002953552,0.005719839,0.00026499218,0.0000032555195,0.000060112907,0.0000048573734,0.00052311923,0.12136029],"study_design_scores_gemma":[0.06143759,0.023420356,0.893216,0.000068501184,0.00011035589,0.00020904645,0.00010011783,0.00014329201,0.000035409434,0.000007638538,0.021048395,0.00020326476],"about_ca_topic_score_codex":0.00013357359,"about_ca_topic_score_gemma":0.00023054487,"teacher_disagreement_score":0.12115702,"about_ca_system_score_codex":0.0003106979,"about_ca_system_score_gemma":0.00020125594,"threshold_uncertainty_score":0.71257704},"labels":[],"label_agreement":null},{"id":"W4362657172","doi":"10.1001/jamaoncol.2023.0175","title":"Association of Polycystic Ovary Syndrome With Pancreatic Cancer","year":2023,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Ovarian function and disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Otorhinolaryngology; Family medicine; Neurology; MEDLINE; Psychiatry","score_opus":0.0157692679212009,"score_gpt":0.29071536937567954,"score_spread":0.2749461014544786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362657172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9518812,0.00010208736,0.00007628625,0.021114338,0.0003795298,0.00023515335,0.000009886307,0.00012089229,0.026080662],"genre_scores_gemma":[0.9808843,0.000082995124,0.00017187675,0.0017829435,0.00007144547,0.00004668286,0.00002832645,0.000013290733,0.016918125],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993643,0.000049162445,0.00015047769,0.00011643947,0.00015772492,0.00016187434],"domain_scores_gemma":[0.99944645,0.00019539503,0.0001161192,0.00010624088,0.00007701916,0.0000587632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001846445,0.00006196276,0.00025677003,0.00013168433,0.000024325902,0.0000030946062,0.000027719245,0.00013699358,0.0007682601],"category_scores_gemma":[0.0002164727,0.000049054303,0.000035909856,0.0004262432,0.000029923103,0.000034017503,0.000012486042,0.00011595503,0.00017155016],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003354144,0.0004672823,0.7704313,0.00031878854,0.0011222066,0.00079195725,0.0008400444,0.00012989664,0.002813562,0.00065177935,0.19422701,0.024852073],"study_design_scores_gemma":[0.004194564,0.0013587808,0.94385874,0.00006527955,0.00034653896,0.00015072417,0.0004086946,0.00032060134,0.00006483529,0.00013340446,0.04902476,0.00007306405],"about_ca_topic_score_codex":0.00022191525,"about_ca_topic_score_gemma":0.00010193081,"teacher_disagreement_score":0.1734275,"about_ca_system_score_codex":0.00022512268,"about_ca_system_score_gemma":0.00030891332,"threshold_uncertainty_score":0.84119093},"labels":[],"label_agreement":null},{"id":"W4362657579","doi":"10.1001/jamaoncol.2023.0339","title":"Long-term Mortality in Individuals Diagnosed With Cancer During Pregnancy or Postpartum","year":2023,"lang":"en","type":"review","venue":"JAMA Oncology","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; University of Ottawa; Children's Hospital of Eastern Ontario; University of Calgary; Institute for Clinical Evaluative Sciences; SickKids Foundation; University of Toronto; Alberta Health Services","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Pregnancy; Hazard ratio; Breast cancer; Cancer; Obstetrics; Proportional hazards model; Population; Retrospective cohort study; Postpartum period; Cohort study; Cohort; Gynecology; Confidence interval; Internal medicine; Environmental health","score_opus":0.12571682531697,"score_gpt":0.44491754313090254,"score_spread":0.31920071781393256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362657579","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05006115,0.9456135,4.4987732e-7,0.0002472476,0.0006234564,0.0026354145,0.00033083107,0.00011721351,0.00037070992],"genre_scores_gemma":[0.0006639398,0.9942588,0.00001360234,0.00011139424,0.00058599026,0.0021756792,0.00027904418,0.00013045594,0.0017810953],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99723244,0.00020785129,0.0008770707,0.0007239206,0.00032656346,0.00063213543],"domain_scores_gemma":[0.998162,0.0004178598,0.00057013094,0.00055959617,0.000065047265,0.00022536551],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001924593,0.00051277736,0.0031403196,0.00040771675,0.000050754545,0.000028870742,0.00024007024,0.00082886766,0.00069323863],"category_scores_gemma":[0.00015338835,0.00032602355,0.00029087212,0.00077342807,0.00013303249,0.00008464874,0.00015915043,0.0010766619,0.00007174135],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000112567555,0.00026699857,0.3271423,0.039589353,0.0007394691,0.009305422,0.00032047366,4.4679663e-7,1.7218333e-7,0.0000047673543,0.00038658924,0.62213147],"study_design_scores_gemma":[0.0029592835,0.00067572744,0.62225467,0.09573235,0.0018948286,0.00033615832,0.000025464842,2.2055605e-7,8.9544096e-7,0.0000023521413,0.27571693,0.0004011157],"about_ca_topic_score_codex":0.002026148,"about_ca_topic_score_gemma":0.02815442,"teacher_disagreement_score":0.6217303,"about_ca_system_score_codex":0.0013632508,"about_ca_system_score_gemma":0.0028125104,"threshold_uncertainty_score":0.9999192},"labels":[],"label_agreement":null},{"id":"W4362657687","doi":"10.1001/jamaoncol.2023.0147","title":"Efficacy and Safety of Nivolumab Plus Ipilimumab vs Nivolumab Alone for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck","year":2023,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Université de Montréal; University of Alberta","funders":"National Institute for Health and Care Research; Seagen; MacroGenics; Mirati Therapeutics; Kowa Company; Sanofi; EMD Serono; Rakuten Medical; Bristol-Myers Squibb; AstraZeneca; Pfizer; Coherus Biosciences","keywords":"Medicine; Nivolumab; Ipilimumab; Head and neck; Oncology; Head and neck squamous-cell carcinoma; Internal medicine; Metastatic melanoma; Basal cell; Expanded access; Head and neck cancer; Melanoma; Dermatology; Immunotherapy; Surgery; Radiation therapy; Cancer; Cancer research","score_opus":0.052095093963368706,"score_gpt":0.3452510310749039,"score_spread":0.2931559371115352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362657687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913592,0.0038990255,0.000008785849,0.0022946834,0.00022043013,0.0014526729,0.00014557797,0.0000145045815,0.000605153],"genre_scores_gemma":[0.99698746,0.00143401,0.00047485888,0.000071379036,0.000058194542,0.00010056772,0.000014091176,0.000019307523,0.000840124],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986774,0.000106458334,0.00053253066,0.00026650596,0.00015294766,0.00026420673],"domain_scores_gemma":[0.99829084,0.00096181536,0.00025349334,0.00027459816,0.00013646229,0.000082764396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019571274,0.00017321142,0.0012161602,0.000100317746,0.000084815634,0.0000020848959,0.000067520166,0.000093396004,0.00002069867],"category_scores_gemma":[0.00020185976,0.00010639529,0.000119305456,0.00025174892,0.0003233438,0.000022760527,0.00008600938,0.00006634058,0.0000010904558],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13578707,0.007265874,0.040453594,0.008443674,0.0010611574,0.00016859038,0.038059592,0.000050341703,0.013371481,0.00031014977,0.01313741,0.7418911],"study_design_scores_gemma":[0.16940801,0.106946856,0.64714473,0.00050136383,0.0018665558,0.0001457893,0.0033448837,0.0017159298,0.019894196,0.00009971659,0.048620716,0.00031127062],"about_ca_topic_score_codex":0.00044079672,"about_ca_topic_score_gemma":0.00083337823,"teacher_disagreement_score":0.7415798,"about_ca_system_score_codex":0.00024017748,"about_ca_system_score_gemma":0.00048241136,"threshold_uncertainty_score":0.4338674},"labels":[],"label_agreement":null},{"id":"W4376604358","doi":"10.1001/jamaoncol.2023.1175","title":"American Radium Society Appropriate Use Criteria for Radiation Therapy in the Multidisciplinary Management of Thymic Carcinoma","year":2023,"lang":"en","type":"review","venue":"JAMA Oncology","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Thymic carcinoma; Radiation therapy; Delphi method; Consensus conference; General surgery; Medical physics; Surgery; Internal medicine; Thymoma","score_opus":0.1337509627166226,"score_gpt":0.43372906125346355,"score_spread":0.299978098536841,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376604358","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027847877,0.960486,0.000084388135,0.0019039093,0.00066503155,0.008457257,0.000219243,0.000061751714,0.00027454624],"genre_scores_gemma":[0.0010279865,0.99365115,0.0021960682,0.00028007786,0.00041543596,0.0014509417,0.0005266637,0.00008352883,0.000368144],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977009,0.00044872935,0.00081872527,0.00045849732,0.00020669955,0.00036641],"domain_scores_gemma":[0.9980635,0.00067793013,0.00056425465,0.00057531224,0.000062586616,0.000056402547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011229295,0.00033820324,0.0018896807,0.00017636163,0.000064959,0.00002311991,0.00032565207,0.00032551482,0.000016043523],"category_scores_gemma":[0.00003293351,0.00020725936,0.000817236,0.00056279014,0.0001734065,0.000047285033,0.00010259587,0.00039302142,0.000014238306],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021411653,0.00030464577,0.00012665114,0.009475512,0.0004324747,0.00008679799,0.0013823305,3.4771602e-7,0.0000034438494,0.0003418556,0.0025495898,0.9850822],"study_design_scores_gemma":[0.0030237427,0.0018641861,0.011449694,0.0019024344,0.0008195286,0.0000723822,0.00085846725,0.00022852076,0.0000012788767,0.00013362918,0.97942674,0.0002193808],"about_ca_topic_score_codex":0.00018225212,"about_ca_topic_score_gemma":0.000018412566,"teacher_disagreement_score":0.98486286,"about_ca_system_score_codex":0.0002994594,"about_ca_system_score_gemma":0.00026608468,"threshold_uncertainty_score":0.84517914},"labels":[],"label_agreement":null},{"id":"W4378173491","doi":"10.1001/jamaoncol.2023.0983","title":"Vaccinia (Smallpox) for the Treatment of Ovarian Cancer—Turning an Old Foe Into a Friend?","year":2023,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Otorhinolaryngology; Family medicine; Smallpox; Neurology; Psychiatry; Vaccination; Pathology","score_opus":0.042499233787287434,"score_gpt":0.3745586490476901,"score_spread":0.33205941526040267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378173491","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.34782982,0.0057679247,0.0002872082,0.6399326,0.0019202116,0.0030729233,0.00075133255,0.000070209986,0.00036779864],"genre_scores_gemma":[0.0753515,0.033363994,0.0036575769,0.73577243,0.081162006,0.017716778,0.011937235,0.001423044,0.03961546],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975829,0.00038473852,0.00041995183,0.00074426056,0.00021959828,0.00064854557],"domain_scores_gemma":[0.99799496,0.0003869364,0.00030472156,0.0009904118,0.00023754763,0.000085445245],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00046593123,0.00038397938,0.00057917583,0.00013676364,0.00018535677,0.000037327118,0.0007340541,0.0015387129,0.00011016307],"category_scores_gemma":[0.000104687526,0.00028068654,0.00034034898,0.00016133537,0.0001471767,0.000003815517,0.00011756853,0.00052328326,0.000015012017],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005975365,0.0003087531,0.00014306248,0.00016272237,0.0015344898,0.00012651194,0.0012458441,0.00013813333,0.18722926,0.000019233074,0.6203948,0.1827218],"study_design_scores_gemma":[0.0022588829,0.026419913,0.000118990036,0.000017375365,0.00014680279,0.000010322709,0.00010003753,0.00015844918,0.048243165,0.00012309151,0.9221375,0.00026545144],"about_ca_topic_score_codex":0.0010148075,"about_ca_topic_score_gemma":0.006054062,"teacher_disagreement_score":0.3017427,"about_ca_system_score_codex":0.0002844455,"about_ca_system_score_gemma":0.0008833194,"threshold_uncertainty_score":0.99996454},"labels":[],"label_agreement":null},{"id":"W4379768913","doi":"10.1001/jamaoncol.2023.1374","title":"Changes to Primary End Points in Randomized Clinical Trials on Immune Checkpoint Inhibitors in Urothelial, Renal Cell, and Lung Cancers","year":2023,"lang":"en","type":"review","venue":"JAMA Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Oncology; Clinical trial; Nivolumab; Immune checkpoint; Internal medicine; Endpoint Determination; Urothelial cancer; Immunotherapy; Cancer; Bladder cancer","score_opus":0.1272674042778694,"score_gpt":0.4600022332855313,"score_spread":0.33273482900766194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379768913","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018211415,0.9792099,0.0000021077437,0.00657101,0.0022926186,0.008354119,0.00008170958,0.000051276573,0.0016161151],"genre_scores_gemma":[0.000034616,0.99243164,0.00013380594,0.0031529553,0.0013819456,0.001758736,0.00012390649,0.000103049446,0.0008793186],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9868091,0.007066942,0.0043153563,0.00089393265,0.00033784716,0.00057687645],"domain_scores_gemma":[0.98676604,0.011094897,0.0014209363,0.00045412875,0.000045864206,0.0002181077],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.03366315,0.00058646034,0.010632473,0.001239319,0.000036906862,0.000029314051,0.00022242275,0.0013861159,0.00018875941],"category_scores_gemma":[0.00536221,0.00041990148,0.0013218791,0.0007992153,0.00033724125,0.00003643736,0.00016665505,0.0014371043,0.00004531511],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12602058,0.00021541514,0.000007972708,0.0054020504,0.0005218238,0.000351373,0.0002868039,2.687292e-7,0.00015895546,0.0000042939823,0.0042431797,0.8627873],"study_design_scores_gemma":[0.16772933,0.0014724288,0.00013405358,0.022959456,0.000838579,0.000047480462,0.000053939166,0.0000044006442,0.000050371746,0.000012128929,0.8063414,0.00035644262],"about_ca_topic_score_codex":0.0016425638,"about_ca_topic_score_gemma":0.0019865495,"teacher_disagreement_score":0.8624309,"about_ca_system_score_codex":0.002731046,"about_ca_system_score_gemma":0.0028477765,"threshold_uncertainty_score":0.9999103},"labels":[],"label_agreement":null},{"id":"W4384120373","doi":"10.1001/jamaoncol.2023.2163","title":"Management of Down Syndrome–Associated Leukemias","year":2023,"lang":"en","type":"review","venue":"JAMA Oncology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Down syndrome; Myeloid leukemia; Internal medicine; Clinical trial; Leukemia; Population; Pediatrics; Oncology; Myeloid","score_opus":0.09827267579934236,"score_gpt":0.42358201095335213,"score_spread":0.3253093351540098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384120373","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011929527,0.95513177,0.0000048848924,0.0005610078,0.00042346926,0.0025200094,0.00012099583,0.00022051296,0.04089804],"genre_scores_gemma":[0.000014328379,0.96263564,0.0004277908,0.00013585326,0.00016176628,0.00046952732,0.00069182285,0.00016212501,0.035301153],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.996042,0.00053650653,0.001294153,0.0006811429,0.00065731973,0.00078884134],"domain_scores_gemma":[0.9969357,0.00095287536,0.0007426553,0.00089587754,0.00020807283,0.00026481575],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015021993,0.00048714536,0.004291206,0.00078840647,0.000056100947,0.000014872477,0.00061874354,0.0016655324,0.0005055981],"category_scores_gemma":[0.00043876035,0.00038992238,0.00085250515,0.0016339099,0.00024194576,0.000043279404,0.0007305706,0.0017181752,0.002501685],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044507247,0.00021148748,0.000004273285,0.049709648,0.0034123207,0.01583149,0.00003348999,2.526023e-7,3.25312e-7,0.0003910205,0.048883982,0.8814772],"study_design_scores_gemma":[0.0021083036,0.00089904893,0.0001387743,0.02314174,0.003236678,0.0013328287,0.00007799407,0.000008573985,5.094414e-7,0.000050393508,0.9687488,0.00025634744],"about_ca_topic_score_codex":0.0001026026,"about_ca_topic_score_gemma":0.000014019085,"teacher_disagreement_score":0.91986483,"about_ca_system_score_codex":0.0066707106,"about_ca_system_score_gemma":0.0030512083,"threshold_uncertainty_score":0.9998553},"labels":[],"label_agreement":null},{"id":"W4384818727","doi":"10.1001/jamaoncol.2023.2312","title":"Association of Reducing the Recommended Colorectal Cancer Screening Age With Cancer Incidence, Mortality, and Costs in Canada Using OncoSim","year":2023,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Alberta Health Services; St. Paul's Hospital; Vancouver General Hospital; Canadian Centre for Applied Research in Cancer Control; Simon Fraser University; University of British Columbia","funders":"","keywords":"Medicine; Colorectal cancer; Cancer; Incidence (geometry); Cancer incidence; Oncology; Internal medicine","score_opus":0.05215501913569704,"score_gpt":0.35368109143153836,"score_spread":0.30152607229584133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384818727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942649,0.00018966587,0.000020763317,0.004059234,0.00035835707,0.00036223303,0.000023265142,0.000030395115,0.0006911789],"genre_scores_gemma":[0.998698,0.00024411785,0.00019710329,0.00046838928,0.00017839935,0.00010879584,0.000009455192,0.00001629694,0.00007943717],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99866074,0.00018326026,0.00029867076,0.0002433566,0.00031788117,0.00029610944],"domain_scores_gemma":[0.9988875,0.00050558447,0.00029409822,0.00010418818,0.00013591169,0.00007275896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007060463,0.000118299366,0.00038191993,0.00013744572,0.000102018384,0.000013542682,0.00006409658,0.00013014121,0.00002934653],"category_scores_gemma":[0.00023365376,0.00009073345,0.000027792961,0.0008358574,0.00004675049,0.000080801394,0.000070309965,0.00039364852,2.1377325e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017851839,0.00001567707,0.92696786,0.000042310872,0.00017282777,0.0001296688,0.00063778675,0.004121822,0.0036153756,0.000003479522,0.0019764795,0.06053155],"study_design_scores_gemma":[0.0019162433,0.00072123256,0.96196365,0.0004150885,0.00016078698,0.0000458572,0.0011772756,0.029328112,0.003034426,0.00000942638,0.0011037491,0.0001241204],"about_ca_topic_score_codex":0.97706616,"about_ca_topic_score_gemma":0.99460155,"teacher_disagreement_score":0.06040743,"about_ca_system_score_codex":0.00642607,"about_ca_system_score_gemma":0.0029297653,"threshold_uncertainty_score":0.99738806},"labels":[],"label_agreement":null},{"id":"W4385294431","doi":"10.1001/jamaoncol.2023.1830","title":"Vigorous Intermittent Lifestyle Physical Activity and Cancer Incidence Among Nonexercising Adults","year":2023,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Physical Activity and Health","field":"Medicine","cited_by":154,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Medicine; Incidence (geometry); Physical activity; Cancer; Internal medicine; Gerontology; Physical therapy","score_opus":0.03467971875067961,"score_gpt":0.38130180971947303,"score_spread":0.34662209096879343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385294431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98918444,0.000027903367,0.000029340717,0.009282652,0.00020023625,0.00029538965,0.000008650542,0.00013136766,0.0008400291],"genre_scores_gemma":[0.9978543,0.0002628884,0.000048309266,0.0007460177,0.0007708061,0.000071943374,0.0000045318197,0.000016675598,0.00022456283],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99891067,0.00009385622,0.00011738343,0.00033899682,0.00017933309,0.0003597625],"domain_scores_gemma":[0.9989218,0.0005133416,0.00009268997,0.00016985621,0.00006073735,0.0002415899],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016656148,0.00013140665,0.00051572017,0.000078987745,0.00010997777,0.000015237428,0.00006658488,0.00015214657,0.000014803446],"category_scores_gemma":[0.00020789845,0.00011260252,0.000066920984,0.000259633,0.00020302375,0.000226807,0.00016217286,0.00054334657,0.00007632386],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010828531,0.001343821,0.035378236,0.0002686446,0.000042437863,0.0003556452,0.0032815218,0.0000075303087,0.014422563,0.000097691394,0.0017857768,0.9419333],"study_design_scores_gemma":[0.0016116474,0.0013064042,0.97921145,0.00031213337,0.00005979879,0.00004893218,0.00024060294,0.012177208,0.002491958,0.0002701518,0.0021328602,0.00013686955],"about_ca_topic_score_codex":0.0022671788,"about_ca_topic_score_gemma":0.00069046015,"teacher_disagreement_score":0.9438332,"about_ca_system_score_codex":0.00026908756,"about_ca_system_score_gemma":0.00022855074,"threshold_uncertainty_score":0.45917976},"labels":[],"label_agreement":null},{"id":"W4385897829","doi":"10.1001/jamaoncol.2023.2934","title":"Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19","year":2023,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"National Center for Advancing Translational Sciences; National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Institute on Aging","keywords":"Medicine; Internal medicine; Cancer; Retrospective cohort study; Intensive care unit; Incidence (geometry); Cancer registry; Lung cancer","score_opus":0.0641370124742738,"score_gpt":0.42488484549575817,"score_spread":0.3607478330214844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385897829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95846176,0.0009569579,0.0000037278776,0.03925148,0.0001543,0.0009366994,0.000029317873,0.000079149184,0.0001265982],"genre_scores_gemma":[0.9716256,0.0053018946,0.000030175106,0.022705747,0.00006650177,0.00012324553,0.000015123108,0.000021968879,0.00010969033],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99884117,0.000087809385,0.00024036305,0.00030083198,0.00017662894,0.00035320898],"domain_scores_gemma":[0.9989321,0.0004072553,0.000092672046,0.00016697144,0.0000700716,0.00033087723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025902755,0.00015162789,0.00065937755,0.0002250067,0.000063633095,0.000014677733,0.000044942863,0.00018226616,0.000053293596],"category_scores_gemma":[0.00032302566,0.000102615784,0.000022910686,0.00031906943,0.00014434187,0.00007226105,0.000040017447,0.00019203564,0.0000064547653],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060135964,0.0000998217,0.9706348,0.0003275735,0.0000629656,0.00008350632,0.0023981982,0.0000027415156,0.000052513835,0.0000799823,0.0012709841,0.024385551],"study_design_scores_gemma":[0.012765921,0.0012409779,0.9724051,0.000116286894,0.00002889837,0.000018153767,0.00024217751,0.000048148428,0.000005462796,0.000088493354,0.01292692,0.000113460395],"about_ca_topic_score_codex":0.004782346,"about_ca_topic_score_gemma":0.0019645416,"teacher_disagreement_score":0.024272092,"about_ca_system_score_codex":0.00051439827,"about_ca_system_score_gemma":0.0011421383,"threshold_uncertainty_score":0.7229509},"labels":[],"label_agreement":null},{"id":"W4386501692","doi":"10.1001/jamaoncol.2023.2960","title":"The Global, Regional, and National Burden of Adult Lip, Oral, and Pharyngeal Cancer in 204 Countries and Territories","year":2023,"lang":"en","type":"review","venue":"JAMA Oncology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":167,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of British Columbia","funders":"Division of Mathematical Sciences; National Heart, Lung, and Blood Institute; Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences; Leibniz-Gemeinschaft; National Health and Medical Research Council; Medical Research Council; University of Florida Health; Samsung; King Saud University; Universitätsklinikum Heidelberg; Monash University Malaysia; Fakultet Medicinskih Nauka, Univerziteta U Kragujevcu; Institute for Advanced Studies in Basic Sciences; University of Colombo; Xiamen University; National Institute for Medical Research Development; Yasuj University of Medical Sciences; University of Washington; Wuhan University; Sigrid Juséliuksen Säätiö; Guilan University of Medical Sciences; Masarykova Univerzita; Shahid Beheshti University of Medical Sciences; Hacettepe Üniversitesi; Birjand University of Medical Sciences; Zhejiang University; Kerman University of Medical Sciences; Rajarata University of Sri Lanka; Ain Shams University; Shiraz University of Medical Sciences; College of Medicine, Korea University; World Health Organization; Mazandaran University of Medical Sciences; King Abdulaziz University; Isfahan University of Medical Sciences; Pasteur Institute of Iran; Universitatea din București; Alexandria University; Università degli Studi di Padova; Korea University; Oulun Yliopisto; Pohang University of Science and Technology; University of Gondar; Massachusetts General Hospital; Lékařská fakulta, Masarykova univerzita; Radboud Universiteit; Imperial College London; Shiraz University; National Natural Science Foundation of China; Monash University; Karolinska Institutet; National Institute for Health and Care Research; University of Queensland; Amity University; Mashhad University of Medical Sciences; Public Health England; Royal College of Surgeons in Ireland; University of Leeds; Public Health Foundation of India; St. Jude Children's Research Hospital; Indian Council of Medical Research; National University of Singapore; University of Warwick; Coventry University; European Commission; National Human Genome Research Institute; Macquarie University; JSS Academy of Higher Education and Research; Dire Dawa University; Politechnika Gdańska; University of Exeter; Moderna; Kasturba Medical College, Manipal; Kermanshah University of Medical Sciences; Vanderbilt University; U.S. Department of Veterans Affairs; Rafsanjan University of Medical Sciences; Louisiana State University; Seres Therapeutics; Wellcome Trust; Johns Hopkins University; Amarin Corporation; Iran University of Medical Sciences; Bill and Melinda Gates Foundation; Instituto de Salud Carlos III; Università degli Studi di Milano; Saveetha Dental College; National Defense Medical College; Intuitive Surgical; Sveučilište u Zagrebu; Social Science Research Council; National Cancer Institute; University of South Carolina; Bournemouth University; The Wellcome Trust DBT India Alliance; Flinders University; Universidade Federal do Rio Grande do Sul; Harvard University; Università di Catania; Golestan University of Medical Sciences; Tehran University of Medical Sciences and Health Services; Anglia Ruskin University; Tehran Heart Center; National Institutes of Health; University of Veterinary and Animal Sciences; Florida Department of Health; King Abdullah University of Science and Technology; Department of Biotechnology, Ministry of Science and Technology, India; Jordan University of Science and Technology; McMaster University; School of Medicine, University of Alabama at Birmingham; Plastic Surgery Foundation","keywords":"Medicine; Cancer; MEDLINE; Family medicine; Internal medicine","score_opus":0.07646881709137004,"score_gpt":0.4355770112345375,"score_spread":0.35910819414316747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386501692","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00079383556,0.9835658,6.338002e-8,0.013782033,0.00034960682,0.00045650586,0.00031005955,0.000014796639,0.00072730286],"genre_scores_gemma":[0.000074979485,0.9981857,0.000027351874,0.00046841518,0.00062617793,0.00021900065,0.000024914856,0.000015532534,0.00035791087],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987251,0.000107212036,0.00044117158,0.00028801133,0.00023006748,0.00020842753],"domain_scores_gemma":[0.9985868,0.00080937945,0.00020222235,0.00009087934,0.00024002444,0.00007074109],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003032411,0.00021186961,0.001439443,0.00007714684,0.000114803195,0.000022131373,0.000069243484,0.00029670377,0.000008165648],"category_scores_gemma":[0.0002934381,0.00013356646,0.000052287054,0.00019675234,0.00071197265,0.000050335595,0.00013643001,0.00025834964,0.0000014939411],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020196363,0.00003198933,0.0024422375,0.012235118,0.0004725046,0.000059999315,0.0006584783,8.250174e-8,2.0856633e-7,0.0031305181,0.06106101,0.91970587],"study_design_scores_gemma":[0.0010069354,0.00034787465,0.0015565119,0.0055086226,0.00029179547,0.0001321548,0.00025596443,0.0000044728245,9.838881e-8,0.00028789582,0.9904998,0.00010790362],"about_ca_topic_score_codex":0.0026999866,"about_ca_topic_score_gemma":0.010032815,"teacher_disagreement_score":0.92943877,"about_ca_system_score_codex":0.00035638874,"about_ca_system_score_gemma":0.0012663903,"threshold_uncertainty_score":0.5598546},"labels":[],"label_agreement":null},{"id":"W4386725777","doi":"10.1001/jamaoncol.2023.3495","title":"Individualized Stereotactic Ablative Radiotherapy for Lung Tumors","year":2023,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; SABR volatility model; Lung cancer; Radiation therapy; Radiosurgery; Ablative case; Lung; Internal medicine; Oncology; Nuclear medicine","score_opus":0.033523061032147305,"score_gpt":0.38652899438591465,"score_spread":0.35300593335376734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386725777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93986595,0.00091788074,0.00025364468,0.043687902,0.00084243604,0.0025942258,0.000087680855,0.0002966987,0.011453614],"genre_scores_gemma":[0.9805416,0.0007868989,0.004659129,0.0069665588,0.0006960819,0.0018096713,0.00022012561,0.00006590314,0.004254049],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99904454,0.000065577166,0.0002085366,0.00025788715,0.00012627957,0.00029716056],"domain_scores_gemma":[0.99884355,0.00069407077,0.000100817684,0.00018515489,0.0000688607,0.00010752811],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024732726,0.00012644884,0.00041829864,0.00014145198,0.00006862778,0.000015718582,0.00005848036,0.000127068,0.0002775103],"category_scores_gemma":[0.00010477346,0.00009858506,0.00012599697,0.0002416384,0.000047494494,0.000057104346,0.00002062592,0.000107206695,0.000044783745],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036803116,0.001450637,0.27750885,0.00047720099,0.0045219827,0.0010068378,0.00901038,0.000039494935,0.00089958083,0.0041432763,0.51953,0.17773145],"study_design_scores_gemma":[0.029315995,0.004937776,0.3127476,0.00016819281,0.0005903661,0.00012652876,0.00049483526,0.0022084704,0.0013324921,0.00053654466,0.64729816,0.00024306019],"about_ca_topic_score_codex":0.0000454542,"about_ca_topic_score_gemma":0.000026839081,"teacher_disagreement_score":0.17748839,"about_ca_system_score_codex":0.000931235,"about_ca_system_score_gemma":0.00027042153,"threshold_uncertainty_score":0.4020182},"labels":[],"label_agreement":null},{"id":"W4386909784","doi":"10.1001/jamaoncol.2023.3651","title":"Risk of Death Due to Pregnancy-Associated Cancers—More Questions Than Answers—Reply","year":2023,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Otorhinolaryngology; Family medicine; MEDLINE; Psychiatry","score_opus":0.02973289275205126,"score_gpt":0.3361973467334496,"score_spread":0.3064644539813983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386909784","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.061907593,0.001021109,0.000071517,0.9211979,0.0039738826,0.0019139223,0.0032516753,0.0003994113,0.0062630014],"genre_scores_gemma":[0.054857455,0.0031622788,0.00063183927,0.8952104,0.008669862,0.00092537556,0.0026288673,0.00041784914,0.033496078],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99733204,0.00025288196,0.0006388525,0.00066714,0.0004424498,0.00066663796],"domain_scores_gemma":[0.9975374,0.0005564588,0.0006257057,0.0007076072,0.00036821002,0.00020465723],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00026792093,0.000404029,0.0014531714,0.00044847344,0.000097125645,0.00001578226,0.00027635248,0.0016384419,0.00025299142],"category_scores_gemma":[0.0008922825,0.00036405196,0.0003949161,0.00058216427,0.00014624893,0.0000453705,0.00012325513,0.0024334623,0.000121532925],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001405507,0.000085226435,0.025752164,0.00018654655,0.00060805364,0.002182626,0.0010929297,0.000020143005,0.000026327636,0.000009486961,0.9580925,0.0118034305],"study_design_scores_gemma":[0.0015086968,0.0016133916,0.18805304,0.0013147849,0.000925945,0.00006014907,0.00012807177,0.000022035807,0.000032544853,0.00009174137,0.80595237,0.00029720442],"about_ca_topic_score_codex":0.046443723,"about_ca_topic_score_gemma":0.010996429,"teacher_disagreement_score":0.16230087,"about_ca_system_score_codex":0.0025461474,"about_ca_system_score_gemma":0.0019384958,"threshold_uncertainty_score":0.99988115},"labels":[],"label_agreement":null},{"id":"W4386909796","doi":"10.1001/jamaoncol.2023.3352","title":"Rare Genetic Drivers of Lethal Prostate Cancer","year":2023,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia","funders":"","keywords":"Medicine; Otorhinolaryngology; Family medicine; MEDLINE; Neurology; Psychiatry","score_opus":0.042841644843669154,"score_gpt":0.36716397033839254,"score_spread":0.3243223254947234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386909796","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.059117,0.0026436215,0.0000011107235,0.92923355,0.0012871828,0.0013192835,0.0004689304,0.00009761525,0.0058317115],"genre_scores_gemma":[0.010361727,0.020271055,0.00084176124,0.6310699,0.014809257,0.0017820041,0.0032171214,0.00041800272,0.31722918],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979533,0.0001475041,0.0003563782,0.0004659568,0.00046930768,0.0006075687],"domain_scores_gemma":[0.9987936,0.00023916498,0.00021311275,0.0003689109,0.00027943598,0.00010577499],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012711102,0.0002663903,0.0008257679,0.00033398464,0.000047434252,0.00001078304,0.00019146048,0.0011780178,0.00075454847],"category_scores_gemma":[0.00006332994,0.00020613006,0.00020770605,0.00030456288,0.0003634845,0.0000311155,0.00013170631,0.0017517263,0.00020723502],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040890984,0.000054144064,0.008849871,0.00095159945,0.00043843084,0.013549792,0.0005282181,0.000003995139,0.00040768244,0.0000014737404,0.94513613,0.029669736],"study_design_scores_gemma":[0.0038657624,0.0013587548,0.011173974,0.00033939502,0.0003251339,0.00011278024,0.00008118756,0.000013693202,0.0006836837,0.00007299677,0.9817949,0.00017774927],"about_ca_topic_score_codex":0.00052820914,"about_ca_topic_score_gemma":0.00006630534,"teacher_disagreement_score":0.3113975,"about_ca_system_score_codex":0.0008307347,"about_ca_system_score_gemma":0.0019388336,"threshold_uncertainty_score":0.9085952},"labels":[],"label_agreement":null},{"id":"W4387115048","doi":"10.1001/jamaoncol.2023.3867","title":"Anti-TIGIT Antibody Tiragolumab Alone or With Atezolizumab in Patients With Advanced Solid Tumors","year":2023,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Roche (Canada); Princess Margaret Cancer Centre","funders":"Daiichi Sankyo Europe; National Center for Advancing Translational Sciences; National Cancer Institute; EMD Serono; Genentech; European Society for Medical Oncology; Servier; Yonsei University; MacroGenics; LG Chem; Regeneron Pharmaceuticals; BeiGene; F. Hoffmann-La Roche; Handok; Gilead Sciences; Yuhan; Eli Lilly and Company; AstraZeneca; Celgene; TG Therapeutics; Pfizer","keywords":"Medicine; Atezolizumab; Internal medicine; TIGIT; Tolerability; Oncology; Clinical endpoint; Clinical trial; Phases of clinical research; Antibody; Adverse effect; Immunology; Pembrolizumab; Immunotherapy; Cancer","score_opus":0.012491511114451901,"score_gpt":0.3158602043763073,"score_spread":0.3033686932618554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387115048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99480766,0.00007203139,0.000009523125,0.0019669202,0.00016386474,0.00077547284,0.000019404102,0.00014319757,0.0020419413],"genre_scores_gemma":[0.9966364,0.00018087133,0.0003734508,0.0013268795,0.00007712127,0.00006114857,0.0002185538,0.000050587085,0.0010750177],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983132,0.000068237605,0.00039378073,0.00039847707,0.00030474438,0.0005215986],"domain_scores_gemma":[0.9991677,0.00010060268,0.00018088389,0.0003258088,0.0001219534,0.00010307786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019342735,0.00022209217,0.0006918777,0.0002947637,0.000065741464,0.000017034869,0.00012392811,0.00016633353,0.00021129414],"category_scores_gemma":[0.000052822797,0.00014219916,0.000052435407,0.0010451877,0.0002018372,0.00012105269,0.000043343036,0.00026605927,0.00008092604],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12099182,0.0012506762,0.6189919,0.00019739353,0.00042061918,0.0029147046,0.0010237612,0.00008438841,0.005397582,0.000017012242,0.005413306,0.24329682],"study_design_scores_gemma":[0.037362926,0.010448626,0.92832434,0.00039518988,0.000046875903,0.00011403042,0.0003038547,0.00006495638,0.0009197655,0.000007403431,0.021769471,0.00024253853],"about_ca_topic_score_codex":0.00014229276,"about_ca_topic_score_gemma":0.00036154763,"teacher_disagreement_score":0.30933243,"about_ca_system_score_codex":0.00035399615,"about_ca_system_score_gemma":0.00055526476,"threshold_uncertainty_score":0.57987136},"labels":[],"label_agreement":null},{"id":"W4387116241","doi":"10.1001/jamaoncol.2023.3809","title":"Radiotherapy Plus Cisplatin With or Without Lapatinib for Non–Human Papillomavirus Head and Neck Carcinoma","year":2023,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"National Center for Advancing Translational Sciences; National Cancer Institute","keywords":"Medicine; Lapatinib; Internal medicine; Oncology; Cetuximab; Chemoradiotherapy; Progression-free survival; Radiation therapy; Clinical endpoint; Placebo; Head and neck cancer; Cancer; Randomized controlled trial; Breast cancer; Chemotherapy; Trastuzumab; Pathology","score_opus":0.05842564670006368,"score_gpt":0.3941057429627871,"score_spread":0.33568009626272344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387116241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862295,0.0003446142,0.000058346293,0.0076148426,0.00016353291,0.0010487784,0.000021932769,0.00011914104,0.0043993117],"genre_scores_gemma":[0.98492223,0.00029146305,0.003842189,0.0033103032,0.0006059402,0.00047602106,0.000031277246,0.00005618198,0.0064643845],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99880356,0.000040338582,0.00025568853,0.00035395077,0.00013610908,0.0004103284],"domain_scores_gemma":[0.999181,0.00027560734,0.000089611596,0.0002096411,0.00009121659,0.00015293248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021894928,0.00019472887,0.00084495114,0.000115665745,0.00020531038,0.0000145396125,0.00006259557,0.00017377248,0.000071715906],"category_scores_gemma":[0.000060643717,0.00012822734,0.000051594492,0.00023188471,0.0001691002,0.000050237395,0.000036140238,0.00018123079,0.000013575095],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02410666,0.00036734625,0.5894697,0.0009775017,0.0006296834,0.0010729614,0.016507436,0.0000069515504,0.017596355,0.00054633484,0.09850865,0.25021043],"study_design_scores_gemma":[0.044448156,0.030280408,0.5734921,0.00027353305,0.00017457642,0.0003229467,0.0011506624,0.002166303,0.0008302199,0.00008194596,0.3464149,0.0003642264],"about_ca_topic_score_codex":0.0002815797,"about_ca_topic_score_gemma":0.0018190353,"teacher_disagreement_score":0.24984622,"about_ca_system_score_codex":0.00020188413,"about_ca_system_score_gemma":0.00036384148,"threshold_uncertainty_score":0.52289593},"labels":[],"label_agreement":null},{"id":"W4387765725","doi":"10.1001/jamaoncol.2023.4273","title":"Cancers Attributable to Infections in the US in 2017","year":2023,"lang":"en","type":"review","venue":"JAMA Oncology","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Institute for Clinical Evaluative Sciences; Impact; McGill University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Cancer; Merkel cell polyomavirus; Population; Incidence (geometry); Cervical cancer; Internal medicine; Helicobacter pylori; Attributable risk; Hepatitis C; Hepatitis B; Immunology; Hepatitis C virus; Skin cancer; Epidemiology; Virus; Merkel cell carcinoma; Environmental health; Carcinoma","score_opus":0.0953750256596236,"score_gpt":0.43034355871528446,"score_spread":0.3349685330556609,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387765725","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026152807,0.9653935,0.000002062311,0.0043031243,0.0008137514,0.0017810315,0.000090511574,0.000044663615,0.027309833],"genre_scores_gemma":[0.00007361407,0.99388355,0.000009820023,0.0027989948,0.00026722017,0.0011940051,0.00014803493,0.000036381953,0.001588362],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99816835,0.00032239518,0.00051288836,0.0003385021,0.00016397158,0.0004939133],"domain_scores_gemma":[0.9989315,0.00042746612,0.00018821041,0.00032382098,0.0000414375,0.00008754683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008004725,0.00023093101,0.0015951662,0.0004942246,0.000061161285,0.000020294263,0.00021936021,0.00068355445,0.000118206015],"category_scores_gemma":[0.00062477565,0.00016312324,0.00023966827,0.0017211993,0.000045352623,0.000037907885,0.00006747983,0.0010376497,0.0004276272],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035737023,0.00018125071,0.0010249699,0.00225247,0.00012249009,0.0004234632,0.00043668266,0.000095540265,1.1228097e-7,0.0001135262,0.24923694,0.7460768],"study_design_scores_gemma":[0.001353578,0.00053146365,0.00058426353,0.0029628405,0.00027476286,0.00006198072,0.00022750863,0.0000046996247,1.6360698e-8,0.00005965013,0.9937892,0.00015003291],"about_ca_topic_score_codex":0.012805236,"about_ca_topic_score_gemma":0.066309445,"teacher_disagreement_score":0.7459268,"about_ca_system_score_codex":0.003990657,"about_ca_system_score_gemma":0.0030899274,"threshold_uncertainty_score":0.99983287},"labels":[],"label_agreement":null},{"id":"W4387949767","doi":"10.1001/jamaoncol.2023.4447","title":"Risk Model–Based Lung Cancer Screening and Racial and Ethnic Disparities in the US","year":2023,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brock University","funders":"National Cancer Institute","keywords":"Medicine; Lung cancer screening; Ethnic group; Population; Cohort; Demography; Incidence (geometry); Cancer screening; Lung cancer; Cancer; Internal medicine; Gerontology; Environmental health","score_opus":0.036077618688851634,"score_gpt":0.3848904457327718,"score_spread":0.3488128270439202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387949767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9688705,0.003960667,0.00006544883,0.026118483,0.00007618731,0.00033641126,0.000028613214,0.000025982852,0.000517671],"genre_scores_gemma":[0.9919009,0.003947636,0.00024252429,0.003287535,0.00014015031,0.00036174254,0.000013366394,0.00000956784,0.00009654635],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99931353,0.000095708725,0.00011931277,0.00018037963,0.00009914308,0.00019193917],"domain_scores_gemma":[0.9994441,0.00034091697,0.000042662454,0.000104329614,0.000019128478,0.00004881537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003114407,0.00008464439,0.00021361314,0.00007410571,0.000075030686,0.000015010297,0.000034445522,0.00010259279,0.000016145494],"category_scores_gemma":[0.000060338585,0.000055115626,0.000027442908,0.00015158701,0.00008783072,0.000038245118,0.000033939894,0.0002019844,0.000001264468],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027902448,0.00009966235,0.8979514,0.00008919571,0.000078118384,0.00015269945,0.0021358684,0.0014431793,0.000015040865,0.00021361577,0.0076818326,0.089860335],"study_design_scores_gemma":[0.0037096522,0.00024729758,0.8838715,0.00008717621,0.00021086719,0.000008327468,0.00016899173,0.108455434,0.000023520275,0.00014303307,0.00301425,0.0000599754],"about_ca_topic_score_codex":0.002498736,"about_ca_topic_score_gemma":0.0065223877,"teacher_disagreement_score":0.10701226,"about_ca_system_score_codex":0.00015266285,"about_ca_system_score_gemma":0.00011991199,"threshold_uncertainty_score":0.3777358},"labels":[],"label_agreement":null},{"id":"W4388220040","doi":"10.1001/jamaoncol.2023.4817","title":"Derailing Carcinogens—Oncologists and the Ohio Train Derailment","year":2023,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Healthcare and Environmental Waste Management","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Derailment; MEDLINE; Train","score_opus":0.04589094491178461,"score_gpt":0.33864314463902667,"score_spread":0.2927521997272421,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388220040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.800512,0.00043481638,0.00005861919,0.16483971,0.00027947844,0.00080610375,0.000003719597,0.0000914431,0.032974105],"genre_scores_gemma":[0.9791929,0.0008473241,0.00038097485,0.015879534,0.0002529244,0.00011689857,0.000021738057,0.000016118664,0.0032915613],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998796,0.0001938483,0.00024952623,0.00024890222,0.00016903646,0.00034270488],"domain_scores_gemma":[0.9992393,0.00035299567,0.000053282478,0.00020846231,0.000012474323,0.00013343696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009641628,0.00011343756,0.00031075501,0.0000769136,0.00014683974,0.000015384674,0.00006990948,0.00013556804,0.00009449187],"category_scores_gemma":[0.00012030708,0.000073568735,0.000065493885,0.000159136,0.00026896194,0.00002705582,0.00016105644,0.00023528542,0.00021492892],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008231047,0.0001515555,0.010832318,0.00018891512,0.00017206777,0.0010243072,0.0046020127,0.00006864738,0.0009365615,0.003199168,0.04096132,0.93704003],"study_design_scores_gemma":[0.00905544,0.0010183377,0.24152155,0.000035875426,0.00014167621,0.0002558679,0.0055663395,0.0019792754,0.0001949662,0.0006658975,0.73941547,0.00014931787],"about_ca_topic_score_codex":0.00013638572,"about_ca_topic_score_gemma":0.00014471755,"teacher_disagreement_score":0.9368907,"about_ca_system_score_codex":0.00027723986,"about_ca_system_score_gemma":0.00007445083,"threshold_uncertainty_score":0.3000046},"labels":[],"label_agreement":null},{"id":"W4389728363","doi":"10.1001/jamaoncol.2023.5410","title":"Pembrolizumab or Placebo Plus Chemotherapy With or Without Bevacizumab for Persistent, Recurrent, or Metastatic Cervical Cancer","year":2023,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Carboplatin; Bevacizumab; Internal medicine; Oncology; Pembrolizumab; Population; Chemoradiotherapy; Chemotherapy; Pemetrexed; Response Evaluation Criteria in Solid Tumors; Cancer; Surgery; Cisplatin; Phases of clinical research; Immunotherapy","score_opus":0.09245552719655493,"score_gpt":0.4002722129984446,"score_spread":0.3078166858018897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389728363","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91093993,0.0017587958,0.0007992663,0.0603581,0.0024263815,0.012470089,0.00087794656,0.0010434542,0.009326046],"genre_scores_gemma":[0.8712435,0.0030506735,0.0074446513,0.012581054,0.0023192593,0.007856621,0.0004865423,0.00030246118,0.094715245],"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","domain_scores_codex":[0.99751496,0.00013545787,0.0004797836,0.00066363224,0.0004319209,0.00077424175],"domain_scores_gemma":[0.997686,0.0010969694,0.00021604095,0.00035846455,0.00024064047,0.0004018524],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002786485,0.00039197668,0.0012661994,0.0002868969,0.00016470793,0.000035726935,0.00021395543,0.00023944535,0.0045716558],"category_scores_gemma":[0.00038364885,0.00019944423,0.00027347295,0.0012505526,0.000157656,0.000103882456,0.00006389604,0.00031939356,0.00012164936],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6569577,0.0011116375,0.002357853,0.0011131996,0.002650918,0.00092755613,0.0017357297,0.000048949427,0.00011439378,0.00006851708,0.022296213,0.3106174],"study_design_scores_gemma":[0.319277,0.067772396,0.0057707215,0.0005678158,0.0036544884,0.0014606977,0.0033050263,0.006204324,0.00054504763,0.000112442656,0.59048206,0.000847989],"about_ca_topic_score_codex":0.00034612196,"about_ca_topic_score_gemma":0.003646634,"teacher_disagreement_score":0.56818587,"about_ca_system_score_codex":0.0013816697,"about_ca_system_score_gemma":0.0022438567,"threshold_uncertainty_score":0.9963383},"labels":[],"label_agreement":null},{"id":"W4390061675","doi":"10.1001/jamaoncol.2023.6060","title":"Stereotactic Radiosurgery vs Conventional Radiotherapy for Spine Metastases","year":2023,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Otorhinolaryngology; Radiosurgery; Family medicine; Neurology; MEDLINE; Internal medicine; Psychiatry; Radiation therapy","score_opus":0.04776169589400364,"score_gpt":0.3674210172704063,"score_spread":0.3196593213764027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390061675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6919255,0.0033149193,0.019492159,0.24790885,0.0063014063,0.010015463,0.0018124084,0.0017658701,0.017463382],"genre_scores_gemma":[0.66459036,0.0017671527,0.10205271,0.10581651,0.0053538983,0.0051620477,0.015355606,0.0004996248,0.09940207],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984742,0.00015013597,0.00039672016,0.00032045657,0.0002819614,0.00037657388],"domain_scores_gemma":[0.9985634,0.0006623511,0.00016484802,0.00029587973,0.00011442822,0.00019909664],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009232913,0.00016343364,0.0005524031,0.00034460038,0.0000657949,0.000024245217,0.00009794959,0.00008591808,0.0036350074],"category_scores_gemma":[0.0008668574,0.00014838847,0.00028335874,0.0003318115,0.00007468432,0.00010686691,0.00003807676,0.00011976062,0.00025189042],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025451572,0.00082782423,0.0026568302,0.00067597796,0.0013771513,0.00091365323,0.00008580348,0.00001484597,0.001143651,0.005324124,0.9153417,0.069093294],"study_design_scores_gemma":[0.009716134,0.0012091683,0.044901334,0.000050139508,0.0004771967,0.00009090011,0.00011942303,0.00235019,0.000121971,0.00046943073,0.9403405,0.00015359002],"about_ca_topic_score_codex":0.0000050740364,"about_ca_topic_score_gemma":0.0000020221387,"teacher_disagreement_score":0.14209233,"about_ca_system_score_codex":0.0001584548,"about_ca_system_score_gemma":0.00027596735,"threshold_uncertainty_score":0.9972758},"labels":[],"label_agreement":null},{"id":"W4391655278","doi":"10.1001/jamaoncol.2023.6698","title":"Hyperbaric Oxygen Therapy for Management of Late Radiation Toxicity—A Honey of a Trial?","year":2024,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Otorhinolaryngology; Family medicine; Neurology; MEDLINE; Psychiatry","score_opus":0.03683930611037208,"score_gpt":0.35554456457100986,"score_spread":0.3187052584606378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391655278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9362279,0.003962484,0.0047885645,0.024506807,0.0010716079,0.005308459,0.00006665421,0.00009464325,0.023972841],"genre_scores_gemma":[0.981676,0.0015055912,0.009029581,0.002035744,0.00019525271,0.00040653205,0.00008777996,0.000034446453,0.005029085],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989023,0.000079169135,0.00043581243,0.0002170759,0.0002087842,0.00015685419],"domain_scores_gemma":[0.99928343,0.0002075985,0.00013950942,0.00024149242,0.00006545892,0.00006248826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000691331,0.000103662605,0.00040669081,0.00020725325,0.000015667953,0.0000080608725,0.0000897964,0.00008095128,0.00024190426],"category_scores_gemma":[0.00007099822,0.00008638147,0.00017532341,0.00024320168,0.000044900204,0.00005451186,0.00003429396,0.00006783252,0.000015140755],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04426865,0.0020666933,0.00010592398,0.003992182,0.0022250244,0.00020113506,0.0008139971,0.000033936234,0.0073640123,0.027695367,0.060387246,0.8508458],"study_design_scores_gemma":[0.13617791,0.010332388,0.012899438,0.00036656167,0.0019151187,0.000009742339,0.00082751794,0.0070297094,0.0045772907,0.0052371146,0.8203814,0.00024579684],"about_ca_topic_score_codex":0.000010265397,"about_ca_topic_score_gemma":9.549595e-7,"teacher_disagreement_score":0.85060006,"about_ca_system_score_codex":0.00008405971,"about_ca_system_score_gemma":0.00011858964,"threshold_uncertainty_score":0.3522534},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"commentary","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"not_applicable","genre":"commentary","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"}],"label_agreement":"agree"},{"id":"W4392284556","doi":"10.1001/jamaoncol.2023.6937","title":"Bilateral Oophorectomy and All-Cause Mortality in Women With <i>BRCA1</i> and <i>BRCA2</i> Sequence Variations","year":2024,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Juravinski Cancer Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; University of Toronto; University Health Network; Public Health Ontario; McMaster University; Women's College Hospital","funders":"National Cancer Institute","keywords":"Medicine; Oophorectomy; Gynecology; Sequence (biology); BRCA2 Protein; MEDLINE; Oncology; Hysterectomy; Surgery; Mutation; Genetics; Germline mutation","score_opus":0.026749539504267124,"score_gpt":0.31194481746054104,"score_spread":0.2851952779562739,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392284556","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.67043585,0.002583009,0.000085896165,0.32265103,0.0007475737,0.0007299603,0.00043464973,0.000046524394,0.0022854842],"genre_scores_gemma":[0.19861044,0.0038596615,0.0031242983,0.7862186,0.0036328945,0.0014127062,0.001150143,0.00019678657,0.0017945063],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978077,0.00020787344,0.00035992078,0.00095908047,0.00016200941,0.00050342956],"domain_scores_gemma":[0.9991255,0.00007463497,0.00014738797,0.0004766316,0.00008733946,0.000088510526],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0003256224,0.0003642697,0.00041267523,0.00015822146,0.00005481412,0.000109470675,0.00021157603,0.001296638,0.000032629927],"category_scores_gemma":[0.000046602152,0.00032716326,0.000034494435,0.00020355826,0.00036574225,0.00001170942,0.00025666016,0.001072872,0.000009803868],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029224026,0.00008207291,0.003267157,0.0003957033,0.002410099,0.001784773,0.0015592509,0.00004536982,0.02180593,0.0000909429,0.96117276,0.0070937243],"study_design_scores_gemma":[0.0010026508,0.00064424024,0.002833178,0.00005193204,0.00024987923,0.0004831368,0.000059235404,0.000043061813,0.0006560848,0.0007994416,0.9927326,0.0004445793],"about_ca_topic_score_codex":0.00016009182,"about_ca_topic_score_gemma":0.0005278958,"teacher_disagreement_score":0.47182542,"about_ca_system_score_codex":0.00049153017,"about_ca_system_score_gemma":0.000831844,"threshold_uncertainty_score":0.9999999},"labels":[],"label_agreement":null},{"id":"W4392548257","doi":"10.1001/jamaoncol.2023.7269","title":"Stereotactic Radiation Therapy in Early Non–Small Cell Lung Cancer and Interstitial Lung Disease","year":2024,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Western University; Health Sciences Centre; Sunnybrook Health Science Centre; University of Alberta; Princess Margaret Cancer Centre; Centre Hospitalier de l’Université de Montréal; University of Toronto; London Health Sciences Centre","funders":"","keywords":"Medicine; SABR volatility model; Lung cancer; Interstitial lung disease; Radiation therapy; Internal medicine; Population; Clinical endpoint; Surgery; Lung; Randomized controlled trial","score_opus":0.013995637729194085,"score_gpt":0.3136319455670084,"score_spread":0.2996363078378143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392548257","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.35926363,0.022082653,0.000004021752,0.6133764,0.002128862,0.0014964455,0.00011113194,0.000040891344,0.0014959823],"genre_scores_gemma":[0.42236784,0.01741306,0.00003836514,0.54448247,0.009571385,0.0017811357,0.000386012,0.00013090868,0.0038288278],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984102,0.00010182273,0.00032906077,0.0006094706,0.00017708604,0.00037234623],"domain_scores_gemma":[0.9991593,0.00023281756,0.00014503114,0.00026789127,0.000048831633,0.00014617578],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00009803246,0.00033248524,0.00061310775,0.0002939573,0.000030330091,0.00007442147,0.00008582629,0.0006295582,0.00020464833],"category_scores_gemma":[0.00001432526,0.00026950837,0.00013946611,0.00012459922,0.00005985927,0.00007573628,0.000057322923,0.0012637494,0.000025618801],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058779324,0.00021529933,0.1576234,0.0015053443,0.00046975786,0.007518758,0.0011939332,0.0000017656157,0.0000075977655,0.000003569694,0.8031233,0.027749512],"study_design_scores_gemma":[0.008393983,0.0012555008,0.15236269,0.0013587145,0.0016352353,0.000031197043,0.000019476567,0.0008194794,0.000037405745,0.000028164935,0.833697,0.00036116282],"about_ca_topic_score_codex":0.0016564695,"about_ca_topic_score_gemma":0.00035114904,"teacher_disagreement_score":0.06889393,"about_ca_system_score_codex":0.0027487958,"about_ca_system_score_gemma":0.0008553581,"threshold_uncertainty_score":0.9999757},"labels":[],"label_agreement":null},{"id":"W4392800293","doi":"10.1001/jamaoncol.2023.7291","title":"Noninferiority of Hypofractionated vs Conventional Postprostatectomy Radiotherapy for Genitourinary and Gastrointestinal Symptoms","year":2024,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Hôpital de l'Enfant-Jésus","funders":"National Cancer Institute","keywords":"Medicine; Prostatectomy; Prostate cancer; Randomized controlled trial; Genitourinary system; Radiation therapy; Salvage therapy; Urology; Adverse effect; Prostate-specific antigen; Internal medicine; Surgery; Cancer; Chemotherapy","score_opus":0.018124961319206986,"score_gpt":0.3160372760175603,"score_spread":0.29791231469835333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392800293","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.061002597,0.005553056,0.00021705143,0.92763984,0.0011274432,0.0023425245,0.0014527496,0.00010059151,0.0005641506],"genre_scores_gemma":[0.023090804,0.0043579848,0.032756757,0.902184,0.015860623,0.0036686864,0.009348372,0.0004226658,0.008310122],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983818,0.00007206986,0.0004632424,0.0005169458,0.0002180057,0.0003479522],"domain_scores_gemma":[0.99848586,0.0005995304,0.0002814107,0.00020349243,0.0003348452,0.00009485608],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016637408,0.00032217987,0.0008713669,0.00023155918,0.00005378294,0.000026430751,0.00006848942,0.000493017,0.0002359064],"category_scores_gemma":[0.00005728211,0.0002746678,0.0002623551,0.00010172283,0.00024469235,0.00007439154,0.00004477585,0.00097198103,0.000010688426],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002736872,0.00043144586,0.010912125,0.001977172,0.0011167144,0.0033416362,0.000053920758,9.843179e-7,0.0006816795,0.000105832245,0.96550983,0.013131781],"study_design_scores_gemma":[0.006234182,0.012765274,0.01942275,0.000743593,0.00065729424,0.0056997533,0.000011615263,0.0001180757,0.0002952449,0.0003583992,0.9534952,0.00019861844],"about_ca_topic_score_codex":0.00007894722,"about_ca_topic_score_gemma":0.0000035323403,"teacher_disagreement_score":0.03791179,"about_ca_system_score_codex":0.0007633638,"about_ca_system_score_gemma":0.00086115743,"threshold_uncertainty_score":0.99997056},"labels":[],"label_agreement":null},{"id":"W4393037627","doi":"10.1001/jamaoncol.2024.0057","title":"Neoadjuvant Chemoimmunotherapy for NSCLC","year":2024,"lang":"en","type":"review","venue":"JAMA Oncology","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":205,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; McGill University Health Centre","funders":"University of Texas MD Anderson Cancer Center; Eisai; Regeneron Pharmaceuticals; Amgen; Johns Hopkins University; AstraZeneca","keywords":"Medicine; Chemoimmunotherapy; Neoadjuvant therapy; Oncology; Internal medicine; Chemotherapy; Cancer; Cyclophosphamide; Breast cancer","score_opus":0.07003444763824695,"score_gpt":0.45243535753577946,"score_spread":0.3824009098975325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393037627","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[9.323931e-7,0.9842067,0.000017252587,0.003965616,0.0016290586,0.0026751142,0.00011802741,0.000095297946,0.0072920043],"genre_scores_gemma":[0.0000013207966,0.98658574,0.00067047763,0.0013832839,0.0015635672,0.0035400763,0.00038926693,0.00012321604,0.005743043],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984562,0.000049223516,0.0005221395,0.00052093447,0.0001194959,0.0003320432],"domain_scores_gemma":[0.9988415,0.00035671177,0.00018997556,0.00043915797,0.00006684334,0.00010579523],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020154257,0.00040028786,0.0024894506,0.00016064369,0.0000381811,0.000031806503,0.00012929058,0.00071638357,0.00024305188],"category_scores_gemma":[0.000029916268,0.0002472597,0.0011232428,0.00016561175,0.00005224034,0.00002129911,0.000032482076,0.0004092265,0.00054105744],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059300513,0.0002697142,8.055061e-7,0.019058393,0.0013526438,0.0001838516,0.000048983296,9.320681e-9,1.8506334e-7,0.0005570998,0.12648681,0.85198224],"study_design_scores_gemma":[0.0021431795,0.0016888368,0.0000022853048,0.01730382,0.007840467,0.00037554803,0.0000062980844,0.0000020715581,0.0000017333689,0.00013076125,0.9703074,0.00019761123],"about_ca_topic_score_codex":0.000021927957,"about_ca_topic_score_gemma":0.0000135284945,"teacher_disagreement_score":0.8517846,"about_ca_system_score_codex":0.0019876184,"about_ca_system_score_gemma":0.0013762327,"threshold_uncertainty_score":0.999998},"labels":[],"label_agreement":null},{"id":"W4393278281","doi":"10.1001/jamaoncol.2024.0228","title":"Comment on the Burden of Infection-Attributable Cancers in the US—Reply","year":2024,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Otorhinolaryngology; Family medicine; Neurology; MEDLINE; Psychiatry","score_opus":0.03854557456724228,"score_gpt":0.2800599658136508,"score_spread":0.2415143912464085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393278281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.48911688,0.0025481628,0.00019175031,0.2936694,0.0017039342,0.00043199753,0.00016608652,0.000023847966,0.21214795],"genre_scores_gemma":[0.9754546,0.0007098861,0.000017761331,0.02291518,0.00043384804,0.000089057845,0.000004642998,0.000011595013,0.0003633835],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.999037,0.00004310407,0.00044864533,0.00021230134,0.000024612511,0.00023433198],"domain_scores_gemma":[0.99901503,0.0005110099,0.00016474092,0.00026657165,0.00001757475,0.00002507368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012635292,0.000099736084,0.0003117383,0.00013637001,0.00006589799,0.00006354237,0.00022248153,0.000108861794,0.00050689705],"category_scores_gemma":[0.00018851332,0.00007112812,0.00009820284,0.00025449228,0.00010084939,0.00013995454,0.000037380054,0.00031930514,0.0003182933],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042486037,0.00005867911,0.011730518,0.000028589111,0.000059861824,0.000008957659,0.0024305112,0.002674013,0.0000034896275,0.7221696,0.25456738,0.0062259613],"study_design_scores_gemma":[0.00026803266,0.00026262394,0.014242997,0.000026683914,0.000004485725,0.0000036490642,0.00013757114,0.0017383094,0.000027546705,0.02229043,0.960916,0.000081697195],"about_ca_topic_score_codex":0.018350182,"about_ca_topic_score_gemma":0.00053586415,"teacher_disagreement_score":0.7063486,"about_ca_system_score_codex":0.00071219524,"about_ca_system_score_gemma":0.00014617789,"threshold_uncertainty_score":0.9881867},"labels":[],"label_agreement":null},{"id":"W4393931424","doi":"10.1001/jamaoncol.2024.0194","title":"Clinical Value of Molecular Targets and FDA-Approved Genome-Targeted Cancer Therapies","year":2024,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Clinical trial; Personalized medicine; Targeted therapy; Cancer drugs; Oncology; Cancer; Internal medicine; Bioinformatics","score_opus":0.012530383679306862,"score_gpt":0.32397191031379474,"score_spread":0.3114415266344879,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393931424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9239164,0.070307344,0.0015433705,0.0019277239,0.00071648567,0.00019920312,0.00012140727,0.00001489886,0.0012531466],"genre_scores_gemma":[0.9834678,0.012148142,0.0019223077,0.0016063799,0.000518854,0.000045282908,0.00007320297,0.00003171389,0.00018627405],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988592,0.00010488136,0.00034508758,0.0004029129,0.00007197769,0.00021594146],"domain_scores_gemma":[0.9994124,0.00008922643,0.00008389428,0.00023624266,0.000085736756,0.000092485956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032594905,0.00014466498,0.0002851404,0.000047305264,0.00002945238,0.000025894107,0.00014173689,0.0003337761,0.000047530888],"category_scores_gemma":[0.00014779881,0.00013298745,0.00012734298,0.00007533901,0.00021145685,0.0000032359317,0.00015427393,0.0001594769,0.000004104285],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021571807,0.00013028199,0.004402112,0.00009503223,0.00048080247,0.000052242194,0.0002343569,0.00016132822,0.90065664,0.0037877592,0.0051010116,0.08468269],"study_design_scores_gemma":[0.0014398488,0.001751403,0.022605484,0.000028759241,0.00014850729,0.000028246297,0.00012692528,0.00085698575,0.08601157,0.0023655186,0.8842749,0.0003618737],"about_ca_topic_score_codex":0.00009062474,"about_ca_topic_score_gemma":0.000101048194,"teacher_disagreement_score":0.8791739,"about_ca_system_score_codex":0.00003282694,"about_ca_system_score_gemma":0.00034352983,"threshold_uncertainty_score":0.5423071},"labels":[],"label_agreement":null},{"id":"W4394727423","doi":"10.1001/jamaoncol.2024.0294","title":"American Radium Society Appropriate Use Criteria for Unresectable Locally Advanced Non–Small Cell Lung Cancer","year":2024,"lang":"en","type":"review","venue":"JAMA Oncology","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"G1 Therapeutics; ViewRay; National Cancer Institute; Incyte; RefleXion Medical; AstraZeneca","keywords":"Medicine; Lung cancer; Guideline; Radiation therapy; Oncology; Internal medicine","score_opus":0.045850571577881645,"score_gpt":0.4147705081213863,"score_spread":0.3689199365435047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394727423","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021151078,0.9882199,0.0002941335,0.0016193627,0.00230877,0.005700945,0.0006488938,0.00012979227,0.0008667009],"genre_scores_gemma":[0.000039325452,0.9696428,0.009302534,0.0016549882,0.0016978354,0.010484372,0.00051973906,0.00024124318,0.0064171166],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967513,0.00014306484,0.00083824253,0.0011924076,0.00021589093,0.000859073],"domain_scores_gemma":[0.9976702,0.00060819305,0.0004851769,0.0006630709,0.00024479747,0.00032856327],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003137093,0.0007782135,0.0036436177,0.0001457346,0.00010545973,0.00011511769,0.0002675121,0.0006677374,0.00015113439],"category_scores_gemma":[0.000060037553,0.0005510524,0.0015639318,0.0004834221,0.00017353384,0.00009455578,0.00018535652,0.00079425087,0.000057275123],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001860794,0.000491936,0.000048894162,0.06269346,0.001911179,0.000162735,0.00025697192,0.0000053943827,0.0000065920285,0.00001954923,0.13836205,0.79585516],"study_design_scores_gemma":[0.003160742,0.00175725,0.000017993705,0.013224941,0.014329145,0.000055808094,0.000059655988,0.00041544004,0.000022887742,0.000009191602,0.96646667,0.00048029053],"about_ca_topic_score_codex":0.001024327,"about_ca_topic_score_gemma":0.00046626866,"teacher_disagreement_score":0.8281046,"about_ca_system_score_codex":0.0050313557,"about_ca_system_score_gemma":0.004256772,"threshold_uncertainty_score":0.9996941},"labels":[],"label_agreement":null},{"id":"W4394727793","doi":"10.1001/jamaoncol.2024.0286","title":"Second Primary Breast Cancer in Young Breast Cancer Survivors","year":2024,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Lumpectomy; Breast cancer; Cumulative incidence; Incidence (geometry); Mastectomy; Hazard ratio; Gynecology; Proportional hazards model; Young adult; Cancer; Prospective cohort study; Internal medicine; Cohort; Confidence interval","score_opus":0.0069118740200994466,"score_gpt":0.28200540740884705,"score_spread":0.2750935333887476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394727793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9518097,0.012501324,0.000018263476,0.015466068,0.0024413802,0.0003019704,0.0027088986,0.00006539864,0.014686971],"genre_scores_gemma":[0.9925373,0.00263401,0.000050131177,0.0012216277,0.0013180987,0.00042397412,0.00010948686,0.000052456206,0.0016529036],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983825,0.00010820392,0.00027318837,0.00063911686,0.00012670865,0.000470267],"domain_scores_gemma":[0.999461,0.00004275793,0.000061793464,0.00025711767,0.000087729844,0.0000895863],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00017015144,0.00027326282,0.00034363422,0.000108266984,0.00006512055,0.000040060633,0.00019501382,0.00033240736,0.0010011675],"category_scores_gemma":[0.000006976097,0.00024504715,0.000113670314,0.00024270036,0.00015964851,0.000015106687,0.00020677343,0.00024419517,0.00003428666],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011668381,0.00044610447,0.60219705,0.00037826685,0.0010473183,0.00031529384,0.0010255091,0.000121175595,0.058496695,0.00027275144,0.032687023,0.30184597],"study_design_scores_gemma":[0.001181745,0.00008027102,0.90404457,0.00009855374,0.00006850898,0.00064024725,0.00015600014,0.000031662552,0.0012301786,0.000049482172,0.09209981,0.00031898325],"about_ca_topic_score_codex":0.005047589,"about_ca_topic_score_gemma":0.10526276,"teacher_disagreement_score":0.3018475,"about_ca_system_score_codex":0.0006133908,"about_ca_system_score_gemma":0.00065186655,"threshold_uncertainty_score":0.999912},"labels":[],"label_agreement":null},{"id":"W4394760621","doi":"10.1001/jamaoncol.2023.6944","title":"MRI Surveillance and Breast Cancer Mortality in Women With <i>BRCA1</i> and <i>BRCA2</i> Sequence Variations","year":2024,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Juravinski Cancer Centre; Princess Margaret Cancer Centre; Public Health Ontario; Women's College Hospital; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Breast cancer; Breast MRI; Hazard ratio; Magnetic resonance imaging; Cancer registry; Proportional hazards model; Cancer; Mammography; Demography; Gynecology; Oncology; Internal medicine; Confidence interval; Radiology","score_opus":0.011956445389394997,"score_gpt":0.30190920306287955,"score_spread":0.28995275767348455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394760621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882163,0.0032105385,0.0005711547,0.006271808,0.00022536035,0.00019316563,0.00027188068,0.00002302476,0.001016803],"genre_scores_gemma":[0.99504554,0.0021824082,0.0007466468,0.0013722106,0.00021755697,0.0002620061,0.000025439016,0.000020348736,0.0001278577],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99892217,0.00009890241,0.00017143108,0.00047501648,0.00007973302,0.00025274226],"domain_scores_gemma":[0.99955803,0.00004998953,0.000044086813,0.00020528003,0.00006533756,0.00007730255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033233347,0.00013404695,0.00016919013,0.000052891428,0.000052167285,0.000055463617,0.00008930021,0.00018322901,0.000034071683],"category_scores_gemma":[0.000020983622,0.00012034445,0.000012665916,0.00020970852,0.00021747607,0.000013648366,0.00008799705,0.00015658645,0.000002128354],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010570849,0.00025741968,0.4895165,0.00045035646,0.00085178844,0.00026813208,0.004306342,0.0014991254,0.2362008,0.0029804527,0.015425469,0.24718653],"study_design_scores_gemma":[0.0016607771,0.00050361984,0.79794157,0.00006929835,0.00003672359,0.000608748,0.00035038122,0.0010926947,0.0019480858,0.00095432764,0.19436665,0.0004671467],"about_ca_topic_score_codex":0.00033811558,"about_ca_topic_score_gemma":0.0032186985,"teacher_disagreement_score":0.30842504,"about_ca_system_score_codex":0.0002768533,"about_ca_system_score_gemma":0.0006437115,"threshold_uncertainty_score":0.49075043},"labels":[],"label_agreement":null},{"id":"W4395466551","doi":"10.1001/jamaoncol.2024.0578","title":"Omission of Axillary Dissection Following Nodal Downstaging With Neoadjuvant Chemotherapy","year":2024,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"National Cancer Institute; Dipartimento di Scienze Biomediche Avanzate, Università degli Studi di Napoli Federico II","keywords":"Medicine; Axillary Lymph Node Dissection; Breast cancer; Sentinel lymph node; Biopsy; Axilla; Neoadjuvant therapy; Retrospective cohort study; Stage (stratigraphy); Surgery; Dissection (medical); Lymph node; Radiology; Cancer; Internal medicine","score_opus":0.0052991081853735935,"score_gpt":0.27903550498234436,"score_spread":0.27373639679697076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395466551","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98897296,0.003088312,0.0012490498,0.0025621902,0.00047573983,0.00013584622,0.000009204197,0.00003603216,0.0034706728],"genre_scores_gemma":[0.9978323,0.00029319042,0.0010467878,0.00023998192,0.00027991837,0.000026226933,0.000045726763,0.000024693652,0.00021116556],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992596,0.00003664495,0.00014233774,0.00030325432,0.00008847446,0.00016967297],"domain_scores_gemma":[0.99969476,0.000026660144,0.000045615085,0.00016165327,0.000033102566,0.000038205486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001040481,0.00013230875,0.00018891433,0.000048681846,0.000056475903,0.000014077439,0.000067600624,0.00013518365,0.00001827015],"category_scores_gemma":[0.000014964645,0.00009748212,0.00009740891,0.00010546061,0.00005871792,0.000006632327,0.000047813886,0.000082623774,0.00000357404],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012027572,0.00020619463,0.024836117,0.00010581771,0.0008769404,0.00019833237,0.00094546244,0.00006476736,0.61125976,0.00014761185,0.0034865602,0.35666972],"study_design_scores_gemma":[0.0069473204,0.0036059446,0.091587074,0.00049207476,0.000333412,0.00069936557,0.0015586034,0.00032179776,0.45587185,0.00023615615,0.4376613,0.00068511453],"about_ca_topic_score_codex":0.000058502927,"about_ca_topic_score_gemma":0.000049161692,"teacher_disagreement_score":0.43417475,"about_ca_system_score_codex":0.0000737512,"about_ca_system_score_gemma":0.00013140956,"threshold_uncertainty_score":0.39752054},"labels":[],"label_agreement":null},{"id":"W4396577124","doi":"10.1001/jamaoncol.2024.0851","title":"Genetic Testing in Men With Metastatic Castration-Resistant Prostate Cancer","year":2024,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Medicine; Prostate cancer; Oncology; Genetic testing; Internal medicine; Homologous recombination; Cancer; Genetics; Gene","score_opus":0.048688765978499124,"score_gpt":0.370808606759038,"score_spread":0.32211984078053885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396577124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95728785,0.0038731932,0.00016212146,0.013678175,0.00021306216,0.00091297604,0.00003775959,0.00013231425,0.023702575],"genre_scores_gemma":[0.985923,0.00014992128,0.010751544,0.001154097,0.00023545774,0.0005805268,0.000009254043,0.000033947883,0.0011622877],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99893564,0.000081141574,0.00028847446,0.00027889843,0.00016903806,0.00024678148],"domain_scores_gemma":[0.99937755,0.0002616873,0.000058381753,0.00013206893,0.00009319423,0.00007711469],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021372922,0.00012057546,0.00025745758,0.00015696883,0.000030832038,0.00003220648,0.000042234944,0.000057525485,0.00027318043],"category_scores_gemma":[0.00005181677,0.00009242788,0.000023974559,0.00047608238,0.000088256915,0.000079834754,0.000010630704,0.0002589451,0.000032900887],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048904275,0.00063398364,0.06817142,0.001768118,0.00072536356,0.016760916,0.00996265,0.0041028783,0.37791887,0.0014714805,0.024924172,0.48866972],"study_design_scores_gemma":[0.029582685,0.01120013,0.56395906,0.005149636,0.00087750674,0.0040451684,0.0029997663,0.034849036,0.016698118,0.004231401,0.32529414,0.0011133638],"about_ca_topic_score_codex":0.0006278349,"about_ca_topic_score_gemma":0.0010922977,"teacher_disagreement_score":0.49578765,"about_ca_system_score_codex":0.0006646207,"about_ca_system_score_gemma":0.0012866829,"threshold_uncertainty_score":0.37690994},"labels":[],"label_agreement":null},{"id":"W4396769281","doi":"10.1001/jamaoncol.2024.0591","title":"Metastatic Hormone-Sensitive Prostate Cancer and Combination Treatment Outcomes","year":2024,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Prostate cancer; Oncology; Cancer; Prostate; Internal medicine; Hormone therapy; Gynecology; Breast cancer","score_opus":0.041834624394988744,"score_gpt":0.3974128393724129,"score_spread":0.35557821497742415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396769281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9371781,0.010807401,0.000010841714,0.04690872,0.0002559945,0.0009350531,0.000071929426,0.00009005777,0.0037419526],"genre_scores_gemma":[0.9743192,0.008021559,0.00022801102,0.0004984697,0.00006757602,0.0003371941,0.000080685844,0.000020932559,0.01642637],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9991597,0.00006091334,0.00014609864,0.00025998167,0.00013844106,0.0002348972],"domain_scores_gemma":[0.99945754,0.00022424704,0.0000260165,0.00009358418,0.00008233438,0.00011629921],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013025122,0.0001362064,0.0003360123,0.000148382,0.000058418485,0.000040264244,0.000018998084,0.00006626059,0.00004382822],"category_scores_gemma":[0.00002858749,0.00008372421,0.00006038928,0.00014678064,0.00012246758,0.00009851601,0.000025386566,0.00013250389,0.000045798573],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017735126,0.0008741649,0.023204109,0.00027274358,0.0020380463,0.004049715,0.007487482,0.0000027246977,0.0056040944,0.002976066,0.008041512,0.9436758],"study_design_scores_gemma":[0.03225344,0.019566488,0.5372493,0.00033201955,0.0021988193,0.00067432085,0.003021114,0.0041113426,0.012770462,0.0032848064,0.3840139,0.00052396156],"about_ca_topic_score_codex":0.00033675454,"about_ca_topic_score_gemma":0.00008887071,"teacher_disagreement_score":0.9431519,"about_ca_system_score_codex":0.0008127265,"about_ca_system_score_gemma":0.00042929425,"threshold_uncertainty_score":0.34141743},"labels":[],"label_agreement":null},{"id":"W4396977150","doi":"10.1001/jamaoncol.2024.0836","title":"Physician and Artificial Intelligence Chatbot Responses to Cancer Questions From Social Media","year":2024,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; McMaster University; University of Toronto","funders":"","keywords":"Medicine; Chatbot; Social media; MEDLINE; World Wide Web; Data science","score_opus":0.23294635570343822,"score_gpt":0.501416852682031,"score_spread":0.2684704969785927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396977150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84636444,0.0015313007,0.0012715089,0.14681283,0.002757947,0.00029374528,0.00007037566,0.00012310584,0.0007747299],"genre_scores_gemma":[0.9870664,0.00035970763,0.0007700838,0.0056400914,0.005785538,0.00015217217,0.000031239568,0.000020727959,0.00017404748],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99875635,0.00012117839,0.0003542634,0.0003520322,0.0001486191,0.00026753705],"domain_scores_gemma":[0.9983072,0.0011913136,0.00003915676,0.00012275572,0.00014741112,0.00019214334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028971286,0.00012023262,0.00025495855,0.00018288886,0.00016218162,0.00006129389,0.00006658799,0.00022950997,0.0003152662],"category_scores_gemma":[0.00065951626,0.000112023634,0.00005073699,0.00035337202,0.00015167533,0.00010194851,0.000038245045,0.0003389912,0.00035634128],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036758863,0.00009220264,0.0003915372,0.000032552696,0.000029348059,0.000044774348,0.01995839,0.0000023184398,0.005731947,0.008986222,0.0057379394,0.9586252],"study_design_scores_gemma":[0.000095431875,0.0020351706,0.060327116,0.0011286528,0.0005763795,0.000078163896,0.04538004,0.0035365704,0.092904195,0.21153197,0.5815244,0.0008819652],"about_ca_topic_score_codex":0.002483647,"about_ca_topic_score_gemma":0.0034059682,"teacher_disagreement_score":0.9577432,"about_ca_system_score_codex":0.00032392505,"about_ca_system_score_gemma":0.00079763983,"threshold_uncertainty_score":0.45801648},"labels":[],"label_agreement":null},{"id":"W4399627166","doi":"10.1001/jamaoncol.2024.1796","title":"Stereotactic Ablative Radiotherapy for Gynecological Oligometastatic and Oligoprogessive Tumors","year":2024,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; McMaster University","funders":"","keywords":"Medicine; SABR volatility model; Cumulative incidence; Radiation therapy; Incidence (geometry); Radiosurgery; Retrospective cohort study; Ablative case; Cervix; Internal medicine; Surgery; Cancer; Cohort","score_opus":0.036587463691654436,"score_gpt":0.3692842752625899,"score_spread":0.33269681157093545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399627166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9625581,0.0104450295,0.0009519374,0.01595019,0.00075632846,0.0019299536,0.00006886344,0.00016682541,0.007172797],"genre_scores_gemma":[0.9891953,0.0005402032,0.0049457597,0.0031624716,0.00037264125,0.0004561874,0.000026076714,0.000027186112,0.0012741651],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99894005,0.00008375731,0.0002404675,0.00034347334,0.000113300695,0.00027897785],"domain_scores_gemma":[0.99763703,0.0019722907,0.000053511863,0.00010029872,0.00006362998,0.00017324797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021062493,0.00015600742,0.0005100726,0.00016479343,0.000054427408,0.000038373673,0.00004571311,0.00015102688,0.00046968675],"category_scores_gemma":[0.00036968978,0.00010344187,0.000113092974,0.00029662836,0.00012227752,0.00008657013,0.000023906703,0.00019904955,0.000024972493],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049501,0.00096686924,0.0066303075,0.0008266491,0.0032341054,0.0023581563,0.002062532,0.000002840012,0.00311572,0.011966411,0.003930027,0.9599563],"study_design_scores_gemma":[0.04995768,0.055396557,0.19830279,0.00051820703,0.0026054436,0.0030500502,0.0014855015,0.0038256696,0.0040486935,0.025407568,0.6545078,0.00089404866],"about_ca_topic_score_codex":0.00002139002,"about_ca_topic_score_gemma":0.000009103575,"teacher_disagreement_score":0.9590622,"about_ca_system_score_codex":0.00040783355,"about_ca_system_score_gemma":0.00021084286,"threshold_uncertainty_score":0.51427406},"labels":[],"label_agreement":null},{"id":"W4399854590","doi":"10.1001/jamaoncol.2024.1805","title":"Current Management of Desmoid Tumors","year":2024,"lang":"en","type":"review","venue":"JAMA Oncology","topic":"Soft tissue tumor case studies","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Princess Margaret Cancer Centre; University of Toronto; University Health Network; Mount Sinai Hospital","funders":"","keywords":"Medicine; Guideline; MEDLINE; Randomized controlled trial; Evidence-based medicine; Cryotherapy; Radiation therapy; Clinical trial; Sarcoma; Surgery; Pathology; Alternative medicine","score_opus":0.10312701699273753,"score_gpt":0.4600195676058344,"score_spread":0.3568925506130969,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399854590","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000013804851,0.97556466,0.0000037046314,0.00024985013,0.0016513298,0.0013224175,0.000037584483,0.00011107554,0.021045564],"genre_scores_gemma":[0.000015946593,0.9965507,0.0005686925,0.000050722174,0.00045058018,0.00040336835,0.00007997065,0.00007875726,0.0018013036],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99786705,0.00012510334,0.00089424953,0.0005021979,0.00027479284,0.00033657937],"domain_scores_gemma":[0.9987765,0.0002002353,0.0003420594,0.00048687437,0.00008131615,0.00011299006],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00033995463,0.0004260988,0.0031525907,0.0003722754,0.000026560474,0.0000070155506,0.00018498703,0.0002474227,0.0001636456],"category_scores_gemma":[0.00007758329,0.00030463934,0.00069027924,0.0005039944,0.00019887759,0.000017532217,0.0004260452,0.0007879227,0.0010708792],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015343909,0.00014852695,0.000004196936,0.14275226,0.000997436,0.0038935144,0.0000640286,1.1635063e-8,5.678439e-8,0.0011355379,0.03596581,0.8150233],"study_design_scores_gemma":[0.0004272939,0.0004726612,0.00004786017,0.05525603,0.01104543,0.0012786275,0.00008530217,4.1513434e-7,3.0280137e-7,0.000079372236,0.9311188,0.00018789522],"about_ca_topic_score_codex":0.000005982014,"about_ca_topic_score_gemma":0.000002428591,"teacher_disagreement_score":0.895153,"about_ca_system_score_codex":0.000632308,"about_ca_system_score_gemma":0.00046261694,"threshold_uncertainty_score":0.9999406},"labels":[],"label_agreement":null},{"id":"W4400080240","doi":"10.1001/jamaoncol.2024.1841","title":"Long-Term Prospective Outcomes of Intensity Modulated Radiotherapy for Locally Advanced Lung Cancer","year":2024,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"National Cancer Institute","keywords":"Medicine; Common Terminology Criteria for Adverse Events; Chemoradiotherapy; Lung cancer; Radiation therapy; Hazard ratio; Internal medicine; Prospective cohort study; Oncology; Pneumonitis; Univariate analysis; Carboplatin; Multivariate analysis; Chemotherapy; Lung; Confidence interval","score_opus":0.013806438506688508,"score_gpt":0.3746829165921156,"score_spread":0.3608764780854271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400080240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9719259,0.009733126,0.0015850978,0.0131162135,0.0011543387,0.001967874,0.000057816254,0.000101061094,0.00035858442],"genre_scores_gemma":[0.99418366,0.0013996732,0.0013435078,0.001295555,0.0002017938,0.00075937307,0.000024719431,0.00003319967,0.00075852824],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99906236,0.000019235351,0.00025672672,0.0003347946,0.000110632194,0.00021627244],"domain_scores_gemma":[0.9992122,0.00020028967,0.00007438787,0.00018953889,0.00024730407,0.00007624861],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009622814,0.00015514325,0.0006227223,0.00008600819,0.0000283527,0.000010453828,0.000055296812,0.00015302747,0.0001342125],"category_scores_gemma":[0.00004045497,0.00011005413,0.00018465037,0.00013603264,0.000080188096,0.00006434772,0.000019590612,0.00013269087,0.0000023247094],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019156085,0.00056977733,0.84710085,0.00059193623,0.0024407054,0.00017308012,0.0007536297,0.00007186024,0.0020410602,0.00035181595,0.003733919,0.14025578],"study_design_scores_gemma":[0.007209963,0.0022762052,0.976439,0.0005100687,0.0005627347,0.00003637723,0.00002576033,0.0026693803,0.0066652587,0.00011766697,0.0033607332,0.00012685984],"about_ca_topic_score_codex":0.00012746794,"about_ca_topic_score_gemma":0.0002454205,"teacher_disagreement_score":0.14012893,"about_ca_system_score_codex":0.0018847977,"about_ca_system_score_gemma":0.00043060526,"threshold_uncertainty_score":0.49286804},"labels":[],"label_agreement":null},{"id":"W4400192544","doi":"10.1001/jamaoncol.2024.3196","title":"Fluorine-18 Prostate-Specific Membrane Antigen–1007 PET/CT vs Multiparametric MRI for Locoregional Staging of Prostate Cancer","year":2024,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Prostate Cancer Canada; University of Calgary; University of Alberta","funders":"","keywords":"Medicine; Prostate cancer; Glutamate carboxypeptidase II; Prostate; Prostate-specific antigen; Multiparametric MRI; Nuclear medicine; Cancer; Urology; Radiology; Oncology; Internal medicine","score_opus":0.05833779788555239,"score_gpt":0.38914261966567226,"score_spread":0.3308048217801199,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400192544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95953774,0.019765876,0.00016535251,0.011921165,0.0015015589,0.004348527,0.0005056884,0.0001909635,0.00206313],"genre_scores_gemma":[0.95950574,0.02115403,0.003436768,0.00034039782,0.00073880405,0.0014485111,0.00040282187,0.00010987729,0.012863058],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973893,0.00008661923,0.0005674873,0.00069887197,0.00047924247,0.0007784819],"domain_scores_gemma":[0.99811876,0.0006769654,0.00013969687,0.0003297803,0.00048417237,0.0002506557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060768344,0.00030492299,0.0007367923,0.00073812157,0.00012265769,0.000056492772,0.00017182172,0.000064039545,0.0005081383],"category_scores_gemma":[0.000100204896,0.00023017306,0.00024392689,0.0011188441,0.0003764037,0.00018322196,0.00009432712,0.00048086714,0.000049475926],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03379959,0.002847823,0.129108,0.010940343,0.002830823,0.016496044,0.004796938,0.00064740254,0.073861465,0.003201502,0.25410402,0.46736607],"study_design_scores_gemma":[0.0108564915,0.0031313747,0.0074259555,0.00065162167,0.00018837878,0.0005475598,0.00058844057,0.005105528,0.06452223,0.00023474602,0.906397,0.0003507181],"about_ca_topic_score_codex":0.00027869342,"about_ca_topic_score_gemma":0.000033641154,"teacher_disagreement_score":0.65229297,"about_ca_system_score_codex":0.00085978705,"about_ca_system_score_gemma":0.0015421242,"threshold_uncertainty_score":0.9386185},"labels":[],"label_agreement":null},{"id":"W4400775048","doi":"10.1001/jamaoncol.2024.2156","title":"Neoadjuvant Exercise Therapy in Prostate Cancer","year":2024,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; Prostate cancer; Neoadjuvant therapy; Cancer; Internal medicine; Physical therapy; Urology; Oncology; Breast cancer","score_opus":0.024639205550594956,"score_gpt":0.33112161825445274,"score_spread":0.3064824127038578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400775048","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0112911165,0.033812396,4.165957e-7,0.9354688,0.005636104,0.0010640613,0.00013775742,0.00011715246,0.012472181],"genre_scores_gemma":[0.0036701437,0.023768015,0.000021697224,0.9204213,0.007741526,0.0012673413,0.00035920247,0.00013809915,0.042612657],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997977,0.0001088187,0.00041142807,0.000630048,0.00031154303,0.00056111836],"domain_scores_gemma":[0.9991595,0.00010750855,0.00011300195,0.0004255636,0.00011271863,0.000081702565],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0002134782,0.00035788544,0.0009990081,0.00037088364,0.000021204072,0.000037965292,0.00017187026,0.0013314771,0.0011926179],"category_scores_gemma":[0.000016139946,0.00028404198,0.00022653902,0.00035136583,0.00010467515,0.000044193835,0.00007300469,0.003483987,0.0002666533],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000412891,0.000038251437,0.0006993692,0.0004412328,0.00006258949,0.009988242,0.0018556416,6.162906e-7,0.000030013918,0.000003524977,0.70648736,0.27998024],"study_design_scores_gemma":[0.0019502672,0.0006498351,0.00093907607,0.0012094378,0.0001318718,0.00013046809,0.0001564427,0.0000109755465,0.000083640894,0.00022257099,0.99423385,0.00028159653],"about_ca_topic_score_codex":0.0060238885,"about_ca_topic_score_gemma":0.0053191604,"teacher_disagreement_score":0.28774646,"about_ca_system_score_codex":0.0009973656,"about_ca_system_score_gemma":0.0013257196,"threshold_uncertainty_score":0.999965},"labels":[],"label_agreement":null},{"id":"W4400978609","doi":"10.1001/jamaoncol.2024.2212","title":"Bilateral Mastectomy and Breast Cancer Mortality","year":2024,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Mastectomy; Oncology; MEDLINE; Cancer; Internal medicine; General surgery","score_opus":0.016948588401975766,"score_gpt":0.3093466901121295,"score_spread":0.29239810171015373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400978609","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07307522,0.0075325025,0.0000043342666,0.9121717,0.0017945137,0.00030827156,0.0018727026,0.00005306579,0.003187676],"genre_scores_gemma":[0.061094817,0.003350063,0.00018609676,0.9040393,0.022336839,0.0007176914,0.0014459529,0.00017744968,0.006651785],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99825835,0.000109178276,0.00024615997,0.0008141535,0.00013924463,0.00043289474],"domain_scores_gemma":[0.99933803,0.000027756889,0.00011421753,0.00037415783,0.00008779358,0.00005805958],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.000085615866,0.00040517483,0.0004767659,0.0000738535,0.000067401634,0.000053245865,0.00017509694,0.0013463221,0.0001362588],"category_scores_gemma":[0.000010245887,0.0003330062,0.00014376263,0.000073418814,0.00026024028,0.0000037714851,0.0003887123,0.000771589,0.000041874533],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007415255,0.000027456144,0.008047346,0.00020411026,0.0010059519,0.0005877215,0.000056718232,7.012407e-7,0.00079915964,0.000005550962,0.97694343,0.012247669],"study_design_scores_gemma":[0.000706917,0.00013196182,0.035560742,0.000060766848,0.00036405292,0.00062954106,0.000013638916,0.0000024043413,0.00031690838,0.000110002446,0.9617675,0.00033559848],"about_ca_topic_score_codex":0.0006938176,"about_ca_topic_score_gemma":0.00044251923,"teacher_disagreement_score":0.027513394,"about_ca_system_score_codex":0.00017408463,"about_ca_system_score_gemma":0.0002750942,"threshold_uncertainty_score":0.9999501},"labels":[],"label_agreement":null},{"id":"W4401214160","doi":"10.1001/jamaoncol.2024.2491","title":"Recurrence of Non–Small Cell Lung Cancer With Visceral Pleural Invasion","year":2024,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre Hospitalier de l’Université de Montréal; Surrey Memorial Hospital; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"National Cancer Institute","keywords":"Medicine; Hazard ratio; Lung cancer; Surgery; Proportional hazards model; Randomized controlled trial; Prophylactic cranial irradiation; Internal medicine; Confidence interval; Conventional PCI","score_opus":0.022005999673415263,"score_gpt":0.32201593246549237,"score_spread":0.3000099327920771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401214160","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09374867,0.007287752,0.000012000531,0.87829155,0.0022707677,0.0015395379,0.00022456619,0.00006019297,0.01656494],"genre_scores_gemma":[0.08682265,0.0060217334,0.0018103984,0.87064916,0.011148453,0.0018910462,0.0010151655,0.00024268322,0.020398682],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99813783,0.00007754571,0.0004008548,0.00064213376,0.0003150113,0.0004266161],"domain_scores_gemma":[0.998798,0.00021505854,0.00028977668,0.00042294624,0.00017734645,0.00009684526],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00010269512,0.00038045837,0.0009776736,0.00019226292,0.000032530526,0.000021507894,0.00016630194,0.0008988819,0.00045264457],"category_scores_gemma":[0.000012512565,0.0002531562,0.00019911381,0.00020289033,0.00012529567,0.000039057035,0.000102712045,0.0016757093,0.000050354076],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027392767,0.00021044204,0.020798493,0.0037130655,0.00043812752,0.0036393066,0.00040871938,0.0000052151822,0.000058003447,0.000003881314,0.9616465,0.0088043185],"study_design_scores_gemma":[0.0035916576,0.0033803456,0.007402411,0.0038944855,0.0024271826,0.00017572899,0.000027024544,0.0001369528,0.0014013578,0.000014061297,0.97724324,0.00030552348],"about_ca_topic_score_codex":0.0013205981,"about_ca_topic_score_gemma":0.0006724794,"teacher_disagreement_score":0.015596769,"about_ca_system_score_codex":0.0016813123,"about_ca_system_score_gemma":0.0017167275,"threshold_uncertainty_score":0.9999921},"labels":[],"label_agreement":null},{"id":"W4401611660","doi":"10.1001/jamaoncol.2024.3044","title":"Breast Cancer Index in Premenopausal Women With Early-Stage Hormone Receptor–Positive Breast Cancer","year":2024,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Oncology; Tamoxifen; Internal medicine; Exemestane; Cancer; Population; Gynecology; Letrozole","score_opus":0.006700657720811611,"score_gpt":0.27272006821835565,"score_spread":0.266019410497544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401611660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853226,0.0036821635,0.000038585727,0.0066803102,0.00038181507,0.0003726904,0.0018983715,0.000049573227,0.0015739052],"genre_scores_gemma":[0.99417794,0.0018584239,0.00006733823,0.00059484964,0.0008444228,0.0011939027,0.00007228271,0.00006388622,0.0011269539],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980768,0.00011725466,0.0002516657,0.0007257912,0.00018524069,0.0006432504],"domain_scores_gemma":[0.99934584,0.000035505273,0.00008707959,0.00025509397,0.00013800175,0.00013847699],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015421363,0.00033729512,0.00037716783,0.000110759545,0.00008076909,0.00005282129,0.00019115393,0.0003155685,0.00031745963],"category_scores_gemma":[0.000005066202,0.00027531653,0.00004299674,0.00031823016,0.00023806863,0.000023070643,0.00018802349,0.00030254727,0.000025937301],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024822561,0.0012485334,0.47882167,0.00023760027,0.003941714,0.00069693325,0.007347761,0.0005514061,0.14250095,0.00025149542,0.025319925,0.31425944],"study_design_scores_gemma":[0.0028152987,0.000890269,0.960112,0.00013725241,0.0000662357,0.0002458201,0.0005379376,0.000025939458,0.001949934,0.000018192453,0.032783747,0.00041738147],"about_ca_topic_score_codex":0.0051354207,"about_ca_topic_score_gemma":0.005525723,"teacher_disagreement_score":0.48129034,"about_ca_system_score_codex":0.0011441313,"about_ca_system_score_gemma":0.00070020097,"threshold_uncertainty_score":0.9999699},"labels":[],"label_agreement":null},{"id":"W4402269149","doi":"10.1001/jamaoncol.2024.3645","title":"Inpatient Care and Outcomes Among People With Cancer Experiencing Homelessness","year":2024,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Homelessness and Social Issues","field":"Health Professions","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Medicine; Propensity score matching; Context (archaeology); Cohort; Odds; Odds ratio; Logistic regression; Cancer; Acute care; Retrospective cohort study; Inpatient care; Emergency medicine; Health care; Demography; Family medicine; Internal medicine","score_opus":0.025883592885836065,"score_gpt":0.4118331775147838,"score_spread":0.38594958462894774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402269149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874722,0.003066818,0.000040956267,0.00054535584,0.0014262665,0.00046373392,0.000023129758,0.000150313,0.006811273],"genre_scores_gemma":[0.99776256,0.00046010438,0.00007388779,0.00020066221,0.00032998712,0.00077122316,0.000011943847,0.000034955632,0.00035469094],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.99858147,0.0002531075,0.000276778,0.00031008708,0.00015933519,0.00041924196],"domain_scores_gemma":[0.9990178,0.00048620277,0.00008200782,0.00013820433,0.00015035224,0.00012543888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016290389,0.00015770117,0.00059090153,0.00009446386,0.00044929824,0.000033363583,0.000096722855,0.00031348088,0.00038480293],"category_scores_gemma":[0.000036597077,0.00010939042,0.00003681992,0.00023173649,0.00010733436,0.00019011062,0.00011979509,0.00049085607,0.000028761788],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016842127,0.000011434056,0.55657756,0.00033240917,0.000023352339,0.000028326782,0.40177658,0.0000027201336,0.0000056658528,0.00085503503,0.000048818485,0.040321212],"study_design_scores_gemma":[0.00045316035,0.0001512662,0.46068895,0.00022832477,0.000025741016,1.8339746e-7,0.51938015,0.00004250634,0.000013378951,0.000041431453,0.018848076,0.00012682252],"about_ca_topic_score_codex":0.01236982,"about_ca_topic_score_gemma":0.23694554,"teacher_disagreement_score":0.22457573,"about_ca_system_score_codex":0.00045238572,"about_ca_system_score_gemma":0.0005246303,"threshold_uncertainty_score":0.9942069},"labels":[],"label_agreement":null},{"id":"W4402638354","doi":"10.1001/jamaoncol.2024.3089","title":"Stereotactic vs Hypofractionated Radiotherapy for Inoperable Stage I Non–Small Cell Lung Cancer","year":2024,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Hôpital Charles-Le Moyne; Western University; University of Alberta; University of Calgary; Centre Hospitalier de l’Université de Montréal; Saint John Regional Hospital; Hôpital Notre-Dame; NOSM University; Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Saskatchewan Cancer Agency; CancerCare Manitoba; Windsor Regional Hospital; Hôpital Maisonneuve-Rosemont; Juravinski Cancer Centre; University of Manitoba; University of Saskatchewan; Queen's University; McMaster University; Dalhousie University; Hamilton Health Sciences; Kingston Health Sciences Centre; McGill University Health Centre","funders":"","keywords":"Medicine; Stage (stratigraphy); Radiation therapy; Oncology; Lung cancer; Cancer; Stereotactic radiotherapy; Radiosurgery; Internal medicine; Radiology","score_opus":0.019904746270256672,"score_gpt":0.3522619082532794,"score_spread":0.33235716198302273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402638354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91555035,0.02219457,0.0008103586,0.043951146,0.0033644096,0.0028254609,0.00015767636,0.00022047885,0.010925568],"genre_scores_gemma":[0.9295921,0.007508205,0.0029391253,0.010914213,0.0014970568,0.0028223053,0.00009773658,0.00010333454,0.04452592],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989208,0.000039584105,0.00023078345,0.00038667885,0.00010770286,0.00031446156],"domain_scores_gemma":[0.99909204,0.0004094471,0.00006049097,0.0002083688,0.00010486264,0.00012481575],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015376689,0.00017377322,0.0003859278,0.00011969573,0.00007375525,0.00005536083,0.00006246162,0.00019756437,0.0013526286],"category_scores_gemma":[0.00001711009,0.00013532455,0.00013529068,0.00016176257,0.000028561564,0.00014259084,0.000015571348,0.0002382374,0.000033194305],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004949923,0.0036174455,0.09980318,0.0056684343,0.0051552886,0.001807508,0.003455886,0.00051720365,0.019516118,0.0012395043,0.5975956,0.2566739],"study_design_scores_gemma":[0.0061589144,0.0018505281,0.0107519515,0.00020649454,0.00055585284,0.00004707105,0.000076271055,0.008660958,0.005497861,0.000015136472,0.96602136,0.00015762997],"about_ca_topic_score_codex":0.0008098506,"about_ca_topic_score_gemma":0.00023539057,"teacher_disagreement_score":0.36842573,"about_ca_system_score_codex":0.0025936111,"about_ca_system_score_gemma":0.0009312055,"threshold_uncertainty_score":0.9995603},"labels":[],"label_agreement":null},{"id":"W4402859895","doi":"10.1001/jamaoncol.2024.4214","title":"Meta-Analysis Methods for Neoadjuvant Chemoimmunotherapy for Non–Small Cell Lung Cancer—Reply","year":2024,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Chemoimmunotherapy; Neoadjuvant therapy; Lung cancer; Oncology; Meta-analysis; Internal medicine; Cancer; Immunotherapy; Breast cancer","score_opus":0.08003539863057527,"score_gpt":0.4520882897463271,"score_spread":0.3720528911157518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402859895","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018021481,0.34259328,0.4167827,0.19751354,0.003605719,0.0123312585,0.0008924533,0.00043968912,0.007819893],"genre_scores_gemma":[0.122182764,0.009543712,0.7374361,0.04454619,0.0023529457,0.046776135,0.0005668737,0.00032037077,0.036274873],"study_design_codex":"meta_analysis","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982447,0.00009612247,0.00047832038,0.00065584126,0.00010463928,0.0004203469],"domain_scores_gemma":[0.9974287,0.0016438311,0.00014072865,0.00045443123,0.00020399163,0.00012830003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009098828,0.00028129353,0.001692726,0.0002495368,0.0000844934,0.00005700564,0.00013341941,0.0002195129,0.00081300206],"category_scores_gemma":[0.00003926825,0.0001930832,0.0023823262,0.000423206,0.00004194441,0.000051699135,0.000029306848,0.00016332249,0.000007679748],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012490969,0.0010851943,0.0011396371,0.0017266362,0.5305175,0.00008285797,0.0021013382,0.00019896633,0.0054658935,0.00072720944,0.08129045,0.3744152],"study_design_scores_gemma":[0.0032211987,0.0012186375,0.00039225945,0.000018793411,0.35706574,0.000008687711,0.000053826003,0.013986823,0.015239141,0.00019497427,0.60843086,0.00016905779],"about_ca_topic_score_codex":0.0005859664,"about_ca_topic_score_gemma":0.00026852803,"teacher_disagreement_score":0.5271404,"about_ca_system_score_codex":0.0011208709,"about_ca_system_score_gemma":0.0006695291,"threshold_uncertainty_score":0.89018023},"labels":[],"label_agreement":null},{"id":"W4403097507","doi":"10.1001/jamaoncol.2024.4318","title":"Fracture Risk Prediction Using the Fracture Risk Assessment Tool in Individuals With Cancer","year":2024,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba; University of Manitoba; University of Alberta","funders":"Medical Research Council","keywords":"Medicine; FRAX; Hip fracture; Cohort; Cohort study; Population; Internal medicine; Retrospective cohort study; Cancer; Cancer registry; Bone mineral; Osteoporosis; Physical therapy; Osteoporotic fracture; Environmental health","score_opus":0.024422698011788185,"score_gpt":0.4089161564127661,"score_spread":0.38449345840097787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403097507","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95105207,0.00353779,0.0010128433,0.041362368,0.00044119745,0.0012661589,0.00018039098,0.00007624271,0.0010709474],"genre_scores_gemma":[0.98723197,0.0026308373,0.0015229176,0.007096817,0.00096038653,0.00024751452,0.000049195183,0.00003394496,0.00022639202],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978244,0.0004845107,0.0003552675,0.00037267993,0.0004944077,0.0004687549],"domain_scores_gemma":[0.9986986,0.00061988767,0.0001421984,0.00029397898,0.00011919692,0.00012611797],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0014350043,0.00016683295,0.00035644774,0.00019974195,0.00019560763,0.000071687966,0.000103143226,0.00048091103,0.00066620315],"category_scores_gemma":[0.00021110736,0.000091158516,0.00005959723,0.00048167893,0.00011343279,0.00015822027,0.000049961785,0.0027534005,0.000014457543],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030315723,0.00017724247,0.8767182,0.00019292712,0.00015934465,0.00016072055,0.0017000248,0.0016403372,0.00011276313,0.000025744603,0.029718133,0.08909137],"study_design_scores_gemma":[0.0014682749,0.0007666267,0.58613664,0.000208113,0.0001685854,0.0001171633,0.00043920559,0.0074645965,0.000047977217,0.0001378735,0.40297413,0.00007081905],"about_ca_topic_score_codex":0.004910643,"about_ca_topic_score_gemma":0.0017138777,"teacher_disagreement_score":0.373256,"about_ca_system_score_codex":0.0009928764,"about_ca_system_score_gemma":0.0025045548,"threshold_uncertainty_score":0.9995473},"labels":[],"label_agreement":null},{"id":"W4403097680","doi":"10.1001/jamaoncol.2024.4330","title":"Biomarkers to Inform Prognosis and Treatment for Unresectable or Metastatic GEP-NENs","year":2024,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Ottawa; Lawson Health Research Institute; University of Toronto; Western University; Fluidigm (Canada); Princess Margaret Cancer Centre; University of Calgary; Impact; University of British Columbia; Ottawa Hospital; BC Cancer Agency","funders":"","keywords":"Medicine; MEDLINE; Neuroendocrine tumors; Grading (engineering); Randomized controlled trial; Evidence-based medicine; Internal medicine; Oncology; Intensive care medicine; Family medicine; Alternative medicine; Pathology","score_opus":0.08450052173136242,"score_gpt":0.43317302473165814,"score_spread":0.34867250300029573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403097680","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8131393,0.0033455496,0.00035123833,0.15950611,0.0007594008,0.009600275,0.0002153389,0.00042096616,0.012661819],"genre_scores_gemma":[0.89130473,0.0018091999,0.05044076,0.005331374,0.0006290596,0.0074354163,0.000095082694,0.0001422678,0.042812105],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99878776,0.00004147266,0.00021764287,0.00032219273,0.00015824185,0.0004726626],"domain_scores_gemma":[0.99848115,0.00095992174,0.000024193,0.00015192614,0.00008036341,0.00030244127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015699287,0.00014984926,0.00035477063,0.00029387834,0.000069643946,0.000057425153,0.00006216735,0.000014308549,0.00018341123],"category_scores_gemma":[0.00070496777,0.00009460139,0.000069405614,0.0004032698,0.000082336715,0.00013744821,0.00006635121,0.0001000618,0.000064749],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008806085,0.0006829615,0.0017393132,0.0013003316,0.0011290829,0.013240963,0.0006112984,0.0000066869598,0.0067861257,0.00082675664,0.16440246,0.80046797],"study_design_scores_gemma":[0.002865512,0.016206136,0.0006135926,0.00007425602,0.00016670993,0.0013610128,0.0002632952,0.0005777273,0.006895555,0.00016217094,0.9707202,0.00009387946],"about_ca_topic_score_codex":0.000091372116,"about_ca_topic_score_gemma":0.00072947313,"teacher_disagreement_score":0.8063177,"about_ca_system_score_codex":0.00037283465,"about_ca_system_score_gemma":0.00048559622,"threshold_uncertainty_score":0.38577327},"labels":[],"label_agreement":null},{"id":"W4403097762","doi":"10.1001/jamaoncol.2024.4327","title":"Ensuring Safety and Consistency in Artificial Intelligence Chatbot Responses—Reply","year":2024,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Chatbot; Medicine; Consistency (knowledge bases); Natural language processing; Artificial intelligence; Computer science","score_opus":0.18665603076798565,"score_gpt":0.4587237640772963,"score_spread":0.27206773330931067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403097762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90189123,0.0031595647,0.0009989938,0.08414653,0.0018154077,0.0004864127,0.0000059703434,0.00011466311,0.007381196],"genre_scores_gemma":[0.9945643,0.0010046135,0.0006297646,0.0026847073,0.0005862356,0.000030989144,0.000008299035,0.000015999292,0.00047509876],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983819,0.00016588166,0.00066848105,0.0003633261,0.000118809905,0.00030156792],"domain_scores_gemma":[0.99828935,0.0012420198,0.00004753497,0.00019000625,0.00009334636,0.00013777391],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011872603,0.000114141134,0.00028436788,0.0003090689,0.0000829759,0.000039984625,0.000052389467,0.00021158149,0.00020931104],"category_scores_gemma":[0.0012156287,0.00010687607,0.000045440607,0.00035995914,0.0001888981,0.00010945234,0.00003842105,0.00047073758,0.00018242082],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010783188,0.00011461348,0.004061856,0.00017032807,0.000014946487,0.00042338108,0.005487019,0.000008226674,0.0013272576,0.018447172,0.00030414917,0.9685627],"study_design_scores_gemma":[0.00024635924,0.0056020166,0.086580016,0.0023194544,0.00022370632,0.0035844697,0.039284036,0.029530508,0.039338905,0.100013345,0.6922763,0.0010009009],"about_ca_topic_score_codex":0.0007875083,"about_ca_topic_score_gemma":0.0006414374,"teacher_disagreement_score":0.96756184,"about_ca_system_score_codex":0.00035260315,"about_ca_system_score_gemma":0.0008263854,"threshold_uncertainty_score":0.43582797},"labels":[],"label_agreement":null},{"id":"W4403299266","doi":"10.1001/jamaoncol.2024.4376","title":"Endometrial Cancer Classification and Management in the Molecular Subtyping Era","year":2024,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Subtyping; Endometrial biopsy; Endometrial cancer; POSTMENOPAUSAL BLEEDING; Adenocarcinoma; Biopsy; Gynecology; Vaginal bleeding; Oncology; Internal medicine; Cancer; Pregnancy","score_opus":0.04884621008771139,"score_gpt":0.3767754390035115,"score_spread":0.3279292289158001,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403299266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84898114,0.021383783,0.00018359892,0.06403203,0.0010958688,0.0012890815,0.000009313618,0.00006261659,0.06296256],"genre_scores_gemma":[0.99284613,0.0034230752,0.00027383375,0.0026350117,0.00031491264,0.00028986772,0.00001127004,0.000008248295,0.000197667],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99925935,0.00009322196,0.00015763656,0.0002033484,0.000143339,0.00014311554],"domain_scores_gemma":[0.99954206,0.00027264556,0.000022014116,0.0001082801,0.000015887194,0.00003911811],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003144716,0.00007343026,0.00016527098,0.00023696605,0.000024085772,0.00003167592,0.00005420099,0.000081875965,0.000112994],"category_scores_gemma":[0.00006451929,0.000045515742,0.00004347768,0.0006803042,0.000036862417,0.00003946829,0.000026577798,0.0001895253,0.000019620707],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070411136,0.00017128495,0.0035701094,0.0001927218,0.0002192896,0.0009823617,0.00038596717,0.0000020900438,0.0019035235,0.027413238,0.0011299077,0.9633254],"study_design_scores_gemma":[0.012909385,0.0011230251,0.34823164,0.00021160574,0.0005690737,0.00012253289,0.00060995127,0.0006045276,0.00052259327,0.0024927964,0.63244784,0.00015501687],"about_ca_topic_score_codex":0.00016277847,"about_ca_topic_score_gemma":0.0000602196,"teacher_disagreement_score":0.96317035,"about_ca_system_score_codex":0.00027332306,"about_ca_system_score_gemma":0.00006323022,"threshold_uncertainty_score":0.1856078},"labels":[],"label_agreement":null},{"id":"W4403299677","doi":"10.1001/jamaoncol.2024.4354","title":"Ninth Version of the AJCC and UICC Nasopharyngeal Cancer TNM Staging Classification","year":2024,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Medicine; Nasopharyngeal carcinoma; Cancer; Stage (stratigraphy); AJCC staging system; Cancer staging; Internal medicine; Oncology; Radiation therapy; Staging system","score_opus":0.03465590052636265,"score_gpt":0.3610580777752746,"score_spread":0.32640217724891196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403299677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.927037,0.0068492633,0.000010020283,0.04734219,0.0009298348,0.00017292534,0.000014928492,0.000031749547,0.017612072],"genre_scores_gemma":[0.9959679,0.0016332445,0.00006641349,0.0009809143,0.0002515007,0.000022557299,0.0000026069804,0.000007605215,0.0010672173],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994793,0.00003990956,0.00012610616,0.00014790063,0.00009881635,0.00010798696],"domain_scores_gemma":[0.9996624,0.00011774764,0.000035017627,0.000101065634,0.000048410657,0.000035357814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014286129,0.000058737423,0.00019515392,0.000042728192,0.000057172936,0.000005791577,0.000038429862,0.00007423557,0.000095674906],"category_scores_gemma":[0.000046109613,0.0000369016,0.000036548427,0.00012908482,0.00012060136,0.000041075455,0.00005467201,0.00017445994,0.0000074770683],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004913898,0.000117278345,0.096934415,0.00080446556,0.00023206174,0.000052412706,0.0054071117,0.000002494685,0.073781155,0.0029214115,0.14288488,0.6763709],"study_design_scores_gemma":[0.0011814322,0.00047787288,0.42601702,0.0004077136,0.0001506194,0.000022660259,0.0007961195,0.001244355,0.0037917763,0.000098460696,0.56574845,0.00006353142],"about_ca_topic_score_codex":0.00015521776,"about_ca_topic_score_gemma":0.00008130053,"teacher_disagreement_score":0.6763074,"about_ca_system_score_codex":0.00019024123,"about_ca_system_score_gemma":0.0002662059,"threshold_uncertainty_score":0.15048036},"labels":[],"label_agreement":null},{"id":"W4403485115","doi":"10.1001/jamaoncol.2024.4381","title":"Lenvatinib Plus Ifosfamide and Etoposide in Children and Young Adults With Relapsed Osteosarcoma","year":2024,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; Ifosfamide; Lenvatinib; Internal medicine; Etoposide; Clinical endpoint; Oncology; Response Evaluation Criteria in Solid Tumors; Clinical trial; Surgery; Phases of clinical research; Chemotherapy; Cancer","score_opus":0.008763653281383671,"score_gpt":0.26912362336592016,"score_spread":0.2603599700845365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403485115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97862136,0.010182219,0.0000033813612,0.007541623,0.000086547516,0.0006225121,0.000012074496,0.00006223513,0.0028680405],"genre_scores_gemma":[0.996611,0.0013268536,0.0008068571,0.0007523162,0.00010606069,0.00011535853,0.000041978616,0.00002526488,0.00021430996],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998959,0.000063059735,0.00021177655,0.00039128916,0.00011382524,0.00026103194],"domain_scores_gemma":[0.9994171,0.00025863785,0.000034317094,0.0001544616,0.000023744742,0.000111707755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016093176,0.00016084561,0.00036544126,0.00015827718,0.000035572506,0.00003299067,0.000033862078,0.00016862316,0.000023205892],"category_scores_gemma":[0.000055293174,0.00011399548,0.000029151695,0.00016035076,0.00011510891,0.000080200785,0.00005355488,0.00029216762,0.000015676635],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068766315,0.00021075898,0.85898745,0.000060196013,0.00014579642,0.0017716989,0.0011637597,5.5640817e-7,0.000071169576,0.0009052375,0.0011176191,0.13487811],"study_design_scores_gemma":[0.009252315,0.0018360111,0.98119503,0.00041655268,0.00015240033,0.003938786,0.00029998098,0.00018217969,0.00017132236,0.000196418,0.0022387237,0.00012028337],"about_ca_topic_score_codex":0.00084803684,"about_ca_topic_score_gemma":0.0012675191,"teacher_disagreement_score":0.13475783,"about_ca_system_score_codex":0.00021295807,"about_ca_system_score_gemma":0.00017276783,"threshold_uncertainty_score":0.46486005},"labels":[],"label_agreement":null},{"id":"W4403940424","doi":"10.1001/jamaoncol.2024.4899","title":"metastatic","year":2024,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Organometallic Complex Synthesis and Catalysis","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine","score_opus":0.025878173892400845,"score_gpt":0.2974916556019802,"score_spread":0.2716134817095794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403940424","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19604301,0.0038088558,0.00031530534,0.005833535,0.0003169078,0.000031391788,0.00003545635,0.00032066662,0.79329485],"genre_scores_gemma":[0.96435136,0.00006886432,0.00070045836,0.00027280202,0.0003471678,0.000030318852,0.000025280993,0.000024063238,0.034179684],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999318,0.000019323375,0.00016995668,0.00022522963,0.000096650474,0.00017085887],"domain_scores_gemma":[0.999374,0.0003132188,0.000023313129,0.00021669273,0.000014926257,0.000057901467],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00014699294,0.00008960558,0.00019932548,0.00006212362,0.00003304245,0.000069407564,0.00015407018,0.00006714014,0.13106233],"category_scores_gemma":[0.0000735942,0.00007475036,0.00012860159,0.00016058552,0.00004544423,0.000071224036,0.000060618786,0.00014767643,0.001318986],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007526474,0.0000773162,0.000022170854,0.00013046282,0.0002338537,0.00022022476,0.000205072,0.0000014193755,0.06464135,0.009028747,0.006607211,0.9188247],"study_design_scores_gemma":[0.000099719,0.00001748649,0.000059486538,0.000013219885,0.00012070272,0.00006938457,0.00015735834,0.00059371535,0.0078167785,0.0015728705,0.9893885,0.00009074008],"about_ca_topic_score_codex":0.000020729298,"about_ca_topic_score_gemma":0.000017465401,"teacher_disagreement_score":0.98278135,"about_ca_system_score_codex":0.00010885254,"about_ca_system_score_gemma":0.000092504204,"threshold_uncertainty_score":0.9994586},"labels":[],"label_agreement":null},{"id":"W4405062157","doi":"10.1001/jamaoncol.2024.5381","title":"Estimation of Cancer Deaths Averted From Prevention, Screening, and Treatment Efforts, 1975-2020","year":2024,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Breast cancer; Cervical cancer; Colorectal cancer; Cancer prevention; Cancer; Population; Prostate cancer; Psychological intervention; Cancer registry; Gynecology; Oncology; Internal medicine; Environmental health","score_opus":0.058527763615800234,"score_gpt":0.3975389296846087,"score_spread":0.33901116606880843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405062157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799072,0.010162543,0.0035065645,0.003068179,0.00025047112,0.00034006938,0.00005036929,0.00006929324,0.0026452916],"genre_scores_gemma":[0.990199,0.0009820183,0.006976949,0.00038287378,0.00026384622,0.00006670679,0.00009964314,0.000011709822,0.0010172297],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992012,0.000036096935,0.0002451858,0.00023878601,0.00013938647,0.00013938261],"domain_scores_gemma":[0.99957454,0.00010169003,0.000068028974,0.00011771223,0.000052646894,0.00008536754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000104252766,0.000107277694,0.00029569183,0.00006038909,0.00003380178,0.000016895141,0.000035203528,0.00014038783,0.00038028933],"category_scores_gemma":[0.000045968452,0.000085911306,0.00007292142,0.00014186424,0.000056195157,0.000105411586,0.000024736146,0.00009733452,0.000010396509],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033542924,0.00006162051,0.022526331,0.000053172513,0.00028004765,0.00016327371,0.000469226,0.00015690655,0.00083416887,0.00035447167,0.0053846417,0.96938074],"study_design_scores_gemma":[0.007300024,0.006628544,0.39257738,0.0022241122,0.0021129255,0.00026202764,0.00044409416,0.12457464,0.0085432185,0.002242944,0.45273772,0.000352368],"about_ca_topic_score_codex":0.0048661395,"about_ca_topic_score_gemma":0.0012822951,"teacher_disagreement_score":0.96902835,"about_ca_system_score_codex":0.00022700075,"about_ca_system_score_gemma":0.00029820783,"threshold_uncertainty_score":0.735618},"labels":[],"label_agreement":null},{"id":"W4405566423","doi":"10.1001/jamaoncol.2024.5403","title":"Stereotactic Body Radiotherapy vs Sorafenib Alone in Hepatocellular Carcinoma","year":2024,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Princess Margaret Cancer Centre; Hamilton Health Sciences; University Health Network; University of Toronto; Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute","keywords":"Medicine; Sorafenib; Hepatocellular carcinoma; Internal medicine; Clinical endpoint; Hazard ratio; Adverse effect; Oncology; Randomized controlled trial; Liver function; Progression-free survival; Radiation therapy; Confidence interval; Chemotherapy","score_opus":0.04433366409207469,"score_gpt":0.2965384348592674,"score_spread":0.2522047707671927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405566423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9678896,0.013249886,0.000076292665,0.012367366,0.0006203214,0.0009582332,0.000013004084,0.00019317308,0.004632137],"genre_scores_gemma":[0.9942861,0.00052331627,0.0006886196,0.0014561623,0.0005940892,0.00020011285,0.00011954171,0.00007689609,0.002055113],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99789846,0.0002503587,0.0004725321,0.0005786519,0.0002478332,0.00055217725],"domain_scores_gemma":[0.99896413,0.00028745484,0.000058172576,0.0004016838,0.000054968004,0.00023358368],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00046580745,0.00030500576,0.00073376385,0.00047470906,0.00005086971,0.00007060088,0.00012832222,0.0004318725,0.00094754976],"category_scores_gemma":[0.000048022914,0.0002622822,0.00025393986,0.00054460013,0.00009931013,0.00017825283,0.00004275129,0.0005724059,0.00038635996],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008753068,0.0005300072,0.9329866,0.00024736614,0.00026486313,0.024252469,0.0011014475,2.1294385e-7,0.008159758,0.00041873564,0.004882605,0.026280632],"study_design_scores_gemma":[0.0116944015,0.005376505,0.18440543,0.00028938812,0.0005663768,0.002446215,0.00016080654,0.050762966,0.01103128,0.00032956648,0.7323443,0.0005927134],"about_ca_topic_score_codex":0.00039616114,"about_ca_topic_score_gemma":0.00005086498,"teacher_disagreement_score":0.7485812,"about_ca_system_score_codex":0.0008398067,"about_ca_system_score_gemma":0.00054503453,"threshold_uncertainty_score":0.99998295},"labels":[],"label_agreement":null},{"id":"W4405615932","doi":"10.1001/jamaoncol.2024.5661","title":"Government Funding for the Development of Enzalutamide","year":2024,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Enzalutamide; Medicine; Government (linguistics); Drug development; Family medicine; Cancer; Drug; Prostate cancer; Pharmacology; Internal medicine","score_opus":0.07835133754982908,"score_gpt":0.40447987717722983,"score_spread":0.32612853962740074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405615932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87188905,0.017216103,0.0073347995,0.051034544,0.00185179,0.0027085163,0.000051324285,0.00010376088,0.047810115],"genre_scores_gemma":[0.9859331,0.00019662609,0.004239834,0.00028223183,0.00023587752,0.0002734208,0.000010116571,0.00001295073,0.008815837],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993479,0.000014739644,0.00015851829,0.00011646279,0.00018862066,0.00017375224],"domain_scores_gemma":[0.99924845,0.00056455756,0.000022388818,0.00009017523,0.000032257398,0.00004215626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004149746,0.000054894772,0.00013285218,0.000025819863,0.00005916122,0.0000101124115,0.000055911514,0.00005788092,0.00008383571],"category_scores_gemma":[0.000064784836,0.000029401019,0.00005581963,0.000081005404,0.0000546003,0.000022233302,0.000042985463,0.00010043771,0.000017709319],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084882684,0.00013463982,0.0011780491,0.00043129962,0.0004959508,0.00004647991,0.0027352,0.0000020366172,0.026533693,0.0027446179,0.014411956,0.95043725],"study_design_scores_gemma":[0.0013380453,0.0005361795,0.0074666296,0.00010396587,0.00008676106,0.000016179756,0.00084451056,0.0005140071,0.0382956,0.00018106007,0.9505776,0.00003946033],"about_ca_topic_score_codex":0.000003970751,"about_ca_topic_score_gemma":0.000019113844,"teacher_disagreement_score":0.9503978,"about_ca_system_score_codex":0.0007054776,"about_ca_system_score_gemma":0.00056463666,"threshold_uncertainty_score":0.18447994},"labels":[],"label_agreement":null},{"id":"W4405989572","doi":"10.1001/jamaoncol.2024.5627","title":"Transplant-Free Approach in Relapsed Hodgkin Lymphoma in Children, Adolescents, and Young Adults","year":2025,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Medicine; Brentuximab vedotin; Bendamustine; Internal medicine; Nivolumab; Oncology; Young adult; Cohort; Pediatrics; Hodgkin lymphoma; Cancer; Lymphoma; Rituximab","score_opus":0.008159520686991968,"score_gpt":0.2401589212079284,"score_spread":0.23199940052093643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405989572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.61526245,0.003326127,0.000004550674,0.36755872,0.0006002194,0.0028000849,0.0003242449,0.000083491046,0.010040105],"genre_scores_gemma":[0.60180044,0.002951472,0.0006732302,0.38899532,0.0014378377,0.0008157123,0.0023091608,0.00008160596,0.00093520456],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970163,0.00032404225,0.00069958635,0.000980858,0.00030613012,0.0006730993],"domain_scores_gemma":[0.99878013,0.00017314813,0.00018077056,0.0007180588,0.000044025128,0.00010389102],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00024169213,0.0005311778,0.0013701894,0.0007330934,0.000039398197,0.00002587292,0.0003079472,0.0023292883,0.000022225471],"category_scores_gemma":[0.000085236396,0.00046419897,0.0001715657,0.00034321364,0.00013100375,0.000045191788,0.00012995466,0.0011247786,0.000013948599],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090026954,0.0015386273,0.61087936,0.0006290045,0.00017132792,0.0046012737,0.0004241737,5.180689e-7,0.0000016041201,0.000021862237,0.34066474,0.040167216],"study_design_scores_gemma":[0.047140118,0.00066344684,0.8827585,0.002443523,0.0003389298,0.0014367538,0.000041462506,0.00004398361,0.000014762127,0.00004806324,0.06472673,0.00034372092],"about_ca_topic_score_codex":0.0026189021,"about_ca_topic_score_gemma":0.00077895797,"teacher_disagreement_score":0.275938,"about_ca_system_score_codex":0.0013673665,"about_ca_system_score_gemma":0.0005945488,"threshold_uncertainty_score":0.99978095},"labels":[],"label_agreement":null},{"id":"W4405989592","doi":"10.1001/jamaoncol.2024.5648","title":"Transplant-Free Salvage Therapy for Low-Risk Relapsed Pediatric Hodgkin Lymphoma","year":2025,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; Salvage therapy; Hodgkin lymphoma; Lymphoma; Radiation therapy; Chemotherapy; Oncology; Clinical trial; Internal medicine; Surgery","score_opus":0.015207195881695454,"score_gpt":0.2821397839153472,"score_spread":0.2669325880336518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405989592","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04027279,0.0061916243,0.00013918903,0.9323642,0.0031766216,0.0041813646,0.0026376515,0.00029145592,0.010745082],"genre_scores_gemma":[0.006812207,0.025087249,0.0022688687,0.9344185,0.015835414,0.0028952616,0.0038930601,0.0001778129,0.008611624],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99652684,0.00033839222,0.00079664116,0.0010329594,0.0004198698,0.0008853292],"domain_scores_gemma":[0.99505776,0.0027945675,0.0004931595,0.0013263223,0.00017208762,0.00015610713],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0003727212,0.0007243455,0.0017078925,0.0005440645,0.0001806858,0.000047406815,0.0005556561,0.0031887968,0.00029054203],"category_scores_gemma":[0.00026091057,0.00056950585,0.0009162277,0.0002746241,0.000102922335,0.000058916867,0.00007522925,0.00089644676,0.0001267693],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015503212,0.0011295,0.01002516,0.0005763691,0.00086016883,0.0038246352,0.00017964917,5.181908e-7,0.00000857098,0.000045905144,0.8792785,0.10252071],"study_design_scores_gemma":[0.042919934,0.0037592524,0.025993478,0.00016078082,0.002359956,0.00020950052,0.000011178006,0.000015007265,0.00020965094,0.0005007689,0.9234176,0.00044284546],"about_ca_topic_score_codex":0.00026599097,"about_ca_topic_score_gemma":0.00004876422,"teacher_disagreement_score":0.10207787,"about_ca_system_score_codex":0.0012314991,"about_ca_system_score_gemma":0.0018755859,"threshold_uncertainty_score":0.99967563},"labels":[],"label_agreement":null},{"id":"W4407768026","doi":"10.1001/jamaoncol.2024.7012","title":"Improving the Clinical Utility of FRAX in Patients With Cancer—The Need for More Detailed Analysis—Reply","year":2025,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of Manitoba; University of Alberta","funders":"","keywords":"Medicine; FRAX; Intensive care medicine; Medical physics; MEDLINE; Oncology; Internal medicine","score_opus":0.030155862172930707,"score_gpt":0.41060784987947435,"score_spread":0.38045198770654365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407768026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90985674,0.000043150754,0.01383569,0.07446296,0.000055235887,0.0012424849,0.000016614762,0.000025359683,0.0004617446],"genre_scores_gemma":[0.985789,0.000011706634,0.0048667607,0.008734409,0.000044727636,0.00040376303,0.000020290736,0.000004343875,0.0001250098],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99906975,0.00008817005,0.00041660795,0.00018610049,0.00010548898,0.00013386515],"domain_scores_gemma":[0.99843687,0.0007552919,0.00016688605,0.00041411186,0.00018753375,0.0000392963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087622216,0.00006371487,0.0003633687,0.00006594205,0.000048414822,0.0000040414334,0.00016879718,0.000099919285,0.000043655516],"category_scores_gemma":[0.0007139004,0.000031045947,0.000110901,0.0005357501,0.0003322924,0.000014059474,0.00005839957,0.00030078393,2.9353487e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004197542,0.00032972806,0.9098338,0.000032279488,0.00018175584,5.149909e-7,0.000060847033,0.00000164954,0.000026916156,0.0002755399,0.011547136,0.07729009],"study_design_scores_gemma":[0.002189638,0.0002532335,0.95658356,0.000028763227,0.0007288597,1.7175647e-7,0.00009696957,0.013801689,0.000086317596,0.00020035516,0.02599877,0.000031697906],"about_ca_topic_score_codex":0.0005514264,"about_ca_topic_score_gemma":0.00049306825,"teacher_disagreement_score":0.07725839,"about_ca_system_score_codex":0.000051774536,"about_ca_system_score_gemma":0.0003412097,"threshold_uncertainty_score":0.13067733},"labels":[],"label_agreement":null},{"id":"W4408405629","doi":"10.1001/jamaoncol.2025.0029","title":"Veliparib Plus Temozolomide for <i>MGMT</i>-Methylated Glioblastoma","year":2025,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Veliparib; Temozolomide; Medicine; Glioblastoma; Oncology; O-6-methylguanine-DNA methyltransferase; Cancer research; Internal medicine; Methylation; Genetics; Methyltransferase; Poly ADP ribose polymerase; DNA","score_opus":0.0164503816226078,"score_gpt":0.3369605497561127,"score_spread":0.3205101681335049,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408405629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9269185,0.0014643205,0.00049743045,0.041355137,0.0011022497,0.0017652188,0.000042379197,0.00018774788,0.026667012],"genre_scores_gemma":[0.98797715,0.000073084855,0.0022402827,0.0071364823,0.00021742782,0.00068161526,0.00006246955,0.00002319562,0.0015882893],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99876773,0.000059742466,0.00034199966,0.000354079,0.00010172567,0.0003747183],"domain_scores_gemma":[0.9986309,0.00065298757,0.00009485895,0.00030929738,0.0001845047,0.0001274847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022364616,0.00018150505,0.0005755101,0.00023629941,0.00010211946,0.000019441419,0.00010057408,0.00034906119,0.00009716398],"category_scores_gemma":[0.0003934918,0.00014852168,0.00019003595,0.00033870185,0.00007910025,0.000043108153,0.00006509407,0.00017641095,0.00008075366],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064731142,0.0027874252,0.01354967,0.0003127631,0.0015445546,0.0008132775,0.00033215032,0.00007743256,0.037558988,0.014751198,0.5111625,0.4106369],"study_design_scores_gemma":[0.021939049,0.0034691403,0.019617036,0.00012186418,0.00063476665,0.00008442707,0.00014572307,0.0011184689,0.053100046,0.0015400947,0.89805627,0.0001731372],"about_ca_topic_score_codex":0.0000624601,"about_ca_topic_score_gemma":0.00016725584,"teacher_disagreement_score":0.41046378,"about_ca_system_score_codex":0.0005760894,"about_ca_system_score_gemma":0.00050092046,"threshold_uncertainty_score":0.6056538},"labels":[],"label_agreement":null},{"id":"W4409148665","doi":"10.1001/jamaoncol.2025.0329","title":"Chromosome 1p Loss and 1q Gain for Grading of Meningioma","year":2025,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University of British Columbia; University Health Network","funders":"","keywords":"Medicine; Meningioma; CDKN2A; Grading (engineering); Internal medicine; CDKN2B; Proportional hazards model; Oncology; Concordance; Cohort; Pathology; Cancer; Biology","score_opus":0.022009808259677036,"score_gpt":0.339073733570681,"score_spread":0.31706392531100397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409148665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96456146,0.0004197544,0.001995446,0.007906523,0.00026977187,0.0005636633,0.000005413162,0.000031736396,0.024246238],"genre_scores_gemma":[0.9911586,0.000010525569,0.0049307044,0.00044063214,0.000105143125,0.000074284035,0.000013522999,0.0000082822535,0.0032583082],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99915874,0.000042523003,0.0002843909,0.0002184229,0.00008259411,0.00021334352],"domain_scores_gemma":[0.99933743,0.00026913706,0.00009375188,0.00017387327,0.00006149306,0.00006432744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004083235,0.0000990459,0.0003957824,0.0002188063,0.000056772406,0.000009148439,0.00006997684,0.00012727205,0.000039101073],"category_scores_gemma":[0.00016740916,0.000088899935,0.00007305968,0.00014266773,0.00009679726,0.00004119525,0.00007983234,0.00008550411,0.0000027948574],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004342821,0.0012188352,0.03892397,0.004686412,0.0020188421,0.0039480915,0.0037099014,0.000023721608,0.19227104,0.3075872,0.14420928,0.29705986],"study_design_scores_gemma":[0.028348831,0.008664614,0.0626131,0.0009140494,0.0014767665,0.001393938,0.0022585238,0.0074898438,0.08053452,0.01991519,0.7857955,0.00059509964],"about_ca_topic_score_codex":0.000014402922,"about_ca_topic_score_gemma":0.0000028039226,"teacher_disagreement_score":0.64158624,"about_ca_system_score_codex":0.00009272705,"about_ca_system_score_gemma":0.00008899015,"threshold_uncertainty_score":0.3625234},"labels":[],"label_agreement":null},{"id":"W4409329509","doi":"10.1001/jamaoncol.2025.0519","title":"Local Control and Extended Survival in Locally Advanced Hepatocellular Carcinoma—Reply","year":2025,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Hepatocellular carcinoma; Oncology; Internal medicine; MEDLINE","score_opus":0.02245679219716079,"score_gpt":0.27309288930963216,"score_spread":0.25063609711247137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409329509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9680349,0.0035083564,0.0031322576,0.011295964,0.00029090574,0.0011491916,0.000008891426,0.00007190524,0.012507597],"genre_scores_gemma":[0.9937534,0.0001360277,0.0006258765,0.004351383,0.00006591875,0.00019109709,0.000034164557,0.000022752276,0.00081938435],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981,0.0002755679,0.00046648367,0.00051919534,0.00017227246,0.00046650734],"domain_scores_gemma":[0.9989061,0.00037757555,0.00007856562,0.00032687778,0.00012023412,0.00019068272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048880605,0.00025699195,0.0007967074,0.00028711645,0.00006416472,0.000019106266,0.00009896916,0.0003273077,0.00007264283],"category_scores_gemma":[0.00015515523,0.00023177284,0.0001247173,0.00034324027,0.00023017994,0.0000852158,0.00006994975,0.00038941888,0.000028556553],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001891656,0.00046163582,0.84874135,0.00009890323,0.00010220501,0.002452058,0.00013386767,0.0000018205584,0.002144882,0.0012652524,0.00036663632,0.14233972],"study_design_scores_gemma":[0.03914709,0.0029446196,0.83009523,0.000177774,0.00043982413,0.00017034124,0.00062162,0.038377605,0.0039752256,0.00092716905,0.08274937,0.0003741615],"about_ca_topic_score_codex":0.00039330762,"about_ca_topic_score_gemma":0.00020260582,"teacher_disagreement_score":0.14196557,"about_ca_system_score_codex":0.0003793649,"about_ca_system_score_gemma":0.00056536414,"threshold_uncertainty_score":0.9451422},"labels":[],"label_agreement":null},{"id":"W4409329675","doi":"10.1001/jamaoncol.2025.0473","title":"National Cancer System Characteristics and Global Pan-Cancer Outcomes","year":2025,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Cancer Institute","keywords":"Medicine; Demography; Population; Per capita; Human Development Index; Gross domestic product; Cancer; Gross national income; Gerontology; Environmental health; Human development (humanity); Economic growth; Internal medicine","score_opus":0.02895249680210092,"score_gpt":0.3086793287352443,"score_spread":0.27972683193314335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409329675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6216911,0.009352584,0.0011371548,0.023266565,0.0059493734,0.0003890072,0.0027713822,0.00009731595,0.33534548],"genre_scores_gemma":[0.9895288,0.0013006101,0.00018533577,0.00552029,0.00040471958,0.0001500304,0.000010173081,0.000011007363,0.0028890881],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871224,0.000014410917,0.0005890462,0.00036170872,0.000027793076,0.00029479834],"domain_scores_gemma":[0.9992434,0.00009178087,0.00035985597,0.00013794871,0.000095455725,0.000071552226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033217733,0.00016088165,0.0006312118,0.00011701458,0.00010757577,0.00007955422,0.0001739533,0.0002654177,0.00020964668],"category_scores_gemma":[0.00018843425,0.00017724227,0.00008087654,0.0001523644,0.00010724127,0.00022853915,0.00009173912,0.0001498223,0.00012814093],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003321011,0.000031033673,0.47889867,0.000050655897,0.00009548281,0.0000025605057,0.00004106701,0.0000061043297,0.0000016433661,0.47253385,0.008743337,0.039562374],"study_design_scores_gemma":[0.00074189913,0.00002761941,0.6474763,0.000028243105,0.000011282776,0.000002471845,0.00003205882,0.00044917283,0.000002673373,0.009895707,0.34119648,0.00013610609],"about_ca_topic_score_codex":0.0013159848,"about_ca_topic_score_gemma":0.00045844202,"teacher_disagreement_score":0.46263814,"about_ca_system_score_codex":0.0015644048,"about_ca_system_score_gemma":0.0003474663,"threshold_uncertainty_score":0.722773},"labels":[],"label_agreement":null},{"id":"W4409994539","doi":"10.1001/jamaoncol.2025.0908","title":"Modeling Population-Level Impacts of Cell-Free DNA Screening for Colorectal Cancer in Canada","year":2025,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Paul's Hospital; Providence Health Care; BC Cancer Agency; Alberta Health Services; University of Calgary","funders":"","keywords":"Medicine; Colorectal cancer; Colonoscopy; Population; Cell-free fetal DNA; Cancer; Colorectal cancer screening; Internal medicine; Oncology; Demography; Environmental health","score_opus":0.016289173855125932,"score_gpt":0.2875883100314656,"score_spread":0.2712991361763397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409994539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926163,0.0007300983,0.0044901073,0.0006493875,0.0003409791,0.00023633718,0.0004261573,0.000001765591,0.00050884957],"genre_scores_gemma":[0.99656767,0.00021386478,0.0022571934,0.00061496184,0.000113520706,0.00006583737,0.00011156544,0.000010720072,0.000044647466],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99925286,0.000021455959,0.0002634247,0.0001968058,0.000051496947,0.000213953],"domain_scores_gemma":[0.9995407,0.00008273579,0.00007703323,0.00015593409,0.00010060139,0.000043000986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011476836,0.0000915469,0.00019673635,0.000054423654,0.000033267992,0.0000056021436,0.00016784095,0.00014374121,0.000006535167],"category_scores_gemma":[0.00026373073,0.000101319805,0.000046377907,0.000083962936,0.000018488981,0.0000023236498,0.00011290197,0.00006665968,5.774315e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015693292,0.00015745791,0.15195246,0.00021238225,0.00014616037,0.000009272959,0.0001349103,0.24393168,0.5429489,0.0006484441,0.015239329,0.04304964],"study_design_scores_gemma":[0.0141854035,0.001077379,0.2213939,0.00019771759,0.00015301583,0.000007167055,0.0010652731,0.23226368,0.5070277,0.0016770619,0.020144006,0.00080770813],"about_ca_topic_score_codex":0.75717235,"about_ca_topic_score_gemma":0.9821269,"teacher_disagreement_score":0.22495456,"about_ca_system_score_codex":0.0003335346,"about_ca_system_score_gemma":0.002415789,"threshold_uncertainty_score":0.4285506},"labels":[],"label_agreement":null},{"id":"W4410932301","doi":"10.1001/jamaoncol.2025.1002","title":"Overall Survival and Quality-of-Life Superiority in Modern Phase 3 Oncology Trials","year":2025,"lang":"en","type":"review","venue":"JAMA Oncology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Quality of life (healthcare); Clinical endpoint; Randomized controlled trial; Internal medicine; Clinical trial; End point; Oncology","score_opus":0.26053154335615336,"score_gpt":0.5225963334631009,"score_spread":0.2620647901069475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410932301","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002422029,0.97821015,0.00005463396,0.00093240757,0.0024241013,0.001824074,0.00040670348,0.00003782842,0.013688083],"genre_scores_gemma":[0.0006805174,0.99636334,0.00009729155,0.0006592731,0.00076518336,0.00029365745,0.00029980525,0.000039126015,0.0008018187],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99028224,0.005450591,0.002753734,0.00074147014,0.0003095268,0.00046244008],"domain_scores_gemma":[0.9899399,0.008022016,0.0009813954,0.0005821872,0.00018522493,0.00028925444],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0062125903,0.0005076292,0.011027131,0.00057590794,0.000037268288,0.000016368933,0.00024331677,0.0019975286,0.00023785298],"category_scores_gemma":[0.005666254,0.00042264262,0.0008882036,0.00042206715,0.00024207885,0.00006366672,0.00024058248,0.0013050572,0.000006905315],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015570739,0.0007354069,0.00023047687,0.037519015,0.0003521568,0.00015866589,0.00061376684,1.14045534e-7,0.000006487353,0.0014281527,0.0005090827,0.9568896],"study_design_scores_gemma":[0.011601435,0.0013912731,0.000106208056,0.005288082,0.0012836878,0.000048599733,0.0003510176,0.0000046648706,9.3232785e-7,0.00021204815,0.9794049,0.00030713432],"about_ca_topic_score_codex":0.0032510092,"about_ca_topic_score_gemma":0.009198348,"teacher_disagreement_score":0.97889584,"about_ca_system_score_codex":0.0010560132,"about_ca_system_score_gemma":0.00809096,"threshold_uncertainty_score":0.99982256},"labels":[],"label_agreement":null},{"id":"W4411046343","doi":"10.1001/jamaoncol.2025.1340","title":"Body Mass Index, Physical Activity, and Subsequent Neoplasm Risk Among Childhood Cancer Survivors","year":2025,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute","keywords":"Medicine; Body mass index; Cancer; Cohort; Cohort study; Pediatrics; Cancer registry; Internal medicine; Young adult","score_opus":0.013623695164829579,"score_gpt":0.3325704076860578,"score_spread":0.3189467125212282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411046343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.970252,0.00040452782,0.00022718828,0.017798653,0.0010553799,0.00077093404,0.00006291265,0.00016617341,0.009262238],"genre_scores_gemma":[0.9945928,0.00056156225,0.0001298297,0.002670617,0.000880105,0.0001611342,0.000014703188,0.000042453274,0.00094682083],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99732566,0.00055591844,0.00038010004,0.00074145215,0.0004152447,0.0005815966],"domain_scores_gemma":[0.99785966,0.00084014353,0.00030281694,0.0005473626,0.0001311335,0.00031887458],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00067823875,0.0003623999,0.001047942,0.00025073535,0.00018780293,0.00005001941,0.0002057764,0.0004576539,0.000080136706],"category_scores_gemma":[0.00045885472,0.00034313157,0.00019972032,0.0004574735,0.00042728413,0.00019655531,0.0002350429,0.0011951587,0.000020546333],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005222957,0.0012761572,0.9152371,0.00020266669,0.0006079366,0.00008454951,0.002224872,0.000027114233,0.0010059775,0.0006184376,0.0028558418,0.07533701],"study_design_scores_gemma":[0.0043956544,0.00047786752,0.9743975,0.000184347,0.00036533375,0.000022883527,0.00046460566,0.00069695007,0.0017338686,0.0010935098,0.015880086,0.00028742146],"about_ca_topic_score_codex":0.02700867,"about_ca_topic_score_gemma":0.025420351,"teacher_disagreement_score":0.07504959,"about_ca_system_score_codex":0.00057782955,"about_ca_system_score_gemma":0.0009743807,"threshold_uncertainty_score":0.99990207},"labels":[],"label_agreement":null},{"id":"W4412003127","doi":"10.1001/jamaoncol.2025.1891","title":"First-Line Therapy For Advanced Non–Clear Cell Renal Cell Carcinoma","year":2025,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Oncology; Renal cell carcinoma; Meta-analysis; Cochrane Library; Observational study; MEDLINE; Clinical trial; Immunotherapy; Atezolizumab; Nivolumab; Cancer","score_opus":0.020000997743431965,"score_gpt":0.3031120302561916,"score_spread":0.28311103251275965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412003127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9228559,0.002056988,0.0010875176,0.008024007,0.0004886298,0.0018013229,0.000018805416,0.000066367305,0.06360047],"genre_scores_gemma":[0.9652871,0.0003304217,0.0069195917,0.0036027036,0.0003301465,0.00040900699,0.00007490622,0.00004499908,0.02300115],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99832076,0.00006442372,0.00042341268,0.00053334935,0.00016236556,0.0004956869],"domain_scores_gemma":[0.99848765,0.00044768312,0.00015042485,0.0005305171,0.00021197312,0.0001717732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020667889,0.00028515706,0.00064308586,0.00020052673,0.00013244367,0.000015369198,0.00017581489,0.00033809923,0.00018678624],"category_scores_gemma":[0.000051977306,0.0002332244,0.00027875748,0.00023957671,0.00008696377,0.000057391513,0.00006897842,0.00029553944,0.00008708402],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04245461,0.0075881053,0.03851374,0.0016866658,0.00042680214,0.0017002607,0.0016832238,0.00052734127,0.5027126,0.00053621916,0.12789764,0.27427277],"study_design_scores_gemma":[0.031439897,0.015757348,0.061163276,0.000058882517,0.00024901045,0.000037788013,0.00018818765,0.0010077786,0.39142227,0.0003277215,0.4980796,0.00026824474],"about_ca_topic_score_codex":0.000061391045,"about_ca_topic_score_gemma":0.000039256953,"teacher_disagreement_score":0.37018195,"about_ca_system_score_codex":0.0005902539,"about_ca_system_score_gemma":0.000531844,"threshold_uncertainty_score":0.9510615},"labels":[],"label_agreement":null},{"id":"W4413043431","doi":"10.1001/jamaoncol.2025.2361","title":"Bacterial Decolonization With Mupirocin Ointment for Acute Radiation Oral Mucositis Prevention","year":2025,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Oral health in cancer treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Mucositis; Nasopharyngeal carcinoma; Mupirocin; Radiation therapy; Head and neck cancer; Internal medicine; Surgery; Quality of life (healthcare); Gastroenterology; Methicillin-resistant Staphylococcus aureus; Staphylococcus aureus","score_opus":0.021398022668147963,"score_gpt":0.41643659211267603,"score_spread":0.3950385694445281,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413043431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9369193,0.00018391595,0.01818284,0.036621135,0.0017183904,0.0038572906,0.00005080878,0.00010771631,0.0023586052],"genre_scores_gemma":[0.9410634,0.00023072642,0.047046803,0.003807374,0.00064298604,0.0018000661,0.0011176832,0.000032476528,0.004258509],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99904525,0.00008117924,0.00027409734,0.00025219304,0.00009596553,0.0002512923],"domain_scores_gemma":[0.999388,0.00009561098,0.00014131845,0.00014842837,0.00014496532,0.00008166756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018758092,0.000116032934,0.00030776186,0.00011467748,0.00009731228,0.0000140365555,0.00003764182,0.00019262379,0.00012996879],"category_scores_gemma":[0.000042161093,0.0000974024,0.00005127352,0.00017827822,0.000031376072,0.00009158306,0.00001751336,0.00008359735,0.000013479248],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008071479,0.0008427219,0.011701395,0.00022232717,0.0005359721,0.00004113902,0.00021129027,0.000021757238,0.0010626718,0.0015378122,0.02088173,0.9548697],"study_design_scores_gemma":[0.050856333,0.04572365,0.2452765,0.00037440614,0.0025794334,0.00013754422,0.00013457678,0.0019260772,0.018465774,0.001594753,0.632638,0.00029298468],"about_ca_topic_score_codex":0.000061765735,"about_ca_topic_score_gemma":0.0004236247,"teacher_disagreement_score":0.95457673,"about_ca_system_score_codex":0.0023217162,"about_ca_system_score_gemma":0.0010471706,"threshold_uncertainty_score":0.6071207},"labels":[],"label_agreement":null},{"id":"W4413375901","doi":"10.1001/jamaoncol.2025.2590","title":"Predicting Chronic Kidney Disease After Cisplatin Treatment Using Population-Level Data","year":2025,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Chemotherapy-induced organ toxicity mitigation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; Princess Margaret Cancer Centre; University Health Network; Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Medicine; Kidney disease; Internal medicine; Cohort; Population; Retrospective cohort study; Renal function; Incidence (geometry); Environmental health","score_opus":0.06722165293175308,"score_gpt":0.375462238814315,"score_spread":0.3082405858825619,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413375901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847378,0.00027522282,0.0009155162,0.011945463,0.00036759384,0.00063259306,0.00024043303,0.00009316914,0.00079218094],"genre_scores_gemma":[0.98977065,0.000032277847,0.0039799702,0.003419666,0.0007273986,0.00003511043,0.0010773331,0.000028409846,0.0009292111],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986984,0.0000864973,0.00034930368,0.00045270397,0.00015228686,0.00026076945],"domain_scores_gemma":[0.99869984,0.00013442765,0.00012160418,0.00074472075,0.00005962061,0.00023979552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016995035,0.0001733608,0.00031729077,0.00016092614,0.00009819091,0.000024551253,0.00012882802,0.00020077548,0.00035777668],"category_scores_gemma":[0.0005510124,0.00016173018,0.00005971122,0.00024357569,0.00005155898,0.00018687232,0.00011838108,0.0001762207,0.000019945699],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013391792,0.00080306665,0.76932156,0.00031021875,0.0004014664,0.00023822849,0.00051294186,0.00008329068,0.047654137,0.00014075096,0.0037423458,0.17545283],"study_design_scores_gemma":[0.009058726,0.00049537973,0.88717496,0.00055536564,0.0007714,0.00005140234,0.000079733174,0.06871604,0.0078594135,0.000323372,0.024672914,0.0002412795],"about_ca_topic_score_codex":0.00044666854,"about_ca_topic_score_gemma":0.00029821816,"teacher_disagreement_score":0.17521155,"about_ca_system_score_codex":0.002420037,"about_ca_system_score_gemma":0.0016232703,"threshold_uncertainty_score":0.6595165},"labels":[],"label_agreement":null},{"id":"W4413375935","doi":"10.1001/jamaoncol.2025.2738","title":"Impact of a Weight Loss Intervention on 1-Year Weight Change in Women With Stage II/III Breast Cancer","year":2025,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Victoria; University of British Columbia; University of Toronto; Mount Sinai Hospital","funders":"National Cancer Institute","keywords":"Medicine; Breast cancer; Weight change; Weight loss; Body mass index; Obesity; Population; Randomized controlled trial; Cancer; Internal medicine; Overweight; Physical therapy; Gynecology","score_opus":0.015166605637391705,"score_gpt":0.3595881782400391,"score_spread":0.3444215726026474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413375935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924594,0.00018399172,0.000010166545,0.0033557648,0.00023202042,0.00040025136,0.00012855715,0.000017958282,0.0032118761],"genre_scores_gemma":[0.99698657,0.00037468903,0.0000148397,0.00061567576,0.00019943828,0.00020335856,0.0000116389165,0.000013517266,0.0015803],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990568,0.000051385112,0.00025984677,0.00022550233,0.000121486395,0.0002849912],"domain_scores_gemma":[0.9994599,0.000038477556,0.0001388989,0.0002008523,0.000076941455,0.000084934836],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016786392,0.00013881779,0.00046703074,0.00030575143,0.000024766838,0.000004494983,0.000075502656,0.00016462881,0.0020054355],"category_scores_gemma":[0.000009348459,0.00009517271,0.00009301527,0.00036229216,0.000086467015,0.00007450056,0.000052381194,0.0002760401,0.0000049102837],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020853555,0.0013681782,0.7547996,0.00016485857,0.00033708205,0.00012737903,0.0033432639,0.0000069122284,0.0004503704,0.00029999224,0.0031094018,0.21513942],"study_design_scores_gemma":[0.010075955,0.0041438206,0.9605567,0.00055974885,0.00004244858,0.0000147537685,0.00020855236,0.00003827314,0.00016991897,0.000025958272,0.024076391,0.00008752184],"about_ca_topic_score_codex":0.010950874,"about_ca_topic_score_gemma":0.0036445048,"teacher_disagreement_score":0.21505189,"about_ca_system_score_codex":0.0018221971,"about_ca_system_score_gemma":0.00035536336,"threshold_uncertainty_score":0.99890685},"labels":[],"label_agreement":null},{"id":"W4414123226","doi":"10.1001/jamaoncol.2025.3153","title":"Patient-Reported Outcomes as Prognostic Indicators for Overall Survival in Cancer","year":2025,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Princess Margaret Cancer Centre; BC Cancer Agency; University of Toronto","funders":"","keywords":"Overall survival; Cancer; Risk stratification; MEDLINE; Survival analysis; Cancer survival; Prognostic model; Proportional hazards model","score_opus":0.021739823009151598,"score_gpt":0.36028717613197114,"score_spread":0.3385473531228195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414123226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96585816,0.00041652122,0.000036232985,0.01269684,0.0023627563,0.001044464,0.000020536814,0.0000528622,0.017511621],"genre_scores_gemma":[0.9894477,0.000053405383,0.00006404893,0.00714459,0.000101507896,0.00078978593,0.00004051633,0.000016231506,0.0023421783],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987728,0.00007064788,0.00039094136,0.0003000384,0.0001552604,0.00031028813],"domain_scores_gemma":[0.9989934,0.00047202854,0.00013027308,0.00020919797,0.00010654076,0.000088588095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021037091,0.00013986505,0.00049810164,0.00031674694,0.000035639398,0.000010482369,0.000073111325,0.00025917418,0.0001818799],"category_scores_gemma":[0.00071638136,0.000120267985,0.00012095648,0.0003591993,0.000057821755,0.00004138123,0.000051477764,0.00024231791,0.000006494982],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067428395,0.0002780731,0.89541566,0.00011566239,0.00014749971,0.000100086116,0.00083258364,0.0000028837896,0.00007397253,0.0014486955,0.004017373,0.09689319],"study_design_scores_gemma":[0.0042946916,0.00064708805,0.72635734,0.00009560871,0.00014155984,0.00000724963,0.0005178987,0.000019090474,0.00022843372,0.00063684897,0.2669439,0.00011028355],"about_ca_topic_score_codex":0.0038197157,"about_ca_topic_score_gemma":0.012582446,"teacher_disagreement_score":0.26292655,"about_ca_system_score_codex":0.00053127133,"about_ca_system_score_gemma":0.0011393495,"threshold_uncertainty_score":0.70213},"labels":[],"label_agreement":null},{"id":"W4414508430","doi":"10.1001/jamaoncol.2025.3700","title":"Ribociclib Plus Endocrine Therapy in Hormone Receptor–Positive/ <i>ERBB2</i> -Negative Early Breast Cancer","year":2025,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"BC Cancer Agency; College of Medicine, Seoul National University; University of California, Los Angeles; Instituto de Investigación Sanitaria Gregorio Marañón; Peter MacCallum Cancer Centre; Chinese Academy of Medical Sciences; Seoul National University Hospital; Universidad Complutense de Madrid; Seoul National University; Peking Union Medical College; University of Washington; University of Texas MD Anderson Cancer Center; Novartis Pharmaceuticals Corporation; Cancer Research Institute","keywords":"Endocrine system; Breast cancer; Hormone receptor; Cancer; Hormone therapy; Hormone","score_opus":0.012892989743431714,"score_gpt":0.33173204803363404,"score_spread":0.3188390582902023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414508430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91004145,0.006541041,0.0003411612,0.06434149,0.00078277645,0.0013554122,0.00021382562,0.00017897446,0.01620389],"genre_scores_gemma":[0.9768889,0.0030818658,0.0018078367,0.012771964,0.00058928656,0.000608802,0.000031079348,0.000054980886,0.00416531],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99793535,0.00021798031,0.00045998066,0.000549645,0.00022388317,0.0006131628],"domain_scores_gemma":[0.9986334,0.00040857415,0.00017176426,0.00035346634,0.00029273154,0.00014007262],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019986802,0.00032029382,0.00081894035,0.00029329,0.000085453175,0.000020061843,0.00020555758,0.00025036518,0.00045708372],"category_scores_gemma":[0.00007143111,0.00028315213,0.00012547382,0.00078893115,0.00034557405,0.00025110593,0.000097606404,0.00071558234,0.00005387746],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022445276,0.0007477313,0.032375738,0.000048666567,0.00057330047,0.0003187985,0.0032506578,0.000057025536,0.07367278,0.0014710256,0.0057382053,0.8593008],"study_design_scores_gemma":[0.033064425,0.001752863,0.7713318,0.00036204967,0.000074112824,0.00023281759,0.00078869925,0.000058701247,0.016406564,0.0017110651,0.17382136,0.0003955858],"about_ca_topic_score_codex":0.0025241338,"about_ca_topic_score_gemma":0.00054503646,"teacher_disagreement_score":0.8589052,"about_ca_system_score_codex":0.0021141279,"about_ca_system_score_gemma":0.0009458327,"threshold_uncertainty_score":0.9999621},"labels":[],"label_agreement":null},{"id":"W4414756817","doi":"10.1001/jamaoncol.2025.3458","title":"The Breakup Letter","year":2025,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Educational Leadership and Practices","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ovarian Cancer Canada","funders":"","keywords":"","score_opus":0.043577352084523256,"score_gpt":0.440078787668521,"score_spread":0.39650143558399775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414756817","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003550491,0.00018432993,0.000009845781,0.5154064,0.0010231296,0.000037707585,2.250092e-7,0.000011063336,0.47977677],"genre_scores_gemma":[0.77507246,0.00025961912,0.00024277723,0.096868485,0.0020882885,0.000041011008,0.000001557355,0.0000029283137,0.12542285],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991773,0.00044026118,0.0000719823,0.00007330041,0.00008646439,0.00015070422],"domain_scores_gemma":[0.9965733,0.003229423,0.000040039602,0.00007871114,0.000053811134,0.000024674435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010607408,0.000027279593,0.000043375487,0.000020576681,0.0006742114,0.000085423184,0.00020448136,0.00009128502,0.00024143021],"category_scores_gemma":[0.000900442,0.000019292109,0.000022934824,0.0001412474,0.0002765989,0.00012243059,0.00001624689,0.00015092464,0.00018797799],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011606608,0.000019485962,0.0016571665,0.0000010389787,0.000009771442,9.860531e-7,0.0043491763,1.8133922e-7,0.000008974548,0.42644015,0.48425135,0.08325012],"study_design_scores_gemma":[0.000063457206,0.000010557808,0.0056575774,0.0000019463562,0.0000060881007,3.5980034e-7,0.009474698,7.218555e-7,0.0000075068447,0.012436285,0.9723187,0.00002208772],"about_ca_topic_score_codex":0.00092773425,"about_ca_topic_score_gemma":0.0061135436,"teacher_disagreement_score":0.771522,"about_ca_system_score_codex":0.00009537154,"about_ca_system_score_gemma":0.00063234253,"threshold_uncertainty_score":0.51855576},"labels":[],"label_agreement":null},{"id":"W4414756848","doi":"10.1001/jamaoncol.2025.3746","title":"Prostate-Specific Membrane Antigen PET-Guided Intensification of Salvage Radiotherapy After Radical Prostatectomy","year":2025,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bausch Health (Canada); Public Works and Government Services Canada; Centre Integre de Sante et de Services Sociaux de Laval; Hôpital Charles-Le Moyne; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Prostatectomy; Radiation therapy; Prostate-specific antigen; Prostate cancer; Salvage therapy; Glutamate carboxypeptidase II","score_opus":0.018358800683848365,"score_gpt":0.32015336691437063,"score_spread":0.30179456623052225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414756848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9652029,0.0070906207,0.0003124827,0.020597924,0.00046797865,0.0020880464,0.00004510048,0.00008706036,0.004107836],"genre_scores_gemma":[0.9818474,0.009470756,0.003909053,0.0030786516,0.00012879894,0.00065487286,0.000112709036,0.00003107616,0.00076668494],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99829465,0.00012631346,0.00059608713,0.00045269978,0.00019605021,0.0003342013],"domain_scores_gemma":[0.99875677,0.00017477649,0.0001815913,0.00045431723,0.0003117438,0.00012082141],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030853588,0.0002167168,0.0006805575,0.000251659,0.00004626175,0.000019223407,0.00010310242,0.00016064194,0.00031522242],"category_scores_gemma":[0.00007986311,0.00017321606,0.00015013943,0.00038363543,0.00030852034,0.00008495546,0.00003912714,0.00024647833,0.00002188763],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016390549,0.00545399,0.2754778,0.0013267653,0.001702457,0.002694138,0.0038391037,0.000018974099,0.21799524,0.0058625727,0.09063649,0.3786019],"study_design_scores_gemma":[0.011496324,0.0018244404,0.3139587,0.00037010596,0.00013708542,0.00016948614,0.00021482309,0.00012246692,0.11142313,0.000275097,0.55981517,0.00019317215],"about_ca_topic_score_codex":0.000048704052,"about_ca_topic_score_gemma":0.0000093335375,"teacher_disagreement_score":0.46917868,"about_ca_system_score_codex":0.0006540216,"about_ca_system_score_gemma":0.0004964948,"threshold_uncertainty_score":0.7063546},"labels":[],"label_agreement":null},{"id":"W4416194118","doi":"10.1001/jamaoncol.2025.4543","title":"Immune Checkpoint Inhibitor–Associated Cardiovascular Toxic Effects","year":2025,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ted Rogers Centre for Heart Research; Toronto General Hospital; Population Health Research Institute","funders":"","keywords":"Myocarditis; Pericarditis; Cardiotoxicity; Disease; Cancer; Acute pericarditis; Heart disease","score_opus":0.008894360964312868,"score_gpt":0.2788533286064106,"score_spread":0.26995896764209776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416194118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9238559,0.02268698,0.00015669435,0.008482334,0.002321466,0.0008504335,0.0000043816453,0.00017512609,0.04146671],"genre_scores_gemma":[0.9916082,0.0006196447,0.00014624892,0.003491744,0.00025241953,0.00009454008,0.00002817781,0.000018942827,0.0037400508],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99864507,0.00020451809,0.00037134704,0.0002809708,0.00018301982,0.00031507935],"domain_scores_gemma":[0.99913824,0.00019467766,0.00008515994,0.0004199107,0.00010080876,0.00006119987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080301036,0.00016049224,0.0006677849,0.00015949243,0.000082501196,0.000015824624,0.00010381811,0.0004050667,0.00010284415],"category_scores_gemma":[0.00039465496,0.00013959713,0.0006683348,0.00045417438,0.000121451536,0.000044157092,0.000065336644,0.00032610405,0.00004348661],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043436657,0.00092428667,0.003647043,0.00044439413,0.0069526336,0.000574542,0.00045214023,0.000005301504,0.39909172,0.0001810889,0.023661563,0.55972165],"study_design_scores_gemma":[0.018287241,0.0014845426,0.20519854,0.00047443967,0.00069006643,0.00007679645,0.00012858234,0.000044732074,0.130602,0.00015951015,0.6426445,0.00020902806],"about_ca_topic_score_codex":0.0002793078,"about_ca_topic_score_gemma":0.000039326867,"teacher_disagreement_score":0.618983,"about_ca_system_score_codex":0.0008869737,"about_ca_system_score_gemma":0.00043651415,"threshold_uncertainty_score":0.5692606},"labels":[],"label_agreement":null},{"id":"W4416424420","doi":"10.1001/jamaoncol.2025.4800","title":"Optimal Duration of Androgen Deprivation Therapy With Definitive Radiotherapy for Localized Prostate Cancer","year":2025,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; McGill University Health Centre; Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Prostate cancer; Androgen deprivation therapy; Radiation therapy; Duration (music); Androgen; MEDLINE","score_opus":0.021694330905656836,"score_gpt":0.33790397822259133,"score_spread":0.3162096473169345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416424420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9731946,0.004912218,0.0064512384,0.012201798,0.0001100574,0.0023258177,0.000069103044,0.000026558942,0.0007086104],"genre_scores_gemma":[0.96456414,0.012076455,0.016200226,0.003596845,0.00008999574,0.0030042408,0.00016230447,0.000022603155,0.00028316354],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99932927,0.000037940797,0.00022625146,0.00019355079,0.00007203744,0.0001409608],"domain_scores_gemma":[0.99929285,0.00016000285,0.00014635028,0.00011214345,0.00025543084,0.00003321755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010968197,0.0001041719,0.00032447997,0.00007987925,0.00004129808,0.00000745016,0.00003042678,0.000093322546,0.000034557397],"category_scores_gemma":[0.00002462017,0.000072852636,0.000053470438,0.00015568743,0.00007745502,0.00005603326,0.000005718918,0.00005447472,4.1342392e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030375365,0.0013030596,0.22043395,0.00019436677,0.0016186985,0.000026435877,0.0019908964,0.00048746236,0.008675289,0.0030256985,0.0040977634,0.72777104],"study_design_scores_gemma":[0.0808364,0.021411184,0.12381944,0.0005529655,0.0005044645,0.000031353706,0.00053253694,0.0023590052,0.3938674,0.0007333608,0.3750647,0.00028718598],"about_ca_topic_score_codex":0.00010414482,"about_ca_topic_score_gemma":0.000052813808,"teacher_disagreement_score":0.7274838,"about_ca_system_score_codex":0.00038317093,"about_ca_system_score_gemma":0.0007141749,"threshold_uncertainty_score":0.29708442},"labels":[],"label_agreement":null},{"id":"W4416998993","doi":"10.1001/jamaoncol.2025.5144","title":"Predictive Role of Circulating Tumor DNA in Stage III Colon Cancer Treated With Celecoxib","year":2025,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec","funders":"","keywords":"Circulating tumor DNA; Colorectal cancer; Celecoxib; Circulating tumor cell; Stage (stratigraphy); Cancer","score_opus":0.005151098990225925,"score_gpt":0.26069703864595867,"score_spread":0.25554593965573275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416998993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98785335,0.00088784046,0.0001111165,0.00017697312,0.00007389724,0.00028735303,0.0000971298,0.0000061169394,0.010506235],"genre_scores_gemma":[0.9985653,0.00019048687,0.00016008345,0.00045394234,0.00007622147,0.00012031417,0.000054840617,0.0000123972395,0.00036641335],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99918187,0.00005017905,0.00023336051,0.0002723284,0.000052512998,0.00020975304],"domain_scores_gemma":[0.99947566,0.000062279396,0.00013929058,0.0001787721,0.00010629466,0.000037679492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010434838,0.00011431325,0.0002518646,0.00007590467,0.000030033225,0.000007544356,0.00011398672,0.00016291978,0.000024555444],"category_scores_gemma":[0.00007790213,0.00010946192,0.000038023416,0.00017124164,0.00008676549,0.0000026377481,0.000082747836,0.00010759581,5.256475e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016864976,0.00028359305,0.13348357,0.000048167385,0.00015259281,0.000039674924,0.00025050543,0.0039477027,0.84668493,0.0005748376,0.00087969843,0.011968224],"study_design_scores_gemma":[0.00817282,0.0029288563,0.11321033,0.00013059584,0.000109341665,0.000012540762,0.0011999387,0.002451468,0.7805722,0.00019792454,0.090672076,0.00034193503],"about_ca_topic_score_codex":0.0014103169,"about_ca_topic_score_gemma":0.005037552,"teacher_disagreement_score":0.08979238,"about_ca_system_score_codex":0.00016142597,"about_ca_system_score_gemma":0.000659563,"threshold_uncertainty_score":0.44637278},"labels":[],"label_agreement":null},{"id":"W4417246830","doi":"10.1001/jamaoncol.2025.5234","title":"Stroke in Patients With Cancer—Time Is Brain","year":2025,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotchkiss Brain Institute; Alberta Cancer Foundation; University of Calgary","funders":"","keywords":"Stroke (engine); MEDLINE; Acute stroke; Ischemic stroke; Central nervous system disease","score_opus":0.0055103377443961946,"score_gpt":0.28357903293255493,"score_spread":0.27806869518815874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417246830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7813718,0.000052045645,0.00006811127,0.045272794,0.0001536608,0.00053181354,0.000024574418,0.000034685985,0.17249055],"genre_scores_gemma":[0.83535004,0.000025762998,0.0018172837,0.06653033,0.00013811355,0.00017208378,0.000057215715,0.000024692148,0.095884494],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9991237,0.000034543948,0.00019514143,0.0002500239,0.00015038697,0.00024619524],"domain_scores_gemma":[0.9994812,0.00010105363,0.0000634367,0.00023544091,0.00006918957,0.00004967922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000117335854,0.00011103333,0.00031414648,0.0001958272,0.000018307572,0.000005825486,0.000101242775,0.00013684794,0.0007198468],"category_scores_gemma":[0.00008615132,0.00009044732,0.00003223636,0.0002422904,0.00005969811,0.00003952999,0.00010472411,0.00022357995,0.000067974455],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005643225,0.00021091962,0.44821844,0.000025444555,0.00011251446,0.000032834752,0.00011599865,0.0000028425777,0.00021816429,0.000041927913,0.5175921,0.03286451],"study_design_scores_gemma":[0.0069180517,0.00051597005,0.49720666,0.00007724947,0.00006528248,8.915069e-7,0.000044953,0.00007804891,0.00038496286,0.000005706904,0.4946398,0.00006241151],"about_ca_topic_score_codex":0.00016931957,"about_ca_topic_score_gemma":0.00005894455,"teacher_disagreement_score":0.07660606,"about_ca_system_score_codex":0.00057887926,"about_ca_system_score_gemma":0.00023146613,"threshold_uncertainty_score":0.7881818},"labels":[],"label_agreement":null},{"id":"W4417468103","doi":"10.1001/jamaoncol.2025.5364","title":"Glucagon-Like Peptide-1 Receptor Agonists and Cancer","year":2025,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Spinal Cord Injury BC","funders":"","keywords":"Cancer; Agonist; Receptor; Clinical trial; Immunotherapy","score_opus":0.013714749655027057,"score_gpt":0.3210673079292796,"score_spread":0.30735255827425256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417468103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7003303,0.0034165315,0.000030250982,0.04974363,0.0014573601,0.0006230685,0.000007938014,0.00010322516,0.24428767],"genre_scores_gemma":[0.6847149,0.004653039,0.0029444243,0.02994111,0.00045690112,0.000483085,0.00007889431,0.00002827169,0.27669936],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99933696,0.000028523717,0.00013743839,0.00022225639,0.00006597472,0.00020886802],"domain_scores_gemma":[0.9996155,0.00006920551,0.000039790855,0.00015931782,0.000043202956,0.000072968214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010189872,0.000104017025,0.00026826936,0.0001007097,0.00005236163,0.000017636568,0.000047081445,0.00011204124,0.00037400165],"category_scores_gemma":[0.000033986318,0.0000859079,0.00004278832,0.00012437896,0.00007894728,0.000043062675,0.00008867517,0.00010020877,0.000076138414],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019473177,0.00026144666,0.029049797,0.00011976914,0.0003706138,0.000044027067,0.00015604735,5.4961293e-7,0.0012752821,0.0032860003,0.36615214,0.5990896],"study_design_scores_gemma":[0.0026969116,0.00041879056,0.041536562,0.00007341167,0.0002432784,0.0000022920376,0.000103431536,0.000025699956,0.00065421755,0.0001726692,0.95400715,0.00006555901],"about_ca_topic_score_codex":0.00012347805,"about_ca_topic_score_gemma":0.00010676634,"teacher_disagreement_score":0.59902406,"about_ca_system_score_codex":0.00024963875,"about_ca_system_score_gemma":0.00014859361,"threshold_uncertainty_score":0.4095056},"labels":[],"label_agreement":null},{"id":"W4417474102","doi":"10.1001/jamaoncol.2025.5376","title":"Enhancing Clinical Cancer Research Through Sharing of Data and Biospecimens","year":2025,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vector Institute; Structural Genomics Consortium; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Data sharing; Clinical trial; Quality (philosophy); MEDLINE; Patient data; Stakeholder; Data quality; Stakeholder engagement","score_opus":0.13940819094857965,"score_gpt":0.5028676831765788,"score_spread":0.36345949222799917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417474102","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799872,0.0061870366,0.0007814849,0.002336103,0.00047927012,0.00016454693,0.00012001635,0.000003988509,0.009940367],"genre_scores_gemma":[0.9798543,0.014255244,0.0034571139,0.0010392597,0.0006062596,0.000018824096,0.00008120966,0.000011278385,0.00067649566],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99884665,0.000084526364,0.0003249284,0.00046354518,0.00006832617,0.00021199587],"domain_scores_gemma":[0.9988494,0.00027372947,0.000072021285,0.0006173154,0.00014634867,0.00004120817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010688651,0.000070710565,0.0002031307,0.00004063613,0.000064366744,0.000017343482,0.00040871202,0.0002461988,0.000022696899],"category_scores_gemma":[0.00054147304,0.00007051953,0.00002930907,0.00011459576,0.00025684762,0.0000051196566,0.0015512963,0.00020040823,0.0000019973388],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006647072,0.0003936356,0.07827271,0.00016499416,0.0003874337,0.000019589565,0.0002640032,0.000018605624,0.6183212,0.011060693,0.106491536,0.1839409],"study_design_scores_gemma":[0.0013049832,0.00048858474,0.009090166,0.00005842464,0.000039042738,0.0000054583397,0.00024916226,0.00012109881,0.10212694,0.0017877027,0.88461274,0.00011569913],"about_ca_topic_score_codex":0.00040403122,"about_ca_topic_score_gemma":0.0020193541,"teacher_disagreement_score":0.7781212,"about_ca_system_score_codex":0.000036650206,"about_ca_system_score_gemma":0.0004924278,"threshold_uncertainty_score":0.2875703},"labels":[],"label_agreement":null}]}